0001213900-14-003276.txt : 20140515 0001213900-14-003276.hdr.sgml : 20140515 20140515060621 ACCESSION NUMBER: 0001213900-14-003276 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20140331 FILED AS OF DATE: 20140515 DATE AS OF CHANGE: 20140515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Arista Power, Inc. CENTRAL INDEX KEY: 0001424640 STANDARD INDUSTRIAL CLASSIFICATION: ENGINES & TURBINES [3510] IRS NUMBER: 000000000 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-53510 FILM NUMBER: 14843625 BUSINESS ADDRESS: STREET 1: 1999 MOUNT READ BLVD CITY: ROCHESTER STATE: NY ZIP: 14615 BUSINESS PHONE: 585-243-4040 MAIL ADDRESS: STREET 1: 1999 MOUNT READ BLVD CITY: ROCHESTER STATE: NY ZIP: 14615 FORMER COMPANY: FORMER CONFORMED NAME: WindTamer Corp DATE OF NAME CHANGE: 20081126 FORMER COMPANY: FORMER CONFORMED NAME: Future Energy Solutions Inc DATE OF NAME CHANGE: 20080123 10-Q 1 f10q0314_aristapowerinc.htm QUARTERLY REPORT f10q0314_aristapowerinc.htm


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 10-Q
 
x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the quarterly period ended March 31, 2014
 
OR
 
o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number: 001-53510
 
 ARISTA POWER, INC.
(Exact name of Registrant as specified in its charter)

New York
 
16-1610794
(State or other jurisdiction of incorporation or organization)
 
(I.R.S. Employer Identification No.)
     
1999 Mount Read Blvd
   
Rochester, New York
 
14615
(Address of principal executive offices)
 
(Zip Code)
 
(585) 243-4040
(Registrant's telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨
 
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant has been required to submit and post such files). Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer    ¨
Accelerated filer                       ¨
   
Non-accelerated filer      ¨ (Do not check if a smaller reporting company)
Smaller reporting company     x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

As of May 5, 2014 the Registrant had outstanding 19,938,694 shares common stock, $0.002 par value.
 


 
 

 
 
ARISTA POWER INC.
TABLE OF CONTENTS
 
PART I. FINANCIAL INFORMATION
 
   
Item 1.
Financial Statements
  1
     
 
Unaudited Condensed Balance Sheets as of  March 31, 2014 and December 31, 2013
  1
     
 
Unaudited Condensed Statements of Operations for the Three Months Ended March 31, 2014 and 2013
  2
     
 
Unaudited Condensed Statements of Cash Flows for the Three Months Ended March 31, 2014 and 2013
  3
     
 
Unaudited Statement of Stockholders' Deficit through  March 31, 2014
  4
     
 
Notes to Unaudited Condensed Financial Statements
  5
     
Item 2.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
14
     
Item 4. 
Controls and Procedures
  18
     
PART II. OTHER INFORMATION
 
     
Item 1.
Legal Proceedings
18
     
Item 1A.
Risk Factors
18
     
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds
18
     
Item 3.
Quantitative and Qualitative Disclosure about Market Risk
19
     
Item 4.
Mine Safety Disclosures
19
     
Item 5.
Other Information
19
     
Item 6.
Exhibits
19
     
Signatures
20
     
Exhibits
 
 
 
 

 
 
PART I – FINANCIAL INFORMATION

Item 1. Financial Statements and Notes
 
ARISTA POWER, INC.
Balance Sheets (Unaudited)
 
   
March 31,
   
December 31,
 
   
2014
   
2013
 
ASSETS
Current assets
           
Cash
 
$
1,273,843
   
$
297,385
 
Accounts Receivable (less allowance for doubtful accounts of $0 at March 31, 2014 and December 31, 2013)
   
41,465
     
265,245
 
Prepaid expenses and other current assets
   
153,988
     
232,570
 
Inventory
   
496,313
     
496,313
 
Deferred debt discount
   
820,750
     
820,750
 
Total current assets
   
2,786,359
     
2,112,263
 
                 
Other assets
   
161,356
     
172,362
 
                 
Intangible assets, net
   
24,802
     
25,305
 
                 
Property and equipment, net
   
56,975
     
69,555
 
                 
Total assets
 
$
3,029,492
   
$
2,379,485
 
                 
Current liabilities
               
Accounts payable
 
$
1,018,776
   
$
1,175,221
 
Borrowings under line of credit, net of debt discount
   
769,784
     
684,994
 
Customer deposits
   
20,850
     
19,000
 
Accrued payroll
   
98,619
     
146.465
 
Deferred revenue
   
61,217
     
63,311
 
Accrued warranty costs
   
140,074
     
140,074
 
Accrued liabilities
   
451,316
     
496,011
 
Accrued loss contract
   
495,369
     
519,092
 
Derivative liabilities, short term
   
0
     
13,200
 
Current portion of long term debt
   
11,193
     
11,782
 
Total current liabilities
   
3,067,198
     
3,269,150
 
                 
Long term liabilities
               
Long term debt
   
14,612
     
16,169
 
Derivative liabilities
   
3,917,772
     
762,396
 
Total long term liabilities
   
3,932,384
     
778,565
 
Total liabilities
   
6,999,582
     
4,047,715
 
                 
Stockholders' (deficit)
               
Preferred stock, 5,000,000 shares authorized, $0.002 par value; 1,500 and 0 issued and outstanding at March 31, 2014 or December 31, 2013
   
3
     
0
 
Common stock, 500,000,000 shares authorized, $0.002 par value; 19,498,694 and 17,993,694 shares issued and outstanding at March 31, 2014 and December 31, 2013, respectively
   
38,497
     
35,987
 
Additional paid-in capital
   
23,778,389
     
25,330,474
 
Deficit accumulated
   
(27,786,979
)
   
(27,034,691
)
Total stockholders' (deficit)
   
(3,970,090
   
(1,668,230
)
                 
Total liabilities and stockholders' deficit
 
$
3,029,492
   
$
2,379,485
 
 
The accompanying notes are an integral part of the financial statements.
 
 
1

 
 
ARISTA POWER, INC.
Statements of Operations (Unaudited)
 
   
Three Months
   
Three Months
 
   
Ended
March 31, 2014
   
Ended
March 31, 2013
 
             
Sales
 
$
129,870
   
$
108,644
 
Cost of Goods Sold
   
198,226
     
197,233
 
Gross Loss
   
(68,356
)
   
(88,589
)
Operating Expenses:
               
Research and development expenses
   
22,517
     
126,538
 
Selling, general and administrative expenses
   
425,545
     
734,130
 
Total expenses
   
448,062
     
860,668
 
Loss from operations
   
(516,418
)
   
(949,257
)
Non-operating revenue/(expense)
               
Interest expense
   
(112,345
)
   
(224,820
)
Unrealized gain/(loss) on change in fair value of derivative liabilities
   
(121,650
   
71,400
 
Net loss before income taxes
   
(750,413
)
   
(1,102,677
)
Income taxes
   
1,875
     
500
 
Net loss
 
$
(752,288
)
 
$
(1,103,177
)
Net loss per common share - basic and diluted
 
$
(.04
)
 
$
(.09
)
Weighted average number of common shares outstanding - basic and diluted
   
18,495,360
     
12,676,895
 
 
The accompanying notes are an integral part of the financial statements.
 
 
2

 
 
ARISTA POWER, INC.
Statements of Cash Flows (Unaudited)
 
   
Three Months Ended
March 31, 2014
   
Three Months Ended
March 31, 2013
 
             
Operating activities
           
Net loss
  $ (752,288 )   $ (1,103,177 )
Adjustments to reconcile net loss to net cash used in operating activities:
               
Amortization and depreciation expense
    13,084       18,140  
Stock-based compensation
    70,954       363,369  
Amortization of prepaid warrants for rent, non-cash
    11,006       7,337  
Amortization of prepaid warrants for consulting, non-cash
    95,353       0  
Stock issued for rent and services
    0       100,488  
Amortization of debt discount
    84,790       199,852  
Impairment of intangible assets
    0       3,396  
Change in derivative liability
    121,650       (71,400 )
Changes in operating assets and liabilities:
               
(Increase) in prepaid expenses and other current assets
    (16,772 )     (121,647 )
Decrease in trade accounts receivable
    223,780       365,891  
Decrease in inventory
    0       43,188  
Increase in customer deposits
    1,850       18,484  
(Decrease) in deferred revenue
    (2,094 )     (43,618 )
(Decrease) in accrued loss contract
    (23,723     0  
(Decrease) in trade accounts payable and accrued liabilities
    (248,986 )     (69,494 )
Net cash provided by/(used in) operating activities
    (421,396 )     (289,191 )
                 
Financing activities
               
Proceeds from issuance of preferred stock
    1,500,000       0  
Stock offering costs paid
    (100,000     0  
Borrowings on line of credit
    0       270,0000  
Payments on debt
    (2,146 )     (2,863 )
Net cash provided by financing activities
    1,397,854       67,137  
                 
Increase/(decrease) in cash
    976,458       (22,054 )
                 
Cash – beginning of period
    297,385       78,253  
                 
Cash – end of period
  $ 1,273,843     $ 56,199  
                 
Supplemental Information:
               
Income Taxes Paid/(Tax credits received)
  $ 1,875     $ 500  
Interest Paid
  $ 236     $ 1,511  
Non-cash investing and financing activities:
               
Warrant derivative liability incurred with preferred stock offering
  $ 3,020,526     $ 0  
Preferred stock
  $ (2,868,750 )   $ 0  
Additional warrants
  $ (151,776 )   $ 0  
Stock issued for accrued expenses
  $ 0     $ 157,903  
Application of deferred debt discount
  $ 0     $ 270,000  
Warrants issued for prepaid rent
  $ 0     $ 256,800  
 
 
The accompanying notes are an integral part of the financial statements.
 
 
3

 
 
ARISTA POWER, INC.
Statement of Stockholders’ (Deficit)
(Unaudited)
 
   
Number of Shares
   
Par Value
   
Additional
Paid-In
   
Accumulated
   
Total
Stockholders'
 
   
Common
   
Preferred
   
Common
   
Preferred
   
Capital
    Deficit     (Deficit)  
Balance, December 31, 2013
    17,993,694       0     $ 35,987     $ 0     $ 25,330,474     $ (27,034,691 )   $ (1,668,230 )
Issuance of convertible preferred stock for cash
            1,500               3       1,499,997               1,500,000  
Stock offering costs
                                    (100,000 )             (100,000 )
Issuance of warrants with private placement
                                    (2,868,750 )             (2,868,750 )
Issuance of common stock and warrants for antidilution clause
    1,255,000               2,510               (154,286 )             (151,776 )
Stock options and stock compensation
    250,000                               70,954               70,954  
Net loss for quarter
                                            (752,288 )     (752,288 )
Balance, March 31, 2014
    19,498,694       1,500     $ 38,497     $ 3     $ 23,778,389     $ (27,798,979 )   $ (3,970,090 )
 
The accompanying notes are an integral part of the financial statements.
 
 
4

 
 
ARISTA POWER, INC.

Notes to the Financial Statements
Three-Month Period ended March 31, 2014
(Unaudited)

Note 1 – Description of Business and Summary of Significant Accounting Policies

Description of Business

Arista Power, Inc. (the “Company”) was incorporated on March 30, 2001 in the State of New York as Future Energy Solutions, Inc. and in November 2008 changed its name to WindTamer Corporation. In May 2011, the Company changed its name to Arista Power, Inc. The name change more accurately reflects the broadening of the Company’s focus beyond the WindTamer® brand and entry into areas within the energy storage and power management industries.

The Company is a developer, integrator, and supplier of custom-designed power management systems, and a supplier, designer and installer of solar energy systems.  The Company’s patent-pending Power on Demand system utilizes inputs from multiple energy sources including solar, wind, fuel cells, generators, and the grid, in conjunction with a custom-designed battery storage system and a proprietary smart monitoring technology that releases energy at optimal times to reduce electricity costs for large energy users. The Company also designs, sells and installs residential and commercial solar PV systems. 

Basis of Preparation

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q.  Accordingly, they do not include all of the information required by GAAP for complete annual financial statement presentation.

In the opinion of management, all adjustments (consisting only of normal and recurring adjustments) necessary for a fair presentation of the results of operations have been included in the accompanying unaudited condensed financial statements.  Operating results for the three-month period ended March 31, 2014 are not necessarily indicative of the results to be expected for other interim periods or the full fiscal year.  These financial statements should be read in conjunction with the financial statements and accompanying notes contained in the Arista Power Form 10-K for the fiscal year ended December 31, 2013.

Method of Accounting

The accompanying financial statements have been prepared in accordance with GAAP.  Arista Power maintains its books and prepares its financial statements on the accrual basis of accounting.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.

Cash and Cash Equivalents

For financial statement presentation purposes, the Company considers all short-term, highly liquid investments with original maturities of three months or less to be cash and cash equivalents.  The Company maintains its cash and cash equivalents in bank deposit accounts, which at times may exceed federally insured limits.  The Company believes it is not exposed to any significant credit risk as a result of any non-performance by the financial institutions.
 
 
5

 
 
Accounts Receivable

Accounts receivable represents amounts due from customers in the ordinary course of business, based upon invoiced amounts, net of any allowance for doubtful accounts.  We evaluate accounts receivable quarterly on a specific account basis to determine the need to an allowance for doubtful account reserve.  As of March 31, 2014 and December 31, 2013, the allowance for doubtful accounts was $0.

Inventory

Inventory consists primarily of parts and subassemblies for Power on Demand systems, solar photovoltaic (“PV”) systems, and is stated at the lower of cost or market value.  The Company capitalizes applicable direct and indirect costs incurred in the Company’s manufacturing operations to bring its products to a sellable state.  The inventory as of March 31, 2014 consisted of raw materials amounting to $346,014 and work-in-process amounting to $150,299.  Inventory is reviewed quarterly to determine the need for an excess and obsolete inventory reserve.  As of March 31, 2014 and December 31, 2013, no reserve was necessary.

Fixed Assets

Fixed assets are recorded at cost.  Depreciation is on a straight line basis over the shorter of the estimated useful lives or the related lease for leasehold improvements.  Leasehold improvements for space leased on a month-to-month basis are expensed when incurred.  Expenditures for renewals and betterments are capitalized.  Expenditures for minor items, repairs and maintenance are charged to operations as incurred.  Any gain or loss upon sale or retirement due to obsolescence is reflected in the operating results in the period the event takes place.

Intangible Assets

Intangible assets consist of costs associated with the application and acquisition of the Company’s patents.  Patent application costs are capitalized and amortized over the estimated useful life of the patent, which generally approximates its legal life. For the three months ended March 31, 2013, trademark costs totaling $3,396 relating to the Company’s WindTamer® trademark were impaired, while no intangible assets were impaired for the three months ended March 31, 2014.  

Impairment of Long-Lived Assets

Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.  Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future net undiscounted cash flows expected to be generated by the asset, including its ultimate disposition.  If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets.  Fair value is determined based on discounted cash flows or appraised values, depending on the nature of the assets.   For the three months ended March 31, 2014 and 2013, no assets were impaired.
 
Fair Value of Financial Instruments

The carrying amount of cash, accounts receivable, accounts payable and accrued expenses are reasonable estimates of their fair value due to their short maturity.
 
 
6

 
 
Revenue Recognition

Revenue is recognized when all of the following conditions are satisfied:  (1) there is persuasive evidence of an arrangement; (2) the service or product has been provided to the customer; (3) the sale price to be paid by the customer is fixed or determinable; and (4) the collection of the sale price is reasonably assured.  Amounts collected prior to satisfying our revenue recognition policy are reflected as customer deposits.

For research and development contracts, we recognize the revenue using the proportional effort method based upon the relationship of costs incurred to date to the total estimated cost to complete the contract. Cost elements include direct labor, materials, overhead costs and outside contractor costs.  The excess of amounts billed on a milestone basis versus the amounts recorded as revenue on a proportional effort basis is classified as deferred revenue. We provide for any loss that we expect to incur in the agreements when the loss is probable.

The Company uses contract accounting for certain Power on Demand system sales. Due to the limited number of these systems that have been installed to date, revenue is recognized based on the completed contract method whereby revenue and costs are deferred until the contract is completed. For contracts that contain provisions related to proceeds being paid based upon cost savings generated by the system, revenue is recorded as the costs savings are realized by and billed to the customer. If accumulated costs exceed accumulated billings at the reporting date the asset is presented net as costs of uncompleted contracts in excess of related billings. If there is a net liability it is presented as billings on uncompleted contracts in excess of related costs. We provide for any loss that we expect to incur on a contract at the time the loss is probable.

At March 31, 2014, the Company had costs of uncompleted contracts in excess of related billings totaling $143,481 ($0 as of March 31, 2013). This amount was netted with the accrued loss contract on the Company’s balance sheet.

Research and Development Costs

All costs related to research and development are expensed when incurred. Research and development costs consist of expenses associated with the development of the Company’s Power on Demand system and the Mobile Renewable Power Station.  Specifically, these costs consist of labor, materials, and consulting.

Warranty Costs

The Company’s standard warranty on each Power on Demand system, wind turbine, and solar system sold protects against defects in design, material, and workmanship under normal use for varying periods, based upon the product sold.  Several warranties have specific additional terms and conditions.  The Company provides for estimated cost of warranties at the time the revenue is recognized.  Factors that affect the warranty reserve are projected cost of repair and/or replacement, component life cycles, manufacturer’s warranty on component parts, and historical data. These estimates are reviewed quarterly and are updated as new information becomes available. The impact of any change in estimates will be taken into account when analyzing future warranty reserve requirements.
 
Stock-Based Compensation

The Company accounts for stock option awards granted under the Company’s Equity Incentive Plan in accordance with ASC 718. Under ASC 718, compensation expense related to stock-based payments is recorded over the requisite service period based on the grant date fair value of the awards.  Compensation previously recorded for unvested stock options that are forfeited is reversed upon forfeiture.  The Company uses the Black-Scholes option pricing model for determining the estimated fair value for stock-based awards. The Black-Scholes model requires the use of assumptions which determine the fair value of stock-based awards, including the option’s expected term and the price volatility of the underlying stock.

The Company’s accounting policy for equity instruments issued to consultants and vendors in exchange for goods and services follows the provisions of ASC 505-50.  Accordingly, the measurement date for the fair value of the equity instruments issued is determined at the earlier of (i) the date at which a commitment for performance by the consultant or vendor is reached or (ii) the date at which the consultant’s or vendor’s performance is complete. In the case of equity instruments issued to consultants, the fair value of the equity instrument is recognized over the term of the consulting agreement, or over the specified vesting period.

Income Taxes

The Company accounts for income taxes using the asset and liability approach, which requires recognition of deferred tax liabilities and assets for the expected future tax consequences of temporary differences between the carrying amounts and the tax basis of such assets and liabilities.  This method utilizes enacted statutory tax rates in effect for the year in which the temporary differences are expected to reverse and gives immediate effect to changes in income tax rates upon enactment.  Deferred assets are recognized, net of any valuation allowance, for temporary differences and net operating loss and tax credit carry forwards.  Deferred income tax expense represents the change in net deferred assets and liability balances.
 
 
7

 
 
Basic and Diluted Loss Per Share

Basic earnings per share reflect the actual weighted average of shares issued and outstanding during the period.  Diluted earnings per share are computed including the number of additional shares that would have been outstanding if dilutive potential shares had been issued.  In a loss period, the calculation for basic and diluted earnings per share is considered to be the same, as the impact of potentially issued common shares would be anti-dilutive.

As of March 31, 2014, there were 1,500 shares of Preferred Stock, convertible into 7,500,000 shares of common stock, 1,430,608 stock options and 18,933,267 warrants outstanding which, upon exercise, could dilute future earnings per share.

Reclassifications

Certain prior year amounts have been reclassified to conform to the current year presentation.
 
Note 2 - Going Concern

The financial statements have been prepared assuming that the Company will continue as a going concern.  Since its formation, the Company utilized funds generated from private placement offerings and debt to fund its product development and operations and has incurred a cumulative net loss of $27,786,979 as of March 31, 2014.  The recurring losses from operations and current liquidity raise substantial doubt about the Company’s ability to continue as a going concern.  Continuation of the Company is dependent on achieving sufficiently profitable operations and obtaining additional financing.

Note 3 – Debt

On September 4, 2012, the Company entered into an unsecured loan agreement with TMK-ENT, Inc. that provided for a $500,000 working capital revolving line of credit.  Advances under the line of credit bear interest at 10% per year, payable annually. On November 13, 2012, the Company amended its loan agreement to increase the revolving line of credit agreement from $500,000 to $750,000, and on December 21, 2012 amended its loan agreement to increase the revolving credit agreement for $750,000 to $1,250,000.  The note matures on December 21, 2014. Borrowings under the line of credit amount to $1,018,500 as of March 31, 2014 and December 31, 2013. In conjunction with the line of credit facility, the Company issued 1,250,000 warrants to purchase the Company’s common stock at varying prices from $1.38 to $1.62 per share. The warrants vest one year from issuance and have a ten year term. The fair market value of the warrants at grant date was determined utilizing the Black Scholes option pricing model and amounted to $1,839,250. The difference between the fair market value of the warrants and draws on the line of credit is $820,750 as of March 31, 2014 and December 31, 2013, which is recorded as deferred debt discount.  The deferred debt discount will be recognized and recorded as debt discount as the Company continues to borrow against the line of credit. Debt discount costs will be recognized as the Company draws down the available line of credit, and will be amortized over the remaining term of the loan. As a result of the amortization of the debt discount, the Company expensed $84,790 and $199,852, respectively, for the three months ended March 31, 2014 and 2013.

Annual maturities of debt are as follows:
 
2014 (includes TMK-ENT, Inc. line of credit repayment)
 
$
1,028,136
 
2015
 
$
9,540
 
2016
 
$
6,629
 
 
 
8

 
 
Note 4 – Stockholders’ Equity

On March 31, 2014, the Company sold, pursuant to a securities purchase agreement, an aggregate of 1,500 shares of Series A Convertible Preferred Stock, with a stated value of $1,500,000 that are convertible into shares of the Company’s common stock at a conversion price of $0.20 in stated value per share (7,500,000 shares of common stock), and five-year warrants, which vested in full upon issuance, to purchase up to 11,250,000 additional shares of common stock at a purchase price of $0.25 per share to 8 institutional investors. Stock offering costs for the private placement amounted to $100,000. Each share of Preferred Stock is entitled to cash interest payments of 9% of the stated value per year, payable quarterly. The Preferred Stock is voluntarily and mandatorily convertible into shares of common stock pursuant to the provisions of the securities purchase agreement, with any shares of Preferred Stock outstanding on March 31, 2017 automatically converting into common stock. The investors received rights of first refusal and rights of participation in future financings of the Company until March 31, 2015. In addition, the investors received most favored nation protections on the terms and conditions of the warrants and preferred stock so long as such securities remain outstanding. Additionally, until September 30, 2015, each investor has the right to invest an amount equal to the amount invested by such investor in the above-referenced transaction in preferred stock of Arista Power on substantially similar terms. The Preferred Stock and warrants have customary anti-dilution protections and registration rights including a “full ratchet” anti-dilution adjustment provision. The warrants associated with this transaction were valued at their date of issue utilizing the Black-Scholes option pricing model, which amounted to $2,868,750.  The difference between the warrants valuation of $2,878,750 and the net proceeds received by the Company of $1,400,000 results in a deemed dividend of $1,468,750 , which has been charged to additional paid-in-capital, as the Company has no retained earnings from which to declare a dividend.
  
On March 31, 2014, in conjunction with the full ratchet and anti-dilution provisions of the July and August 2013 private placement of common stock, shareholders were awarded an additional 1,255,000 shares of common stock and 612,000 warrants to purchase common stock for $0.25 per share, and the exercise price for the 3,060,000 warrants outstanding that were associated with this transaction were reset to $0.25 per warrant.

Note 5 – Stock Based Compensation

The Company has established the 2008 Equity Incentive Plan, which is a shareholder-approved plan that permits the granting of stock options and restricted stock to employees, directors and consultants.   The 2008 Equity Incentive Plan provides for the issuance of up to 1,550,000 shares of common stock of which 50,000 shares are available for grant as Incentive Stock Options.  The exercise price for options awarded is no less than 100% of the fair market value of the common stock on the day of grant.  The options generally vest either immediately on the date of grant or 1 to 3 years from the date of grant.  

For the three months ended March 31, 2014, the Company recorded compensation costs for options and warrants of $70,954, as compared to $363,369 for the three months ended March 31, 2013. For the three months ended March 31, 2013, compensation costs relating to the issuance of options and warrants amounted to $287,171 and the Company recorded an expense of $76,198 associated with the repricing of options and warrants held by a consultant of the Company, while for the three months ended March 31, 2014, there was no expense associated with the repricing of options or warrants.
 
 
9

 
 
The Company has valued the options at their date of grant utilizing the Black Scholes option pricing model.  Prior to the fourth quarter of 2009, there was not a public market for the Company shares.  Accordingly, the fair value of the underlying shares was determined based on recent transactions by the Company to sell shares to third parties and other factors determined by management to be relevant to the valuation of such shares.  Beginning in the fourth quarter of 2009, the quoted price for the Company’s shares on the OTCBB was used to value the underlying shares.  Expected volatility is based upon a weighted average historical volatility of peer companies operating in a similar industry.  The risk-free interest rate is based on the implied yield available on U.S. Treasury issues with an equivalent term approximating the expected life of the options depending on the date of the grant and expected life of the options.  The expected life of options used was based on the contractual life of the option granted.  The Company determined the expected dividend rate based on the assumption and expectation that earnings generated from operations are not expected to be adequate to allow for the payment of dividends in the near future.  The following weighted-average assumptions were utilized in the fair value calculations for options granted:
 
   
Three Months Ended
   
Three Months Ended
 
   
March  31,
2014
   
March 31,
2013
 
             
Expected dividend yield
   
0
%
   
0
%
Expected stock price volatility
   
112
%
   
108
%
Risk-free interest rate
   
3.63
%
   
2.60-2.68
%
Expected life of options
 
.14-9.78 years
   
.47-9.78 years
 
 
The following table summarizes the status of the Company’s aggregate stock options granted:

   
Number of Shares Remaining Options
   
Weighted Average
Exercise Price
 
Weighted-Average Remaining
Contractual Term
 
Aggregate
Intrinsic Value
 
                     
Outstanding at January 1, 2014
   
1,386,108
   
$
.61
         
Options granted during 2014
   
115,000
   
$
.23
         
Options cancelled or expired during 2014
   
(70,500)
     
.75
         
Outstanding at March 31, 2014
   
1,430,608
   
$
.52
 
7.8 years
 
$
26,450
 
Exercisable at March 31, 2014
   
772,308
   
$
.64
 
6.4 years
 
$
26,450
 
   
For the three months ended March 31, 2014, the Company recorded compensation costs for options granted under the plan of $65,992, as compared to $160,751 for the three months ended March 31, 2013. Stock option grants amounted to 115,000 for the three months ended March 31, 2014 (135,000 for the three months ended March 31, 2013) while 160,000 options vested during that period (141,650 options vested for the three months ended March 31, 2013). There were 70,500 options cancelled or expired for the three months ended March 31, 2014, while no options were cancelled for the three months ended March 31, 2013. No options were exercised for the three months ended March 31, 2014 or March 31, 2013.

The weighted average fair value of options granted during the three months ended March 31, 2014 was $.23, compared to $1.13 for the three months ended March 31, 2013. 

For the three months ended March 31, 2013, the Company recorded expenses totaling $13,575 associated with the repricing of 25,000 options awarded to a consultant (now an employee) of the Company. No such expense was recorded for the three months ended March 31, 2014.
  
On December 13, 2010, the Board of Directors approved a restricted stock grant award to certain employees in lieu of future salary cash payments.  The employees forfeited salary over a twelve-week period to purchase common shares, which were valued at fair market value as of the date of grant.  The Compensation Committee of the Company’s Board of Directors have approved a change in the vesting date for restricted stock held by certain employees from April 1, 2011 to April 1, 2015. A total of 55,969 shares vested on April 1, 2011, and the remaining 169,368 shares are scheduled to vest on April 1, 2015.

On March 31, 2014, Adeeb Saba was named Chief Operating Officer and the Compensation Committee awarded him 250,000 shares of restricted stock, which will vest one half each on the first and second anniversary of the award. Compensation costs associated with this award amount to $72,500 and will be recognized over the vesting period of the stock.
 
 
10

 
 
The following table summarizes the status of the Company’s restricted share awards:
 
 
Restricted Shares
 
Number of
Restricted Shares
   
Weighted Average
Fair Value at
Grant Date
 
Non-vested at  March 31, 2014
   
118,378
   
$
2.80
 
Awarded during 2014
   
250,000
     
.29
 
Non-vested at March 31, 2014
   
419,368
   
$
1.10
 
 
There was no expense associated with this restricted stock grant for the three months ended March 31, 2014 and 2013. 
 
Note 6 – Warrants
 
The Company has valued warrants at their date of issue utilizing the Black-Scholes option pricing model.  The risk-free interest rate is based on the implied yield available on U.S. Treasury issues with an equivalent term approximating the expected life of the warrants depending on the date of the issue and their expected life.  The expected life of warrants used was based on the term of the warrant.  The Company determined the expected dividend rate based on the assumption and expectation that earnings generated from operations are not expected to be adequate to allow for the payment of dividends in the near future.  The following weighted-average assumptions were utilized in the fair value calculations for warrants granted:
 
   
Three Months Ended
   
Three Months Ended
 
   
March 31, 2014
   
March 31,2013
 
Expected dividend yield
   
0
%
   
0
%
Expected stock price volatility
   
134
%
   
93-108
%
Risk-free interest rate
   
1.73-1.75
%
   
.14–2.60
%
Expected life of warrants
 
4.1-8.8 years
   
.9-9.8 years
 

The following table summarizes the status of the Company’s warrants granted:
 
   
Number of Shares Remaining Warrants
   
Weighted Average
Exercise Price
 
Weighted-Average Remaining
Contractual Term
 
Aggregate
Intrinsic Value
 
Outstanding at January 1, 2014
   
7,671,267
   
$
1.51
         
Warrants granted during 2014
   
11,862,000
   
$
.25
         
Warrants expired during 2014
   
(600,000)
     
.25
         
Outstanding at March 31,2014
   
18,933,267
   
$
.78
 
5.3 years
 
$
0
 
Exercisable at March 31,2014
   
18,139,250
   
$
.76
 
5.6 years
 
$
0
 

The weighted average fair value of warrants issued during three months ended March 31, 2014 and 2013 was $.25 and $.73, respectively.  During the three months ended March 31, 2014, 11,878,000 warrants vested (646,375 vested for the three months ended March 31, 2013), and 600,000 warrants expired for the three months ended March 31, 2014. No options expired or were cancelled for the three months ended March 31, 2013.

For the three months ended March 31, 2014 and 2013, respectively, the Company recorded compensation costs of $4,962 and $126,420 for warrants issued to a consultant (now an employee) of the Company.  The warrants have a ten year life, a $1.20 exercise price, and vest from six months to three years from grant date.

For the three months ended March 31, 2013, the Company recorded expenses totaling $62,623 associated with the repricing of 423,125 outstanding warrants awarded to a consultant (now an employee) of the Company.  No such expense was recorded for the three months ended March 31, 2014.
 
 
11

 
 
Note 7 – Derivative Liabilities

Certain warrants issued by the Company do not have fixed settlement provisions because their exercise prices may be lowered if the Company issues securities at lower prices in the future, are classified as derivative liabilities, and are revalued at each reporting date. These warrants include (1) warrants issued to 1999 Mt RB, LLC in conjunction with our lease modification on February 4, 2013, which expired on February 4, 2014 (2) warrants issued in conjunction with the Company’s strategic advisory agreement with Sunrise Financial Group, Inc. on May 21, 2013 and (3) warrants issued in conjunction with the Company’s private placements on July 31, 2013, August 6, 2013 and March 31, 2014. The reset provisions protect the warrant holders from the potential dilution associated with future financings.
 
The Company has valued warrants at their date of issue utilizing the Black-Scholes option pricing model. Expected volatility is based upon a weighted average historical volatility of peer companies operating in a similar industry, or if applicable based upon the term of the warrant, based upon the Company’s historical volatility. The risk-free interest rate is based on the implied yield available on U.S. Treasury issues with an equivalent term approximating the expected life of the warrants depending on the date of the issue and their expected life. The expected life of warrants used was based on the term of the warrant. The Company determined the expected dividend rate based on the assumption and expectation that earnings generated from operations are not expected to be adequate to allow for the payment of dividends in the near future. The following weighted-average assumptions were utilized in the fair value calculations for warrants granted and subsequent revaluation:
 
 
Three Months Ended
 
Three Months Ended
 
 
March 31, 2014
 
March 31, 2013
 
Expected dividend yield
0%
   
0
%
Expected stock price volatility
134%
   
90-93
%
Risk-free interest rate
1.75%
   
.14
%
Expected life of warrants
4.1-5.0 years
 
.8 years
 
Number of warrants
15,562,351
   
600,000
 
Fair value of warrants
$3,917,772
 
$
185,400
 

The fair value of these warrant liabilities was $3,917,772 at March 31, 2014. The change in fair value for the three months ended March 31, 2014 was $121,650 and is reported in our statement of operations as an unrealized loss on the change in fair value of the derivative liabilities. For the three months ended March 31, 2013, we recorded an unrealized gain on the change in fair value of the derivative liabilities totaling $71,400. The fair value of the derivative liabilities are re-measured at the end of every reporting period and upon the exercise of the warrant.

Fair Value Measurement

Valuation Hierarchy
ASC 820, “Fair Value Measurements and Disclosures,” establishes a valuation hierarchy for disclosure of the inputs to valuation used to measure fair value. This hierarchy prioritizes the inputs into three broad levels as follows. Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs are quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly or indirectly through market corroboration, for substantially the full term of the financial instrument. Level 3 inputs are unobservable inputs based on the Company’s own assumptions used to measure assets and liabilities at fair value. A financial asset or liability’s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement.

The following table provides the liabilities carried at fair value measured on a recurring basis as of March 31, 2014:
 
         
Fair Value Measurements at March 31,2014
 
   
Total
Carrying
Value at
March 31, 2014,
   
Quoted
prices in
active
markets
(Level 1)
   
Significant
other
observable
inputs
(Level 2)
   
Significant
unobservable
inputs
(Level 3)
 
Derivative liabilities
 
$
3,917,722
   
$
-
   
$
-
   
$
3,917,722
 

 
12

 
 
The derivative liabilities are measured at fair value using quoted market prices and estimated volatility factors, and are classified within Level 3 of the valuation hierarchy.

The following table sets forth a summary of the changes in the fair value of our Level 3 financial liabilities that are measured at fair value on a recurring basis:
 
   
Year ended
December 31,
2013
 
Beginning balance January 1, 2014
 
$
775,596
 
Issuance of derivative financial instruments in 2014
   
3,020,526
 
Net unrealized (gain) loss on derivative financial instruments
   
121,650
 
Ending balance as of March 31,2014
 
$
3,917,722
 
 
Note 8- Subsequent Events
 
In April 2014, we issued 440,000 shares of our common stock to one of our outside attorneys (Schwell Wimpfheimer & Associates, LLP) for legal services rendered in satisfaction of a $110,000 account payable to such law firm.
 
In April 2014, expenses totaling approximately $200,000 that were recorded by the Company as accounts payable as of March 31, 2014 were approved to be paid by the Company’s director and officers insurance policy, with such payments expected in May 2014.

Note 9- Recent Accounting Pronouncements

The Company has considered recent accounting pronouncements and believes that these recent pronouncements will not have a material effect on the Company’s financial statements.
 
 
13

 
 
Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion should be read in conjunction with the unaudited historical financial statements and the related notes and the other financial information included elsewhere  in  this report and in the Company’s annual report on Form 10-K filed with the Securities and Exchange Commission on March 31, 2014. This discussion contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of any number of factors, including those set forth under “Information Concerning Forward-Looking Statements” and under other captions contained elsewhere in this report.

Company Overview

During 2013, we continued our product development, with most of such efforts directed at our Power on Demand system and Mobile Renewable Power Station. We expect to continue further development and product enhancement on our products in 2014.

In May 2013, we entered into an Agreement with City Lights at Queens Landing, Inc. pursuant to which City Lights has agreed to purchase a Power on Demand system for installation and use at City Lights’ 43-story, 525-unit, cooperative building located in Long Island City, New York. The City Lights Building is managed by Rose Associates, Inc., a New York-based full service real estate firm. Separately City Lights intends to purchase and have installed a combined heating and power co-generation system at the City Lights Building. The Power on Demand system will consist of a micro-grid that will include the integration of the newly installed solar PV, the newly installed CHP co-generation system, energy storage and power distribution.  This represents the Company’s first sale of a Power on Demand system to be installed in the New York City area.  We expect the Power on Demand system to be installed in the second quarter of 2014.

In 2012, we were awarded $1.8 million in U.S. Army contracts to be the prime contractor to complete Phase One and Phase Two activities to develop an Intelligent Micro-Grid for the Renewable Energy for Distributed Under-Supplied Command Environments (“REDUCE”) program under the guidance of the U.S. Army Communications-Electronics Research, Development and Engineering Center. In the latter half of September 2012, we completed Phase One activities. Work commenced on Phase Two late in 2012, which continued into 2013. We expect to complete Phase Two of the project in the second quarter of 2014. In September 2013,  the Company was awarded a single vendor contract valued at $625,000 to continue development under this contract, which will follow the completion of Phase Two in the second quarter of 2014. The Company believes that the micro-grid that it is developing for the U.S. Army will complement the development of the products that it will sell to commercial, military and governmental customers.

In November 2013, we partnered with EaglePicher Technologies by integrating the EPT’s Power Pyramid™ system into the Power on Demand system to be installed at the City Lights building in Long Island City, NY.
 
As of May 6, 2014, the Company’s current order backlog was approximately $1.7 million which consists of orders for several Power on Demand systems, multiple solar PV systems, and two government contracts. A portion of this backlog will be recognized as an installment sale based upon contract provisions relating to system generated cost savings.

 
14

 
 
Results of Operations

Results of Operations for Quarter Ended March 31, 2014 Compared to Quarter Ended March 31, 2013.

Revenues

During the quarter ended March 31, 2014, we reported revenues of $130,000 as compared with revenues of $109,000 for the quarter ending March 31, 2013.  We have received deposits from customers totaling approximately $21,000 as of March 31, 2014. We expect to realize sales associated with these deposits during the next several quarters, as we obtain permits and zoning approvals from customers’ town officials and NYSEDRA for solar PV installations, complete site assessments, and complete installations and inter-connection agreements, although there can be no assurance that we will be able to meet this schedule.
 
We continue to expand our selling efforts where by coupling our power management systems with renewable solar and related incentive packages, we can provide our customers with an attractive return on investment.

Gross Loss

For the quarter ended March 31, 2014, gross loss amounted to $68,000 as compared to $89,000 for the quarter ended March 31, 2013.  The gross loss is primarily attributable to the costs associated with maintaining an operations staff, responsible for not only solar products, and Power on Demand systems, but also for troubleshooting customer issues, inventory management, and maintaining day to day operations. The reduction of gross loss relates to a non-recurring sales returns reserve recorded for the quarter ending March 31, 2013.
  
Research and Development

Research and development costs for the quarter ended March 31, 2014 totaled $23,000 as compared to $127,000 for the quarter ended March 31, 2013. This decrease results from lower salaries and related expenses, as well as an increase in the allocation of costs to cost of goods sold relating to the REDUCE program.
 
Selling, General and Administrative

Selling, general and administrative expenses amounted to $426,000 for the quarter ended March 31, 2014, as compared to $734,000 for the quarter ended March 31, 2013.  The decrease over the prior year was related primarily to reduced salary and headcount related expenses partially offset by higher consulting and legal expense in 2014 as compared to 2013.

Depreciation and Amortization

Depreciation and amortization charges were $13,000 for the quarter ended March 31, 2014, compared to $18,000 during the quarter ended March 31, 2013 due to a lower depreciable asset base in 2014. The Company also impaired costs totaling $3,000 related to the WindTamer™ trademark for the quarter ended March 31, 2013.
 
 
15

 
 
Other Income (Expense)

Interest expense for the quarter ended March 31, 2014 was $112,000, as compared to an expense of $225,000 for the quarter ended March 31, 2013. The decrease is due to the amortization of deferred debt discount relating to the Company’s line of credit over an extended period as of March 31, 2014 due to the deferral of the loan due date in May 2013 to December 2014 from December 2013.

In 2013, we recorded derivative liabilities associated with the issuance of warrants for (1) a lease modification with our existing landlord, (2) an advisory agreement with Sunrise Financial Group, LLC and (3) in conjunction with our private placement funding which occurred during the third quarter of 2013 and in the first quarter of 2014. The warrants do not have a fixed settlement provision because their exercise prices may be lowered if the Company issues securities at lower prices in the future. Accordingly, the Company revalues these derivative liabilities each quarter, and the financial statements reflect a loss on the revaluation of the derivative liabilities for the first quarter of 2014 of $122,000, as compared to a gain of $71,000 for the quarter ended March 31, 2013.

Statutory income tax payments of $1,875 and $500 were made during the quarter ending March 31, 2014 and 2013, respectively.

Net Loss

We incurred net losses of $752,000 and $1,103,000 for the quarter ended March 31, 2014 and 2013, respectively.  Operating losses of amounted to $516,000 and $949,000 for the quarter ended March 31, 2014 and 2013 respectively due to decreased operating expenses for the quarter ended March 31, 2014 as compared to the quarter ended March 31, 2013.  Increases in net loss for the quarter were due to the interest and debt discount amortization amounting to $112,000 and $225,000 relating to our TMK-ENT, Inc. line of credit for the quarter ended March 31, 2014, and 2013, respectively. Additionally, the Company recorded an unrealized loss on the change in fair value of derivative liabilities of $122,000 for the quarter ended March 31, 2014, as compared to an unrealized gain of $71,000 for the quarter ended March 31, 2013.
 
Liquidity and Capital Resources

As of March 31, 2014, our accumulated deficit totaled $28 million.
 
We had a working capital deficit of $281,000 as of March 31, 2014 as compared to working capital deficit of $1,157,000 as of December 31, 2013. The increase in working capital relates to the March 2014 private placement which provided the company working capital of $1.4 million, offset by net loss for the quarter ended March 31, 2014.

On March 31, 2014, the Company sold, pursuant to a securities purchase agreement, an aggregate of 1,500 shares of Series A Convertible Preferred Stock, with a stated value of $1,500,000 that are convertible into shares of the Company’s common stock at a conversion price of $0.20 in stated value per share, and five-year warrants, which vested in full upon issuance, to purchase up to 11,250,000 additional shares of common stock at a purchase price of $0.25 per share to 8 institutional investors. The Company received a total of $1,400,000 in net proceeds from the sales.  Each share of preferred stock is entitled to cash interest payments of 9% of the stated value per year, payable quarterly.  The preferred stock is voluntarily and mandatorily convertible into shares of common stock pursuant to the provisions of the securities purchase agreement, with any shares of preferred stock outstanding on March 31, 2017 automatically converting into common stock.  The investors received rights of first refusal and rights of participation in future financings of the Company until March 31, 2015.  In addition, the investors received “most favored nation” protections on the terms and conditions of the warrants and preferred stock so long as such securities remain outstanding.  Additionally, until September 30, 2015, each investor has the right to invest the amount invested by such investor in the above-referenced transaction in preferred stock of Arista Power on substantially similar terms. The Preferred Stock and warrants have customary anti-dilution protections and registration rights including a “full ratchet” anti-dilution adjustment provision.
 
We believe that we will require additional funding of approximately $1.0 million to satisfy our operating cash needs and our anticipated growth for the next twelve months.
 
Due to the uncertainty of our ability to meet our current operating expenses, in their report on our audited annual financial statements as of and for the years ended December 31, 2013 and 2012, our independent auditors included an explanatory paragraph regarding concerns about our ability to continue as a going concern. Our financial statements contain additional note disclosures describing the circumstances that led to this disclosure by our independent auditors. There is substantial doubt about our ability to continue as a going concern as the continuation and expansion of our business is dependent upon obtaining further financing, successful and sufficient market acceptance of our products, and achieving a profitable level of operations.
 
The issuance of additional equity securities by us may result in a significant dilution in the equity interests of our current shareholders. Obtaining commercial loans, assuming those loans would be available, will increase our liabilities and future cash commitments. There is no assurance that we will be able to obtain further funds required for our continued operations or that additional financing will be available to us when needed or, if available, that it can be obtained on commercially reasonable terms. If we are not able to obtain the additional financing on a timely basis, we will not be able to meet our other obligations as they become due and we will be forced to scale down or perhaps even cease our operations.
 
Operating Activities
 
Our operating activities used net cash of $421,000 for the quarter ended March 31, 2014, as compared to $289,000 for the quarter ended March 31, 2013.  For the quarter ended March 31, 2014, cash used in operations resulted from a net loss of $752,000, reduced by non-cash adjustments of $397,000 consisting primarily of $71,000 of stock based compensation, the amortization of debt discount of $85,000, and a loss in fair value of derivative liabilities of $122,000. Net changes to working capital amounted to $66,000 and were primarily due to decreases in accounts receivable offsetting a decrease in accrued liabilities. For the quarter ended March 31, 2013, cash used in operations resulted from a net loss of $1,103,000, reduced by non-cash expenses of $621,000 for stock based compensation, stock and warrants issued for rent and services of $108,000, and the amortization of debt discount of $200,000.  Net changes to working capital for the quarter ended March 31, 2103 amounted to $193,000 due to a decrease in trade accounts receivable of $366,000, offset by an increase to prepaid expenses of $122,000 and decreases in accrued liabilities and deferred revenue of $44,000 and $69,000 respectively.
 
 
16

 
 
Investing Activities

The Company did not utilize any funds for investing activities for the quarters ended March 31, 2014 and 2013.

Financing Activities

Our financing activities provided $1,398,000 and $267,000 for the quarters ended March 31, 2014 and 2013, respectively. In 2014, the Company raised $1,500,000 in the sale of convertible preferred stock, with offering costs amounting to $100,000.  For the quarter ended March 31, 2013, the Company drew $270,000 from its line of credit. Repayments on long term debt were $2,000 and $3,000, respectively for the quarters ended March 31, 2014 and 2013.

Off-Balance Sheet Arrangements

We have no significant off-balance sheet arrangements that have, or are reasonably likely to have, a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures, or capital resources that is material to shareholders.

Critical Accounting Policies
 
As of March 31, 2014, the Company’s critical accounting policies and estimates have not changed materially from those set forth in the Company’s Annual Report on Form 10-K for the year ended December 31, 2013, filed on March 31, 2014 with the Securities and Exchange Commission.

Information Concerning Forward-Looking Statements

All statements in this Form 10-Q, future filings by the Company with the Securities and Exchange Commission (“Commission”), the Company’s press releases and oral statements by authorized officers of the Company, other than statements of historical facts, that address future activities, events or developments are “forward-looking statements.”

These forward-looking statements include, but are not limited to, statements relating to our anticipated financial performance, business prospects, new developments, new merchandising strategies and similar matters, and/or statements preceded by, followed by or that include the words “believes,” “could,” “expects,” “anticipates,” “estimates,” “intends,” “plans,” “projects,” “seeks,” or similar expressions. We have based these forward-looking statements on certain assumptions and analyses made by us in light of our experience and on our assessment of historical trends, current conditions, expectations, and projections about expected future developments and events, as well as on other factors we believe are appropriate under the circumstances and other information currently available to us. These forward-looking statements are subject to risks, uncertainties and assumptions, including those described under the heading “Risk Factors” in Item 1A of Part I of the Company’s 10-K filed with the Commission, for the fiscal year ended December 31, 2013, that may affect the operations, performance, development and results of our business. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date stated, or if no date is stated, as of the date hereof.
 
Although we believe that the expectations reflected in the forward-looking statements are reasonable, there can be no assurance that such expectations or any of the forward-looking statements will prove to be correct, and actual results could differ materially from those projected or assumed in the forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to inherent risks and uncertainties. All forward-looking statements and reasons why results may differ contained herein are made as of the date hereof, and we assume no obligation to update any such forward-looking statement or reason why actual results might differ. All of the forward-looking statements contained herein are qualified by these cautionary statements.
 
 
17

 
 
Item 3. Quantitative and Qualitative Disclosures about Market Risk

None.
 
Item 4. Controls and Procedures

The Company’s management has established disclosure controls and procedures designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) is recorded, processed, summarized and reported within time periods specified in the SEC rules and forms. Such disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the Company’s management to allow timely decisions regarding required disclosure.

Based on the evaluation of the effectiveness of our disclosure controls and procedures, our Chief Executive Officer and Acting Chief Financial Officer concluded that our disclosure controls and procedures were effective as of March 31, 2014.
 
There can be no assurance, however, that our disclosure controls and procedures will detect or uncover all failures of persons within the Company to disclose material information otherwise required to be set forth in our periodic reports. There are inherent limitations to the effectiveness of any system of disclosure controls and procedures, including the possibility of human error and the circumvention or overriding of the controls and procedures. Accordingly, even effective disclosure controls and procedures can only provide reasonable, not absolute, assurance of achieving their control objectives.

Changes in Internal Control over Financial Reporting
 
There have been no changes in the Company’s internal control over financial reporting that occurred during the three months ended March 31, 2014 that has materially affected, or is likely to materially affect, the Company’s internal control over financial reporting.

Part II – OTHER INFORMATION

Item 1. Legal Proceedings

There were no reportable events during the quarter.

Item 1A. Risk Factors
 
Smaller reporting companies are not required to provide the information required by this item.
 
Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds

On March 31, 2014, the Company sold, pursuant to a securities purchase agreement, an aggregate of 1,500 shares of Series A Convertible Preferred Stock, with a stated value of $1,500,000, that are convertible into shares of the Company’s common stock at a conversion price of $0.20 in stated value per share (7,500,000 shares of common stock), and five-year warrants, which vested in full upon issuance, to purchase up to 11,250,000 additional shares of common stock at a purchase price of $0.25 per share to 8 institutional investors. Stock offering costs for the private placement amounted to $100,000. Each share of preferred stock is entitled to cash interest payments of 9% of the stated value per year, payable quarterly. The preferred stock is voluntarily and mandatorily convertible into shares of common stock pursuant to the provisions of the securities purchase agreement, with any shares of preferred stock outstanding on March 31, 2017 automatically converting into common stock. The investors received rights of first refusal and rights of participation in future financings of the Company until March 31, 2015. In addition, the investors received most favored nation protections on the terms and conditions of the warrants and preferred stock so long as such securities remain outstanding. Additionally, until September 30, 2015, each investor has the right to invest the amount invested by such investor in the above-referenced transaction in preferred stock of Arista Power on substantially similar terms. The Preferred Stock and warrants have customary anti-dilution protections and registration rights including a “full ratchet” anti-dilution adjustment provision.

On March 31, 2014, in conjunction with the full ratchet and anti-dilution provisions of the July and August 2013 private placement of common stock, shareholders were awarded an additional 1,255,000 shares of common stock and 612,000 warrants to purchase common stock for $0.25 per share, and the exercise price for the 3,060,000 warrants outstanding that were associated with this transaction were decreased from $0.30 to $0.25.
 
We registered the resale of the securities sold in the private placement pursuant to a registration statement on form S-1 that was filed with the Securities and Exchange Commission on April 30, 2014 and  was declared effective on May 13, 2014.
 
In April 2014, we issued 440,000 shares of our common stock to one of our outside attorneys (Schwell Wimpfheimer & Associates, LLP) for legal services rendered in satisfaction of a $110,000 account payable to such law firm.
 
 
18

 
 
The terms of sales of unregistered sales of securities by us are described in Item 5 Market for Registrant’s Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities under the captions “Recent Unregistered Sales of Securities”.
 
The securities referenced above were issued in reliance upon the exemption from securities registration afforded by the provisions of Section 4(2) of the Securities Act of 1933, as amended (“Securities Act”), and/or Regulation D, as promulgated by the U.S. Securities and Exchange Commission under the Securities Act, based upon the following: (a) each of the persons to whom the securities were issued (each such person, an “Investor”) confirmed to the Company that it or he is an “accredited investor,” as defined in Rule 501 of Regulation D promulgated under the Securities Act and has such background, education and experience in financial and business matters as to be able to evaluate the merits and risks of an investment in the securities, (b) there was no public offering or general solicitation with respect to the offering of such units, (c) each Investor was provided with certain disclosure materials and all other information requested with respect to the Company, (d) each Investor acknowledged that all securities being acquired were being acquired for investment intent and were “restricted securities” for purposes of the Securities Act, and agreed to transfer such securities only in a transaction registered under the Securities Act or exempt from registration under the Securities Act and (e) a legend has been, or will be, placed on the certificates representing each such security stating that it was restricted and could only be transferred if subsequently registered under the Securities Act or transferred in a transaction exempt from registration under the Securities Act.
 
Item 3.  Defaults Upon Senior Securities

None.

Item 4.  Mine Safety Disclosures

Not Applicable.

Item 5.  Other Information

None

Item 6.
 
(a)
 
Exhibits:
 
 
 
 
 
 
 
31.1
Certification of the Chief Executive Officer Pursuant to Rule 13a-14 or 15d-14 of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
 
 
 
 
 
 
31.2
Certification of the Chief Financial Officer Pursuant to Rule 13a-14 or 15d-14 of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
 
 
 
 
 
 
32.1
Certification Pursuant to 18 U.S.C. Section 1350 by the Chief Executive Officer, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
 
 
 
 
 
32.2
Certification Pursuant to 18 U.S.C. Section 1350 by the Chief Financial Officer, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
 
19

 
 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
ARISTA POWER, INC.
 
 
 
May 15, 2014
 
 
 
By:
/s/ William A. Schmitz
 
 
William A. Schmitz
 
 
President and Chief Executive Officer
 
 
20 

EX-31.1 2 f10q0314ex31i_aristapower.htm CERTIFICATION f10q0314ex31i_aristapower.htm
Exhibit 31.1
 
Certification of Chief Executive Officer
as required by Rule 13a-14 Or 15d-14 of the Securities Exchange Act of 1934, 
 as adopted pursuant to Section 302 of The Sarbanes-Oxley Act of 2002
 
I, William A. Schmitz, certify that:
 
1.      I have reviewed this quarterly report on Form 10-Q of Arista Power, Inc.;
 
2.      Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3.      Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4.      The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
 
5.      The registrant 's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant 's auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
 
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
 
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
 
 
Date:  May 15, 2014
   
 
/s/ William A. Schmitz
 
William A. Schmitz
 
President and Chief Executive Officer
EX-31.2 3 f10q0314ex31ii_aristapower.htm CERTIFICATION f10q0314ex31ii_aristapower.htm
Exhibit 31.2
 
Certification of Chief Financial Officer
as required by Rule 13a-14 Or 15d-14 of the Securities Exchange Act of 1934,
as adopted pursuant to Section 302 of The Sarbanes-Oxley Act of 2002
 
I, Molly Hedges, certify that:
 
1.      I have reviewed this quarterly report on Form 10-Q of Arista Power, Inc.;
 
2.      Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3.      Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4.      The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
 
5.      The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
 
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
 
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
 
 
Date: May 15, 2014
   
 
/s/ Molly Hedges
 
Molly Hedges,
Chief Financial Officer
EX-32.1 4 f10q0314ex32i_aristapower.htm CERTIFICATION f10q0314ex32i_aristapower.htm
Exhibit 32.1
 
Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
 
In connection with the Quarterly Report of Arista Power, Inc. (the “Company”) on Form 10-Q for the quarter ended March 31, 2014 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, William A. Schmitz, as Chief Executive Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 to the best of my knowledge, that:
 
(1)           The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
(2)           The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
 
 
Date:  May 15, 2014
   
 
/s/ William A. Schmitz
 
William A. Schmitz
 
President and Chief Executive Officer
EX-32.2 5 f10q0314ex32ii_aristapower.htm CERTIFICATION f10q0314ex32ii_aristapower.htm
Exhibit 32.2
 
Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
 
In connection with the Quarterly Report of Arista Power, Inc. (the “Company”) on Form 10-Q for the quarter ended March 31, 2014 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Molly Hedges, as Chief Financial Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 to the best of my knowledge, that:
 
(1)           The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
(2)           The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
 
 
Date: May 15, 2014
   
 
/s/ Molly Hedges
 
Molly Hedges
 
Chief Financial Officer
EX-101.INS 6 aspw-20140331.xml XBRL 0001424640 us-gaap:DirectorMember 2011-03-31 2011-04-01 0001424640 2011-12-31 0001424640 2012-09-04 0001424640 2012-09-01 2012-09-04 0001424640 2012-09-30 0001424640 2012-11-13 0001424640 2012-12-21 0001424640 2012-12-18 2012-12-21 0001424640 2012-01-01 2012-12-31 0001424640 2012-12-31 0001424640 us-gaap:CommonStockMember 2012-12-31 0001424640 us-gaap:AdditionalPaidInCapitalMember 2012-12-31 0001424640 us-gaap:RetainedEarningsMember 2012-12-31 0001424640 2013-01-01 2013-03-31 0001424640 us-gaap:DirectorMember 2013-01-01 2013-03-31 0001424640 us-gaap:WarrantMember 2013-01-01 2013-03-31 0001424640 us-gaap:StockOptionMember 2013-01-01 2013-03-31 0001424640 us-gaap:StockOptionsMember 2013-01-01 2013-03-31 0001424640 us-gaap:WarrantMember 2013-01-01 2013-03-31 0001424640 us-gaap:WarrantMember aspw:ConsultantMember 2013-01-01 2013-03-31 0001424640 2013-03-31 0001424640 us-gaap:WarrantMember 2013-03-31 0001424640 us-gaap:WarrantMember 2013-03-31 0001424640 2013-12-31 0001424640 us-gaap:CommonStockMember 2013-12-31 0001424640 us-gaap:AdditionalPaidInCapitalMember 2013-12-31 0001424640 us-gaap:RetainedEarningsMember 2013-12-31 0001424640 us-gaap:WarrantMember 2013-12-31 0001424640 us-gaap:StockOptionsMember 2013-12-31 0001424640 us-gaap:RestrictedStockMember 2013-12-31 0001424640 us-gaap:PreferredStockMember 2013-12-31 0001424640 2014-01-01 2014-03-31 0001424640 us-gaap:DirectorMember 2014-01-01 2014-03-31 0001424640 us-gaap:CommonStockMember 2014-01-01 2014-03-31 0001424640 us-gaap:AdditionalPaidInCapitalMember 2014-01-01 2014-03-31 0001424640 us-gaap:RetainedEarningsMember 2014-01-01 2014-03-31 0001424640 us-gaap:WarrantMember 2014-01-01 2014-03-31 0001424640 us-gaap:StockOptionMember 2014-01-01 2014-03-31 0001424640 us-gaap:StockOptionsMember 2014-01-01 2014-03-31 0001424640 us-gaap:WarrantMember 2014-01-01 2014-03-31 0001424640 us-gaap:WarrantMember aspw:ConsultantMember 2014-01-01 2014-03-31 0001424640 us-gaap:RestrictedStockMember 2014-01-01 2014-03-31 0001424640 us-gaap:PreferredStockMember 2014-01-01 2014-03-31 0001424640 aspw:SecuritiesPurchaseAgreementMember 2014-01-01 2014-03-31 0001424640 us-gaap:StockOptionsMember 2014-01-01 2014-03-31 0001424640 us-gaap:WarrantMember 2014-01-01 2014-03-31 0001424640 us-gaap:PrivatePlacementMember aspw:SecuritiesPurchaseAgreementMember 2014-01-01 2014-03-31 0001424640 us-gaap:ConvertiblePreferredStockMember aspw:SecuritiesPurchaseAgreementMember 2014-01-01 2014-03-31 0001424640 us-gaap:ChiefOperatingOfficerMember 2014-01-01 2014-03-31 0001424640 us-gaap:ConvertiblePreferredStockMember 2014-01-01 2014-03-31 0001424640 2014-03-31 0001424640 us-gaap:CommonStockMember 2014-03-31 0001424640 us-gaap:AdditionalPaidInCapitalMember 2014-03-31 0001424640 us-gaap:RetainedEarningsMember 2014-03-31 0001424640 us-gaap:WarrantMember 2014-03-31 0001424640 us-gaap:StockOptionsMember 2014-03-31 0001424640 us-gaap:WarrantMember 2014-03-31 0001424640 us-gaap:RestrictedStockMember 2014-03-31 0001424640 us-gaap:PreferredStockMember 2014-03-31 0001424640 aspw:SecuritiesPurchaseAgreementMember 2014-03-31 0001424640 us-gaap:FairValueInputsLevel1Member 2014-03-31 0001424640 us-gaap:FairValueInputsLevel2Member 2014-03-31 0001424640 us-gaap:FairValueInputsLevel3Member 2014-03-31 0001424640 us-gaap:ConvertiblePreferredStockMember 2014-03-31 0001424640 us-gaap:SubsequentEventMember 2014-04-30 0001424640 us-gaap:SubsequentEventMember 2014-04-01 2014-04-30 0001424640 2014-05-05 xbrli:shares iso4217:USD iso4217:USDxbrli:shares xbrli:pure Arista Power, Inc. 0001424640 false --12-31 10-Q 2014-03-31 2014 Q1 Smaller Reporting Company 19938694 297385 1273843 265245 41465 232570 153988 496313 496313 820750 820750 2112263 2786359 172362 161356 25305 24802 69555 56975 2379485 3029492 1175221 1018776 684994 769784 19000 20850 146465 98619 63311 61217 140074 140074 496011 451316 519092 495369 13200 0 11782 11193 3269150 3067198 16169 14612 762396 3917772 778565 3932384 4047715 6999582 0 3 35987 38497 25330474 23778389 -27034691 -27786979 24813 24038807 -23761751 -1668230 35987 25330474 -27034691 0 -3970090 38497 23778389 -27798979 3 2379485 3029492 0 0 5000000 5000000 0.002 0.002 0 1500 0 1500 500000000 500000000 0.002 0.002 17993694 19498694 17993694 19498694 108644 129870 197233 198226 -88589 -68356 126538 22517 734130 425545 860668 448062 -949257 -516418 224820 112345 71400 -121650 -1102677 -750413 -500 -1875 -1103177 -752288 -752288 -0.09 -0.04 12676895 18495360 18140 13084 363369 70954 7337 11006 95353 100488 0 199852 84790 3396 0 121647 16772 -365891 -223780 -43188 0 18484 1850 -43618 -2094 0 -23723 -69494 -248986 -289191 -421396 0 1500000 0 -100000 -100000 2700000 0 -2863 -2146 67137 1397854 -22054 976458 371132 55533 78253 56199 297385 1273843 500 1875 1511 236 0 3020526 0 -2868750 0 -151776 157903 0 270000 0 256800 0 12406633 17993694 0 19498694 1500 1500000 1499997 3 1500 -2868750 -2868750 -151776 2510 -154286 1255000 440000 70954 70954 250000 <div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Note 1 &#8211; Description of Business and Summary of Significant Accounting Policies</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Description of Business</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Arista Power, Inc. (the &#8220;Company&#8221;) was incorporated on March 30, 2001 in the State of New York as Future Energy Solutions, Inc. and in November 2008 changed its name to WindTamer Corporation. In May 2011, the Company changed its name to Arista Power, Inc. The name change more accurately reflects the broadening of the Company&#8217;s focus beyond the WindTamer&#174; brand and entry into areas within the energy storage and power management industries.</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The Company is a developer, integrator, and supplier of custom-designed power management systems, and a supplier, designer and installer of solar energy systems.&#160;&#160;The Company&#8217;s patent-pending Power on Demand system utilizes inputs from multiple energy sources including solar, wind, fuel cells, generators, and the grid, in conjunction with a custom-designed battery storage system and a proprietary smart monitoring technology that releases energy at optimal times to reduce electricity costs for large energy users.&#160;The Company also designs, sells and installs residential and commercial solar PV systems.&#160;</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Basis of Preparation</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) for interim financial information and with the instructions to Form 10-Q.&#160;&#160;Accordingly, they do not include all of the information required by GAAP for complete annual financial statement presentation.</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">In the opinion of management, all adjustments (consisting only of normal and recurring adjustments) necessary for a fair presentation of the results of operations have been included in the accompanying unaudited condensed financial statements.&#160;&#160;Operating results for the three-month period ended March 31, 2014 are not necessarily indicative of the results to be expected for other interim periods or the full fiscal year.&#160;&#160;These financial statements should be read in conjunction with the financial statements and accompanying notes contained in the Arista Power Form 10-K for the fiscal year ended December 31, 2013.</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Method of Accounting</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The accompanying financial statements have been prepared in accordance with GAAP.&#160;&#160;Arista Power maintains its books and prepares its financial statements on the accrual basis of accounting.</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Use of Estimates</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.&#160;&#160;Actual results could differ from those estimates.</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Cash and Cash Equivalents</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">For financial statement presentation purposes, the Company considers all short-term, highly liquid investments with original maturities of three months or less to be cash and cash equivalents.&#160;&#160;The Company maintains its cash and cash equivalents in bank deposit accounts, which at times may exceed federally insured limits.&#160; The Company believes it is not exposed to any significant credit risk as a result of any non-performance by the financial institutions.</font></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Accounts Receivable</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Accounts receivable represents amounts due from customers in the ordinary course of business, based upon invoiced amounts, net of any allowance for doubtful accounts.&#160;&#160;We evaluate accounts receivable quarterly on a specific account basis to determine the need to an allowance for doubtful account reserve.&#160;&#160;As of March 31, 2014 and December 31, 2013, the allowance for doubtful accounts&#160;was $0.</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Inventory</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Inventory consists primarily of parts and subassemblies for Power on Demand systems, solar photovoltaic (&#8220;PV&#8221;) systems, and is stated at the lower of cost or market value.&#160;&#160;The Company capitalizes applicable direct and indirect costs incurred in the Company&#8217;s manufacturing operations to bring its products to a sellable state.&#160;&#160;The inventory as of March 31, 2014 consisted of raw materials amounting to $346,014 and work-in-process amounting to $150,299.&#160;&#160;Inventory is reviewed quarterly to determine the need for an excess and obsolete inventory reserve.&#160;&#160;As of March 31, 2014 and December 31, 2013, no reserve was necessary.</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Fixed Assets</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Fixed assets are recorded at cost.&#160;&#160;Depreciation is on a straight line basis over the shorter of the estimated useful lives or the related lease for leasehold improvements.&#160;&#160;Leasehold improvements for space leased on a month-to-month basis are expensed when incurred.&#160;&#160;Expenditures for renewals and betterments are capitalized.&#160;&#160;Expenditures for minor items, repairs and maintenance are charged to operations as incurred.&#160; Any gain or loss upon sale or retirement due to obsolescence is reflected in the operating results in the period the event takes place.</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Intangible Assets</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Intangible assets consist of costs associated with the application and acquisition of the Company&#8217;s patents.&#160;&#160;Patent application costs are capitalized and amortized over the estimated useful life of the patent, which generally approximates its legal life. For the three months ended March 31, 2013, trademark costs totaling $3,396 relating to the Company&#8217;s WindTamer&#174; trademark were impaired, while no intangible assets were impaired for the three months ended March 31, 2014.&#160;&#160;</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Impairment of Long-Lived Assets</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.&#160;&#160;Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future net undiscounted cash flows expected to be generated by the asset, including its ultimate disposition.&#160;&#160;If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets.&#160;&#160;Fair value is determined based on discounted cash flows or appraised values, depending on the nature of the assets.&#160;&#160; For the three months ended March 31, 2014 and 2013, no assets were impaired.</font></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Fair Value of Financial Instruments</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The carrying amount of cash, accounts receivable, accounts payable and accrued expenses are reasonable estimates of their fair value due to their short maturity.</font></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Revenue Recognition</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Revenue is recognized when all of the following conditions are satisfied:&#160;&#160;(1) there is persuasive evidence of an arrangement; (2) the service or product has been provided to the customer; (3) the sale price to be paid by the customer is fixed or determinable; and (4) the collection of the sale price is reasonably assured.&#160;&#160;Amounts&#160;collected prior to satisfying our revenue recognition policy are reflected as customer deposits.</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">For research and development contracts, we recognize the revenue using the proportional effort method based upon the relationship of costs incurred to date to the total estimated cost to complete the contract. Cost elements include direct labor, materials, overhead costs and outside contractor costs.&#160;&#160;The excess of amounts billed on a milestone basis versus the amounts recorded as revenue on a proportional effort basis is classified as deferred revenue. We provide for any loss that we expect to incur in the agreements when the loss is probable.</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The Company uses contract accounting for certain Power on Demand system sales. Due to the limited number of these systems that have been installed to date, revenue is recognized based on the completed contract method whereby revenue and costs are deferred until the contract is completed. For contracts that contain provisions related to proceeds being paid based upon cost savings generated by the system, revenue is recorded as the costs savings are realized by and billed to the customer. If accumulated costs exceed accumulated billings at the reporting date the asset is presented net as costs of uncompleted contracts in excess of related billings. If there is a net liability it is presented as billings on uncompleted contracts in excess of related costs. We provide for any loss that we expect to incur on a contract at the time the loss is probable.</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">At March 31, 2014, the Company had costs of uncompleted contracts in excess of related billings totaling $143,481( $0 as of March 31, 2013).&#160;This amount was netted with the accrued loss contract on the Company&#8217;s balance sheet.</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Research and Development Costs</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">All costs related to research and development are expensed when incurred.&#160;Research and development costs consist of expenses associated with the development of the Company&#8217;s Power on Demand system and the Mobile Renewable Power Station.&#160;&#160;Specifically, these costs consist of labor, materials, and consulting.</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Warranty Costs</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The Company&#8217;s standard warranty on each Power on Demand system, wind turbine, and solar system sold protects against defects in design, material, and workmanship under normal use for varying periods, based upon the product sold.&#160;&#160;Several warranties have specific additional terms and conditions.&#160;&#160;The Company provides for estimated cost of warranties at the time the revenue is recognized.&#160;&#160;Factors that affect the warranty reserve are projected cost of repair and/or replacement, component life cycles, manufacturer&#8217;s warranty on component parts, and historical data. These estimates are reviewed quarterly and are updated as new information becomes available. The impact of any change in estimates will be taken into account when analyzing future warranty reserve requirements.</font></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Stock-Based Compensation</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The Company accounts for stock option awards granted under the Company&#8217;s Equity Incentive Plan in accordance with ASC 718. Under ASC 718, compensation expense related to stock-based payments is recorded over the requisite service period based on the grant date fair value of the awards.&#160;&#160;Compensation previously recorded for unvested stock options that are forfeited is reversed upon forfeiture.&#160;&#160;The Company uses the Black-Scholes option pricing model for determining the estimated fair value for stock-based awards. The Black-Scholes model requires the use of assumptions which determine the fair value of stock-based awards, including the option&#8217;s expected term and the price volatility of the underlying stock.</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The Company&#8217;s accounting policy for equity instruments issued to consultants and vendors in exchange for goods and services follows the provisions of ASC 505-50.&#160;&#160;Accordingly, the measurement date for the fair value of the equity instruments issued is determined at the earlier of (i)&#160;the date at which a commitment for performance by the consultant or vendor is reached or (ii)&#160;the date at which the consultant&#8217;s or vendor&#8217;s performance is complete. In the case of equity instruments issued to consultants, the fair value of the equity instrument is recognized over the term of the consulting agreement, or over the specified vesting period.</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Income Taxes</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The Company accounts for income taxes using the asset and liability approach, which requires recognition of deferred tax liabilities and assets for the expected future tax consequences of temporary differences between the carrying amounts and the tax basis of such assets and liabilities.&#160;&#160;This method utilizes enacted statutory tax rates in effect for the year in which the temporary differences are expected to reverse and gives immediate effect to changes in income tax rates upon enactment.&#160;&#160;Deferred assets are recognized, net of any valuation allowance, for temporary differences and net operating loss and tax credit carry forwards.&#160;&#160;Deferred income tax expense represents the change in net deferred assets and liability balances.</font></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Basic and Diluted Loss Per Share</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Basic earnings per share reflect the actual weighted average of shares issued and outstanding during the period.&#160;&#160;Diluted earnings per share are computed including the number of additional shares that would have been outstanding if dilutive potential shares had been issued.&#160;&#160;In a loss period, the calculation for basic and diluted earnings per share is considered to be the same, as the impact of potentially issued common shares would be anti-dilutive.</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">As of March 31, 2014, there were 1,500 shares of Preferred Stock, convertible into 7,500,000 shares of common stock, 1,430,608 stock options and 18,933,267 warrants outstanding which, upon exercise, could dilute future earnings per share.</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Reclassifications</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Certain prior year amounts have been reclassified to conform to the current year presentation.</font></div> <div align="justify" style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">Note 2 - Going Concern</font></div><div style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block;">&#160;</div><div align="justify" style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">The financial statements have been prepared assuming that the Company will continue as a going concern.&#160;&#160;Since its formation, the Company utilized funds generated from private placement offerings and debt to fund its product development and operations and has incurred a cumulative net loss of $27,786,979 as of March 31, 2014.&#160; The recurring losses from operations and current liquidity raise substantial doubt about the Company&#8217;s ability to continue as a going concern.&#160;&#160;Continuation of the Company is dependent on achieving sufficiently profitable operations and obtaining additional financing.</font></div> <div align="justify" style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">Note 3 &#8211; Debt</font></div><div style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block;">&#160;</div><div align="justify" style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">On September 4, 2012, the Company entered into an unsecured loan agreement with TMK-ENT, Inc. that provided for a $500,000 working capital revolving line of credit.&#160;&#160;Advances under the line of credit bear interest at 10% per year, payable annually. On November 13, 2012, the Company amended its loan agreement to increase the revolving line of credit agreement from $500,000 to $750,000, and on December 21, 2012 amended its loan agreement to increase the revolving credit agreement for $750,000 to $1,250,000.&#160;&#160;The note matures on December 21, 2014. Borrowings under the line of credit amount to $1,018,500 as of March 31, 2014 and December 31, 2013. In conjunction with the line of credit facility, the Company issued 1,250,000 warrants to purchase the Company&#8217;s common stock at varying prices from $1.38 to $1.62 per share. The warrants vest one year from issuance and have a ten year term. The fair market value of the warrants at grant date was determined utilizing the Black Scholes option pricing model and amounted to $1,839,250. The difference between the fair market value of the warrants and draws on the line of credit is $820,750 as of March 31, 2014 and December 31, 2013, which is recorded as deferred debt discount.&#160;&#160;The deferred debt discount will be recognized and recorded as debt discount as the Company continues to borrow against the line of credit. Debt discount costs will be recognized as the Company draws down the available line of credit, and will be amortized over the remaining term of the loan. As a result of the amortization of the debt discount, the Company expensed $84,790 and $199,852, respectively, for the three months ended March 31, 2014 and 2013.</font></div><div style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block;">&#160;</div><div align="justify" style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">Annual maturities of debt are as follows:</font></div><div align="left" style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></div><div align="left" style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><table style="width: 100%; font-family: 'times new roman'; font-size: 10pt;" cellspacing="0" cellpadding="0"><tr bgcolor="#cceeff"><td align="left" width="88%" valign="bottom"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">2014 (includes TMK-ENT, Inc. line of credit repayment)</font></div></td><td align="right" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td><td align="left" width="1%" valign="bottom"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">$</font></div></td><td align="right" width="9%" valign="bottom"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">1,028,136</font></div></td><td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="white"><td align="left" width="88%" valign="bottom"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">2015</font></div></td><td align="right" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td><td align="left" width="1%" valign="bottom"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">$</font></div></td><td align="right" width="9%" valign="bottom"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">9,540</font></div></td><td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="#cceeff"><td align="left" width="88%" valign="bottom"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">2016</font></div></td><td align="right" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td><td align="left" width="1%" valign="bottom"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">$</font></div></td><td align="right" width="9%" valign="bottom"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">6,629</font></div></td><td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td></tr></table></div> <div align="justify" style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">Note 4 &#8211; Stockholders&#8217; Equity</font></div> <div style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block;">&#160;</div> <div align="justify" style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">On March 31, 2014, the Company sold, pursuant to a securities purchase agreement, an aggregate of 1,500 shares of Series A Convertible Preferred Stock, with a stated value of $1,500,000 that are convertible into shares of the Company&#8217;s common stock at a conversion price of $0.20 in stated value per share (7,500,000 shares of common stock), and five-year warrants, which vested in full upon issuance, to purchase up to 11,250,000 additional shares of common stock at a purchase price of $0.25 per share to 8 institutional investors. Stock offering costs for the private placement amounted to $100,000. Each share of Preferred Stock is entitled to cash interest payments of 9% of the stated value per year, payable quarterly. The Preferred Stock is voluntarily and mandatorily convertible into shares of common stock pursuant to the provisions of the securities purchase agreement, with any shares of Preferred Stock outstanding on March 31, 2017 automatically converting into common stock. The investors received rights of first refusal and rights of participation in future financings of the Company until March 31, 2015. In addition, the investors received most favored nation protections on the terms and conditions of the warrants and preferred stock so long as such securities remain outstanding. Additionally, until September 30, 2015, each investor has the right to invest an amount equal to the amount invested by such investor in the above-referenced transaction in preferred stock of Arista Power on substantially similar terms. The Preferred Stock and warrants have customary anti-dilution protections and registration rights including a &#8220;full ratchet&#8221; anti-dilution adjustment provision. The warrants associated with this transaction were valued at their date of issue utilizing the Black-Scholes option pricing model, which amounted to $2,868,750.&#160;&#160;The difference between the warrants valuation of $2,878,750 and the net proceeds received by the Company of $1,400,000 results in a deemed dividend of $1,468,750 , which has been charged to additional paid-in-capital, as the Company has no retained earnings from which to declare a dividend.</font></div> <div style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block;">&#160;</div> <div align="justify" style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">On March 31, 2014, in conjunction with the full ratchet and anti-dilution provisions of the July and August 2013 private placement of common stock, shareholders were awarded an additional 1,255,000 shares of common stock and 612,000 warrants to purchase common stock for $0.25 per share, and the exercise price for the 3,060,000 warrants outstanding that were associated with this transaction were reset to $0.25 per warrant.</font></div> <div align="justify" style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">Note 5 &#8211; Stock Based Compensation</font></div> <div style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block;">&#160;</div> <div align="justify" style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">The Company has established the 2008 Equity Incentive Plan, which is a shareholder-approved plan that permits the granting of stock options and restricted stock to employees, directors and consultants.&#160;&#160; The 2008 Equity Incentive Plan provides for the issuance of up to 1,550,000 shares of common stock of which 50,000 shares are available for grant as Incentive Stock Options.&#160;&#160;The exercise price for options awarded is no less than 100% of the fair market value of the common stock on the day of grant.&#160;&#160;The options generally vest either immediately on the date of grant or 1 to 3 years from the date of grant.&#160;&#160;</font></div> <div style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block;">&#160;</div> <div align="justify" style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">For the three months ended March 31, 2014, the Company recorded compensation costs for options and warrants of $70,954, as compared to $363,369 for the three months ended March 31, 2013. For the three months ended March 31, 2013, compensation costs relating to the issuance of options and warrants amounted to $287,171 and the Company recorded an expense of $76,198 associated with the repricing of options and warrants held by a consultant of the Company, while for the three months ended March 31, 2014, there was no expense associated with the repricing of options or warrants.</font></div> <div align="justify" style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;<font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></div> <div align="justify" style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">The Company has valued the options at their date of grant utilizing the Black Scholes option pricing model.&#160;&#160;Prior to the fourth quarter of 2009, there was not a public market for the Company shares.&#160;&#160;Accordingly, the fair value of the underlying shares was determined based on recent transactions by the Company to sell shares to third parties and other factors determined by management to be relevant to the valuation of such shares.&#160;&#160;Beginning in the fourth quarter of 2009, the quoted price for the Company&#8217;s shares on the OTCBB was used to value the underlying shares.&#160;&#160;Expected volatility is based upon a weighted average historical volatility of peer companies operating in a similar industry.&#160;&#160;The risk-free interest rate is based on the implied yield available on U.S. Treasury issues with an equivalent term approximating the expected life of the options depending on the date of the grant and expected life of the options.&#160;&#160;The expected life of options used was based on the contractual life of the option granted.&#160;&#160;The Company determined the expected dividend rate based on the assumption and expectation that earnings generated from operations are not expected to be adequate to allow for the payment of dividends in the near future.&#160;&#160;The following weighted-average assumptions were utilized in the fair value calculations for options granted:</font></div> <div align="left" style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></div> <div align="left" style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px;"> <table style="width: 100%; font-family: 'times new roman'; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr> <td align="left" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">Three&#160;Months Ended</font></div> </td> <td align="left" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">Three&#160;Months Ended</font></div> </td> <td align="left" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">March &#160;31,</font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">2014</font></div> </td> <td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">March 31,</font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">2013</font></div> </td> <td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td align="left" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom" colspan="2"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom" colspan="2"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" width="76%" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">Expected dividend yield</font></div> </td> <td align="right" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="right" width="9%" valign="bottom"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">0</font></div> </td> <td align="left" width="1%" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">%</font></div> </td> <td align="right" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="right" width="9%" valign="bottom"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">0</font></div> </td> <td align="left" width="1%" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">%</font></div> </td> </tr> <tr bgcolor="white"> <td align="left" width="76%" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">Expected stock price volatility</font></div> </td> <td align="right" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="right" width="9%" valign="bottom"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">112</font></div> </td> <td align="left" width="1%" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">%</font></div> </td> <td align="right" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="right" width="9%" valign="bottom"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">108</font></div> </td> <td align="left" width="1%" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">%</font></div> </td> </tr> <tr bgcolor="#cceeff"> <td align="left" width="76%" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">Risk-free interest rate</font></div> </td> <td align="right" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="right" width="9%" valign="bottom"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">3.63</font></div> </td> <td align="left" width="1%" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">%</font></div> </td> <td align="right" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="right" width="9%" valign="bottom"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">2.60-2.68</font></div> </td> <td align="left" width="1%" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">%</font></div> </td> </tr> <tr bgcolor="white"> <td align="left" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">Expected life of options</font></div> </td> <td align="right" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="right" valign="bottom" colspan="2"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">.14-9.78 years</font></div> </td> <td align="left" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="right" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="right" valign="bottom" colspan="2"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">.47-9.78 years</font></div> </td> <td align="left" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> </tr> </table> </div> <div align="left" style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></div> <div align="left" style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">The following table summarizes the status of the Company&#8217;s aggregate stock options granted:</font></div> <div style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block;">&#160;</div> <div align="left" style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px;"> <table style="width: 100%; font-family: 'times new roman'; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr> <td align="left" width="54%" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td width="10%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">Number of Shares Remaining Options</font></div> </td> <td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td width="10%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">Weighted Average</font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">Exercise Price</font></div> </td> <td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td width="10%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">Weighted-Average Remaining</font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">Contractual Term</font></div> </td> <td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td width="10%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">Aggregate</font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">Intrinsic Value</font></div> </td> <td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td align="left" width="54%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="10%" valign="bottom" colspan="2"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="10%" valign="bottom" colspan="2"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="10%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="10%" valign="bottom" colspan="2"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" width="54%" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">Outstanding at January 1, 2014</font></div> </td> <td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="right" width="9%" valign="bottom"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">1,386,108</font></div> </td> <td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="1%" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">$</font></div> </td> <td align="right" width="9%" valign="bottom"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">.61</font></div> </td> <td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="10%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="10%" valign="bottom" colspan="2"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="white"> <td align="left" width="54%" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">Options granted during 2014</font></div> </td> <td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="right" width="9%" valign="bottom"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">115,000</font></div> </td> <td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="1%" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">$</font></div> </td> <td align="right" width="9%" valign="bottom"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">.23</font></div> </td> <td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="10%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="10%" valign="bottom" colspan="2"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" width="54%" valign="bottom" style="padding-bottom: 2px;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">Options cancelled or expired during 2014</font></div> </td> <td width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td width="1%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="right" width="9%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">(70,500)</font></div> </td> <td width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="right" width="9%" valign="bottom" style="padding-bottom: 2px;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">.75</font></div> </td> <td width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td width="10%" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td width="10%" valign="bottom" style="padding-bottom: 2px;" colspan="2"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="white"> <td align="left" width="54%" valign="bottom" style="padding-bottom: 4px;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">Outstanding at March 31, 2014</font></div> </td> <td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="1%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="right" width="9%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">1,430,608</font></div> </td> <td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="1%" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">$</font></div> </td> <td align="right" width="9%" valign="bottom" style="padding-bottom: 4px;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">.52</font></div> </td> <td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="right" width="10%" valign="bottom" style="padding-bottom: 4px;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">7.8 years</font></div> </td> <td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="1%" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">$</font></div> </td> <td align="right" width="9%" valign="bottom" style="padding-bottom: 4px;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">26,450</font></div> </td> <td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" width="54%" valign="bottom" style="padding-bottom: 4px;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">Exercisable at March 31, 2014</font></div> </td> <td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="1%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="right" width="9%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">772,308</font></div> </td> <td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="1%" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">$</font></div> </td> <td align="right" width="9%" valign="bottom" style="padding-bottom: 4px;"> <div style="text-indent: 0pt; display: block;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">.64</font></div> </td> <td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="right" width="10%" valign="bottom" style="padding-bottom: 4px;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">6.4 years</font></div> </td> <td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="1%" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">$</font></div> </td> <td align="right" width="9%" valign="bottom" style="padding-bottom: 4px;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">26,450</font></div> </td> <td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> </tr> </table> </div> <div align="left" style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;&#160;&#160;</font></div> <div align="justify" style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">For the three months ended March 31, 2014, the Company recorded compensation costs for options granted under the plan of $65,992, as compared to $160,751 for the three months ended March 31, 2013. Stock option grants amounted to 115,000 for the three months ended March 31, 2014 (135,000 for the three months ended March 31, 2013) while 160,000 options vested during that period (141,650 options vested for the three months ended March 31, 2013). There were 70,500 options cancelled or expired for the three months ended March 31, 2014, while no options were cancelled for the three months ended March 31, 2013. No options were exercised for the three months ended March 31, 2014 or March 31, 2013.</font></div> <div style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block;">&#160;</div> <div align="justify" style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">The weighted average fair value of options granted during the three months ended March 31, 2014 was $.23, compared to $1.13 for the three months ended March 31, 2013.&#160;</font></div> <div style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block;">&#160;</div> <div align="justify" style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="justify" style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">For the three months ended March 31, 2013, the Company recorded expenses totaling $13,575 associated with the repricing of 25,000 options awarded to a consultant (now an employee) of the Company. No such expense was recorded for the three months ended March 31, 2014.</font></font></font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">On December 13, 2010, the Board of Directors approved a restricted stock grant award to certain employees in lieu of future salary cash payments.&#160;&#160;The employees forfeited salary over a twelve-week period to purchase common shares, which were valued at fair market value as of the date of grant.&#160;&#160;The Compensation Committee of the Company&#8217;s Board of Directors have approved a change in the vesting date for restricted stock held by certain employees from April 1, 2011 to April 1, 2015. A total of 55,969 shares vested on April 1, 2011, and the remaining 169,368 shares are scheduled to vest on April 1, 2015.</font></div> </div> <div style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block;">&#160;</div> <div align="justify" style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">On March 31, 2014, Adeeb Saba was named Chief Operating Officer and the Compensation Committee awarded him 250,000 shares of restricted stock, which will vest one half each on the first and second anniversary of the award. Compensation costs associated with this award amount to $72,500 and will be recognized over the vesting period of the stock.</font></div> <div align="left" style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></div> <div align="left" style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">The following table summarizes the status of the Company&#8217;s restricted share awards:</font></div> <div align="left" style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></div> <div align="left" style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px;"> <table style="width: 100%; font-family: 'times new roman'; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr> <td align="left" valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></div> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">Restricted Shares</font></div> </td> <td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">Number of</font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">Restricted Shares</font></div> </td> <td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">Weighted Average</font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">Fair Value at</font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">Grant Date</font></div> </td> <td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" width="76%" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">Non-vested at&#160;&#160;March 31, 2014</font></div> </td> <td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="right" width="9%" valign="bottom"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">118,378</font></div> </td> <td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="1%" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">$</font></div> </td> <td align="right" width="9%" valign="bottom"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">2.80</font></div> </td> <td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="white"> <td align="left" width="76%" valign="bottom" style="padding-bottom: 2px;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">Awarded during 2014</font></div> </td> <td width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td width="1%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="right" width="9%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">250,000</font></div> </td> <td width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td width="1%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="right" width="9%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">.29</font></div> </td> <td width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" width="76%" valign="bottom" style="padding-bottom: 4px;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">Non-vested at March 31, 2014</font></div> </td> <td width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td width="1%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="right" width="9%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">419,368</font></div> </td> <td width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="1%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">$</font></div> </td> <td align="right" width="9%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">1.10</font></div> </td> <td width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> </tr> </table> </div> <div align="left" style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block; margin-left: 18pt; margin-right: 7.7pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></div> <div align="justify" style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">There was no expense associated with this restricted stock grant for the three months ended March 31, 2014 and 2013.&#160;</font></div> <div align="left" style="font: 13px/normal 'times new roman'; color: #000000; text-transform: none; text-indent: 0pt; letter-spacing: normal; margin-right: 0pt; margin-left: 0pt; word-spacing: 0px; display: block; white-space: normal; -webkit-text-stroke-width: 0px;"><font style="font-family: 'times new roman'; font-size: 10pt; font-weight: bold; display: inline;">Note 6 &#8211; Warrants</font></div><div align="left" style="font: 13px/normal 'times new roman'; color: #000000; text-transform: none; text-indent: 0pt; letter-spacing: normal; margin-right: 0pt; margin-left: 0pt; word-spacing: 0px; display: block; white-space: normal; -webkit-text-stroke-width: 0px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></div><div align="justify" style="font: 13px/normal 'times new roman'; color: #000000; text-transform: none; text-indent: 0pt; letter-spacing: normal; margin-right: 0pt; margin-left: 0pt; word-spacing: 0px; display: block; white-space: normal; -webkit-text-stroke-width: 0px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">The Company has valued warrants at their date of issue utilizing the Black-Scholes option pricing model.&#160; The risk-free interest rate is based on the implied yield available on U.S. Treasury issues with an equivalent term approximating the expected life of the warrants depending on the date of the issue and their expected life.&#160;&#160;The expected life of warrants used was based on the term of the warrant.&#160;&#160;The Company determined the expected dividend rate based on the assumption and expectation that earnings generated from operations are not expected to be adequate to allow for the payment of dividends in the near future.&#160;&#160;The following weighted-average assumptions were utilized in the fair value calculations for warrants granted:</font></div><div align="left" style="font: 13px/normal 'times new roman'; color: #000000; text-transform: none; text-indent: 0pt; letter-spacing: normal; margin-right: 0pt; margin-left: 0pt; word-spacing: 0px; display: block; white-space: normal; -webkit-text-stroke-width: 0px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></div><div align="left" style="font: 13px/normal 'times new roman'; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; -webkit-text-stroke-width: 0px;"><table style="width: 100%; font-family: 'times new roman'; font-size: 10pt;" cellspacing="0" cellpadding="0"><tr><td align="left" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td valign="bottom" colspan="2"><div align="center" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; font-weight: bold; display: inline;">Three Months Ended</font></div></td><td align="left" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td valign="bottom" colspan="2"><div align="center" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; font-weight: bold; display: inline;">Three Months Ended</font></div></td><td align="left" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td></tr><tr><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" colspan="2"><div align="center" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; font-weight: bold; display: inline;">March 31, 2014</font></div></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" colspan="2"><div align="center" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; font-weight: bold; display: inline;">March 31,2013</font></div></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td></tr><tr bgcolor="#cceeff"><td align="left" width="76%" valign="bottom"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">Expected dividend yield</font></div></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" width="9%" valign="bottom"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">0</font></div></td><td align="left" width="1%" valign="bottom"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">%</font></div></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" width="9%" valign="bottom"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">0</font></div></td><td align="left" width="1%" valign="bottom"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">%</font></div></td></tr><tr bgcolor="white"><td align="left" width="76%" valign="bottom"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">Expected stock price volatility</font></div></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" width="9%" valign="bottom"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">134</font></div></td><td align="left" width="1%" valign="bottom"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">%</font></div></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" width="9%" valign="bottom"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">93-108</font></div></td><td align="left" width="1%" valign="bottom"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">%</font></div></td></tr><tr bgcolor="#cceeff"><td align="left" width="76%" valign="bottom"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">Risk-free interest rate</font></div></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" width="9%" valign="bottom"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">1.73-1.75</font></div></td><td align="left" width="1%" valign="bottom"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">%</font></div></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" width="9%" valign="bottom"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">.14&#8211;2.60</font></div></td><td align="left" width="1%" valign="bottom"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">%</font></div></td></tr><tr bgcolor="white"><td align="left" valign="bottom"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">Expected life of warrants</font></div></td><td align="left" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" valign="bottom" colspan="2"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">4.1-8.8 years</font></div></td><td align="left" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" valign="bottom" colspan="2"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">.9-9.8 years</font></div></td><td align="left" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td></tr></table></div><div style="font: 13px/normal 'times new roman'; color: #000000; text-transform: none; text-indent: 0pt; letter-spacing: normal; word-spacing: 0px; display: block; white-space: normal; -webkit-text-stroke-width: 0px;">&#160;</div><div align="left" style="font: 13px/normal 'times new roman'; color: #000000; text-transform: none; text-indent: 0pt; letter-spacing: normal; margin-right: 0pt; margin-left: 0pt; word-spacing: 0px; display: block; white-space: normal; -webkit-text-stroke-width: 0px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">The following table summarizes the status of the Company&#8217;s warrants granted:</font></div><div align="left" style="font: 13px/normal 'times new roman'; color: #000000; text-transform: none; text-indent: 0pt; letter-spacing: normal; margin-right: 0pt; margin-left: 0pt; word-spacing: 0px; display: block; white-space: normal; -webkit-text-stroke-width: 0px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></div><div align="left" style="font: 13px/normal 'times new roman'; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; -webkit-text-stroke-width: 0px;"><table style="width: 100%; font-family: 'times new roman'; font-size: 10pt;" cellspacing="0" cellpadding="0"><tr><td align="left" width="54%" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td width="10%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" colspan="2"><div align="center" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; font-weight: bold; display: inline;">Number of Shares Remaining Warrants</font></div></td><td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td width="10%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" colspan="2"><div align="center" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; font-weight: bold; display: inline;">Weighted Average</font></div><div align="center" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; font-weight: bold; display: inline;">Exercise Price</font></div></td><td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td width="10%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;"><div align="center" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; font-weight: bold; display: inline;">Weighted-Average Remaining</font></div><div align="center" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; font-weight: bold; display: inline;">Contractual Term</font></div></td><td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td width="10%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" colspan="2"><div align="center" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; font-weight: bold; display: inline;">Aggregate</font></div><div align="center" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; font-weight: bold; display: inline;">Intrinsic Value</font></div></td><td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td></tr><tr bgcolor="#cceeff"><td align="left" width="54%" valign="bottom"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">Outstanding at January 1, 2014</font></div></td><td align="right" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" width="9%" valign="bottom"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">7,671,267</font></div></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">$</font></div></td><td align="right" width="9%" valign="bottom"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">1.51</font></div></td><td width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="10%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="10%" valign="bottom" colspan="2"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td></tr><tr bgcolor="white"><td align="left" width="54%" valign="bottom"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">Warrants granted during 2014</font></div></td><td align="right" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" width="9%" valign="bottom"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">11,862,000</font></div></td><td width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">$</font></div></td><td align="right" width="9%" valign="bottom"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">.25</font></div></td><td width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="10%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="10%" valign="bottom" colspan="2"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td></tr><tr bgcolor="#cceeff"><td align="left" width="54%" valign="bottom" style="padding-bottom: 2px;"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">Warrants expired during 2014</font></div></td><td width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td width="1%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" width="9%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">(600,000)</font></div></td><td width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" width="9%" valign="bottom" style="padding-bottom: 2px;"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">.25</font></div></td><td width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td width="10%" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td width="10%" valign="bottom" style="padding-bottom: 2px;" colspan="2"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td></tr><tr bgcolor="white"><td align="left" width="54%" valign="bottom" style="padding-bottom: 4px;"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">Outstanding at March 31,2014</font></div></td><td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td width="1%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" width="9%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">18,933,267</font></div></td><td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">$</font></div></td><td align="right" width="9%" valign="bottom" style="padding-bottom: 4px;"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">.78</font></div></td><td width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" width="10%" valign="bottom" style="padding-bottom: 4px;"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">5.3 years</font></div></td><td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">$</font></div></td><td align="right" width="9%" valign="bottom" style="padding-bottom: 4px;"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">0</font></div></td><td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td></tr><tr bgcolor="#cceeff"><td align="left" width="54%" valign="bottom" style="padding-bottom: 4px;"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">Exercisable at March 31,2014</font></div></td><td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td width="1%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" width="9%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">18,139,250</font></div></td><td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">$</font></div></td><td align="right" width="9%" valign="bottom" style="padding-bottom: 4px;"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">.76</font></div></td><td width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" width="10%" valign="bottom" style="padding-bottom: 4px;"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">5.6 years</font></div></td><td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">$</font></div></td><td align="right" width="9%" valign="bottom" style="padding-bottom: 4px;"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">0</font></div></td><td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td></tr></table></div><div style="font: 13px/normal 'times new roman'; color: #000000; text-transform: none; text-indent: 0pt; letter-spacing: normal; word-spacing: 0px; display: block; white-space: normal; -webkit-text-stroke-width: 0px;">&#160;</div><div align="justify" style="font: 13px/normal 'times new roman'; color: #000000; text-transform: none; text-indent: 0pt; letter-spacing: normal; margin-right: 0pt; margin-left: 0pt; word-spacing: 0px; display: block; white-space: normal; -webkit-text-stroke-width: 0px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">The weighted average fair value of warrants issued during three months ended March&#160;31, 2014 and 2013 was $.25 and $.73, respectively.&#160;&#160;During the three months ended March 31, 2014, 11,878,000 warrants vested (646,375 vested for the three months ended March 31, 2013), and&#160;600,000 warrants expired for the three months ended March 31, 2014. No options expired or were cancelled for the three months ended March 31, 2013.</font></div><div style="font: 13px/normal 'times new roman'; color: #000000; text-transform: none; text-indent: 0pt; letter-spacing: normal; word-spacing: 0px; display: block; white-space: normal; -webkit-text-stroke-width: 0px;">&#160;</div><div align="justify" style="font: 13px/normal 'times new roman'; color: #000000; text-transform: none; text-indent: 0pt; letter-spacing: normal; margin-right: 0pt; margin-left: 0pt; word-spacing: 0px; display: block; white-space: normal; -webkit-text-stroke-width: 0px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">For the three months ended March 31, 2014 and 2013, respectively, the Company recorded compensation costs of $4,962 and $126,420 for warrants issued to a consultant (now an employee) of the Company.&#160;&#160;The warrants have a ten year life, a $1.20 exercise price, and vest from six months to three years from grant date.</font></div><div style="font: 13px/normal 'times new roman'; color: #000000; text-transform: none; text-indent: 0pt; letter-spacing: normal; word-spacing: 0px; display: block; white-space: normal; -webkit-text-stroke-width: 0px;">&#160;</div><div align="justify" style="font: 13px/normal 'times new roman'; color: #000000; text-transform: none; text-indent: 0pt; letter-spacing: normal; margin-right: 0pt; margin-left: 0pt; word-spacing: 0px; display: block; white-space: normal; -webkit-text-stroke-width: 0px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">For the three months ended March 31, 2013, the Company recorded expenses totaling $62,623 associated with the repricing of 423,125 outstanding warrants awarded to a consultant (now an employee) of the company. No such expense was recorded for the three months ended March 31, 2014.</font></div><div align="justify" style="font: 13px/normal 'times new roman'; color: #000000; text-transform: none; text-indent: 0pt; letter-spacing: normal; margin-right: 0pt; margin-left: 0pt; word-spacing: 0px; display: block; white-space: normal; -webkit-text-stroke-width: 0px;">&#160;</div><div style="font: 13px/normal 'times new roman'; color: #000000; text-transform: none; text-indent: 0pt; letter-spacing: normal; margin-right: 0pt; margin-left: 0pt; word-spacing: 0px; white-space: normal; -webkit-text-stroke-width: 0px;">&#160;</div> <div align="left" style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">Note 7 &#8211; Derivative Liabilities</font></div> <div style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block;">&#160;</div> <div align="justify" style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">Certain warrants issued by the Company do not have fixed settlement provisions because their exercise prices may be lowered if the Company issues securities at lower prices in the future, are classified as derivative liabilities, and are revalued at each reporting date. These warrants include (1) warrants issued to 1999 Mt RB, LLC in conjunction with our lease modification on February 4, 2013, which expired on February 4, 2014 (2) warrants issued in conjunction with the Company&#8217;s strategic advisory agreement with Sunrise Financial Group, Inc. on May 21, 2013 and (3) warrants issued in conjunction with the Company&#8217;s private placements on July 31, 2013, August 6, 2013 and March 31, 2014. The reset provisions protect the warrant holders from the potential dilution associated with future financings.</font></font></font></div> <div align="justify" style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></div> </div> <div align="justify" style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block; margin-left: 0pt; margin-right: 0pt;"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">The Company has valued warrants at their date of issue utilizing the Black-Scholes option pricing model. Expected volatility is based upon a weighted average historical volatility of peer companies operating in a similar industry, or if applicable based upon the term of the warrant, based upon the Company&#8217;s historical volatility. The risk-free interest rate is based on the implied yield available on U.S. Treasury issues with an equivalent term approximating the expected life of the warrants depending on the date of the issue and their expected life. The expected life of warrants used was based on the term of the warrant. The Company determined the expected dividend rate based on the assumption and expectation that earnings generated from operations are not expected to be adequate to allow for the payment of dividends in the near future. The following weighted-average assumptions were utilized in the fair value calculations for warrants granted and subsequent revaluation:</font></font></div> </div> <div align="left" style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px;">&#160;</div> <div align="left" style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px;"> <table style="width: 100%; font-family: 'times new roman'; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr> <td align="left" width="78%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td width="10%" valign="bottom"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">Three Months Ended</font></div> </td> <td width="1%" valign="top"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td width="10%" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">Three Months Ended</font></div> </td> <td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td align="left" width="78%" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td width="10%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">March 31,&#160;</font><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">2014</font></div> </td> <td width="1%" valign="top" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td width="10%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">March 31,&#160;</font><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">2013</font></div> </td> <td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" width="78%" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">Expected dividend yield</font></div> </td> <td align="right" width="10%" valign="bottom"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">0%</font></div> </td> <td width="1%" valign="top"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="right" width="9%" valign="bottom"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">0</font></div> </td> <td align="left" width="1%" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">%</font></div> </td> </tr> <tr bgcolor="white"> <td align="left" width="78%" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">Expected stock price volatility</font></div> </td> <td align="right" width="10%" valign="bottom"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">134%</font></div> </td> <td width="1%" valign="top"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="right" width="9%" valign="bottom"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">90-93</font></div> </td> <td align="left" width="1%" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">%</font></div> </td> </tr> <tr bgcolor="#cceeff"> <td align="left" width="78%" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">Risk-free interest rate</font></div> </td> <td align="right" width="10%" valign="bottom"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">1.75%</font></div> </td> <td width="1%" valign="top"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="right" width="9%" valign="bottom"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">.14</font></div> </td> <td align="left" width="1%" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">%</font></div> </td> </tr> <tr bgcolor="white"> <td align="left" width="78%" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">Expected life of warrants</font></div> </td> <td align="right" width="10%" valign="bottom"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">4.1-5.0 years</font></div> </td> <td width="1%" valign="top"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="right" width="10%" valign="bottom" colspan="2"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">.8 years</font></div> </td> <td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" width="78%" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">Number of warrants</font></div> </td> <td align="right" width="10%" valign="bottom"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">15,562,351</font></div> </td> <td width="1%" valign="top"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="right" width="9%" valign="bottom"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">600,000</font></div> </td> <td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="white"> <td align="left" width="78%" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">Fair value of warrants</font></div> </td> <td align="right" width="10%" valign="bottom"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">$3,917,772</font></div> </td> <td width="1%" valign="top"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="1%" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">$</font></div> </td> <td align="right" width="9%" valign="bottom"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">185,400</font></div> </td> <td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> </tr> </table> </div> <div style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block;">&#160;</div> <div align="justify" style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">The fair value of these warrant liabilities was $3,917,772 at March 31, 2014. The change in fair value for the three months ended March 31, 2014 was $121,650 and is reported in our statement of operations as an unrealized loss on the change in fair value of the derivative liabilities. For the three months ended March 31, 2013, we recorded an unrealized gain on the change in fair value of the derivative liabilities totaling $71,400. The fair value of the derivative liabilities are re-measured at the end of every reporting period and upon the exercise of the warrant.</font></div> <div style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block;">&#160;</div> <div align="left" style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">Fair Value Measurement</font></div> <div style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block;">&#160;</div> <div align="left" style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: 'times new roman'; font-size: 10pt;">Valuation Hierarchy</font></div> <div align="justify" style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">ASC 820, &#8220;Fair Value Measurements and Disclosures,&#8221; establishes a valuation hierarchy for disclosure of the inputs to valuation used to measure fair value. This hierarchy prioritizes the inputs into three broad levels as follows. Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs are quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly or indirectly through market corroboration, for substantially the full term of the financial instrument. Level 3 inputs are unobservable inputs based on the Company&#8217;s own assumptions used to measure assets and liabilities at fair value. A financial asset or liability&#8217;s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement.</font></div> <div style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block;">&#160;</div> <div align="justify" style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">The following table provides the liabilities carried at fair value measured on a recurring basis as of March 31, 2014:</font></div> <div align="justify" style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></div> <div align="left" style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px;"> <table style="width: 100%; font-family: 'times new roman'; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr> <td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom" style="padding-bottom: 2px;" colspan="2"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" colspan="10"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">Fair Value Measurements at March 31,2014</font></div> </td> <td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">Total</font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">Carrying</font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">Value at</font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">March 31, 2014,</font></div> </td> <td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">Quoted</font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">prices in</font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">active</font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">markets</font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">(Level 1)</font></div> </td> <td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">Significant</font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">other</font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">observable</font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">inputs</font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">(Level 2)</font></div> </td> <td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">Significant</font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">unobservable</font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">inputs</font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">(Level 3)</font></div> </td> <td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td width="52%" valign="bottom"> <div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">Derivative liabilities</font></div> </td> <td align="right" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="1%" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">$</font></div> </td> <td align="right" width="9%" valign="bottom"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">3,917,722</font></div> </td> <td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="right" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="1%" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">$</font></div> </td> <td align="right" width="9%" valign="bottom"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">-</font></div> </td> <td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="right" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="1%" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">$</font></div> </td> <td align="right" width="9%" valign="bottom"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">-</font></div> </td> <td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="right" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="1%" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">$</font></div> </td> <td align="right" width="9%" valign="bottom"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">3,917,722</font></div> </td> <td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> </tr> </table> </div> <div style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block;">&#160;</div> <div style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-align: justify; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">The derivative liabilities are measured at fair value using quoted market prices and estimated volatility factors, and are classified within Level 3 of the valuation hierarchy.</font></div> <div style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block;">&#160;</div> <div align="left" style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">The following table sets forth a summary of the changes in the fair value of our Level 3 financial liabilities that are measured at fair value on a recurring basis:</font></div> <div align="left" style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></div> <div align="left" style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px;"> <table style="width: 100%; font-family: 'times new roman'; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr> <td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">Year ended</font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">December 31,</font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">2013</font></div> </td> <td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" width="88%" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">Beginning balance January 1, 2014</font></div> </td> <td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="1%" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">$</font></div> </td> <td align="right" width="9%" valign="bottom"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">775,596</font></div> </td> <td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="white"> <td align="left" width="88%" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">Issuance of derivative financial instruments in 2014</font></div> </td> <td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="right" width="9%" valign="bottom"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">3,020,526</font></div> </td> <td width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" width="88%" valign="bottom" style="padding-bottom: 2px;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">Net unrealized (gain) loss on derivative financial instruments</font></div> </td> <td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="1%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="right" width="9%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">121,650</font></div> </td> <td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="white"> <td align="left" width="88%" valign="bottom" style="padding-bottom: 4px;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">Ending balance as of March 31,2014</font></div> </td> <td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="1%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">$</font></div> </td> <td align="right" width="9%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">3,917,722</font></div> </td> <td width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> </tr> </table> </div> <div>&#160;</div> <div align="justify" style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;"><br class="apple-interchange-newline" />Note 9- Recent Accounting Pronouncements</font></div> <div style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block;">&#160;</div> <div align="justify" style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">The Company has considered recent accounting pronouncements and believes that these recent pronouncements will not have a material effect on the Company&#8217;s financial statements.</font></div> <div align="justify" style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0pt; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></div> <div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Basis of Preparation</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) for interim financial information and with the instructions to Form 10-Q.&#160;&#160;Accordingly, they do not include all of the information required by GAAP for complete annual financial statement presentation.</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">In the opinion of management, all adjustments (consisting only of normal and recurring adjustments) necessary for a fair presentation of the results of operations have been included in the accompanying unaudited condensed financial statements.&#160;&#160;Operating results for the three-month period ended March 31, 2014 are not necessarily indicative of the results to be expected for other interim periods or the full fiscal year.&#160;&#160;These financial statements should be read in conjunction with the financial statements and accompanying notes contained in the Arista Power Form 10-K for the fiscal year ended December 31, 2013.</font></div> <div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Method of Accounting</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The accompanying financial statements have been prepared in accordance with GAAP.&#160;&#160;Arista Power maintains its books and prepares its financial statements on the accrual basis of accounting.</font></div> <div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Use of Estimates</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.&#160;&#160;Actual results could differ from those estimates.</font></div> <div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Cash and Cash Equivalents</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">For financial statement presentation purposes, the Company considers all short-term, highly liquid investments with original maturities of three months or less to be cash and cash equivalents.&#160;&#160;The Company maintains its cash and cash equivalents in bank deposit accounts, which at times may exceed federally insured limits.&#160; The Company believes it is not exposed to any significant credit risk as a result of any non-performance by the financial institutions.</font></div> <div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Accounts Receivable</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Accounts receivable represents amounts due from customers in the ordinary course of business, based upon invoiced amounts, net of any allowance for doubtful accounts.&#160;&#160;We evaluate accounts receivable quarterly on a specific account basis to determine the need to an allowance for doubtful account reserve.&#160;&#160;As of March 31, 2014 and December 31, 2013, the allowance for doubtful accounts&#160;was $0.</font></div> <div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Inventory</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Inventory consists primarily of parts and subassemblies for Power on Demand systems, solar photovoltaic (&#8220;PV&#8221;) systems, and is stated at the lower of cost or market value.&#160;&#160;The Company capitalizes applicable direct and indirect costs incurred in the Company&#8217;s manufacturing operations to bring its products to a sellable state.&#160;&#160;The inventory as of March 31, 2014 consisted of raw materials amounting to $346,014 and work-in-process amounting to $150,299.&#160;&#160;Inventory is reviewed quarterly to determine the need for an excess and obsolete inventory reserve.&#160;&#160;As of March 31, 2014 and December 31, 2013, no reserve was necessary.</font></div> <div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Fixed Assets</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Fixed assets are recorded at cost.&#160;&#160;Depreciation is on a straight line basis over the shorter of the estimated useful lives or the related lease for leasehold improvements.&#160;&#160;Leasehold improvements for space leased on a month-to-month basis are expensed when incurred.&#160;&#160;Expenditures for renewals and betterments are capitalized.&#160;&#160;Expenditures for minor items, repairs and maintenance are charged to operations as incurred.&#160; Any gain or loss upon sale or retirement due to obsolescence is reflected in the operating results in the period the event takes place.</font></div> <div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Intangible Assets</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Intangible assets consist of costs associated with the application and acquisition of the Company&#8217;s patents.&#160;&#160;Patent application costs are capitalized and amortized over the estimated useful life of the patent, which generally approximates its legal life. For the three months ended March 31, 2013, trademark costs totaling $3,396 relating to the Company&#8217;s WindTamer&#174; trademark were impaired, while no intangible assets were impaired for the three months ended March 31, 2014.&#160;&#160;</font></div> <div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Impairment of Long-Lived Assets</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.&#160;&#160;Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future net undiscounted cash flows expected to be generated by the asset, including its ultimate disposition.&#160;&#160;If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets.&#160;&#160;Fair value is determined based on discounted cash flows or appraised values, depending on the nature of the assets.&#160;&#160; For the three months ended March 31, 2014 and 2013, no assets were impaired.</font></div> <div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Fair Value of Financial Instruments</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The carrying amount of cash, accounts receivable, accounts payable and accrued expenses are reasonable estimates of their fair value due to their short maturity.</font></div> <div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Revenue Recognition</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Revenue is recognized when all of the following conditions are satisfied:&#160;&#160;(1) there is persuasive evidence of an arrangement; (2) the service or product has been provided to the customer; (3) the sale price to be paid by the customer is fixed or determinable; and (4) the collection of the sale price is reasonably assured.&#160;&#160;Amounts&#160;collected prior to satisfying our revenue recognition policy are reflected as customer deposits.</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">For research and development contracts, we recognize the revenue using the proportional effort method based upon the relationship of costs incurred to date to the total estimated cost to complete the contract. Cost elements include direct labor, materials, overhead costs and outside contractor costs.&#160;&#160;The excess of amounts billed on a milestone basis versus the amounts recorded as revenue on a proportional effort basis is classified as deferred revenue. We provide for any loss that we expect to incur in the agreements when the loss is probable.</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The Company uses contract accounting for certain Power on Demand system sales. Due to the limited number of these systems that have been installed to date, revenue is recognized based on the completed contract method whereby revenue and costs are deferred until the contract is completed. For contracts that contain provisions related to proceeds being paid based upon cost savings generated by the system, revenue is recorded as the costs savings are realized by and billed to the customer. If accumulated costs exceed accumulated billings at the reporting date the asset is presented net as costs of uncompleted contracts in excess of related billings. If there is a net liability it is presented as billings on uncompleted contracts in excess of related costs. We provide for any loss that we expect to incur on a contract at the time the loss is probable.</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">At March 31, 2014, the Company had costs of uncompleted contracts in excess of related billings totaling $143,481( $0 as of March 31, 2013).&#160;This amount was netted with the accrued loss contract on the Company&#8217;s balance sheet.</font></div> <div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Research and Development Costs</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">All costs related to research and development are expensed when incurred.&#160;Research and development costs consist of expenses associated with the development of the Company&#8217;s Power on Demand system and the Mobile Renewable Power Station.&#160;&#160;Specifically, these costs consist of labor, materials, and consulting.</font></div> <div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Warranty Costs</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The Company&#8217;s standard warranty on each Power on Demand system, wind turbine, and solar system sold protects against defects in design, material, and workmanship under normal use for varying periods, based upon the product sold.&#160;&#160;Several warranties have specific additional terms and conditions.&#160;&#160;The Company provides for estimated cost of warranties at the time the revenue is recognized.&#160;&#160;Factors that affect the warranty reserve are projected cost of repair and/or replacement, component life cycles, manufacturer&#8217;s warranty on component parts, and historical data. These estimates are reviewed quarterly and are updated as new information becomes available. The impact of any change in estimates will be taken into account when analyzing future warranty reserve requirements.</font></div> <div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Stock-Based Compensation</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The Company accounts for stock option awards granted under the Company&#8217;s Equity Incentive Plan in accordance with ASC 718. Under ASC 718, compensation expense related to stock-based payments is recorded over the requisite service period based on the grant date fair value of the awards.&#160;&#160;Compensation previously recorded for unvested stock options that are forfeited is reversed upon forfeiture.&#160;&#160;The Company uses the Black-Scholes option pricing model for determining the estimated fair value for stock-based awards. The Black-Scholes model requires the use of assumptions which determine the fair value of stock-based awards, including the option&#8217;s expected term and the price volatility of the underlying stock.</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The Company&#8217;s accounting policy for equity instruments issued to consultants and vendors in exchange for goods and services follows the provisions of ASC 505-50.&#160;&#160;Accordingly, the measurement date for the fair value of the equity instruments issued is determined at the earlier of (i)&#160;the date at which a commitment for performance by the consultant or vendor is reached or (ii)&#160;the date at which the consultant&#8217;s or vendor&#8217;s performance is complete. In the case of equity instruments issued to consultants, the fair value of the equity instrument is recognized over the term of the consulting agreement, or over the specified vesting period.</font></div> <div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Income Taxes</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The Company accounts for income taxes using the asset and liability approach, which requires recognition of deferred tax liabilities and assets for the expected future tax consequences of temporary differences between the carrying amounts and the tax basis of such assets and liabilities.&#160;&#160;This method utilizes enacted statutory tax rates in effect for the year in which the temporary differences are expected to reverse and gives immediate effect to changes in income tax rates upon enactment.&#160;&#160;Deferred assets are recognized, net of any valuation allowance, for temporary differences and net operating loss and tax credit carry forwards.&#160;&#160;Deferred income tax expense represents the change in net deferred assets and liability balances.</font></div> <div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Basic and Diluted Loss Per Share</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Basic earnings per share reflect the actual weighted average of shares issued and outstanding during the period.&#160;&#160;Diluted earnings per share are computed including the number of additional shares that would have been outstanding if dilutive potential shares had been issued.&#160;&#160;In a loss period, the calculation for basic and diluted earnings per share is considered to be the same, as the impact of potentially issued common shares would be anti-dilutive.</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">As of March 31, 2014, there were 1,500 shares of Preferred Stock, convertible into 7,500,000 shares of common stock, 1,430,608 stock options and 18,933,267 warrants outstanding which, upon exercise, could dilute future earnings per share.</font></div> <div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Reclassifications</font></div><div style="text-indent: 0pt; display: block;">&#160;</div><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Certain prior year amounts have been reclassified to conform to the current year presentation.</font></div> <table style="width: 100%; font-family: 'times new roman'; font-size: 10pt;" cellspacing="0" cellpadding="0"><tr bgcolor="#cceeff"><td align="left" width="88%" valign="bottom"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">2014 (includes TMK-ENT, Inc. line of credit repayment)</font></div></td><td align="right" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td><td align="left" width="1%" valign="bottom"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">$</font></div></td><td align="right" width="9%" valign="bottom"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">1,028,136</font></div></td><td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="white"><td align="left" width="88%" valign="bottom"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">2015</font></div></td><td align="right" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td><td align="left" width="1%" valign="bottom"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">$</font></div></td><td align="right" width="9%" valign="bottom"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">9,540</font></div></td><td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="#cceeff"><td align="left" width="88%" valign="bottom" style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">2016</font></div></td><td align="right" width="1%" valign="bottom" style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td><td align="left" width="1%" valign="bottom" style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">$</font></div></td><td align="right" width="9%" valign="bottom" style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">6,629</font></div></td></tr></table> <div align="left" style="font: 13px/normal 'times new roman'; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; -webkit-text-stroke-width: 0px;"><table style="width: 100%; font-family: 'times new roman'; font-size: 10pt;" cellspacing="0" cellpadding="0"><tr><td align="left" valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></div><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; font-weight: bold; display: inline;">Restricted Shares</font></div></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" colspan="2"><div align="center" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; font-weight: bold; display: inline;">Number of</font></div><div align="center" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; font-weight: bold; display: inline;">Restricted Shares</font></div></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" colspan="2"><div align="center" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; font-weight: bold; display: inline;">Weighted Average</font></div><div align="center" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; font-weight: bold; display: inline;">Fair Value at</font></div><div align="center" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; font-weight: bold; display: inline;">Grant Date</font></div></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td></tr><tr bgcolor="#cceeff"><td align="left" width="76%" valign="bottom"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">Non-vested at&#160;&#160;March 31, 2014</font></div></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" width="9%" valign="bottom"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">118,378</font></div></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">$</font></div></td><td align="right" width="9%" valign="bottom"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">2.80</font></div></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td></tr><tr bgcolor="white"><td align="left" width="76%" valign="bottom" style="padding-bottom: 2px;"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">Awarded during 2014</font></div></td><td width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td width="1%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" width="9%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">250,000</font></div></td><td width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td width="1%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" width="9%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">.29</font></div></td><td width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td></tr><tr bgcolor="#cceeff"><td align="left" width="76%" valign="bottom" style="padding-bottom: 4px;"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">Non-vested at March 31, 2014</font></div></td><td width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td width="1%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" width="9%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">419,368</font></div></td><td width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">$</font></div></td><td align="right" width="9%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">1.10</font></div></td><td width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td></tr></table></div><div align="left" style="font: 13px/normal 'times new roman'; color: #000000; text-transform: none; text-indent: 0pt; letter-spacing: normal; margin-right: 7.7pt; margin-left: 18pt; word-spacing: 0px; display: block; white-space: normal; -webkit-text-stroke-width: 0px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></div> <div align="left" style="font: 13px/normal 'times new roman'; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; -webkit-text-stroke-width: 0px;"><table style="width: 100%; font-family: 'times new roman'; font-size: 10pt;" cellspacing="0" cellpadding="0"><tr><td align="left" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td valign="bottom" colspan="2"><div align="center" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; font-weight: bold; display: inline;">Three Months Ended</font></div></td><td align="left" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td valign="bottom" colspan="2"><div align="center" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; font-weight: bold; display: inline;">Three Months Ended</font></div></td><td align="left" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td></tr><tr><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" colspan="2"><div align="center" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; font-weight: bold; display: inline;">March 31, 2014</font></div></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" colspan="2"><div align="center" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; font-weight: bold; display: inline;">March 31,2013</font></div></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td></tr><tr bgcolor="#cceeff"><td align="left" width="76%" valign="bottom"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">Expected dividend yield</font></div></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" width="9%" valign="bottom"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">0</font></div></td><td align="left" width="1%" valign="bottom"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">%</font></div></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" width="9%" valign="bottom"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">0</font></div></td><td align="left" width="1%" valign="bottom"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">%</font></div></td></tr><tr bgcolor="white"><td align="left" width="76%" valign="bottom"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">Expected stock price volatility</font></div></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" width="9%" valign="bottom"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">134</font></div></td><td align="left" width="1%" valign="bottom"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">%</font></div></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" width="9%" valign="bottom"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">93-108</font></div></td><td align="left" width="1%" valign="bottom"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">%</font></div></td></tr><tr bgcolor="#cceeff"><td align="left" width="76%" valign="bottom"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">Risk-free interest rate</font></div></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" width="9%" valign="bottom"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">1.73-1.75</font></div></td><td align="left" width="1%" valign="bottom"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">%</font></div></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" width="9%" valign="bottom"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">.14&#8211;2.60</font></div></td><td align="left" width="1%" valign="bottom"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">%</font></div></td></tr><tr bgcolor="white"><td align="left" valign="bottom"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">Expected life of warrants</font></div></td><td align="left" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" valign="bottom" colspan="2"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">4.1-8.8 years</font></div></td><td align="left" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" valign="bottom" colspan="2"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">.9-9.8 years</font></div></td><td align="left" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td></tr></table></div><div>&#160;</div> <div align="left" style="font: 13px/normal 'times new roman'; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; -webkit-text-stroke-width: 0px;"><table style="width: 100%; font-family: 'times new roman'; font-size: 10pt;" cellspacing="0" cellpadding="0"><tr><td align="left" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td valign="bottom" colspan="2"><div align="center" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; font-weight: bold; display: inline;">Three&#160;Months Ended</font></div></td><td align="left" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td valign="bottom" colspan="2"><div align="center" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; font-weight: bold; display: inline;">Three&#160;Months Ended</font></div></td><td align="left" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td></tr><tr><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" colspan="2"><div align="center" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; font-weight: bold; display: inline;">March &#160;31,</font></div><div align="center" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; font-weight: bold; display: inline;">2014</font></div></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" colspan="2"><div align="center" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; font-weight: bold; display: inline;">March 31,</font></div><div align="center" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; font-weight: bold; display: inline;">2013</font></div></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td></tr><tr><td align="left" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" valign="bottom" colspan="2"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" valign="bottom" colspan="2"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td></tr><tr bgcolor="#cceeff"><td align="left" width="76%" valign="bottom"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">Expected dividend yield</font></div></td><td align="right" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" width="9%" valign="bottom"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">0</font></div></td><td align="left" width="1%" valign="bottom"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">%</font></div></td><td align="right" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" width="9%" valign="bottom"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">0</font></div></td><td align="left" width="1%" valign="bottom"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">%</font></div></td></tr><tr bgcolor="white"><td align="left" width="76%" valign="bottom"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;"><a name="lineip"></a>Expected stock price volatility</font></div></td><td align="right" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" width="9%" valign="bottom"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">112</font></div></td><td align="left" width="1%" valign="bottom"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">%</font></div></td><td align="right" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" width="9%" valign="bottom"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">108</font></div></td><td align="left" width="1%" valign="bottom"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">%</font></div></td></tr><tr bgcolor="#cceeff"><td align="left" width="76%" valign="bottom"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">Risk-free interest rate</font></div></td><td align="right" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" width="9%" valign="bottom"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">3.63</font></div></td><td align="left" width="1%" valign="bottom"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">%</font></div></td><td align="right" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" width="9%" valign="bottom"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">2.60-2.68</font></div></td><td align="left" width="1%" valign="bottom"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">%</font></div></td></tr><tr bgcolor="white"><td align="left" valign="bottom"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">Expected life of options</font></div></td><td align="right" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" valign="bottom" colspan="2"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">.14-9.78 years</font></div></td><td align="left" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" valign="bottom" colspan="2"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">.47-9.78 years</font></div></td><td align="left" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td></tr></table></div><div align="left" style="font: 13px/normal 'times new roman'; color: #000000; text-transform: none; text-indent: 0pt; letter-spacing: normal; margin-right: 0pt; margin-left: 0pt; word-spacing: 0px; display: block; white-space: normal; -webkit-text-stroke-width: 0px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></div> <div align="left" style="font: 13px/normal 'times new roman'; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; -webkit-text-stroke-width: 0px;"><table style="width: 100%; font-family: 'times new roman'; font-size: 10pt;" cellspacing="0" cellpadding="0"><tr><td align="left" width="54%" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td width="10%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" colspan="2"><div align="center" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; font-weight: bold; display: inline;">Number of Shares Remaining Warrants</font></div></td><td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td width="10%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" colspan="2"><div align="center" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; font-weight: bold; display: inline;">Weighted Average</font></div><div align="center" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; font-weight: bold; display: inline;">Exercise Price</font></div></td><td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td width="10%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;"><div align="center" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; font-weight: bold; display: inline;">Weighted-Average Remaining</font></div><div align="center" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; font-weight: bold; display: inline;">Contractual Term</font></div></td><td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td width="10%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" colspan="2"><div align="center" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; font-weight: bold; display: inline;">Aggregate</font></div><div align="center" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; font-weight: bold; display: inline;">Intrinsic Value</font></div></td><td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td></tr><tr bgcolor="#cceeff"><td align="left" width="54%" valign="bottom"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">Outstanding at January 1, 2014</font></div></td><td align="right" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" width="9%" valign="bottom"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">7,671,267</font></div></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">$</font></div></td><td align="right" width="9%" valign="bottom"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">1.51</font></div></td><td width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="10%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="10%" valign="bottom" colspan="2"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td></tr><tr bgcolor="white"><td align="left" width="54%" valign="bottom"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">Warrants granted during 2014</font></div></td><td align="right" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" width="9%" valign="bottom"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">11,862,000</font></div></td><td width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">$</font></div></td><td align="right" width="9%" valign="bottom"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">.25</font></div></td><td width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="10%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="10%" valign="bottom" colspan="2"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td></tr><tr bgcolor="#cceeff"><td align="left" width="54%" valign="bottom" style="padding-bottom: 2px;"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">Warrants expired during 2014</font></div></td><td width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td width="1%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" width="9%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">(600,000)</font></div></td><td width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" width="9%" valign="bottom" style="padding-bottom: 2px;"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">.25</font></div></td><td width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td width="10%" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td width="10%" valign="bottom" style="padding-bottom: 2px;" colspan="2"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td></tr><tr bgcolor="white"><td align="left" width="54%" valign="bottom" style="padding-bottom: 4px;"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">Outstanding at March 31,2014</font></div></td><td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td width="1%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" width="9%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">18,933,267</font></div></td><td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">$</font></div></td><td align="right" width="9%" valign="bottom" style="padding-bottom: 4px;"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">.78</font></div></td><td width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" width="10%" valign="bottom" style="padding-bottom: 4px;"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">5.3 years</font></div></td><td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">$</font></div></td><td align="right" width="9%" valign="bottom" style="padding-bottom: 4px;"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">0</font></div></td><td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td></tr><tr bgcolor="#cceeff"><td align="left" width="54%" valign="bottom" style="padding-bottom: 4px;"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">Exercisable at March 31,2014</font></div></td><td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td width="1%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" width="9%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">18,139,250</font></div></td><td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">$</font></div></td><td align="right" width="9%" valign="bottom" style="padding-bottom: 4px;"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">.76</font></div></td><td width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" width="10%" valign="bottom" style="padding-bottom: 4px;"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">5.6 years</font></div></td><td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">$</font></div></td><td align="right" width="9%" valign="bottom" style="padding-bottom: 4px;"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">0</font></div></td><td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td></tr></table></div><div>&#160;</div> <div align="left" style="font: 13px/normal 'times new roman'; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; -webkit-text-stroke-width: 0px;"><table style="width: 100%; font-family: 'times new roman'; font-size: 10pt;" cellspacing="0" cellpadding="0"><tr><td align="left" width="54%" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td width="10%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" colspan="2"><div align="center" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; font-weight: bold; display: inline;">Number of Shares Remaining Options</font></div></td><td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td width="10%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" colspan="2"><div align="center" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; font-weight: bold; display: inline;">Weighted Average</font></div><div align="center" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; font-weight: bold; display: inline;">Exercise Price</font></div></td><td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td width="10%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;"><div align="center" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; font-weight: bold; display: inline;">Weighted-Average Remaining</font></div><div align="center" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; font-weight: bold; display: inline;">Contractual Term</font></div></td><td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td width="10%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" colspan="2"><div align="center" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; font-weight: bold; display: inline;">Aggregate</font></div><div align="center" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; font-weight: bold; display: inline;">Intrinsic Value</font></div></td><td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td></tr><tr><td align="left" width="54%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="10%" valign="bottom" colspan="2"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="10%" valign="bottom" colspan="2"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="10%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="10%" valign="bottom" colspan="2"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td></tr><tr bgcolor="#cceeff"><td align="left" width="54%" valign="bottom"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">Outstanding at January 1, 2014</font></div></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" width="9%" valign="bottom"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">1,386,108</font></div></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">$</font></div></td><td align="right" width="9%" valign="bottom"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">.61</font></div></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="10%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="10%" valign="bottom" colspan="2"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td></tr><tr bgcolor="white"><td align="left" width="54%" valign="bottom"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">Options granted during 2014</font></div></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" width="9%" valign="bottom"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">115,000</font></div></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">$</font></div></td><td align="right" width="9%" valign="bottom"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">.23</font></div></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="10%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="10%" valign="bottom" colspan="2"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td></tr><tr bgcolor="#cceeff"><td align="left" width="54%" valign="bottom" style="padding-bottom: 2px;"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">Options cancelled or expired during 2014</font></div></td><td width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td width="1%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" width="9%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">(70,500)</font></div></td><td width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td width="1%" valign="bottom"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" width="9%" valign="bottom" style="padding-bottom: 2px;"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">.75</font></div></td><td width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td width="10%" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td width="10%" valign="bottom" style="padding-bottom: 2px;" colspan="2"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td></tr><tr bgcolor="white"><td align="left" width="54%" valign="bottom" style="padding-bottom: 4px;"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">Outstanding at March 31,2014</font></div></td><td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" width="9%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">1,430,608</font></div></td><td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">$</font></div></td><td align="right" width="9%" valign="bottom" style="padding-bottom: 4px;"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">.52</font></div></td><td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" width="10%" valign="bottom" style="padding-bottom: 4px;"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">7.8 years</font></div></td><td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">$</font></div></td><td align="right" width="9%" valign="bottom" style="padding-bottom: 4px;"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">26,450</font></div></td><td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td></tr><tr bgcolor="#cceeff"><td align="left" width="54%" valign="bottom" style="padding-bottom: 4px;"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">Exercisable at March 31,2014</font></div></td><td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" width="9%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">772,308</font></div></td><td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">$</font></div></td><td align="right" width="9%" valign="bottom" style="padding-bottom: 4px;"><div style="text-indent: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">.64</font></div></td><td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="right" width="10%" valign="bottom" style="padding-bottom: 4px;"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">6.4 years</font></div></td><td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td><td align="left" width="1%" valign="bottom"><div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">$</font></div></td><td align="right" width="9%" valign="bottom" style="padding-bottom: 4px;"><div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">26,450</font></div></td><td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;</font></td></tr></table></div><div align="left" style="font: 13px/normal 'times new roman'; color: #000000; text-transform: none; text-indent: 0pt; letter-spacing: normal; margin-right: 0pt; margin-left: 0pt; word-spacing: 0px; display: block; white-space: normal; -webkit-text-stroke-width: 0px;"><font style="font-family: 'times new roman'; font-size: 10pt; display: inline;">&#160;&#160;&#160;</font></div> <div align="left" style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><br class="apple-interchange-newline" /> <table style="width: 100%; font-family: 'times new roman'; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr> <td align="left" width="78%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td width="10%" valign="bottom"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">Three Months Ended</font></div> </td> <td width="1%" valign="top"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td width="10%" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">Three Months Ended</font></div> </td> <td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td align="left" width="78%" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td width="10%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">March 31,&#160;</font><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">2014</font></div> </td> <td width="1%" valign="top" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td width="10%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">March 31,&#160;</font><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">2013</font></div> </td> <td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" width="78%" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">Expected dividend yield</font></div> </td> <td align="right" width="10%" valign="bottom"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">0%</font></div> </td> <td width="1%" valign="top"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="right" width="9%" valign="bottom"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">0</font></div> </td> <td align="left" width="1%" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">%</font></div> </td> </tr> <tr bgcolor="white"> <td align="left" width="78%" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">Expected stock price volatility</font></div> </td> <td align="right" width="10%" valign="bottom"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">134%</font></div> </td> <td width="1%" valign="top"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="right" width="9%" valign="bottom"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">90-93</font></div> </td> <td align="left" width="1%" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">%</font></div> </td> </tr> <tr bgcolor="#cceeff"> <td align="left" width="78%" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">Risk-free interest rate</font></div> </td> <td align="right" width="10%" valign="bottom"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">1.75%</font></div> </td> <td width="1%" valign="top"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="right" width="9%" valign="bottom"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">.14</font></div> </td> <td align="left" width="1%" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">%</font></div> </td> </tr> <tr bgcolor="white"> <td align="left" width="78%" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">Expected life of warrants</font></div> </td> <td align="right" width="10%" valign="bottom"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">4.1-5.0 years</font></div> </td> <td width="1%" valign="top"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="right" width="10%" valign="bottom" colspan="2"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">.8 years</font></div> </td> <td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" width="78%" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">Number of warrants</font></div> </td> <td align="right" width="10%" valign="bottom"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">15,562,351</font></div> </td> <td width="1%" valign="top"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="right" width="9%" valign="bottom"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">600,000</font></div> </td> <td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="white"> <td align="left" width="78%" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">Fair value of warrants</font></div> </td> <td align="right" width="10%" valign="bottom"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">$3,917,772</font></div> </td> <td width="1%" valign="top"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> <td align="left" width="1%" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">$</font></div> </td> <td align="right" width="9%" valign="bottom"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">185,400</font></div> </td> <td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td> </tr> </table> </div> <div>&#160;</div> <div align="left" style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><table style="width: 100%; font-family: 'times new roman'; font-size: 10pt;" cellspacing="0" cellpadding="0"><tr><td valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" colspan="10"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">Fair Value Measurements at March 31,2014</font></div></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td></tr><tr><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td><td valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" colspan="2"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">Total</font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">Carrying</font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">Value at</font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">March 31, 2014,</font></div></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td><td valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" colspan="2"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">Quoted</font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">prices in</font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">active</font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">markets</font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">(Level 1)</font></div></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td><td valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" colspan="2"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">Significant</font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">other</font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">observable</font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">inputs</font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">(Level 2)</font></div></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td><td valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" colspan="2"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">Significant</font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">unobservable</font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">inputs</font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">(Level 3)</font></div></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="#cceeff"><td width="52%" valign="bottom"><div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">Derivative liabilities</font></div></td><td align="right" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td><td align="left" width="1%" valign="bottom"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">$</font></div></td><td align="right" width="9%" valign="bottom"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">3,917,722</font></div></td><td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td><td align="right" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td><td align="left" width="1%" valign="bottom"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">$</font></div></td><td align="right" width="9%" valign="bottom"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">-</font></div></td><td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td><td align="right" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td><td align="left" width="1%" valign="bottom"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">$</font></div></td><td align="right" width="9%" valign="bottom"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">-</font></div></td><td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td><td align="right" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td><td align="left" width="1%" valign="bottom"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">$</font></div></td><td align="right" width="9%" valign="bottom"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">3,917,722</font></div></td><td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td></tr></table></div><div>&#160;</div> <div align="left" style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px;"><table style="width: 100%; font-family: 'times new roman'; font-size: 10pt;" cellspacing="0" cellpadding="0"><tr><td valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" colspan="2"><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">Year ended</font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">December 31,</font></div><div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">2013</font></div></td><td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="#cceeff"><td align="left" width="88%" valign="bottom"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">Beginning balance January 1, 2014</font></div></td><td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td><td align="left" width="1%" valign="bottom"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">$</font></div></td><td align="right" width="9%" valign="bottom"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">775,596</font></div></td><td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="white"><td align="left" width="88%" valign="bottom"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">Issuance of derivative financial instruments in 2014</font></div></td><td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td><td align="left" width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td><td align="right" width="9%" valign="bottom"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">3,020,526</font></div></td><td width="1%" valign="bottom"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="#cceeff"><td align="left" width="88%" valign="bottom" style="padding-bottom: 2px;"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">Net unrealized (gain) loss on derivative financial instruments</font></div></td><td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td><td align="left" width="1%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td><td align="right" width="9%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">121,650</font></div></td><td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td></tr><tr bgcolor="white"><td align="left" width="88%" valign="bottom" style="padding-bottom: 4px;"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">Ending balance as of March 31,2014</font></div></td><td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td><td align="left" width="1%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;"><div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">$</font></div></td><td align="right" width="9%" valign="bottom" style="border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;"><div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">3,917,722</font></div></td><td width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">&#160;</font></td></tr></table></div><div>&#160;</div> 346014 150299 0 0 1500 1500 7500000 7500000 1430608 18933267 0 143481 1028136 9540 6629 500000 500000 750000 0.10 750000 1250000 2014-12-21 1018500 1018500 1250000 1.38 1.62 P1Y P10Y P5Y 1839250 820750 820750 1500000 0.20 11250000 0.25 100000 0.09 2868750 2878750 1400000 1468750 1255000 1.20 0.25 1.20 0.25 423125 600000 3060000 15562351 0.00 0.00 0.00 0.00 1.08 1.34 1.12 1.34 0.0014 0.0363 0.0175 0.0014 0.0260 0.0173 0.0260 0.0268 0.0175 P10M24D P5M19D P4Y1M6D P1M21D P9Y9M18D P9Y9M11D P8Y9M18D P9Y9M11D 7671267 1386108 18933267 1430608 11862000 115000 -600000 70500 -70500 18139250 772308 1.51 0.61 0.78 0.52 1.13 0.25 0.23 0.23 0.25 0.75 0.76 0.64 P5Y3M18D P7Y9M18D P5Y7M6D P6Y4M24D 0 26450 0 26450 118378 419368 2.80 1.10 250000 0.29 25000 13575 135000 115000 160000 141650 Either immediately on the date of grant or 1 to 3 years from the date of grant. 76198 Employees forfeited salary over a twelve-week period to purchase common shares 55969 169368 250000 1550000 50000 No less than 100% of the fair market value of the common stock on the day of grant. 287171 72500 160751 65992 0.93 0.90 1.08 0.93 0.73 0.25 646375 11878000 126420 4962 Vest from six months to three years from grant date. 62623 600000 0.00 0.00 185400 3917722 3917772 3917722 775596 3917722 3020526 121650 612000 P4Y1M6D P5Y P9M18D <div align="left" style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px;"> <div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt; font-weight: bold;">Note 8- Subsequent Events</font></div> <div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div> </div> <div align="left" style="color: #000000; font-family: 'times new roman'; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px;"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">In April 2014, we issued 440,000 shares of our common stock to one of our outside attorneys (Schwell Wimpfheimer &amp; Associates, LLP) for legal services rendered in satisfaction of a $110,000 account payable to such law firm.</font></div> <div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'times new roman'; font-size: 10pt;">In April 2014, expenses totaling approximately $200,000 that were recorded by the Company as accounts payable as of March 31, 2014 were approved to be paid by the Company&#8217;s director and officers insurance policy, with such payments expected in May 2014.</font></div> </div> 200000 110000 EX-101.SCH 7 aspw-20140331.xsd XBRL 001 - Document - Document and Entity Information link:presentationLink link:definitionLink link:calculationLink 002 - Statement - Balance Sheets (Unaudited) link:presentationLink link:definitionLink link:calculationLink 003 - Statement - Balance Sheets (Unaudited) (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 004 - Statement - Statements of Operations (Unaudited) link:presentationLink link:definitionLink link:calculationLink 005 - Statement - Statements of Cash Flows (Unaudited) link:presentationLink link:definitionLink link:calculationLink 006 - Statement - Statement of Shareholders' (Deficit) (Unaudited) link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - Description of Business and Summary of Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - Going Concern link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - Debt link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - Stockholders' Equity link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - Stock Based Compensation link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - Warrants link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - Derivative Liabilities link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 015 - Disclosure - Recent Accounting Pronouncements link:presentationLink link:definitionLink link:calculationLink 016 - Disclosure - Description of Business and Summary of Significant Accounting Policies (Policies) link:presentationLink link:definitionLink link:calculationLink 017 - Disclosure - Debt (Tables) link:presentationLink link:definitionLink link:calculationLink 018 - Disclosure - Stock Based Compensation (Tables) link:presentationLink link:definitionLink link:calculationLink 019 - Disclosure - Warrants (Tables) link:presentationLink link:definitionLink link:calculationLink 020 - Disclosure - Derivative Liabilities (Tables) link:presentationLink link:definitionLink link:calculationLink 021 - Disclosure - Description of Business and Summary of Significant Accounting Policies (Details) link:presentationLink link:definitionLink link:calculationLink 022 - Disclosure - Going Concern (Details) link:presentationLink link:definitionLink link:calculationLink 023 - Disclosure - Debt (Details) link:presentationLink link:definitionLink link:calculationLink 024 - Disclosure - Debt (Details Textual) link:presentationLink link:definitionLink link:calculationLink 025 - Disclosure - Stockholders' Equity (Details) link:presentationLink link:definitionLink link:calculationLink 026 - Disclosure - Stock Based Compensation (Details) link:presentationLink link:definitionLink link:calculationLink 027 - Disclosure - Stock Based Compensation (Details 1) link:presentationLink link:definitionLink link:calculationLink 028 - Disclosure - Stock Based Compensation (Details 2) link:presentationLink link:definitionLink link:calculationLink 029 - Disclosure - Stock Based Compensation (Details Textual) link:presentationLink link:definitionLink link:calculationLink 030 - Disclosure - Warrants (Details) link:presentationLink link:definitionLink link:calculationLink 031 - Disclosure - Warrants (Details 1) link:presentationLink link:definitionLink link:calculationLink 032 - Disclosure - Warrants (Details Textual) link:presentationLink link:definitionLink link:calculationLink 033 - Disclosure - Derivative Liabilities (Details) link:presentationLink link:definitionLink link:calculationLink 034 - Disclosure - Derivative Liabilities (Details 1) link:presentationLink link:definitionLink link:calculationLink 035 - Disclosure - Derivative Liabilities (Details 2) link:presentationLink link:definitionLink link:calculationLink 036 - Disclosure - Derivative Liabilities (Details Textual) link:presentationLink link:definitionLink link:calculationLink 037 - Disclosure - Subsequent Events (Details) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 8 aspw-20140331_cal.xml XBRL EX-101.DEF 9 aspw-20140331_def.xml XBRL EX-101.LAB 10 aspw-20140331_lab.xml XBRL EX-101.PRE 11 aspw-20140331_pre.xml XBRL EXCEL 12 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0`!@`(````(0"I^C`/Y@$``,P7```3``@"6T-O;G1E;G1?5'EP97-= M+GAM;""B!`(HH``"```````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````#,F-%JVS`8A>\+>P>CVQ$K MDM:N&W%ZL767;:'=`VC6G]C$EH2DMLG;5W;:4DJ6$A;8N8E)+/WGB\`?^,PN MUGU7/%"(K;,5$^64%61K9UJ[K-CONU^3^[MM8ID_(':]ZE3)X3RKQS7!.; MUL?/&8/QG0G#G;\'/.^[SD<36D/%C0[I2O<9@Z\[_NC"ZH]SJW+_D!V4;K%H M:S*NON_S"931!](F-D2I[\KQ6O:ZM2_<>_+'Q9&/%W%DD.'_C8,/Y)`@'`J$ MXPL(QRD(QQD(QU<0CG,0CF\@'&**`H)B5(&B5('B5($B58%B58&B58'B58$B M5H%B5HEB5HEB5HEB5HEB5HEB5HEB5HEB5HEB5HEB5HEB5H5B5H5B5H5B5H5B M5H5B5H5B5H5B5O6_S)IR5TI\_/SW!W<<\T%9%].FHWCD%^SMT(^2&QW(W*:0 M6^6C`[R=O8\C=ZXWP?F8V^=`AY_"2[T\[)[X/(A":NFU8-Y5U+XFYN;Z\,!W M33$-W;@ALR.;CUW\_`D``/__`P!02P,$%``&``@````A`+55,"/U````3`(` M``L`"`)?]=J>*V?5@^@8B)G:13'&HX<85?=WFQ?>*24 MFV+7^ZBRBXL:NI3\(V(T'4\4"_'L)MI<3_3_MCAQ(DN)T$C@\SS?BG-`Z^N!+I]HJ?B]SCSBIX3A M363X8<'%#U1?````__\#`%!+`P04``8`"````"$`\*#N9/0!``#)%@``&@`( M`7AL+U]R96QS+W=O_4G9E2_HBT%[12 MKRP\@)6X346;1+9AZ=MC%384B?UV#]%<(ME1QI\^C^?YU>FB,FUM=MUK2_-P4>S7)S]N+WW.Y?R1['9]K'( M4=I8FB:E_L;:6#5^[^*DZWV;WZR[L'3J=VW`:PRR^Q"Q6 M=6G"JB8QQ<.ASTO_.WBW7F\K?]=5SWO?IF_6L+^[\!0;[U,.ZL+&I](,4]$> MWY!,LF9C_R(G^Z$KYPK)X;FR')XC.7(]IIR8#KN<;L-.O8_1^DQCKC]DQJ>$ M8>HC69B0')DIRY$9DG.IK.82B2%65D,,Y6B;0]`=OE!VAR^0.Z)=A`4681FU M"*<,*Y_M_N#!<6B/3WBXM?,7IZ\V!PAR@',;H4I)GJ+TY5&Q-##@,V>&J3]8 MN$9RM"$%TU@[<6#>D+HUT!O6YC=#?HMVR1%8"53K0KLN"2/.JQ^@]W M"**0'+[Y0?TX@T``/__`P!02P,$%``&``@````A``PG?]>H M`P``XPL```\```!X;"]W;W)K8F]O:RYX;6R4EEM/VS`4Q]\G[3MD$:\CMW(5 M+5IIV9"F#:T%'B,W<8E%:@?;:>';[S@EZ4D<.O;4GB3G[W/YV3X7ER^KW%E3 MJ9C@0SSGZ_.EB(^330H@G M!P2X&KJ9UL6YYZDDHRNB#D5!.;Q9"KDB&DSYZ*E"4I*JC%*]RKW0]X^]%6'< MW2J&KC!7*'5TL64[OMQDYI"A^D17$_9*[ M3DZ4GJ9,TW3H'H$I-K3U0);%N&0YO#V+_,CU1DV2M]))Z9*4N9Y#>K4ZU"L< MA.&Q^=*4XI[1C=HY&=-Y>6`\%1OS*93VM;$B"&!3O7I@J<[@O>_[S;,?E#UF MNGX(\A[2KRH(ZU2_#J_2JRL20Z?B*==,O\8W?%M])J"%INHWD%G@.O*)#*`*D,NK&T5:Z(RN)KZ/A;5D@%BMY4Y.A=%1/*+(,T M,I&G`%<\H4N&5(Z12@4$SFA"52)982`U.N-2,4Z5JIHU*Y%*!+NM">:D&\QW M`;LROA+0(MFJYAGR.NUZ3>A"HR4&@&&SQ%GWXYD6R5.=XO2Y!(ZP;XL>O]`JCJ'%3`_@07@`Y&20..Q!V8EL)";4,G6L,J:QC\96;"<:09' MU`ZU`:8DL&$K%XH^ET!;/%T;YK`K1B.P"/M#$^/V+4E$"3L.6G,K!8?_B:$7 MZV`X`HNQ_71`R9MM,SA!O0MZ,%OH>$X6>;L`F*G`@JKJ>$_3MD)X<4Q98&%6 MM\X.X`@3%UC(]7>P1P;#!X=IY^S:7T7`KJEBV!*R&&SM,MCFFK`<4Q%BA,&P MXH`F]'AAC$,+0[-):Z]X3E]T2>#"VH6,(0XM$GMV;2V&1(Y:@5L8O@M"E0S2 M@0MO=X)L;S]\V.W7P3B'&&2OL.VQJU5DH8V,@" M=G]`N+5F3FJN*S#^*S/MC8+VB5HMAVMNL^0'\7]-J.?EOMB5U_:8K];T5-(=J0 M)YZ!'6/O7/I]SV_!R\[D[;<^`[\WUIX>LDO9_<&NO]+B>.H@W0%XQ!U;[;]> M:9M#1,',$@?<4LY*`("_5E7PTH"(9)_]_VNQ[TX;VPN70>1Z".36CK;=6\%- MVE9^:3M6_2-$2)H21K`TX@&]?([G&G$$4._?:]9EVW7#KA84#2S9GC->@F@% MAF^."8S!U7N>@HO>OG(B M)%`!`YNO*])'"@T-UIF/QL50@J-U(V/A1$CB/I<(QR1R#3)-X)+05Q8T,/!N M/A@7&V"!OFXB))$`BPG&H2Y(=4&$/15U#2Q\!HR+#3!CW41(!-@B)%Y@"%)- M0$A`XH%<`XN>`>-BH\JBP:SH`"&!L-RMLD<*#8WO9Z-I\;@5N=B(&3'0A$3$ M#.,`&>CI^#G"8>`I`QI7K'/Q*>;!D'_,QU\R^%1&1.B$1/#Y.`A\HQK3L2#R M?.2I-M$`$=#,CUROUM&(,BS0I$:R^<0-U=#J%:FF(*$;AG>BA_CDG9W67FW` M&:,\D1K9#`$*?:36EG1BW$M)[,H0WKS>0&.\: MIAKP$E-H;I@8A8%BD$D>2R+DNTJ@0_*A/8)\W+C\R\OH7&(T9B(U$BX*7.A- M??BDN@0A%X?1O1)\:K-`T]V"&)M!(C6"#Y'(X$_E\Z#?YX*[<7MJKT!BSFM) M50[+I`J-V/@748`QF72N)H&X>>ANW(P-8V;Q37<.$R)!0@,SCG]M+MRE:Y1G M.E6HZ:X7W__:/>"X,2E"M8`,YGA[0,2/`R]4'2!;1--`"88D5L4@0,6Y1'RW M5[0YTI2696OE[,+/'!A",-P=SD,OF'\#&_<3?D[B]YWA`1Q3SMF1_LB:8U&W M5DD/8-)=1M!CC3CHB(N.G?O3PHYU<$#I?Y[@0$KA&]M=@OC`6'>[X`L,1]SM MOP```/__`P!02P,$%``&``@````A`!]-\*4(!```-0\``!D```!X;"]W;W)K M&ULE%??CZ)($'Z_Y/X'POL*#0RH$3>CD[G;Y#:Y M7.YVGQ%:)0.TH7&<^>^OBD*P&Q;1!Q7X^.JK'UW5O?KZD6?&.R]E*HK09#/; M-'@1BR0M#J'YW[^O7^:F(:NH2*),%#PT/[DTOZY__VUU$>6;/')>&<%Q61E#R+*M`OC^E)7MGR>`I='I5OY].76.0GH-BE65I]UJ2F MD?IW$II-A7,Z"S2&C?YX6UL(!IO4I2\`## M;I1\'YK/;+EE"]-:K^H`_4CY1=[\-^117/XHT^2OM.`0;<@39F`GQ!M"OR5X M"UZV>F^_UAGXNS02OH_.6?6/N/S)T\.Q@G0_@4?HV#+Y?.$RAH@"SF`X32ICJ'I^K.GP'89P(T=E]5KBI2F$9]E)?*?!&(- M%9&X#0G\-B3,F4IBD:#:OY>HBM:K4EP,*!HP*4\1EB!;`O'5,9+1NOHK3\%% M)'E&EM"$:@T%\Y7U#B&-&\RFCV$J8GM%8"9`7JL1HG:K<3CH5RD( M1BF8!-2VH1O`W6IS-+M]1-!!%"40H>E*$!R:WHUA+UBHIC>$@1IHQ7DJ8CN& M4+2!H>G:$`Q%>&MW;JN6-X1A=IU/+&SU^9:>#VM7E`%DNC($Z\JT0MD0)JB% MN;9OPT?31@CX'HBKHLU_1!N"56VNUU4*E1MAABW7B.T80M$6/*(-P?>JC3!C MVL80BC:<;%K?<*&MCJ]-?$F-GS?7XT>87U>=]CQPV\PK^A:JOG%="-9U=;R4 M5\)0S3$V#^;]HKN%^)[O!MV*4;2!5/30,:K0>.ZW#;AK0J#P: M$8LZ=+[C.UUUJ,'#;CT]>-3;U>!U?E/=,0)19.I6I^5^VR"&]:ORM!F!T_[^ MJF5#P\)OT]/(')L&U/<:GBDZ`?-`&!%]K_7A;@U`P\8;?6,0-8X/30W6'QM> M;]@VH('5V8B;/#780V.C1NLK)-"32V.!RM];^%WK:,3=/F>.[SE=C:J!T\;& MG>;2GQ?NHF.N;6\8@93$SK6]YW8(U/JH*M0&Q\0E,C1!]+T>'%!Z):B[@Z>8 M'DA32J<4VL7GO#SP+<\R:<3BC"<0!WI4>[<]'3T[N"'6[F_PU(3WK?8!'%I. MT8%_C\I#6D@CXWN@M&D8P]=5.)4GQUVHH+C2OWW",=3#AMN>P;@O1#5 M]0(-M`?>]?\```#__P,`4$L#!!0`!@`(````(0"N/#I,IP,``'(,```9```` M>&PO=V]R:W-H965T^W"P^/1>Y\\2D MXJ)7CKKI)1%$!Q9KG7+_4 MI*Y3)/-OFU)(NLXA[V<2T>3`7=^>IWB[=<.*-XU%(`.ZLF=(/W%"Z3K)36A3_$$0:*B0) M&A+X;$B"T(N"<3R]@L5'176"]U33U4**O0.[!F*JBIH]2.;`?,@,=;2YGDL5 MC(P8*&B;8#2<8-2/;#P/84^^ MGJA9M'3AVK*'4<>/"A!SA0*`'%ML%$3P['4%9E'?@XB$;8:H`#%QO07B24R" M2=PB>NY/3A5<]L`LLA3$M@+$H`)"IA-HE:-A"?%[))A%E@0R;OG1!,2@A)L) MQ#^GP+P?K,-WN0QFD:U@8BE`3&/"=!:&9^LP.Y5PN0YFD2VAJS.:@)B#!!+. M@O&9.A#8^[8-ES74JVP14\N'!@0?IB<1;WRFY1#3G*Q*7"$!6]IQ5XAB^TS6 MU-!=48)Y0;0:>P>"6&WONJY0K[)B8F_`(FM5G\EQ/L%KC MA;`#/3'H=E@3%D'#87'TP\FH8'+#/K,\5TXB=F:L(R"U?=J.G+=!/32V/\#$ M5]$-^T'EAI?*R5D&2T=>##Y+G!GQ1HNJGKO60L.L5W_=PFS/8'H9>0#.A-"' M&S.5MO\65O\!``#__P,`4$L#!!0`!@`(````(0`W&\3F;P,```L+```9```` M>&PO=V]R:W-H965T=/LRUES[S"6#C@ MT/+,K83HIK[/BPHWB'NTPRT\65'6(`&7;.WSCF%4JD5-[4=!D/@-(JVK':;L M&@^Z6I$"/]!BT^!6:!.&:R2`GU>DX[U;4UQCUR#VO.EN"MIT8+$D-1%ORM1U MFF+Z;=U2AI8UQ/T:QJCHO=7%D7U#"D8Y70D/['P->ASSQ)_XX#2?E00BD&EW M&%YE[GTXSGN%BZ^)5(`/2*#YC-&M`UT#>_(.R1X,I^#<1Z8YAEC/A0HQ M2I-[Z9*YT.X0!8?ZO,SC))KY+Y#38J=9'&M"4Y'W"ED*P!L8(?)#QM-9[U&D M6*+(*DBVA;X!W@.;198?*]*]Q""!#%U/(L50Z8.-XV1DAKS0&FB"`2XV%?DE MA<$6FVRRDO'9'NVS)1>![F#_46PS:LTEQDL*@Q%,KL^?%)OYBZ+`S,Y":Y)( M]9SU,#_ST"!*/D(DQ3;1OE-TNVG-CBCT1G8]]7-`.U%Q@RPUR60]1W!R7>Y^ MN<@DC!.+8*$UIPE4#+E6]%GU)ON.,`CEZ\TZ.]XGE(MLPK%55:VY1*@50Y:# MV\'!()R8A)=S)\4666"3:O;0K^8& MLS7.<5USIZ`;.5?(\VVX.\P\]VKDL>XOY"RDIIGA`8PB'5KC'XBM2T'*+41#'_#P`` M__\#`%!+`P04``8`"````"$`2??*Y[H%``!3&@``&0```'AL+W=O'MZI^:?92MA8P')N5 MO6_;T[WC-/E>EEFSJ$[R"/_95G69M?"VWCG-J9;9IKNH/#CNI&]O.XT.W0/\6\JT9O;::??7V6UUL_BB.$E8;\H09 M>*ZJ%X1^W>!'<+%S'2``>+3*`DL#5B3[T3V_%9MVO[*]"B^(H'G4*6E0V-!^O90*5\ M?_2]X,'Y#MG-%28A##SV&"_4,.M+'L%9TC,""P7V)+Z8@^H@,OTG5X/3_I((Q)!R&B;J5%$"SACW.D)@ZF M`C-`XT@9P`L]+QP&&`\? MO>[F6A+DD&S0^KI=*)!1!_$8(*EB(:GN722B881Q)>B,MRLA/^5*AB%(S2T( M9`ASK2`49AC$L3;H4@80X3(*WM.!%CG2,5-0B.8%Y?M#KE7\!#+&/PM)A0G" M4X'N>+T$\E)X'/85%WL/83+<3N5Z'I(:(5P"+-98PG7[#_SFH&#/CD2,]/DY*IQ!!MLJ%#/GN@D@4:#H()85X5,V$ ML1=J(SLUDC`E[DT&WJ&U>1MHFX=$@4P*YB&I$<(E:"9NKB:73-<\;Q7(*&'> MO(TL7(+FWC,2)EP[T/4A*YX`>]'2@A!)CFX$+0:D>M/9,*,F9@'SF%UHV).^_>\Y#4".$20.8- M$A`]=_B!QWD`FEX_FDKSD-0(X1+0%D=9N&[`NF2F+!M"WPXJD%'*V;?QF`V. M/G6G4Q3P-0,!8B'0W`!FG'/Y&#"L,/ABTMW[P3. MYV=;@QFV+T)]5XR'_$ARMG1V/$("Z`R?#I9+6>_D6AX.C957KW@^[T(E]I_V MOQT\N7C^JGV^AM\4N@-XI_\''.F?LIW\EM6[XMA8![D%RN4B@J34]*,`O6FK M4W><_5RU<)C?O=S#CS<2SG>7"P!OJZH]O\'3X_[GH,?_`0``__\#`%!+`P04 M``8`"````"$`H#5%'/8"``!T"```&0```'AL+W=O+Q)92::(B&_?MY?S8BG M#6LR5LF&)^2%:W*]^OAAN97J49><&P\8&IV0TIAV$00Z+7G-M"];WL";7*J: M&;A51:!;Q5G6!=55$(7A)*B9:`@R+-0Y'#+/16.01/&*&="O2]'J M'5N=GD-7,_6X::]26;=`L1:5,"\=*?'J=/%0-%*Q=06^G^F(I3ON[N85?2U2 M);7,C0]T`0I][7D>S`-@6BTS`0YLV3W%\X3[J4 MV\]*9%]%PZ':T"?;@;64CQ;ZD-E'$!R\BK[O.O!=>1G/V:8R/^3V"Q=%::#= M8W!DC2VRESNN4Z@HT/C1V#*EL@(!N]^MR$R9D'CBCZ=A3`'N MK;DV]\)2$B_=:"/K/PBB/1621#T)_/8D=.R/HO%T=@9+@(HZ@W?,L-52R:T' M4P,Y=AX M,3-BH*'.X,@AC@R.CC/;FL`ALT MK,&^A:@`,=-N!"B=Q=.9DWA4@LDE`FS04,"^N2@`,;`8V"&,_!/II\?IWZ^\ M!0_3QLX6ID4,^H[&(1P.<.3;[@B#S^W?K;=!0P'[T4(!B.E]PS(TFQ\=)^HP MOT2.#1K*&(SJ/)R<$@.`+"M)%#24,)Z$']26A/K5=V1][Q=@@7/QQ M;:RY*O@G7E7:2^7&+NP4YLD]=9O.3=1M&^X%K/DM*_@WI@K1:*_B.82&_A2^ M"H6[!MX8V78K[UH:6.V[RQ)V=P[K5^@#.)?2[&[LON3^+ZS^`@``__\#`%!+ M`P04``8`"````"$`_??5W;`#``!T#```&0```'AL+W=OO7A6/9O[UM:Z<%RHDX\W")5[@.K0I>,F:S<+] M^=_3W<1UI,J;,J]X0Q?N&Y7NU^67/^9[+I[EEE+E`$(C%^Y6J7;F^[+8TCJ7 M'F]I`Y^LN:AS!;=BX\M6T+SLDNK*#X,@]>N<-2XBS,0M&'R]9@5]Y,6NIHU" M$$&K7`%_N66M/*#5Q2UP=2Z>=^U=P>L6(%:L8NJM`W6=NIA]VS1P/E(]+3GJ3_U`6DY+QETH&5W!%TOW'LR>R`3UU_. M.X%^,;J71^\=N>7[OP0K_V$-!;5A3GH"*\Z?=>BW4C^"9/\D^ZF;P`_AE'2= M[RKU+]__3=EFJV#<"72D&YN5;X]4%J`HP'AAHI$*7@$!N#HUTZL!BN2OW>N> ME6J[<*/42[(@(A#NK*A43TQ#NDZQDXK7OS&(]%`($O8@\-J#A)$7ATDVN0'% M1T9=@X^YRI=SP?<.;`W4E&VN=Y#,`/G0&?(PO5YJ%7K4(/<:9>'"ND,7$N;S MLHQ)./=?0-.BCWG`&+B:&&(B?&!C*`&-8TKG13Y4UL&ZLA9=4WG`!\=E!B*C M,M%'RNA@F-H1^2B9&/I8&6-@H*;!V$2,*L?CREKS"';R_49UTL*%JT&/XL#@ M(P.,N8$!A!Q+K!G$\.Q]!CIIK$%,(HL!QF3="I!HDI)@4&FD07K*X+H&.LEF M,&B,&F!,SX`D03"(-"*0?8:`3K()))8$&(,$[K(`&)B`$0']XV!]\Z[/0"?9 M!%*#CPI@3*]`'`7II1E,3QEEN#ZPRZ+)O" ML&8H0A\$+]J-`B^]8#9$VY(UAALHH)D=^T%,II8*'33XZH%".'Q91HM`+,.[ MS0^Z+$N%<%BU7H7>#0\4LF%9QQ2T=WUC;JG@$%P-?8=AY=H?,H;R1ES#(=Q M]S0P:$QC\(^Q&I9#OO_C0,Y88VC[0A\T[;Z381HGP[Z.2UO>>*7T&5,,3_P` M@RZ7QL,?GHUJ*C;T3UI5TBGX3A_L"%`V3\VA\S[LCHWF`SCSM?F&?L_%AC72 MJ>@:4@,O`[T%GAKQ1O&V.WFMN(+37O=V"Z=["N>7P(/@->?J<*//I>;_PO)_ M````__\#`%!+`P04``8`"````"$`\])/?%`#``!["@``&0```'AL+W=O:9",E[/W=`+7(?6 M*<]8O9F[OWX^W(Q=1RI29Z3D-9V[KU2ZMXN/'V8[+IYD0:ERP*&6<[=0JIGZ MODP+6A'I\8;6\"3GHB(*+L7&EXV@)&L'5:4?!<'0KPBK7>TP%==X\#QG*;WG MZ;:BM=(F@I9$`;\L6",/;E5ZC5U%Q-.VN4EYU8#%FI5,O;:FKE.ET\=-S059 MEQ#W2YB0].#=7IS85RP57/)<>6#G:]#3F"?^Q`>GQ2QC$`&FW1$TG[MWX705 MAJZ_F+4)^LWH3O;^.[+@N\^"95]932';L$ZX`FO.GU#ZF.$M&.R?C'YH5^"[ M<#*:DVVI?O#=%\HVA8+E'D!$&-@T>[VG,H6,@HT7#=`IY24`P+=3,2P-R`AY M:7]W+%/%W(V'WF`4Q"'(G365ZH&AI>ND6ZEX]4>+VH@ZDVAO$@.]?A[%7A(- M1N,K7'Q-U`9X3Q19S`3?.5`U,*=L"-9@.`7G0V2:HXOUK5`A1C2Y0Y>Y"^4. M44A8G^=%$B0S_QERFNXURU--:"I6!P4N!>!UC!!YG_%\U@\H*$847`5D6^H; MX-VQ1=:\IXK146*00(:N)T$QK'1OXG@P-J=>:@T400=GI6UU26&P)28;KF3R M9HT>LH6#0->;/XXG%J/67&*\I#`8P>3Z_*'8S%\4!1:;U@RCMN:LAZLW'AI$ MP_<0H=@F.E:*+C>MV1.%7@A;=>]CE[RE#H[U85".WD.)8ILRMO*F-7O*V!M& M$^/SZ<8*:Z4'0$;/%*J!BCVOMZ%J.7K?7<-5A#^YWZATBS MZEZO6V%%Q8:N:%E*)^5;[..XGW1WNS/&781=Q;J_Q+-'>WKH'D#K;\B&?B-B MPVKIE#0'R\`;`;;0AP=]H7C3-N`U5]#TV[\%'/(H=*W``W'.N3I<8$_$0TO; MP1=_`0``__\#`%!+`P04``8`"````"$`N7U+$<4%``!K'0``&0```'AL+W=O M: MD4:CN3RGP4!4@E&2EIY_/]NQD\:&>D-?2C%?5NSE;6>!E]_?RZ/U1JNZ8*>5 M[8ULORPNK7NH#I8T% M"J=Z91^:YKQPG#H_T#*K1^Q,3_#)CE5EUL#;:N_4YXIFV_:B\NCXKCMQRJPX MV4)A4=VCP7:[(JFJ$2$6/60/]KP_%N>[4ROP>N3*K7E[/WW)6GD'B MN3@6S<]6U+;*?/%C?V)5]GR$<;][899WVNV;*_FRR"M6LUTS`CE'=/1ZS'-G M[H#2>KDM8`3<=JNBNY7]Y"U2W[>=];(UZ-^"7NK!_U9]8)>T*K:_%R<*;L,\ M\1EX9NR%HS^VO`DN=JZN)NT,_%E96[K+7H_-7^SR&RWVAP:F>PPCX@-;;'_& MM,[!49`9^6.NE+,C=`#^6F7!2P,L_$]`GI02(KX4@5@-Z:#!@2'VXX2Y'X[S M=OUUP^$P'T[7D:AK^!B?K_5=$'#WW@&-B%$B00ER34RUVZ37R`>A.`(%/72$ MSWP`Z]OL#+](<49OV(B&H1'!+%3-BF\Q8Y5)[F#(#2;\&&U;0^D-9C;I[Z4X M$G[%$7Z1XHC>L!$-8DMJRUIO2+J&C^*Y\HQT3%>3:==P^R)E8+!G#:?:/,4< M7MF@WE=R,)OVAK6F1H*!OSVC3?$&)6*42%""H$1J(A2/8$L>>G3?"48Z,>G7J%$+(AIN[-Z8]=5IR,Q?TQ0_=1$*"[!(V+HDKF2.*RY M,YNI78\$8W(')6*42`0Q[_US=0L)JI&:",4CGET'CU2S1QS6/9IK'@G&Y!%* MQ"B1",)S6Y,@CJF=(*A`:B(4@R#R#`WB2RV$T9F-XA=I1HWU;4DP)J,$(1;2 M%!;252'$*)&@=R$HD9H(Q2N8#\4LLTDMK;DTUW:+2$(FFVX@P5R+:_$-2'L* M)#A"<"0U(JI;//X-UMY]N[@G0J.RC<^U^H\D9'1-Z,AM&KZAW"@O7";!$8(C MJ1%13>.1\7'31-!43;O*_`(RFB8#:[_O:$$P]E"-!$<(CJ1&1'6,A\K''>-7 MZ8M36S&1)R"C8R@2XRH)CA`<224B2U[=3U7+>%Q]W#(19'HDY;_``&1T3"!B8OW9 M9`9/2S41Q+A*@B,$1U(CHGK&@^R@RI"GI8B]:G7IF<(S9>,VX6\DTGDUO>45 MJI+@-R(XDAH1U2L>:`=>W?FL%#%8]4P/]9XI*TO/!"(WCE#=.5HDQE42'"$X MDAH1U3.><0>>(?4E$K'JE;;S1)XI-DNO!"*_OH0WUR*JDN`W(CB2&A'5*YYQ M!U[=65\B&0\]@^)0=Y[(,\5GZ9E`9'WY8Y[%5)485TEPA.!(:D04S_R'TGY+ MJWM]Z&HI/9(09&C^LRS_F5VU88,!L00,3XL$1XAZ&T__?ID:)523M)!O7H3^ M=;@/73W<2TA42^!.KH/[1B(&%V(<27"$*'T)?7[2H+9^>$U"`=" M>H8(73W:2\C@QT8BPM6)!T=O^A+$11(<(3C"S[@^3SS",G&&)0Y'2EKMZ88> MC[65LU=^/A7`\NE;^[.SIY"?$6CM$9RIM;_VZNW^(FIYI_\`CKK.V9[^D57[ MXE1;1[J#6[FC*;A:B<,R\:9AY_:HYIDU<,C5_GN`0TT*AR3N".`=8TWW!CKD M],>DZ_\!``#__P,`4$L#!!0`!@`(````(0#+',S["`0``%4.```9````>&PO M=V]R:W-H965TS^OJ69]HKKV0J MBK7.C(6N\2(625HU7!8'4Q95CQ*FD%Y9EJ+A6?F45KH MY+"L;O$0^WT:\R<1GW)>U&12\2RJ@5\>TU)>W/+X%KL\JEY.Y4,L\A(L=FF6 MUN^-J:[E\?+[H1!5M,M@WF_,B>*+=W,PL<_3N!)2[&L#[$P"GX"D8;$Y&/S<9^+O2$KZ/3EG]CSC_R=/#L89TNS`CG-@R>7_B,H:(@HUA MN>@4BPP`X%O+4RP-B$CTUOR>TZ0^KG7;,UQ_83.0:SLNZ^<4+74M/LE:Y/^1 MB+569&*U)O#;FECL;A.[-8'?UH3=3&+2K)H@/45UM%E5XJQ!Y0&W+".L8[8$ MXTMT:"Y=O#X*%\0)31[19:W#(P.1D)#CUXT3L)7Y"GF)6\UVJADIPHL"TPEX M'2-$;,\&XJAH@?WM2:)(XW?I-5>>`OXC-A( M<9U>80/)[6PH5MFMD2(D!7Q?B:S"YMW#AF*5S79&=]Z2 MYOJ=&_IP3J&P^2K;;76'@SZK.]+,,$PTSBAI6B)FV.-GE*Y?CZ9"QF#1&`8+$VI_NI`THU1& MQQLQ;%O1=0@JNU9RB:P1=(^S"HGK\2"C-T+2*CY<4AS/[>Y`CRTCT2PD27I( MN_-0*>_J#HS6^B&=9?7.+1V)NCS[+JYYW.6YW>!:'%)-!O,*Y+@(\*[&@B;=A#'&W>W5J00CJ<17A-U,U5C M"$9WQ!#5:@P=KR_Y-H8D&A+:XT88XK81G(:B_NE3">]J)FS:3:9=N!51&V:N MZUFV.]E`D1%IFD;=+YLJWZBA?%*%U`.@AOH>.NG$L(?'X`Q:\6`3U009M_F] MA'UQG<%&@O!H%T\;U)Q7!Q[R+)-:+$ZX0\=.T)WMWAX>+=SKCWSCL)1<& MB/="U)<#O$'W0KCY'P``__\#`%!+`P04``8`"````"$`Y77]`L0"```E"0`` M&0```'AL+W=OR`"58P1K;3M/]^US8E@70)?0EQ9!JIPO& M#`*&2B>X,*9>$*+3@@FJ`UFS"O[)I1+4P%)MB:X5HYDK$B6)1J,9$917V#,L MU!`.F><\9?,4@;YF0GL)%R9Z&/F?T)BLE9 M]8.;P)-"&$;X]O"P+BGX,@:6V2O]TRGD"C0!-'4,J6R!`'PB02W MMP8D0E_<]<`S4R1X/`NF\]$X!#C:,&T>N*7$*-UK(\5?#PH;*D\2-21P;4C" M:"@)\8*%Y-XLF2 M/$-R:8-9GV.B%D&@:=L9NIUVMI&.83"7%=BB!$\P:A6,)_.6WZE<>PSDVF*. M&CL*QET%ESM;,"@\98V/SGQGCXE=,N,XG,^C(Z+3&0Q\W+LMZBN8]KQ[S`#O M`/FX`EMT+7V/&:!@UE5P.7T+[GL_9NO3]YA.YTG8YM/)?][M/>S>LT5]#;.6 MWVOPF(Z&%M%18$^&D^=NF`);="U_CQF@(.XJN)R_!?>]]_/WF$[G_^4?PH/^ M&T("&B.AM@Y?'`&?<]3DTH$O;D#_H M_$%0TRW[0=665QJ5+(=-&ULG%5=;YLP%'V?M/]@^;V8CQ!" M%%*UJ[)5VJ1IVL>S8PQ8Q1C93M+^^UWCE.9K5;07P'#NN>?<:U\6M\^R15NN MC5!=@:,@Q(AW3)6BJPO\Z^?J9H:1L;0K::LZ7N`7;O#M\N.'Q4[I)]-P;A$P M=*;`C;7]G!##&BZI"53/._A2*2VIA:6NB>DUI^40)%L2A^&42"HZ[!GF^AH. M556"\0?%-I)WUI-HWE(+^DTC>O/*)MDU=)+JITU_PY3L@6(M6F%?!E*,))L_ MUIW2=-V"[^=H0MDK][`XHY>":65490.@(U[HN>>"[ M:'Z?8;)<#/7Y+?C.'#PCTZC=9RW*KZ+C4&QHDVO`6JDG!WTLW2L()F?1JZ$! MWS4J>44WK?VA=E^XJ!L+W4[!D/,U+U\>N&%04*`)XM0Q,=6"`+@B*=S.@(+0 MY^&^$Z5M"IQ,@S0+DPC@:,V-70E'B1';&*OD'P^*]E2>)-Z3P'U/$J7!)$ZS MV14LQ"L:##Y02Y<+K78(-@WD-#UU6S":`_-E1V#%8>\[[H#'R=.PS=>G]AC?.V3/,JR^'3?^2GB#YGDNN:?>-L: MQ-3&38@(BC:^'8?773S,G_$##(^>UOP;U;7H#&IY!:%AD$'AM1\_?F%5/QSA MM;(P-H;'!OX2'$Y(&`"X4LJ^+MR`&_\[R[\```#__P,`4$L#!!0`!@`(```` M(0`D<`UG&08``)89```8````>&PO=V]R:W-H965T&ULE)EO M;]LV$,;?#]AW,/2^L4B*I!C$*2H5W09LP##LSVO%EF.AMF5(2M-^^QU%QN2= M$L=ZT\3U3Z>'Q[M[1.7NX_?#?O&M[OJF/:X2=I,FB_JX;C?-\7&5_//WEP]Y MLNB'ZKBI]NVQ7B4_ZC[Y>/_S3W?/;?>UW]7UL(`(QWZ5[(;A=+M<]NM=?:CZ MF_94'^&;;=L=J@$^=H_+_M35U6:\Z+!?\C15RT/5'!,7X;:[)D:[W3;K^G.[ M?CK4Q\$%Z>I]-8#^?M><^I=HA_4UX0Y5]_7I]&'='DX0XJ'9-\./,6BR.*QO M?WL\MEWUL(=U?V=9M7Z)/7Z8A#\TZZ[MV^UP`^&63NATS69IEA#I_F[3P`IL MVA==O5TEG]AM*52RO+\;$_1O4S_WT>^+?M<^_](UF]^;8PW9AGVR._#0ME\M M^MO&_A=5D_[X:_V^=>Z>=P-L-T25F07=KOY\;GNUY!1 M"'/#I8VT;O<@`/Y='!I;&I"1ZOOX\[G9#+M5(M2-U*E@@"\>ZG[XTMB0R6+] MU`_MX3\',1_*!>$^"/ST01B?'43X(/`S!.&Y9%*]+V7IEC5FZ7,U5/=W7?N\ M@-(#X?VILH7,;B'RZVF!?%CVDX7'2V#%/>SEMWLN[I;?(/UKCQ2O()@H7R&R M,[($66=MD*[KM5EXE63)(FB3Y["C_,(AL&UG)-QX),I+!)(&J;I>FH6A;J+[ M_9FO;]LK+V(*-1$H4/TJ#!C MF0JW=ZF+O^=*\BP`2!]HH?H$=/7EPK,7$7TYT><0IX])87("E#'`!8<>/D=` M`A46>%F8A8DP M`)`PZY57SQ`+$V&,9,PA3AC7N1*2Y+1$!&. MQ]--D+%:C!%7B9,FE='ASEZ:"^(`9:0,`,[:+$M@;IPC:2&PSYICW)U%RDUF M)GF+$2ZTR=Z:O02; MFD1&!D;AF9>LI*D.Q>3G';*)#!%(')]E$R.-;8(^1Q:><>(RR02C'8L)H]*W M,L=G&<5($W$D+X5GO#@CA:(5AP@)W1"-:YRY65;!IU81/<"ZBO.,'!^!2:N4 M_DN_YP).^>TJ/./OS)@A#P8E`70>ZA5+FV4/?&H/&6G! MPC-.FDB59H:,YA(C7!D6S3\LC]C#9?>R1V+('(@,QDGN77@&R,"<=\TUZD4$ MRYME#'QJ#!DI]<(S?F,SF'%4G`OB`<6B9L'29AD#GQI#M"6^%6)C$(9IK2?B M8D0K+DPH7*QNEC7PJ37(,-B]NM@:A!$&92TUQ$<'R MB$/81SKU[FE?3(\4DFQ@X1DWC,D:2O3E&X-8$'^PTC2L^IT,3GTB.JNX\ALC MOYQVH/0,&8LE!J3)`X"S-\LKQ-0KZ.FT\(RK/3C*Z%SD9.R4F)%"0/V%[&.! MLQQ#3!U#AI7[W#G&"?S`02`\K4\4$B@5&?C&N<.Q1.L#T:'BG>VU-/9;25U# M.,9+%$:GJ0DUYAH8,TRIG$>O7[!`XAO7G7K@E?E$*$E3X1GW4O'UHRU"7C_: MNC?K[IWQJ7JL_ZBZQ^;8+_;U%CHFO;$]T[GWZN[#T)[&=\0/[0#OP\=?=_#W MCQI>(*"`$'Y_\ M[KE.G/GM:UUY+X0+RIH%"@OA9HH\(7&3XXHU9('>B$"W MR\^?YCO>5)B/3`H1$+5$K9SGQ?9"6IL1BPEC0P4C!>8PFG?..+EA.^N3(_N:9IP)5L@!V/D&]+CF MQ$]\<%K.$80\NEX(!7?%Q8*](^A84&D5V.IL00 M[\%U8R>4E9$D.E,GTO3TF(4#95^.H\0.SLA)RD@F&B<*],=6I'T*"PWBOAQ- MB1TTIT4K(PD#S3;\$?WWGQ([1!.'R$BL57445+_&"BRY!D^) M';RI@VLT72N3<3*-$^>V2&W-)$E&AQH;T'GV M]_<5-FDWN8FSNE>=IA_0^'2:TX!F-S?[5(LWY#OF&]H(KR(%/+*#P01N;F[V MEO8O\4M_P$``/__`P!02P,$ M%``&``@````A`'NGBWD9/```5L<``!0```!X;"]S:&%R9613=')I;F=S+GAM M;.R=W6X<27;G[Q?8=T@TY!4%%"D629&BY\.@*&E6=G>+%MG3,`:^*%8EQ9HN M5M&555)SKOP.>[7`+M!/L`_1C^(GV=__G(C(S,@LDNII>[&+!3QML3(RXL3Y M_HK(W_[=CS>SXE.YK*:+^>^^&N[L?E64\_%B,IU__-U7WUV\W7[Y55&M1O/) M:+:8E[_[ZJZLOOJ[W__G__3;JEH5O#NO?O?5]6IU^[?/GU?CZ_)F5.TL;LLY M3ZX6RYO1BC^7'Y]7M\MR-*FNRW)U,WN^M[M[^/QF-)U_58P7Z_F*=0^&++R> M3_]E79[Z3R^&PZ]^_]MJ^OO?KG[_>C%>WY3S50$]_^UQ#??A^\J?\S>?YC\$.#^4'Z=Z!>B_'=V4^:BG)TL>CXJSQ>=R.6!7XYU\2)CH%`0L M1S.&3,H?BW\H[_)Q3W=WV='>P>'!;O[H!.Q-#(-O9Z./^=.G5Z-9U8'L=+U< MLF3Q=EJ-6?:?RM%2""U>CU:=L4^WMX=[V_O#?.:$SHN[V^Y+P]WM?]SXQEFY MG"Y$[?X5T\Q-\-[")U4^X]-[Z1Q>#ZOU3_"/G7T%DKR=SLIE<0I"/BZ677J< MWXQF&O"AO%TL5TA4<;JXN1W-.R,CA1_7*Y,_ M7L]W]FHT&\W')2.1JZK8^FX^6D^FJW+RC'^?ORZ>/,O?>%V.$^_OYP\CP4=5 MQ72=IZ/J.O_M9&SR6['#<3G]-+J[Q6A5((WCZR2.)N``6=Y<@K<@I/N=;9PMR]O1=%*4/Z)J*I`DO;!8 M7?/..'!M_R;>S3_!TCVT>EU>E;#[I)B4EZMB`LM+"^7[O5BLD(3[EWAO8&Q: M'DWZ<2HT^8!!,2\[JYPMT:!+5)QV5?[+>GHKR>T=Z@#U+Q;).9N.+J>SZ6I: M=FB:Z'<[NA/Q\OV^6BR7B\]P7H5NGH#=V71>%M!N#*JF#I+^O!=II^MJM;CA MY0EB4$V[G`44RS6H!XCE8C;+@4BD6980;]T!,K[^>;24EKW#IE2;%[D?&P;' M;`$#C[$@TO-=:)8P^FKZJ009";&#HKI&Q(M5N;S)WXAT,!V`>(,O3.E'&VN8 MRU]H&UJC)YS+M=KV8P4[5 MTV)K4EY-Q]-5GX@'B81[I`Y?##!O^A^H-L4X6J_`^?0OY62`+MG9W=V#@Y;% MI]%L7?ZF&`Y>,%02M%M,JTK\94JBUJ8]V@=5U5$^.?RH<"GI")7#]`5P'0\. MCE\.#H\/#)[AT>#X>-_^#-MZ-+#:3@?:08'-N"W'8M!9Q\Z<3)!:'":4F/3G M]G1>C$>W4Y1:ODN$3F21PE[?K&=8N$D^Q"EM>.B2\WG_Z`;CV/;;;P=>R%^] MS\R=P0JX>N5JBH^RT>QE,VQVXD[N-ULY9-BA-I-V6//!-Q++/CBRQ1^/';VH M^3U_I'KX1[/:P>V'N'7H/P.!*?F;_,A M'\H*'QQO29(_P1C.%N89)#)H)8@,`S( MI_MN3@@YD[HO/A(Z/M^2F7Y6H(K'USA598$RNQI-@P%PK^0QMNW;POZ7S0%Z*C6,X6$FRU'5?E\M-TW&7/'/I[W?)W1*+3I>4$V.AT MGD4F^;9.DY#AN.4N8\?1\-%51E2+*VT'#3^@0^`MI`Q1K\IG>CU2(&HB>_TQ MH1ZND3M;P7Q1->ZKD>; MU_*98_#M=$[8#V/?,X8`=UR6F$BS(')X+5/@\M9TJ/+)72065XS1"A;HF2>; M#VP$KAB(=M2:CST;W06G8MX;CO4AI;AZQ#8CGSPGR&EP=)_2.)4:Q!Z0*YS/ MM37APA)@.;1A).F\S6/.U[>W,_.4L/F-/&E'U((]NY"M*\Z(")YO\>\0W5@GWA$SJG[(0'0>_5Q MV#HZTZ-5:?RH_&1Q\D62"=<2YW(HZB@L1&^*AQY,"9JCET]^VLA$YL]JA#IB M_O2-9>LZ"?&3.G0D3K5P,I_J5>+W&*&1$41A;LY1=MY0YL73`0^\^:ZA9C"_ MG\BP62(NYR/AO4]$O_3]"%B^YSX=EH]IKA6Y,G*];&]9W,Y&)$E[V*+Y:G01 MY?R8"4AS:9/DRJ83N9UBT_%LA)J_#XXOGNP!!-QZ[";54!F`]_EE`6GWOA,S MYODFI+_-P=>F_V4]6A)GY&,:[->,%`\VC(M;"RFDQ*Z=\:_+:KR<&M@2TU?K MB@0JL89V?;Z^N1DM[TQ\IQ_G4R1$12+$1JEG&8&S!6JD)VW[Z\QZ3RWKVP4L M-BS^[5__&]+X'[B#'-W=VEBQ1;('P/X'&NJ62LJ__>O_?%9\'LG3'"^6I%B5 MJ5)0&.H*NRKS[0[-">1%4YK"^+?EY^*?%DO$HBK>KE=KPK$WQ,@?[Q2VFTA4 M7HPS4N'H?;OXY$4)IGL90DZ"%G(1',]]/YY()_+ZGR."0(U@[V%UCN M5&RDY"C@`^2]<_1L^()7;(FQ>^"$/^;*KK75V5V!>9N1[ZML[LOE`D\W>A"- MU?[M7_^[@A?<59R,NP7LIX<)Y)__5W%)\IPXD_^A56!+(H)%@68%0;*W\J)Y M0XD$D(3$6CBJX;>J7!8WHSGQJ843X`&O>`GC=DJ9VDS<_Q0QB&D,E3Y9L/S( MIA;\6_-6\F*F3`VYW,W>GI05D@*!.VM6=Q6Y(6AFFTCO#EC`7I&Z4XQ9D>M4 M28XYJ\6,=''$LP[KXMJ=/5%%\L+;-8+PG<&#.>4:I#Q@V*`2B>D\:^6I>4E\C:L!'/ MV8"-L"EA_^-RRBB%'8OYG]=SPF_`,&]HU$'1Y6B%HJM)%2TIRPFD%;E^'J^F"V@\^H:@[PL9PK'JK@)?EJ@TBAN%OR7WRW"GZRI M1#)R#.7)'(<&EJD65HM`*79;"0%->LD3K0A'T(JL MJ1U@*Q`T@OY9(./9'P,=-'6N1EZ19K&5@,M.5C!`Y^G6L586$=/2]E>99BRMF=::H[ZK:D.5:\)FX%/[.9!,=G8FG: M.\2`2]4HM>W+NT*0&EF6V\BI@A^+ M#1$IQ>C!U(6.%NELHUKDHPUHA*K@):F(09 M$1HF6)$!!MH@*TVK6;P-//T/MA>?.T$;,$:(T>XPZ'#?-R7%10NQ)15K\\<> M5!F]FZB9!,9"^SC8VE93/4AN7`@;[4!P/%3@?Q@,F.]RL?C!D1)F\I][5T5B MM'6664KZE&@V[M6ZOIO.EK^#A##'&X0(P>YF%R&R!Z2N0#6V=VF(`H5@I!M9 M`=,]IA6"FJ@:I(UYECHN;M?XL!C]S&>5EB4YP]Y0`];SL(WUN1D4UQ0J M4#0S.OAHS/'4CZ?5C`/P+$AML3]8"T2H&<7QBTZ3[Z%N/<"RWB%7299",ENO MW)A,3-A.U#C)D6Q+R<;WI"TN1_,?<#2L#\5,M%@([^MZ.J:L!NW-G[G!7R]_ M5(JRN"K9+7N5"A473=@A?"TOHY!`1&?VLL15)=V%H)+`,?T+Y4$@;((;/$[\DT9JL651%OICEEN-JH)B?(+L)FRY=;UR&V'8@9<.VU[?H M(/A@0:4B2:LU,<5M@M;[>L2,SM_#\>KHD#P&W17SDM9M%N)Y&7Q\KD*M#PJD MX]B@^"#!!%\$C43[DE`Y%VV-,&+D>Z`09:BVE"ZBQK.YN47B.O;$I>;^J:N? M?U+@2NM*3IYWL?(@A26OID(V4-S#G=OKQ6KQ:3'#JHS-E3S[HSF2K?@)!C;_%K(A$J`+#(4XC-8JR2FP_$!: MQ7IM.O(86DHL&!IY*E0=;Q-\1)2XP)8[8G]X!A_O25U[R9X'H;+@"PE87U%N M<.W9<+ZD)4RCRC02SQ!_\`_1U`((XP[;18)/2LF:_Q3T@\:,D`'7@,&SY>BS M5!5N%K%)$`@I;.9_LG]P.*#1UG;RF1P";33;`"!7,ALY?+$[V#L^-@AJHH)> M3,2T_,Q2-?\RJS!I[6PHE.HQW'89\ M._T16$]Z^T+]F;<@FN\)85$/C(=Y1%_;_6MIEUBDE2MBTDJU2O5M="IR&7P4 M$K/&J MWH9RU$QDPC^"!5BI(2@P>P.ZX@0#HP8*,[?J>S!%7>$JZ)=EN4(R+8TC[:^9 MC-^J,:<"X#FQKN6;6";:`DP5(1S"P78M2@H/W+DQ8JIS$U6"JX>L*G7=8;%W M=0&ZG\\:`P*S!8&5N+H>X?>%>`S84L@;%)`%JL+9:(PG01=JB"G%/$UU<\O; MD4_.[-]%?VS\B-NTVQZ5>XHMC%T6B@8W::>('`?^Z.2M]1TP,U*KI;,!:7Z,*:9`'%GZ9-/,MJCLYXNJ3Y M$1L"Y^L'"Z'E/P2K.*98>2<4>B@B/D15V[*(IMRXE<>]8[&$#)+M\`/ZT?Y6 M4[;9\P`IPG99%M>(&DN93A@K'$>7$>J+8ZS5;J"S^8V;SDZ^LZ4>JS*)_AR!D'AD3'$^#3WG'F+24R55F4Q92S?+F M3R-1MK]WI%;74^1MWO$ZD$&^]NZ@8R%DST&$^;3@O1^#,)6$MS15#0SKPA539PA M,P"#\)X6FBOV21K`\6/+/EJP#XPSJ"4@X8A>0'%+WCJ:U?;T1W5%BV/>>N," M*N6=)0/-#N5"=]'/5F(94F^>0FBZX8T?^SI.@JG$:)DLCF!><\^B@C1O#`31 MO->@3K`__KNWUX?@,7=0ECHC%M.^_*'_.^,_E\\Y$?87T8,39KM?\=>8M+:I MT!N.L@WUR_(MP:#V_+7R`H80T76;R2I"]BN"BHKLQU9)$H3*+\;XR-MPY\ M+HBBLD'#(ILWXK,;G@+'H/_(#*%%3&A./`'T\T_A?22/5T3>1>%H,N5,@"K] M;W0)>L66NE5QE1F-):-+`P(2\/&X2E>@6$-^`*)#8T1 M#$7*A!(@%LS?RF^PEOSR"O-$)<93CZYQS#G32+?7L,'U]%9DS2(G]FPYJT`P ML_8-GUFCA1=9#PL>C*H!U!T\(!Y3NW&GU/5\"MAFHTN5Y%(T-#`/YUK9W.`. M8:S4?PK/\8MO'Q390Z/4!?!+!>-LBB%#XHY#23-HYEXVO@0UQ10%8!^KM>OK M.%RH]+#"PB>CI[W;AT-WT^$=^AJJBHP`"T';O/UNIR"_P/L2%_-3E'VQ7@$S M\A#03:-09SXT_S6ZC3Z2MW)LF>@*G?:>Y'"YN#1CWZ=5@Z\IXUZ?,8HJ55PA M#V5,;XH\]/Y8'N8&63O%:_?/;6GEI-ABW1W,KU492V*`C,M2)Z*5/D+9\$)@ M&X45+B$F;DDM):NG12+OB.Q.Y,BJH&!98H[C)/)>`FL@70GI:Y*O,T-?FD`4 M"BPY417R/]8`=5'LCX64IW+D.JK-/@@%L?>)9++4) M2\&K\91'9^N1QWS+RKW$&8+U\AYT)M$V`Q,#BXU?P\34Z:CZP^>-_B?'1L@I M-A_H?0,O^)2>WM9F7)S!NQEY4_!2.A3[H#/.G%05^S.1HA0TD/UC:3F-?)]V%/OJ"S20NF_%H+=P\F.+S0T8E,:7[:T^P)U1OOLE84;RY^0W:4%*H MH=\LH(Y<+Z5:E&_T\>X49$=$+OFSM59;-COH/W[>.ZT M%\T7V2X43DY&2Y`87X/5RQ'Q4O_^<".(/`L"ATN29#C:_$$"D,Z5T-#!'W)\ MJ(SB=!0CI7;`M92N_L:*>`=,;&8$*YFF)\-\9*"^LQ?UTN38;3 M2M"]?H>87BZC,(*R4"/.&%1B`T8[JC-!DX@`=FLN:R>!K'?U:'TKTV'^#J(` M!^!2X+S)O;[$AU+#SNC3:`J?DY"P(I;B;RC)_N3_A#XS.*=>\C/*7\D)9?"4 M[$15A##0TY\T?\WN_B)V">F&M,N(SU#]-9^I(T+G=CSGE5EN47_3\9R&,,7U MG3O`&"VNZDJ2X6#Q"09?I\'!@W.W6%93LT,C@^JC9%_>$27AED#P,^Y2D+AH M7\W*_,GY:7$T?+E3?&=2$OYT>D48W5VMF?O2M+XCXR,/$$".5)K)KP9X[$J=#;F+63Z#1SPT,[UJJW0D MX8*7FVP:I,P4L0>LPH>JX3"O-/UR'3G+SK@CF#*W).=@?M>P./83J3P)](]! MN#7)1SNE*JT1V$ZBI+2#TQ#E]XE$N3QN<"*V?['[8OO%KE']Q(0$J((AC4E* MP1)XE!6TXS9J]A[J]]"@!D"VN MG2$^_#\T[YBJTIV!42-%"0]'B5Q:-MZGFONHC$.<;2-%:4BC&BBS8@%P,E()6(GBZO!!J M&Q'L,TB(QW5<_71X$UVITZ]V6BCW)B]`4N#;MF8F;$Y'9A''*.H>U(CYZJ## M2A^0PVH+.$1)DD,6Q90[VTH!)6=TT^OF!L@">L97;*#M)_$,=DFOB)C00@DR MXVT*:R1AU,W@[3;^@#+=9^7"G(*M3+_+E1YH.L\U`%!GXA#1W<3&-S4E`#-DFL=S[%[:CC3C_7B>]^X*.['K/Z=U/(`5<.Y^263'5JN' M4N+N@N![>[L%WUS?OQ<7.['K::85%2& M2-(\>S[Q/@TA.&@1!5X1LIY5Q332F#K]#F?'"I,FJ+-9HSIR",M[?LYZY.J\ M5A.0*7K"#C?AVMT2'.'DL:'PMN)_2W3[+HQUWJG:;VSF@+L6Q@L?Z_H3^97B M5PG[V'9MLP-SSY[,"'BC'`,0+'G.;*CB=`@^OO-?[70G\/#2`EK!"(T'$=S/ ML846FS[=CMOJZ.>3;OKAP'8!BJU$Y'?B!!Q`RK-T-/)<_K-\VOI!@?W=PR)D81E)^%Q&K*J7B0P31ISRS4+86KJ MC+&;9!X-; M+^2S7T>#H MY>'@^.A8^^.75JI._0<65<`#X;"`WL3V91>=&*BVF`7[^.)8(P(L57_5D:<4 MCVD;N_:NH'RR=E)]-R5$%"+$2/54#5>9A97*O8= M7].'*K)5ZRN=N>5WU`IXO.*:)Z7%FIU!4MZ7*C7HA8:2#=PT_]AAZ]>]=XA! MM?BFW_8?O/M13B]9W;"0ID)XZ7!1\63J-.4`S,.]SNPL(!$ M;(:\]HT!QOHGDT_>"`)O!L^Y/0HM;\Z9@"5;A'@-=_]&5M"TQ8#JA-VQQPYT M(&9VMU.P]72L4!7][M8Q&*SFLI!M%ES`\CJ?Y\9E$_`-_!@?I]TSP9,C&A1U MK9JQ-.R3&EGW_#3)'FGK7P!!Z&^N*2/$Q\7$\D^&@SU?VG`K#387FUB!'XGK M`>5@IVC:;(R8M.3:I%] MFU6#^4Z[J^T>`-%2/T93.;F:NF`";E'I5?3VHGR?#G?V7CKJ=PSUC M*S/DGL$+Z;;*0CBP5[J%,H(+)F\11-S-)(QPN^<^0J&B3V'QIAK&T)ARURUD MU<;3W$#62$*ID-&(UEWQ2YKTCB5FBGL30%+C3BSXV\GU[@#>[S4#_8P1@U+>5C@:JX0I;C#3%9N#$E/W M/W9;BU.HF4*?D]#1GABE&N<3G-I)U/HPJ%D,?L6YM$LZ4^:_NV-*Q7\*2>-,%$(](62((6G>!TD_:3`QXC;978,1W;U# M%Q\*&7U)PBH^"#.TS%T+NVV1"^'=!*(>#(Z._<[')\/CX\'+%Q@2YE9S&[Z` M4E720UK\P5Y$8P+U674LX(F?9S1-E[]F>N>KOYX8YG!QXQYR&(?F,5NSH[?4O3/CR%KNU)M M$JE$A/U;JS\)-P6>58\^)MSQE_1BLA=B*1@:P_Y1&0HX)@]=SO$:48TG\K!) M;?A5'F=Y/&-=P*PEEYCT5M1J6)_H`G@=",(A4FD>>:ZY>I:39EZ M6BJV>N6!=P;K;%F]$11Q5D=)U\@V( M3'4HTS(T4=E#@(;!6=_J3RX@"$:WZ>O5^^SN*U'&\]EA5R]JZZ-I7P)!.HY$ MC*US"<2"'/+VFZPAG_OX0?%$&>P&`VUSX('G3O%&Q5''&0!D-%8*%/]PN@K= M+-;5"OW#&_DU@'1&)K@4FP^Z%*CC4=XTI`;M7G$G030%7:[J3#"GU,]4VB41N7:,; MNUH?;(HR;(:&E.'AK^@4:L'[PCRS&*.X?NF!Z$:%VJO1)R[)((7H*X):%<>] ME.&V3(;(0T?H%>K/D3VBF-DN;I-*\?0&]Q38-4OW-HCD9JZ9X,"\I<25 MK(]OJXYV2)S(YW\Q\`:`N!WKPQ0Z#(42,7]B2M&:YU1*`,T\T3`7FS"(;5/R M,-C2?*#]Q9A\KY"U=;*:48WH%IZI:#M3)X)A MLU]:)!X)H>9\>G^ELNV-;)8ISII*[@SY=Q,,NL!,;CPM6-4=,*;VR`-0P5EQ MBBV;L#[I7PN7`YD`(AN2'1A!G32Q8FDSLQLXJQ;$TZ.,K)M-,F<_W/O1 MEP06UM##TY#ST:LD\$**S]TP2__K8A:22#C27/!)*S%Y`A_J4!9Q$ZEC>%P? M/8HR"H.J(4^GX\(1)PQ:V\/4ZW8(33D(5DMI/@M<0I%#Y^)(RLFY2N!TO++W MF7HCD0!'(]S=0*[)-8:N#A\VZI["UM^O@YX_67]\FZ09\&WV7MCMY@U5WIS)@#PD*Z++SQ,#(/S)/+=&6ZR- M\]$PT^Y):"]E2+,*?E@KVN+]P>ZAYWG3_$WCX=EV;"H$?(S$P$FP'Q#*"7(X MPKP=PIF#65"4`"UBR]A2T>O"]HQ[R(U]4;NQ/6_GJUPTA$/,B2-#TFQ*OQW: MDF=V^9/[P%GK2)0(%`@.IVHD3OEMJVKJ/!*]0M+#J!&<0)TAMQDMHI;V0,#< MQ'AS@5LG$*GK=.3F^4-P2L5LMK@KU5SDIVA5W)?&A-MCX=_4B"4S-T/L6C'V M5VEWT7D4+,%E'+SP-,TFUF2DBVE[F$EKBA?%99XY`*7O4&F8=W*S3OKW?M%# M4GP]')HP`A-9-LRT!JTE0B%('>[N)N=N8WZ@)2/8&VUXPBDM=F"P)0#B:O69 M//FS!>TP=,O6=5-T0IK%[8%OD;T.Q?K[EF`)V1M?K#',5LNY[^UCH]-V>)72 M!FPQR0_308'@U-!H3HTV#=$EY@D5@$MFT?#H;' M+WM4F1(RTHM!''M7MN-YF%$+^H*XB8<:"YLJ(-,>E>M#Z(,"8BUEVHRQ(ZQ= M7;L!0&@79OF,S<_BJ1PM<,5Y M'"XP"D&6,(>&.FYC@.0YM@V].R:TLH1D1&4DK<<\-GNG%OL^0E55U8'W&6HZ0,1>T8T_C>]IE@45U0%A6B<>R4?EZ+JQ]Q>GKUX9$](V9YK`L=B+0H/F33PX2D1,K&6=;AA`1Z?E M(T;='H)&?VOC-1CAMD2_2CN,YLKMU,T?;!6;&H(-NJ%QPI9W!L`%^-(M*MM7 MND0DUK MVP(1QA?*7]8GM*/3+X$U&VV=OT$91$GJG`*-X8-@"E81EKEOCK35SJ"XB!%, M3-W:,0X!G.RM'%W0?/%PF$Z(C,+5X%?!F!9-L8"AM[62E95#]VW:C$??YO$D MQ[X^6]PIJJ(`YYR83LNY='"*'5T!.?G3>H>26@W)':F0")G%+H)YKE*5C2+;2W;\:L*-?B079HXE;&CE-7]J(V.D+9Y-5IR,+.K;>'-GW_Z!F+< M\TE"R0OQ*EM_O'6+I,, MG62][[4!2B*BR+RSR-'.!IX*:+>F"+9U_RR'.P?]G"G_JNMA_3M[\H$WW;$Q MU]."2S3AD\,7?%",NE?NTP^)[X]>#)/V?,@IQ:?W^,SEP\Q)<6^%HK2F>H?:1V0X^J]<'0+;XE.SBDMIL- M?2R4G-A3X"QW7/\A1E('09RLEU4?.S6.ON^&G%>NX/7AR]>#ANW',>CVB)23\Y,(T< M3;$U7WPV_S+DV_5LEEBZ564*@;A;^5S.J&'0F/^#LFB2=Q;NY$'-,,>,7);# M[R:(X$``U/ZC:VX;2V")-V):4HQ"[FY%M!'>"9QCOD0/_KSAID;B.+6=:T&I M,7FDMK`HVDGXQ7Q#%[GF0)_@O\V"*;:T4_,':F8GSK\"EASS,4F=$/,%!4KP MTWP#FZ[X5:#571O#PV/2033XNK^CW)X^]3U9AYJKI<>RB5[T<5U+U:`,3R@R M7!;GHTNB1(B@6^Y)`M/`F+[N!VK>JXV1P##"M8$:4FDTXY2.RLWL1CCPJJ96ILY'H1`@YF0NEW9E=*"_+:PK-!I,XKFW M;OY&R6'E,&/)#MY]U@^H+@9YND/E"?[B) M*A$\'*?LA#4?ZM3TN3%&[MTE1SE_\%;!E'F:U-3RAW_0J;XSKNT*!:T#<./:8`"C<1:!U]KB8?K:^- MTU5C0@'EF_K>#XUW>MOC[P]50PZM&A)'Y[.+;X(ZLQJTI7\:]5N<+*3BKZZ` MLB_OL^X/+?]/)V[@&_%@;*RV9'`L%W@&'R18K039<&4)2L02*0>43$?K5RGA M-'E_QD:5]&A8PM`T5Z3,_T_/?%%Z)F'3 M]ACN'/'[SM&+?#AY#CZKHW1)_N1-DX.:O)(//-@9;K_<%-7N'),HV1#Q2KY_ ML5UX$(])W_NY,]T_'?L^OW](;07:W)^BYX].RA);I2(;"S!)!%+$)^N@)K-?N M>S45\CI.^XBH;*!>0764M#H.@O'=.N3^XWT"H?#W8PW;OC@W21M' M2UK*Y[$S<12@$?S&MU4%DXW^)<%T3ONW3"8MOXD(13@O<)!HT,;XAJ!RW'42 ML0E/#G#,.6DAV@WW#@<'](T*%0D_@3&^.("4DV0,&"U:WOVOG"P>/\NJ5S4F M$+Q@Y)&`:.SGGZKICY$;`<01H\;)4.%V)T=Q3,<=?2PROR`4/]P;'.[M]_A? M687T@,3"$+EH-K,DM,:0X=%X%?FX/^3?+3!_343+^3CU1GR]^2.M_:,>\OR. MS//K?S?G_M,0R"=,!0:D>BFA2(Z(?QW(F,JO>:3KAT9AT<]Z68[U<4&] M:XZ2'_1T+M/70#A?':Z8)_SCW&YS#5N97LNZ6QPGE!/D!(16N4@5'\\OP+32 M`/413OSU28W5>-<`Y45G;XWFX)2RW@1E%)\4_-$$H#,,(2RW;"#0U\@(7T/2 MY9OUCWX<&E;BY,%Q\>4++F^X> M2!WX?I;N?#VGNEHV+HWE`_;KVW"V#G#MRW9>"$`:46"Z'_27P`(QVR=#R.&ENO'0,:K12`>?-C[.,+#<#&6`&X(O;E619%')=.85-- M#!_%S`/XD,.J^Y8[JNZB(1Z-SHJ$D5\K@BJ2LUA7[NJXZ=^Y\F[7AR"G%,+U MF5L=*FU4_(7+53>,Z=P?UN3$WI:`0,S_=X-$"X(1[#IN;'K]?O]WIZ;?@UI' M5-+*\4,GGL9+\Z;!NMC MZ.2_DN;Y^:>^B*#]N!LU[FX?=WY48/=B9[<_DM@4U-5A5]Q-;LXMWV8VKLE? M^2BIKG9=!TFN[1Z)?#^RKM8<*]KL#XZ''*@_PG/-JZ?.D>.4ZF[,^V@?WQ<9 MN$* M"=5^9^&+^AO#M<]^0K0%A']VXY<"T:A$'5G3OF.Y@=M[]V">T9(/",;/";@M M*D)SORX(TB5QT?4)>6;AW$Z5M`8SA.\W_AJ(E'.P\ ME0=,]GU>7#].HP*9^H?LPK6=XFO]1.-P>$5^:;-[KRJV^!ZI?>^RG#P3]^O8 M#G'"C?5'>B.2#FK8<2[%1:7.9>%EUE(;%]G;O(B$,_;9A3F$WL8D/4OS3L2; M7:HI=*)!EY_,,XCR;M,U(>(\5&BI]BYV]5-KIO07&%NL/U['%E#.7'.QMC[P MS'$E/\G;/HTD#K6S'4T3&7RUD8XEQLOR(B+V(]S"]GK>`#KLI]7BUO17="2: M#:WC1PIS'MF`.R2NEE;5YFKHNN@Q%SU&,GZEC3GET%X[K;D.%FRDA%LP*U`B M?C=^\\WR+E#P2O-S='"W(:]N<@O,+K'M2/>%\)Q5ERS:TU$"S=-D%]W199>O M-[<>9M1;3`Z[7G_:"VV^60I-,T?N-3FOP8ASG_>"DJAC!:CU?A*P1PF`Z5MT':WMM"I; M[Z$=+9$\N+]19RIJ,8/-Y<5$&&IUT!0ADUBIJ`V((4[NR%!'7/Y)#;&8^G*2 M4Z-Y!4K^K.XVCS>//]#\]R[>-<+.&B2N-U9K8<-'GX1^2_#>\-RVY#4](^>C MKT?H-NN4(^N=-=_"&PP*F9P(?Z9;^M8_K_W_-UP4VKTYO3/@H=S;R^VB\TX. MY[O8B"&0R/J$"N.D.#C(+V`3RXP;)PW5`J,K7P(W*=>I[UGP_??%X3MP M$0N-,[/B>WK@K\C"\8F"XK^,;FY_HZ]H^0E8$F)??WWVS!PC_^283+C=/\.- M9V#=G6[_L(K4&+1@0>6.APY@N*HVW7,$5-:]-.-3BC12W'3D*-NR(M5VQU7= M:<_E'1QR#74#$PA+]:=FJ"PS"94#-%QP&*]=ZK$J7C!()_2`^))$4.-+-DVC M'P_;FL/:9?Q*KI$0W4A\&5[,1ELKS)SC`*%DP44%"#YN7+@0%>Z3:FW2 MIU8'*2K,+^Q<_?YU68V74S^I`/N^"A^M->C.:[7=L+!%DR"Z@ED!\-99^%?' MVKW653M;%_)]J\[#Q@I^"QC.[6I=?PYYTG.[FG?AONHM;U9D]-;SWG(M`[Q.R-RR.[?N(Y7V0?QN.ZE]B`:F_<@,,3DZ?K[ M?)$&"]9G(FI$A-=C]W[^]NO:^GY=1Y:/8<5[$W=(XI?LR:15P5\W39<#W-AN MPW-HNE>-A9.#U>=2W3-SP\%KS,:F[G7L\@E_+=7TNJ0+=U8]*[:^.W]=/.GP MX:^USD7YHRX)[LS_COM_[#/+E,2;7U'.]]L8IXL8L:0R&5QXU^EN2R,Q%O)* MRNX("K.X&+)`H)VZUJ3^]FF^[FGXE@>&%=VEKZ'9T7D[*=>9N,ZNWJ:;8%Q) M8OM(F?G%4YT;<_(UZVE8TV[VM<[`RAHGO9MNK@]M%[+W:125*B)A2XB!7L:U01E]LD!KOWMGP-]^Y]3-"T4\0[,G-HN>!GI]CU`NY>_M#>#"7- MSD-N`]TIXDV@W3?-L]@@==\_\B[3?%8SQ'!:N+*S=80V'_O-B`\3KV_"C8/X M>`-R/1YX^.OY"]GDP=GAGGV\N?O'$K+[34?!?<]')V-:]\9T3@%(Q#:^USN: MM&_XZ)%.XM&;P,VXVO#6&0&3"6M'VR5`'C=AP.!C)E3KC?G1V-Q%)VQ_.K0R M4;Z_$\L16[Q07"P:]T\59PIK"+E.PV6W*51_?U6D37ROV.5#N@;7Z,?S4Z(_ M+MQ_&^X\S1CBOU=)9O!GU)-WENUF9/7SQ7['IY;.\RV#CR/XM M19V2(Z!6TY7I]6`;])EL)90ZO'Z:W1>8SW<1ZN?!&^M8I:RN+3CE+><&B=K[&Y0L^QL7F\Z^M\?.J^R0ZUIP6* M+25'SIV;ZC+A_H$VYY7M)'U#KAGY6A:-JQ\["JC.(Y=G,-^$!XD M0T'?VU8_(09%?\A1N[_G[O'6K>$AU_`\LMB@>%^?[J9IB/XTSES5&=R<%`]/ M/=@4S-[S:@U-_%=L.__R]3=NS3\J\U=-V.A1S^>)V80BWAL0QO*E.SDW7XKG MAZ<+0KDI91(_);,)G--X"W\0B,=F]B(`]9W[0BX]W" M;KZ1IT<=47S9*^P=8&NQZ2YX#^!/P^&$XB#*_MY![X+IA@@!APO:)PUS$K1^40=*IG[ M$>O)Q1_2@<8OF_9>^"R+^@@1V0S*AAD>IDKT@3?%U2>W?/YZUWN"ASFN-D\? MI^V\(8J$'++R-2G7_$!X].;7O:XO!TMVF&*5?-3ZSCBE4&(R1C7IZ`#E+S_] MN>?*D#"C4O4SPF,[V$ZZJWWBWKR[CM?0>R&EDFFZN[6^#B(YH\T?X6GOV@=`<*QF'P+YW[5`W@)5SG@_Z=(*[*@ MI#M_\>F;>,.I>.2OO@3RZ6O;J&"^D,[(E7YJ6W/9DMWI6@GM-SOU2Z[@TI[$UC1KU=A<; M]%,@+'Z956D,U:4JC&[3&8:R`6*9:>?'Y**=6J%.J`XZKS+ZTYG<:XZ8NAT8FPLGQ7VH MXU$!4C%]=@&#U=!-T03+_/-C\0\LP**(4P9)-KK)%S%YW4DN^`;!>LA=H7(+E\C)DHAB2TSMJ,2`RTG/8P/^N\RG11UN2NU$>3H+O8>H MKN'2_>709E-I-T:N$S/QX8=C,=S+BZ>QUOS5CQ*\/.5T:WSA&F_Q)_'2G%@2 MBXQ/_BY(/O#_AVB[G?>9&ZM3+TTN=-D!3^;.#%$]WS>FB(NHC5&VK*:-A?\7 M6.SW,%[M/T:ZA'*#6#4W$R=C)M[3$^':G M&-Z@4]^51[FH+[$3W=]SJF\2+80/Z1_OSNM?3K=.)3ZT/Y^\[`QQ73M!&L6N M<1]+#AZPL]H:-)[79`P2H@-W,:IW6:(U,=5KOG\ZCNO[+P```/__`P!02P,$ M%``&``@````A`"8VF4J;"P``+V<```T```!X;"]S='EL97,N>&ULU%UM;^/& M$?Y>(/^!X+5%`\261%&6Y%@.3K+9'G!U@IR#%FB*@I(HFS%?%)*ZLU/TOW=F M^38KDN)2HK1*A)PE2IQYYIG99U^XHFZ^>W4=Y;,5A+;O3=3>95=5+&_A+VWO M::+^]&A+2M2P(073M3G*%I? M=SKAXMERS?#27UL>O+/R`]>,X&7PU`G7@64N0SS)=3I:MWO5<4W;4V,+U^Y" MQ(AK!B^;]<7"=]=F9,]MQX[>F"U5<1?7'YX\/S#G#D!][>GF(K7-7A3,N_8B M\$-_%5V"N8Z_6MD+JXARW!EWP-+MC;=Q#3<*E86_\:*)JF6'E/B=#\N)>J4J M<<@S?PD@_OSKQH^^_6/\Y]TW[]YU__/UM__ZT5K^^^>_%-_[^6NUD[HA-B$' MNVU>=G>:A;=CRYTD@MN;E>^10'I`$[)U_>+Y7SP#WX-B@/#P8[#P$%]9KHB?X&D^40T#-*37[2*M-&%'=<'?R9Q=#4X66=_H&\-6 M(^-JL9@W=-@WVJ2RQJ'Q?GAW,CK;=U8572+#IVH!V.#:9=&&IKNC?0\-?)RB M3D[=VC! M(@DA1-MQLJ%;?X"#&SAR>P.CR,@*/`->*,GSQ[(XFG&!E1)AS:[NC=F]\PO02:*HL*H8#T:`W MUG3XG^GG\1&TS>E`E9U5@D!25@D"25EE8_!."\J?M!18CI#<5@D"25DE""1E M==BR`@^E9Y4@D)15@D!25MG*48MM%9;Y)+=5@D!25@D"25EM;?"9*/!8>E8) M`DE9)0A.G=5T6C6[OS?8.D)Q9-;:^#CQA8/XYK[8K!'FJ7,_6,+UF/0B0Z\/ M<\3XV.V-8ZTBF)$&]M,S_HW\-?P[]Z,(KE[>=M(STK\[SH3K M.W`I9Z)&S_;B!9QQ2PN,7H M,M^E=0DT(K?U@1,.OL<:5,+OT-7%K<3K!AC+K=>-5,U,]N@P1X2<64 M@R#G%/FL/:6$T=ISFL8*^E)H&U,-'VQT7!)IS1G%.&M.*(FRY@S1&/FZ2;/+ M&<^6+E">2Y!L\`A"I_($R[HQTOZPFI7&>U.ZR1F,'!@9[7% M5K-8DMX1.MN%Y3B?L/O[YRKK<6$1Z_;F=46NO\.F"+Q`C9?W\2FL%"=/X]XU M?@$Q59VD59ZDF.NU\_:P<>=68+"=$LP%.XHKTOFK*1L6Y*_?._:3YUIL&4Z- MS?P0^)&UB-A.#K927X6G7X$'M@$(XSG$OU[A'W@ZB7]8YBE-(O`BU3\4E[#_ M-NL!]ZPD10TIH$6]"T^;"&`RGR*`),A`@'ML$@Z@/&4@@$E2B@`*-$<`<'94 MQ2'ML$?4#&H@=PG^C^42-":-DG-YQ"BKY!?\[XC2X.3W()J)WD*AYS3#BQT` M#G)9);&R)(:D'5I:3@&\V$&!`;UN.UU>KTKSI1%"1!I_^U1#))Z8%H-DKI@"H'K@T_8)F@F MN!Y2$@;`(Z55Y..$'M=CG)`&`D&60I)JT&1)),4@2R/S5&BR)))`D*60-!.R M)))BD*61)!6R)))``$:D*"3-A"R)I!AD:62>BKXLB2009"DDR43_R!+9H;%K"8:@4J?ALNLA?TR)?`7#]:KS`5C:_RO*ZV`F2S MRV2%6!PCO^R;8CTM5;.;,P5J_JM321IR+LR;(SP%8$%:R%`A/ M.6GGBZR2B-K(:<$(NRNOE_U!X+)4T]RWC>&8)=!2XT;-D4T3=._2,=!4(1ZA M)B+86FL;#'4.XPQISH4;:V6SE"I,M$G@!?=F(DV"[V]/@7AE--@R9=JE57)Q MQG#8Y@(!>LI%M(:>-F";S33Y/I((^UK$U(!D9#ZMHG@#$F! M.U>TD:?#NLS=#:$&U4MF@JEYZ@HHA&1>F&,5`M% M.RC4G^(07WL MF9`M9:\I!V%R:M$(Z7@!S;D*#M_]%&#SBB-,(JWZ`_MOKLVWUG_79KF\!6X- MR8[1[1U&%\#.5>H`B=B3'\Y]H9B$.BQQD12Y0%"DH+PA[E79!TX(MP2LK6+: M,W5;I5V8#+:@!,W[&MS/LRI;5"C4EN`B.A6F,X!3FRM1$]U\0" M+M(M%[152N_#:4BQG^2+;2^$@@);47\<9X*)K52U,J%E6W1@4P[YBB/_!<=L M"X^"-P:$FQEW_Z1<*.\7V.]G.>R!X,PWM@.W)<&].;B]:@'S/-^=Q@>3#3&[ M;&4]OX8Y(;9`#IK:`@OQ`I>&6^Z(+;@+\LCVSJ4<>)+0BYJ:T\C[AM MD=B"D)O:RO,("(DM'9PTM97G$;)`;4&Y-;65Y5''MI['.!#D_JHTCWRMXCX_ M$5S45IY'OE;[@K5*;>5YY&L50VZ**\\C6"5\Z?!&4UMY'GF=T`5U@L:8YY'G M?B#(_;:B\A6O"59\;"7/'3PC'.%@5(2CV$J>-;[*^X)5'EO)\\77MRY8W[&5 M/%-@CT2DPQOB$64YZO/LZH+L3LUEJKI\P6`_(P(#[DV[V#CP* M5QQ)0/BM!2%+S];B19G!;0DR0WQ[P&Y4Q-#]Z]HQ/3/R@S<%]ZYFYOBD#P3- M_=7W,XYX"QJ\%`'T-_CI!_A5"05XB1GB:Q@W@#8QD[4%GA[\(EL3,W!VC(:O M/_S*41,S<'9LAA=5'#^)F/G@K3=9AG@MQ:Y;Q,1'VWNQEGSE\`QK`%+$TH.U MB0(SJS^^26F"Q#S@S2PR&[Q$Q'>13N^\D8P_'^#>%2F)N/A%V@Z.H46`?[^) M"(UX%C$"MV45,O)H1W"'G[01R)^M_[Z7!\=V]H%Z/N M='2A]ZW!Q7@PO;L8Z+/IW9TQ[FK=V?^`,OPEF6OX*9(#?JF%_:(,[,_OZ=>A M`[_G$B3!)N`_Y<-(A.F/W2S>W_`0``__\#`%!+`P04 M``8`"````"$`^V*E;90&``"G&P``$P```'AL+W1H96UE+W1H96UE,2YX;6SL M64]OVS84OP_8=R!T;VTGMAL'=8K8L9NM31O$;H<>:9F66%.B0-))?1O:XX`! MP[IAEP&[[3!L*]`"NW2?)EN'K0/Z%?9(2K(8RTO2!AO6U8=$(G]\_]_C(W7U MVH.(H4,B).5QVZM=KGJ(Q#X?TSAH>W>&_4L;'I(*QV/,>$S:WIQ([]K6^^]= MQ9LJ)!%!L#Z6F[CMA4HEFY6*]&$8R\L\(3',3;B(L()7$53&`A\!W8A5UJK5 M9B7"-/90C",@>WLRH3Y!0TW2V\J(]QB\QDKJ`9^)@29-G!4&.Y[6-$+.99<) M=(A9VP,^8WXT)`^4AQB6"B;:7M7\O,K6U0K>3!`6#?!TVM+$6:]?Y&K9/1+(#LXS+M M;K51K;OX`OWU)9E;G4ZGT4IEL40-R#[6E_`;U69]>\W!&Y#%-Y;P]?O/R\1?E>%G$__K#)[_\_'DY$#)H(=&++Y_\]NS)BZ\^_?V[ MQR7P;8%'1?B01D2B6^0('?`(=#.&<24G(W&^%<,04V<%#H%V">F>"AW@K3EF M9;@.<8UW5T#Q*`->G]UW9!V$8J9H"><;8>0`]SAG'2Y*#7!#\RI8>#B+@W+F M8E;$'6!\6,:[BV/'M;U9`E4S"TK']MV0.&+N,QPK')"8**3G^)20$NWN4>K8 M=8_Z@DL^4>@>11U,2TTRI",GD!:+=FD$?IF7Z0RN=FRS=Q=U."O3>H<],9&R;,UM M`?H6G'X#0[TJ=?L>FT1.[P:3?$45*&'=`X+&(_D%,(48SV MN2J#[W$W0_0[^`''*]U]EQ+'W:<7@CLT<$1:!(B>F8D27UXGW(G?P9Q-,#%5 M!DJZ4ZDC&O]=V684ZK;E\*YLM[UMV,3*DF?W1+%>A?L/EN@=/(OW"63%\A;U MKD*_J]#>6U^A5^7RQ=?E12F&*JT;$MMKF\X[6MEX3RAC`S5GY*8TO;>$#6C< MAT&]SAPZ27X02T)XU)D,#!Q<(+!9@P17'U$5#D*<0-]>\S210*:D`XD2+N&\ M:(9+:6L\]/[*GC8;^AQB*X?$:H^/[?"Z'LZ.&SD9(U5@SK09HW5-X*S,UJ^D M1$&WUV%6TT*=F5O-B&:*HL,M5UF;V)S+P>2Y:C"86Q,Z&P3]$%BY"<=^S1K. M.YB1L;:[]5'F%N.%BW21#/&8I#[2>B_[J&:+T5';:S76&A[R<=+V)G!4 MALZ%8JNU'N_*J8E+\@58IA_#]31>\G<`6Q M/M8>\.%V6&"D,Z7M<:%"#E4H":G?%]`XF-H!T0)7O#`-005WU.:_((?ZO\TY M2\.D-9PDU0$-D*"P'ZE0$+(/994FRE)")J(*X,K%BC\@A84-= M`YMZ;_=0"*%NJDE:!@SN9/RY[VD&C0+=Y!3SS:ED^=YK<^"?[GQL,H-2;ATV M#4UF_US$O#U8[*IVO5F>[;U%1?3$HLVJ9UD!S`I;02M-^]<4X9Q;K:U82QJO M-3+AP(O+&L-@WA`E<)&$]!_8_ZCPF?W@H3?4(3^`VHK@^X4F!F$#47W)-AY( M%T@[.(+&R0[:8-*DK&G3UDE;+=NL+[C3S?F>,+:6["S^/J>Q\^;,9>?DXD4: M.[6P8VL[MM+4X-F3*0I#D^P@8QQCOI05/V;QT7UP]`Y\-I@Q)4TPP:&PO=V]R:W-H965TL35HIX<%@.#[GGGOMR^+F637D M"8R5NLUI$L640"MT(=LJI[]_W5]=4V(=;PO>Z!9R^@*6WBP_?UKLM-G8&L`1 M9&AM3FOGNCEC5M2@N(UT!RU^*;51W.'45,QV!GC1+U(-&\7QE"DN6QH8YN8< M#EV64L"=%EL%K0LD!AKN,'Y;R\X>V)0XATYQL]EV5T*K#BG6LI'NI2>E1(GY M0]5JP]<-^GY.)EPL1E#IN6BD.C`IYT8*'.Z M2N:W&67+19^?/Q)V]M4SL;7>?36R^"Y;P&1CF7P!UEIO//2A\*]P,3M9?=\7 MX(O<-9%4[K':*AKRO>?%R!U9@0I$F&J6>2>@&`\"1*.EW!B:$ M/_?WG2Q)P@G*S!NGOI*2D16^NT^AM`R9XJD(SV)'C?DR1I-!FE MV?49+"Q$U!N\XXXO%T;O"&X:U+0=]ULPF2/SP5F(8_#ZD57TZ$E6GB6GN-O1 MA<7R/"W3>+Q@3YA3L MO!5*WQ<:7R+DP5BY-P:F`V_0#A@LZF#R`XN32Y0].*?.SY^D@Y8+*^[)-)C-<`>%/5Z27"'GPL/!MX0[(#9M8+)\G'PMDEPAY\ M))S\-Q2$`R8(8R<^=1PZ23AH"DP%7Z!I+!%ZZ[M$@A$/;X<&MAKU/6CX@`VD MXQ4\&PO M=V]R:W-H965T(54ZFH\@3__K4=/&!D+*U26JJ*)_B5&_RX_/QI<53ZQ12<6P0.E4EP86T] M)\2P@DMJ`E7S"KYD2DMJ8:AS8FK-:=HLDB6)PW!")!45]@YS?8^'RC+!^)-B M>\DKZTTT+ZD%?E.(VES<)+O'3E+]LJ\'3,D:+':B%/:U,<5(LOES7BE-=R7$ M?8I&E%V\F\&-O11,*Z,R&X`=\:"W,<_(C(#3)7@5S3=C3):+ M)C]_!#^:SCLRA3I^T2+])BH.R88RN0+LE'IQTN?43<%B6&AVF,(R,4U3U^?N&&04+`)X@:#J1(`X(FD<)T!":&GYO#@)QM-P&($<[;BQ6^$L,6)[8Y7\ZT61@VI-XK/)$.C/W^-[38@':N)[HI8N M%UH=$?0,;&EJZCHPFH/Q)3"/T8;ZOTB!SIFLG$N"H=DA"`/5.2S'8;0@!T@I M.VO6MYJ>8G-1N$H`7LL(@7<9WT_Z!<6)'8K+G&-;^PGP;MGB:[+-K6+Z)KDB M@0S=3^+$"1YU-AZ';[X>SFN@!UJX40_N(\45&VS497.5'$*C?YPMMPATG?T? M>@!K+YDU51U$<309ASW$KF(:C<*W[U>`$&47\&,P)[X&&\WZR?,:3S:<1=-I MW%/`E>!CV;/_+^2$BN<[[A96D04WMWG&.(NIUM;YI5[+JK-[^&&Z@Y MKZ3]`#=`37/^G>I<5`:5/`/+,)@"C_9WB!]853<'<:#.1OOGL?P'``#__P,`4$L#!!0`!@`(````(0"JJ]`<>@,``+8+```8 M````>&PO=V]R:W-H965T&ULE)9=;YLP%(;O)^T_(.X+F"2D MB4*J0M6MTB9-^[QVP"16`3/;:=I_OV-,B'&2+KE)^'AYS^-C'_LL[EZKTGDA M7%!6QR[R`MQNI&SFOB^R#:FP\%A#:GA3,%YA";=\[8N&$YRW'U6E'P9!Y%>8UJYV MF/-+/%A1T(P\L&Q;D5IJ$TY*+(%?;&@C]FY5=HE=A?GSMKG)6-6`Q8J65+ZU MIJY39?.G=N[TYLJ]HQIE@A?3`SM>@QV.>^3,?G):+G,(( M5-H=3HK8O4?S%(U!1!$M`(51/S=A[D/512_#V->[T,^MM/VC3LY*?"VE-_9 M[C.AZXV$2!-(@\K&/'][("*#:8!87CA1KADKP0)^G8JJ]01IQ*^:CN9R$[NC MR)M,@Q$"N;,B0CY29>DZV59(5OW1(M19:9.P,X'_G7X?7F\RZDS@OS-!@8?& M0?1_$%\/JLW7`Y9XN>!LY\!J!6S18+7VT1Q\3R<%LJ&T]THHRFT;A_/\"`')@8:K&,8)V^GQ?U4>R.C5&/>G?-IQ6P7OJ\'.*WBO0]Q8`0 MPIB$[Y,I,8S`B#NQR+3")(N&BO18<6`?D(')Y61*/"2;#N,F6F&2W0X5Z;'B M#%ET#9D2#\EFP[B)5IADR"J$]%AR!FUZ#9H2#]&055^)E@S8[%(XEIQA4^?F MQ9N#$EML=A5HR8#M$%F7P;'DH!@LMMDU;$ILL=EUH"71?G\(K3E/]7N3_0P8 M@NWB\JRU:@O-*L"DTYBQD54LZ0G-.3ZU`U\\JTCOU^8.@JPR3#K-@,].WPG- M.;ZK3@*D]W63+[1J,>DT)E]HE4UZ0G..3^W41OXN.R*@+;*78&C59=)I3,X# M@RZ/3C)MERF:S4:WT>R@T06BNR)]RE>$KTE*RE(X&=NJ+@?!I_W3OFWK^JG^ M!31`#5Z3KYBO:2V!-@8WK%DK?2-:T/<2*26A]VLL-],<$SN3``W'! MF-S?J!._[[B7_P```/__`P!02P,$%``&``@````A`'AHAA0(!0``V!<``!D` M``!X;"]W;W)K&ULG)C;;JLX%(;O1YIW0-QOC@DA M49*M$DY;FI%&HSE<4^(DJ(`CH$WWV\\R!AH[J5E M]D::MJ#U1K<-2]=(G=-]41\W^M]_Q=]\76N[K-YG):W)1O])6OW[]M=?UA?: MO+0G0CH-%.IVHY^Z[KPRS38_D2IK#7HF-5PYT*;*.CAMCF9[;DBV[SM5I>E8 MEF=665'K7&'5/*)!#X-_F2O4GNNF]MU;]`_!;FT5[^U]D0O25/L?RMJ M`FY#GE@&GBE]8>B//6N"SN9-[[C/P!^-MB>'[+7L_J27E!3'4P?IGL.(V,!6 M^Y\A:7-P%&0,IP\CIR4$`/^UJF!3`QS)WOOCI=AWIXWN>L9\8;DVX-HS:;NX M8)*ZEK^V':W^Y9#-@II$G$'$A>B'ZX[A^'-[[GU!93:HP'T_5+X:BC>(P'$4 M\8R9,U_X7QG08E"!XZCR/P8$:ZSW%HX?*@\.R.1YZM,>9EVV73?THL%:@DRT MYXRM3'L%PF.^>7:F&?#9!("D,9$GIK+1H3_DMH59^[9UO=G:?(.9E@],<(^9 MB\QN9-AL8,+AV/`A;(M=HI$8N\2\`?Y?Q>*)G9*1&3NE5PTF.#/9`U/QVI[[ MRV!T@<',A5$UX`UB*`LQE-T]QA>9\)9Q1"*Z)182$M\BKK<499);QI'2F-XB M[L*:9`3S8/T^;AZ#-SHLVH^T+:1EKU]TNVN@ORX!(0<4>8A0(D:)!"52 M3O"12($*%D*DCUO(8-E"5W0HX(S"@!TG/*=WV3*DF1RB`A%*Q"B1H$2J(@0+ MX07XN(4,EBV45FK`F47O#[Q+[TQ#3D"$GZWV$"4BE(A1(D&)E!-\+-**$DR$ M]__C)C)8-E%Z7P:<\7H39_9R*9F\X]=5%J)$A!(Q2B0HD:H(P4,H,A[WD,&R MAU(M$'!&X=$.)4).#)/9LGV8SN(3(T(U8I1(T+ND*@W!Q:7H(BO[7/A84-$#BP"M\V7"G8!-=(E8AH*JO)I4\3?([:O)(7*R"IS`T&2&DJ MUU$@(:X2X4@\().IGE2W)[A&JD1$4UGY?F6J>L';O-@7S/2E)ULP0`JG=C@2 MXDB$(_$=Q/6EVBNY`TGOS52)B(:R.O[*4+;T9^`%8BSK)2U]7TI\8'-(:2R* MA+A*A"/Q@`S/4]]=0L4FON$27"55(J*MK+2_LA6QDW\(@!E3J>A*X04V^CFQ MPY%P0+@/OF-!M2?:$.$B,8XDZ'U2I8CH)@NO7GTA*)\4`2'&$;JI\/AUO)-TSYSEE%FB/9D;)L MM9R^LLU0%UZ(4^NT4?ODL)T@J3VP5[#+==L>VBO8RH)V<^H`^ZKG[$A^SYIC M4;=:20YP*\M80+0-WYGE)QT]]_MXS[2#'=7^YPEVT`GLGUD&P`=*N_&$W6#: MD]_^!P``__\#`%!+`P04``8`"````"$`\C*Y#D`"````!0``&0```'AL+W=O MSQ)!MTX-H(U18XB6*, M>,M4*=IM@7_^6`\>,#*6MB5M5,L+_,(-?IQ__#`[*KTS-><6`:$U!:ZM[::$ M&%9S24VD.M["DTII22TL]9:83G-:^DVR(6D"F85D95-@(<"49O,^95@9^2Z3+#9#[S]?DE M^-&\N4>F5L=/6I1?1,NAV-`FUX"-4CLG?2[=7["9W.Q>^P9\TZCD%=TW]KLZ M?N9B6UOH]@@"N5S3\F7%#8."`B9*1X[$5`,&X(JD<),!!:$G_WL4I:T+G.;1 M)(GS;`*4#3=V+1P2([8W5LG?092<40&2GB$9N#\_3Z/1),X2./,_$!(,^7PK M:NE\IM41P(C1&W-)S_4!%D$#U>HUKR=[Q?)?BBMO4*S[ MO3EQ@>':GYN-_RK+(FAR7]9!.ID\C/-)?NT?1MQQ>DV<#&ULK)S;4B,Y$H;O-V+?@>!^P&67#3@:)AK7 M^;BQ,;M[[0;3.!HP8;NG9]Y^4U7*DE*_VF,8]F+I^91*J7ZE5$I5E3_]^L?S MT\GOJ^UNO7FY/@W.1J[S?WZY>OUZ7]^2WZY/#W9[9[TUYM__N/3C\WVV^YQM=J?D(>7W?7IXW[_.C\_W]T]KIZ7N[/-Z^J%2AXV MV^?EGOYS^_5\][I=+>^[2L]/Y^/1:';^O%R_G/8>YMMC?&P>'M9WJVAS]_UY M];+OG6Q73\L]]7_WN'[=L;?GNV/7XE%U_63^O]GYW3TY/G MNWG^]66S77YYHNO^(PB7=^R[^P]P_[R^VVYVFX?]&;D[[SN*UWQU?G5.GFX^ MW:_I"I3L)]O5P_7IYV#>3L>GYS>?.H'^NU[]V%G_/MD];GZDV_5]M7Y9D=HT M3FH$OFPVWY1I?J\053Z'VDDW`O_:GMRO'I;?G_;_WOS(5NNOCWL:[BE=D;JP M^?V?T6IW1XJ2F[/Q5'FZVSQ1!^C_3Y[7*C1(D>4?W=\?Z_O]X_7I)#R["$97 MDPOR\F6UVR=KY?+TY.[[;K]Y_E]O%&A7O9.Q=D)_V4TF,Z4EP/-SW1-^JMKSL["\?3BLFO^0,4+79'^OK%)FCZ=;/17 MUSS40#,Z3' MCD;``ZG^<90X0WF.#IOS?@9T$RI:[IT M2I%*N]>E6O."N9I"/)7ZYH?)];.Y19-*>?FLW%R?4F#0M-G1@O#[S3@8?3K_ MG2;QG;:Y19M`6BS80LU8Y39R0>R"Q`6I"S(7Y"XH7%"ZH')![8+&!:T%SDGK M07"*K8\07+E1@K-4MPRL$7#490NN$KD@=D'B@M0%F0MR%Q0N*%U0N:!V0>." MU@)"79I]'Z&NV-SJH_V`RZ`\D!I(`28%D M0'(@!9`22`6D!M(`:6TB]*<%_"/T5VXZ_5FWVYX(L$=GUOW'\H-U+;GC@1ZZPAB\&( M!R`"$@-)@*1`,B`YD`)(":0"4@-I@+0V$7*K#-C>[AV.6&4M5>V)';%`(B`Q MD`1("B0#D@,I@)1`*B`UD`9(:Q,A(64S0L)W1JQR([7MB1.Q[I9B,!HB%D@, M)`&2`LF`Y$`*("60"D@-I`'2VD3(K7)!T%ME*F]<(3H_4G"-',6GSEW-6`V2 M(XH1)8A21!FB'%&!J$14(:H1-8A:@:3\*H^Q5PP5[NJ4Y*WR]_D0[>E8Q5N5 MJM,4<.2?N?(/5EPQ,A49Q8@21"FB#%&.J$!4(JH0U8@:1*U`4GZ5Z-CR'UZP MUH$H0A0C2A"EB#)$.:("48FH0E0C:A"U`DE)5?9B2_K> M(X\^"Q(1K5$X!/E")3%J1`R*-%+G>T-Z,PXN9-S'QHJ#/$%?*:+,5#S@/C=6 M[+X0OJ1D*N'X",GZQ(4:XD9OU3&86@3L\`04L964[-*53%?LCWS5`5+"%8W[ M%%'&2+J_DNYS8\6]+QAU[J5DY,LCV9E:.O>/Z[MOMQL:?%K;/!-Z0@=H^EA- M>7%N6CT2@@&*U`U2R3KKS^)&@;./B(T!7TS"R-8*/&=L-7AV]M2Y,6#/!2./ M3"HQP,@R,OVV>?V93#2!!IWZ_$($ED9FXBT"0)%&XXLA(F-$"59,$658,4=4 MB(HR9-2NW=;"$QKV-?>;?''-&M&HF95E[)S#+@)M-1NN.6)D9D[,J!]GQT?" MI;(EYX@L92O34L;(M)0S\K94<.G/6I(2JEW[&R3L-_E"0HWHCR6A>](1:*LK M2\*A(H=];*S4@7C@GIZEBBH/.#XF55;AW#DULN^L>J1)K&746I86N:(U(A"A&E"!* M$66(0(M$$6(8D0)HA11ABA' M5"`J$56(:D0-HE8@*:G*`.Q%XKT1W6<2]AUM#%G)`E'$2-Z*G$PB-E8\;@DC M:_.-*&,DW$^[?@BF:O'2&*&5WTF<7D<@;91<(VQE.**#/("N>1LW#D M;*73P;.9,W<*-C"-E8@J1+5&$S/-&T2MJ"C'165B]A3XBQNV,G>6(XW$MGOB M[(L7:E>N*IH]=H0HUHAVS'UV.1V-G!M!@K521)E!!X=%=ZI/,.G%2F<9*HP; M7DU*1!6B6J.).8-I$+6BHAP6E;+9PZ)N^I.169F.NWGHQ,\ZFQQK)&]TL(GM MKDY-J.84="-UB\7(QHN>;Z8:!/+48HH0Y1K1"=+*A+4A4O/!=8I M$56(:HTF)A(;1*VH*(9&/ET9S\*IX[HU?DA*.=YNDM[MO__6>&,>/]%( M3,O0N4LLC)49[[[BQ.PJ8FTU44?)O]]<7(PG.-Q#<^PH1=^900>TS=F*9^K, MN?D5;&#=VQB)O5SHQ$G%5J9B;="!+C5LU=_>O<-M"R"'VW^`8%9>GM^';Y0T M`=T;I48J>;9BW+GE+(P5#TV$*$:4($H198AR1`6B$E&%J$;4(&H%DNJ[YP=J MLH4T*][X:'Z"!PL:J:,C2WXG6!?&RLC?^[).)&*T2A"EB#)$.:("48FH0E0C M:A"U`DGYW;.&OPAR/%*@A4C%O276`E&$*$:4($H198AR1`6B$E&%J$;4(&H% MDI)2\.)VX1T1K?PXFX0>.1'M;)06=!]P1B1"%"-*$*6(,D0YH@)1B:A"5"-J M$+4"2?G=%/\O(AI3>4JM'/T6B")$,:($48HH0Y0C*A"5B"I$-:(&42N0E-1- MY=]Y($G)$41TCT*Q[0W='%]7)"NS1@\5&<5HE2!*$66(WRJ\3<5O^'DGY0_<;UY00LPX-9(9)ZSGQLK(W_NRGB?%:)4@2A%EB')$ M!:(2486H1M0@:@62\OLRSG?<3D/,.#62\H?N(9ZQ,O+KC-,ZQ$.K!%&**$.4 M(RH0E8@J1#6B!E$KD)3_;1EGB!FG1E:L+A!%B&)$":(4488H1U0@*A%5B&I$ M#:)6("FI2OC<]?P]$=TGCO8+`^HD1B6AYK1QH9$E?\2(C,U)R]0YS(R-%<=] MPLC$?8HH8R34%+B6&,[Q\T)7%"KJ MO%-.8'-C952T?&YNCTJ(=6(::% M&M$6AGNQT$@(IG-`\\PMYHH&)5@Q190QHFNU1LTYJ\V-%?>K8.2),7_>9M0Y M[F!990?..1`C.93NR::QXLY&B&)&^LDX?:)^X6S7$C8Q(9!&D;S/^?&5HAVI-"^3,N.V>.6@"DF6AI9R^$"480H1I0@2A%E MB')$!:(2486H1M0@:@624G]05D4_^>4NMQK)I';J'M,8*P[;"%&,*$&4(LH0 MY8@*1"6B"E&-J$&D?@]-B=,?I?3R][]OUO\J_R,9(*2"95TQPE0$E))MPMU2Z;J=]JZ-0Y*J!WJL:>= MR6RNSKM])1=4TNT>7&^32RKI3J"AY(I*N@7,+0E'U.MN$P,EU.O^7N*6C*G7 M_;2&$E*'7AOV]9KJT#-67PG5H<=_OA)2E)YB^4JF5-*MOFX/2`*O`B2`]_H# MNG[Z+-O31D#73U\,^TKH6NC#5T_)F.KTH>?TBS;Z<[41PSKT(WZ?O;Y4\Q[[ M6R6^CRL9/?QS./_L#S$5KYX*MZ2M5UJ*2&]`4CSZ+HS>:IJKUYCPDBE!FZO= M,I90GC9769BO9$8EOO:C\()*?-XH>9NKS35ZHQQNKO;86$*IW#SW]H#2$RKQ M]8"VYE3B\T;O8M-H>:]G3-=#[Z9Z>D`EZCU9+*$W7DE1?\D%E?AZ0*_]48EO M2M!;[M2.+P+HY6HJ\?6:7G"?JS>HL6_T!OM]^W8PE]P$Y7ZIO2].TY7:FOA+[SGM]Z M=5M0R<);0E]]4SN^\:'/FZG$US?ZX'NN/F3&7M-WW_/46Y)1B?JX&^O0Q\Y4 MTGD[']9-^B'1U^775;W5@]TL^[?-MWV/T6J7SW57RY_V>SI)T1I M@T\_KD@_&;NBS])'Z@7(A\UFS_]!39\//T)[\W\!````__\#`%!+`P04``8` M"````"$`\_T;WZT"``!0!P``&0```'AL+W=OU)(%UK"U8 MHUN1DQ=AR?7Z\Z?57IM'6POA`F!H;4YJY[J,4LMKH9@-=2=:^%)JHYB#5U-1 MVQG!BGZ1:F@217.JF&R)9\C,)1RZ+"47MYKOE&B=)S&B80[RM[7L["N;XI?0 M*68>=]T5UZH#BJULI'OI24F@>'9?M=JP;0.^G^,IXZ_<_>DYI2H%IO2HD.,"R!T:4.=G$V4U*Z'K5U^>/%'M[]!S86N^_&EE\EZV` M8L,VX09LM7Y$Z'V!(5A,3U;?]1OPPP2%*-FN<3_U_IN05>U@MV=@"'UEQ'JG"3+(W2`X)W"F(5<+F_"T3J+9BCY!Y?@!<^,Q+VRQT#%!X/3`3$R"#27&T0P M[`&0#[2GM?6@"Z0!EN>]X+"^N!<0/%;RD5,OZ9BVGQU+&$'O.\%58WX? M&3M)WSCQ$\QWN!*F$E]$T]B`ZQU.IP1Z=H@.@W.38%N]C4^S33]0Z?`!!EK' M*O'`3"5;&S2B!,HHQ`EF_$CT+TYWD#A,).U@E/6/-?RY!+1MA#M8:NU>7T"8 M#O_"]3\```#__P,`4$L#!!0`!@`(````(0"9&=@W2P0``$H/```8````>&PO M=V]R:W-H965T&ULK%==C^(V%'VOU/\0Y7WS10@0`2L@2;M2 M*U75;ON<20Q$D\0H#L/,O^^U'7O]0>EL-2\#G#D^ON=>V]=>?W[M6N<%#:3! M_<8-O(>;=PW1-S/VY]_6M_P\$S."(T. M*/1DXY['\9+Z/JG.J"N)AR^HA_\<\="5(_P<3CZY#*BLV:"N]:,@2/RN;'J7 M*Z3#>S3P\=A4*,/5M4/]R$4&U)8CQ$_.S84(M:YZCUQ7#L_7RZ<*=Q>0>&K: M9GQCHJ[35>F74X^'\JD%WZ]A7%9"F_VPY+NF&C#!Q]$#.9\':GM>^2L?E+;K MN@$'-.W.@(X;=Q>F13AS_>V:)>BO!MV(\MTA9WS[96CJWYH>0;:A3K0"3Q@_ M4^J7FD(PV+=&%ZP"?PQ.C8[EM1W_Q+=?47,ZCU#N.3BBQM+Z+4.D@HR"C!?- MJ5*%6P@`_CI=0Y<&9*1\99^WIA[/\"WVYHM@%@+=>4)D+!HJZ3K5E8RX^WLB M35)<))I$X',2F24_+#*;1.!31))X81PD-)`'D\?3./@4DWMQ-%\LF8,'`T&6 M64_DP/#1A#[/'"M$5H[E=CW@FP.K&W)#+B7=*V$*6J("?&99DW\K"=2"BNRH MRL:%;0G9)K".7K;A:KGV7Z#VU<39W^'HC(-@T$)3VFI,4:@)BJ+O:]N&,AO*;:C0(#U,VN&4-4%S/H/0 M'Z^-D/=%?G=CO70O(-CI\K",@IFQH`4KD:8R`>D#C?Z0"]:"=_\@6H:S1!^8FKL)6K+IHR"36/ MC0.W$,KLFJ"[HNWO_:YXL]1<3=!J"MC^XEM5QRS$-7$XN7*TDBXTI` MK_U,6:D5O\;SVV.'AA,ZH+8E3H6O](H.:=BN)0G.\ M@RN*TZ`AI#+P%;+2!OX7X MCQ%?(+WPGL$CO&'8US.\61',1_B!?P=M_````__\#`%!+`P04 M``8`"````"$`=)<-3(4"``"$!@``&````'AL+W=O=P(.OK)U631S!6ZB:C<32A!!JA<]F4&?W]Z^[J$R76 M\2;GM6X@H\]@Z?7FXX?U09L'6P$X@H3&9K1RKDT9LZ("Q6VD6VCP2Z&-X@Z' MIF2V-<#S;I&J63*9+)CBLJ&!D)HQ#%T44L"M%GL%C0L0`S5W&+^M9&M/-"7& MX!0W#_OV2FC5(F(G:^F>.R@E2J3W9:,-W]68]U,\X^+$[@87>"6%T587+D(< M"X%>YKQB*X:DS3J7F($O.S%09'0;IS=+RC;KKCY_)!SLV6]B*WWX8F3^33:` MQ<9M\ANPT_K!2^]S/X6+V<7JNVX#?AB20\'WM?NI#U]!EI7#W9YC0CZO-'^^ M!2NPH(B)DKDG"5UC`/@D2OK.P(+PI^Y]D+FK,II,H_ER,HU13G9@W9WT2$K$ MWCJM_@91?$0%2'*$X/L(F2[&0E@(J,OOECN^61M](-@S:&E;[CLP3A'\=D*8 MB==NO3BCV-,8J\5->-S$J]F:/6+EQ%%S$S3X?-'T"H:FO3.ZC7?V8N_L2^M# MN0D3YS;)VS;3]]AX<49GY\&OYCTW.`<-;EN?X$L)!@DB9GR"7HQ[@/`>>UG; M(!IAC9+QUE[<6??%#3/G/O%JT9=AD.3B/4Y>/'0*,]V1&6"70ZP_;\D<`_I_ M?_I50WZ8&6:R?)5)./7A5"@P)7R&NK9$Z+T_T0GV>3_;7S;;Q+?BZ_E9NNTN M(=9_P$N@Y25\YZ:4C24U%(B<1$N,R(1K)`R<;C%PO`JTP^/?_:SPM@=L]4F$ MXD)K=QJ@,>O_/S;_````__\#`%!+`P04``8`"````"$`&XQ^F#T'``!E*``` M&````'AL+W=O*W(LBW4L@Q):=IOO^.)5L0CSQ+W)HB9X_UY/-Z/9T4/ M[[_79^=;V795<]FY_FKM.N6E:/;5Y;AS__[KT[O,=;H^O^SSRSKM5+5>75Q!P_;=HF/YG"HBO)C4[S4Y:4?G+3E.>]A_=VING8W M;W6QQ%V=MU]?KN^*IKZ"B^?J7/4_T*GKU,7V\_'2M/GS&>+^[D=Y>RZS]5PJ7K%"]=W]3_#D88D3?XPJ5]S/O\\:%M M7AW(-UAWUUR<'G\+CF]K&CR,J^06":L33IZ$EYT+!Q7T.]C9;X]^E#YXWV`W M"FGS8;"!GV\VHX4'JQF7!,N8+LF\/3=E82R4Q7:)I7P8!J8R@5DF5&5$Y!&; MC9N!\=*OO\6"T0!I,IM(B M^"`1QXXYC;?XQ3Q&V.0+!X4B[W(Q#&JM0PHD>P4=UB%4:PH/O^Q2S5OQR!&G@[)+%O#L4' M@"V/!:U5,3FD1^/#RJ>>,9P-+.I^.#B-2`A/,*0&Q!2TL)K*SJ@):Z(V#!D" M(JR8\3P``$IU+!)1MD),/6,ADQ@K+O@C&-[4;AB`$:50Q&TSW2%,3)`MJ'N< M279+5KZ:&P9UOE7IHS51XXK?)]6_]+#I'$!/H*H&%#-)LB*!KZ-`#AD.&X'! MS&'3(>#+(?6P)>8X`BL*H+6:&#FDQQ$8*)!$*S@U]R/">43#B(&W!D,YY(&H MXL6,1FNBQF$@L,(`6A//1@R\]0]J'%88"'0,R"%#9OXW!D2#0*!Y&U*KAFD` M`BL,H#7900X#`<'`S!G3JQ\=@)A2-0G3!@16U8_6)`ZN$PA(]2]L!7`:D9`8 M4!*3,,U`:(4!M%;5Y)!^V$*"@?N)06OB61:_FABF!PBMBA^MB1I7_"$I_N5W M)\XD*A($:FZ8?B"T`@%:$S6N'P@)"&9RHQ<_.@"Q:6X"IO9#J]I':Q(&5_LA MJ?V%+0!.(Q*2"VI>F)XFM((`6A,U#@(A@8Z56,B4DW"_I-G$E4)`?4W#!M323*>'$3@-9$33C8N8:8"`?N MYR:2A3[)S6UH6C-^PC0SD57MHS6)@ZM]\:QCND.8FSAA-`#H`,34W#-`BJ_I':Q('5_\1J7^1FR#$QX)S MN=%9@,YH;E*FL8FM6(#6:DRWH0`?A4X?Z\4$!O>3@];$M02`DIR4:6AB*P"@ M-5'C`!`3`(CDQ/Z"NL&)1,34!Z1,;Q-;L0"MB=K``K5*4Z;KB`D?9M*E,P$= MP`+4=#%W:6S%!+0FL7%,B`D3D'.+GGG@3*)BZ@]2YEZ-K?B`UD2-XT-LX(.? MP#\#YM"-$XF()(:"[I2Y5A,K/*"UJB:']&LU(71`Y,7Q@K+"F41%DD*-B;EB M$RM2H#51XTB1&$B1I@NZ'YQ(1(RD8&[8Q(H4:$W4N*XAL:("6A//$A0J%9@; M-K&B`EH3-8X*B8D*ZV#)<=.[!G0&PLIQRY@;-K&B`EJ3F#@J)(0*]XF-UL2S M1(&2FXRY8%,K%*"UJB:'=!2D)A2(KOE^0#B-2)@XD#'7:VK%`;0F:@,'X!C0 MY^XI`<%,(++4)]\9T`&HJ9EA;N[4JOK1F@3"5;_X;D"_,RSK2W$F49$D4*N& MZ0]2*Q*@-5'C2)`:2!"LHP4DP)E$Q=0?9$Q_D%J1`*V)&D>"U(H$:$T\&TG` M-`69%0G06E630SH),A,)_'2^S\&)1,3(`J8GR*Q8@-9$3;)`+5CFNLZL\(#6 M1$T20U5C+M7,"@]H3=0X/&0&//CS_\;&:43"Q(8-O5IQ%%$Q3YW3M&\B!>V`GCE:1P=7R9[ MPD:`CD?;I^$E,V_\"[SD=\/5:7SCF7!_"YQANH'5X3&S[TS176#J]Z M-3V\WH6_GN!UOA)>>UH+)AZ:IK]]$"W(^(+@XW\```#__P,`4$L#!!0`!@`( M````(0!Q5_@XE`0``*82```8````>&PO=V]R:W-H965T&UL MG)C;CJLV%(;O*_4=$/N+ M9EL<28/7^B?N]&^;GW]:G4G[VATP[C50:+JU?NC[T](TN_*`ZZ(SR`DW<&=' MVKKHX6>[-[M3BXOMT*@^FK9E^69=5(W.%);M(QIDMZM*G)+RK<9-ST1:?"QZ MZ']WJ$[=J%:7C\C51?OZ=EJ4I#Z!Q$MUK/K/0537ZG+Y8]^0MG@Y0MP?R"W* M47OX<2-?5V5+.K+K#9`S64=O8X[,R`2ES6I;0034=JW%N[7^'2USY.KF9C48 M]$^%S]WDN]8=R/F7MMK^5C48W(9QHB/P0L@K17]LZ;^@L7G3.A]&X(]6V^)= M\7;L_R3G7W&U/_0PW!Y$1`-;;C]3W)7@*,@8MD>52G*$#L!?K:YH:H`CQ<=P M/5?;_K#6'=_P`LM!@&LON.OSBDKJ6OG6]:3^ET&(2S$1FXO`E8L@]+2(PT7@ M.HJXAAUZR/.?Z(K+5>#*56S7")`5.<'C\0`YF`+74<1Y6L3G(G`=XXD,Y%H/ M1&.R01K&/"WZ8K-JR5F#B03#T)T*.BW1$G3I8#N0,O<'&T:9MOE.&PU-@>X@ M0]\WR(Y6YCMD5^?$"N(@038*X_;P)M))L@I6',&!ZB9]&/:%/""(5- MZ4A0#ZXI/*1:)NB[$7RD3,K'UO=<$CR`+CSO`6TD>R#U(&:,(L)DED@9);/8IN4I# M<"`0'7AL1:"-9"?D+8(QW`D[],/`DV<#0U16S!+9_&-RE8C@!2URG]XN:2/) M"U<*-&;,F!4>"@)IZ4BFA.TA22!EMQ5.95.!!?)<<%Q,S5RE(=@0_1\;:"/9 MANLFQ+9*QBBB2!C!9[[MT354C"*=U'P9:]D"J9F(. ML1`#*_*D33#A@,*E=![)YAZ3*S5$$VAU]?2T0*PF@TWYLLXA5]K08@XI8DTX MPORRATU5RHAYD6P>R96(Z`>MMR9^S"0%J\Y$'Z0QCQ&#^`(1>+8=2AM+PA&% M5>D\DLTCN;(OHA&TXGK<"%:?B4;(921B$*^FG2BPK$A:`1*!<4)7+H)2$1"S M)1-NVDX0A$XH;5VYP$!%'41A%%PAT01:H#S(`ROGI8!\(Z0?OQ!3S(N)TR;_P```/__ M`P!02P,$%``&``@````A`.]`X_^4!@``NAP``!@```!X;"]W;W)KY*N])JM9=G8N,8 MC6TL().9O]]JJ@U=!<9X\I#$[D-Q^M3E&/?3AV_'P^)K7M5%>5H[XL%U%OEI M4VZ+T^O:^>?OS\O(6=1-=MIFA_*4KYWO>>U\>/[YIZ?WLOI2[_.\64"$4[UV M]DUS?ERMZLT^/V;U0WG.3["R*ZMCUL#+ZG55GZL\V[87'0\KZ;K!ZI@5)PXY M7L4KB/3\M"U@!UKV197OULY'\9AZPED]/[4"_5OD[[7U_Z+>E^^_5,7V]^*4 M@]J0)YV!E[+\HJ&_;?5;#LU?Y?NO>?&Z;R#=/NQ( M;^QQ^_U37F]`40CS('T=:5,>@`#\7AP+71J@2/:M_?M>;)O]VE'!@Q^Z2@!\ M\9+7S>="AW06F[>Z*8__(:C=41=$FB`*V)MU.3?("@FU^_N4-=GS4U6^+Z!H MX);U.=,E*!XA\&5C2*/;ZK6=PA9UD(\ZRMJ!:H=-U)">K\^Q^[3Z"HIN#"09 M0@1%I!>$3@2PZRC"OFV*XYI?F&BP9J)SH*DE^`;$[JA)=M\A(NPAA`D(-)^) M!J\=S[IQS':<(`0JH./F,6Y3"$(-[C.?F@9#"5KWC4)ZXP0A<9O+9>A+&444 MD1*$$%#+81^$<(,-VMQTC2EHP>E$ZHN8?'U6,+4(F9)O"D$H!C]"45]$98P5 M%2E!2-C**)0;\?R2]4AX?=<0>B&E-ZVMS.K+Z(\?.[\)A9A!C9!'@=74_M]5"I*W47_P@[?1%CQ^Z>(`39 MQ;[R6=)37!^O2R*?@"ZP]9O.:XMFU/J=HW`&X[<%UQ=3NYB:12.KZWI63U-> M>A1;>;W!"P>W/4YB-BP2@1B\=>2%W!Y2`A!Q'/E]MU-N=]F!P.%.N/6U;#1# MS!7-_J'[J5U$"F"U)/<,L^IMM8/WESVQ#<-@SH8ANC MS##.-+.['$...(9@'9H8$+^MJ3K;+&1(:=.LWN46B3S34CV/S>Z)%#GGQ:%GUD MPPY!4P-934$H/V88\]I#X6,%&9%ARPU`7-^C]CLW'=!)">3+; MF,ESQ#[X![Q$V0ZA7!@@$7R3R-9!$_IHQ/$CC;N&PO=V]R:W-H965T!?/Y=/SQ@92]N2-JKE!3YR@U]F MGS]-]TIO3,VY1<#0F@+7UG8Y(8;57%(3J8ZW$*F4EM3"4:^)Z32GI4^2#4GC M>$0D%2T.#+E^A$-5E6!\H=A6\M8&$LT;:J%^4XO.G-DD>X1.4KW9=D],R0XH M5J(1]NA),9(L?UNW2M-5`[X/R8"R,[<_W-%+P;0RJK(1T)%0Z+WG"9D08)I- M2P$.7-N1YE6!7Y-\/L1D-O7]^2WXWER](U.K_1XO2"9WV4L_@'>-2E[1;6-_J/U7+M:UA6D/P9#SE9?'!3<,&@HT4>K+8*J! M`N`72>$V`QI"#_ZY%Z6M"YR-HN$XSA*`HQ4W=BD<)49L:ZR2?P(H<47U).F) M!)XGDB1]E(2$@KR_!;5T-M5JCV!G0-)TU&U@D@/QOPU!$0[[ZL`^!6HU,(3= M+!ME4[*#SK$39GZ/27L$`=%>&=0>5W;@`@\PNBAG@Y[75S71+@KMC3^*/W@)GXSB1Q^IQDH[[&FPK`R./>'=@INWZG<3+L M*8/M$![[\&0XB/OPC2*TY7%%![Y2O)@(BB$<;(Y&Z>2#8KA%8O-7SJ.*Q<'`&X4LJ>#^Z6]A_/V5\` M``#__P,`4$L#!!0`!@`(````(0#;HZ1&:PL``,DW```9````>&PO=V]R:W-H M965TZW(M*V*9;HD99)Y^VF0:!*-G_$AFYLH_M!H@#^`)AHD/_S^_?`X^K,ZGO;U MT_78N;@OQ7=1K__O&?__CP MK3Y^.3U4U7E$'IY.U^.'\_EY/9F<=@_587NZJ)^K)RJYJX^'[9G^/-Y/3L_' M:GO;5#H\3MS+R\7DL-T_C5L/Z^-;?-1W=_M=Y=6[KX?JZ=PZ.5:/VS/U__2P M?SZQM\/N+>X.V^.7K\^_[>K#,[GXO'_^FS_`_6&_.]:G^NY\0>XF;4?QFE>3U80\??QPNZ3\?_1Z:'^%A[WM]G^J2*U:9S4"'RNZR_*-+Y5B"I/H';0 MC,"_CJ/;ZF[[]?'\[_I;5.WO'\XTW'.Z(G5AZ]N_O.JT(T7)S84[5YYV]2-U M@/X='?9J:I`BV^_-[[?][?F!_G=U,5]>3ATR'WVN3N=@KUR.1[NOIW-]^)\V MTJY:)ZYV0K_:R731.WFAXE17G'45W<7%S)TOKYKF7ZA)G6OZ3;^Z27=UX5[- MG?E"=?R%F@M=DWYUS>7;FESJBO3+3;ZQL[38FL[2KZXYOU@ZEZOI\N6NKG0] M^N46IV_2U:%YU`ZKFE#MD+WQ*IUN1M!_=-4WCJ;#\T#]ASO\1HD;G;2KH%E4WO:\_?CA6'\;4:2B:SX];U7<<];* M+R^G=CYU"^Q'ZXL6EO+R2;FY'M-PT](Y45#X\Z,[O_HP^9,6\D[;W*"-(RTV M;*%6K7+KV<"W06"#T`:1#6(;)#9(;9#9(+=!88/2`!/2NA.<9LJO$%RY48*S M5#<,C!&PU&4+KN+9P+=!8(/0!I$-8ALD-DAMD-D@MT%A@](`0EU:5+]"7>7F M>DP+TYC.*RGG36OCTCAW1C-ILNE,.LF!^$`"("&0"$@,)`&2`LF`Y$`*(*5) MA/RDV*^07[FA@$3-=-)B.&F-7M2_,^GT!^(#"8"$0"(@,9`$2`HD`Y(#*8"4 M)A'Z4P`7^@]OBCAH*^M&9I;GIB5S6EV]\(M+:U9W1ES-`^(#"8"$0"(@,9`$ M2`HD`Y(#*8"4)A&JTL;I':HJ:ZEJ2TA5%FP#Q`/B`PF`A$`B(#&0!$@*)`.2 M`RF`E"81$M(64DBHMAGN_((D?^=&0SF2ZK9D+H+%PMY9=$8\!!X0'T@`)`02 M`8F!)$!2(!F0'$@!I#2)$%REN^:^[N5(H*REJBTQYRP0#X@/)``2`HF`Q$`2 M("F0#$@.I`!2FD1(2$F(D/`GM\;*C=16DUD?#X!X+5&9G1&)71F)_D::)\T,`>GE"OH#$)Y MD3HUC@D90B'R-)JMFK1CYBQ=:Z?F]Q9\,0'Z"1%%&KD4UHQ1F,I1B'LK=I\( M7U(LE1>8"[.=5;U8?]3//Q*+9D.G5IM>T!:)V[Q1>:P24$P9U[YY]U9(V:8$0DR-Y-A9BV>C-OGMK.6K\1#YC.1"G,N%&+"5;!$D MA1:COB)W(F8D6US(%A.V^E&+4E*U;3N M3B5D1>ODQM<5W;YB@+Y"1%%?T9R85GR.>RN6/Q&^I(JDM5#QE56NS&FQFH&R M1;1CY.8V*FB2E8$\1#ZB`%&(*$(4(TH0I8@R1#FB`E$ID)14;=O-B?F*I,K< MDK1%,G%<6O>-C=-9L?`>(A]1@"A$%"&*$26(4D09HAQ1@:@42*JL]NKO4+G= MVHN)JW?[1B+I`/(0^8@"1"&B"%&,*$&4(LH0Y8@*1*5`4E(*6T+2GXVHRH\U MHUODFEH#\F@/H"K*;?K2NN/XO17/^X!1[SY$%#&BZ-3?UZ?6LHI[*W:?,.K= MIXSH[F?XLO8V&5OU%7-&LA/6YJ+HK;@3):/&EQPWE4N82\'>!+\M8]`921_' M;YP6B5$#Y+'5HKL!^(@"1KT4(:*($84V0U9K!L2]%:N3,.K=IXSHGFSXLG9, M&5OU%7-&LA/6]JCHK;@3)2,<(O>UI.YM>4KC1JXL1G(^63NK#5OU8^1IY*[Z M86.K99.G+!=+Q[5W/0';M`^#U6.ED%'O/&(D>G5IS?*8K=ILQ;F86P.=:`.C MCRG7Z=O/$.4:S9WNX@I$I:@HEI0Z!Q=+ZN5[>&-NC8O.'RFD];-O:06(#5?L M!\%CU.\.?8VHN^I1H.-<+>@M"2MN!=IHUE]RR*YZ[Q$CT2T<&-WY-MM2C_[E MWC?!QM+>,Z^'#%&NT71I#$S;F(%*45$.C,K@_N]81Q'-OD,Q$C-V:46+C;8R M)J2GT;1YSZ(Y?/$9.`K1>80HUHAV1FHR#(T->$[1388H MUVC:S[P"42DJRK%1J2",#;W)04M`'5QQC'O[*9:KDTOCGL1(3."E%5DV;-7/ M?$^CN3E.K?NI.C:C=76UFDX'`I[N0Z]*B-XC1J);N*ZT+UY72RLU3+0;8Q&G M[)ENO$8@L19DUEOQZLL9O=BE@JUTE^0Z+[FTN7@YV"K5_;6#K;-N<[`UDHL2 M;F[:JK__>&Z+9OU=PM=HJD[]U&`[TY4[AR#:-<@RAKH>K3=&$2/1+1SLKEOM M0EU:_4ZT&R,$I.Q9;#V6ULE#UEMQEW)&+W:I8*O!X\&22QO1Y&"36QQL>@E) M-6PX.+!@D:&?AM$'B(?48`H1!0ABA$EB%)$&:(<48&H%$A* M2K<@,:=?"1/*W`H3+;(FKG7RN:$358@<@'RT"A"%B")$,:($48HH0Y0C*A"5 M`DF556IN1HY75&XS>?-$C.Y$EGX;1!XB'U&`*$04(8H1)8A21!FB'%&!J!1( M2$J;^O=(VIC+B:N1G+A7UK9CTUMQ>/40^8@"1"&B"%&,*$&4(LH0Y8@*1*5` M4N7W)=M3G9P:^T2-S(B+R$/D(PH0A8@B1#&B!%&**$.4(RH0E0))2>TT^>58 M0%\8V!%7(R%I:V4@#ZU\1`&B$%&$*$:4($H198AR1`4B]:U%'P);2=MO)]K7 MO`_5\;[:5(^/I]&N_JJ^BYBYE$]TN/UHXV;J\E<;=HF[6*N]!RUS*%E227,L M`B575-)D8%"RHI(FQ[5+II?4@R;5A1+U14ES2&274`<&VZ?F!UMWYFOU&&S@ M6ARZRC9ALMMPJ!%Z`C%0QR5OM"W&$CHS6A=T(C14XE))<]IJM4.?S7P:XC=T M\4.>;FC`!NVG)-9`RY]FZT\T5;!+-[,UO4\ZP.GJAB[NAI0:F@[TS&&M#K71 M$SU46*M3:RRA9PMK]>1@J&1%)4-UZ+$"*3)40F>H).[@%*(ZZMD`MK.ADLU@ M"3W;6:O'`EB''MZLU=,!+*%G.&OUD`!+Z%'.6CVH&2I94\!FI0 MA2%.;T)1CX>NGUYDHC:&2CQG1G6&QC^B$O5DGMJ?='.5/J1ZWMY7^?9XOW\Z MC1ZK.PHHETU6?6P_Q6K_..N7F#[79_J$BC88]&$)?3)7T>'[I3I=NZOK,_^A M&N@^POOX-P```/__`P!02P,$%``&``@````A``M,TW^I`@``4P<``!D```!X M;"]W;W)K&ULE%7);MLP$+T7Z#\0O$?4XJ46+`=V M@[0!6J`HNIQIBI((BZ)`TG'R]QV*LFK%0:!WYLW0X[6MT^R1H]<&Z&: M#$=!B!%OF,I%4V;X]Z_[FT\8&4N;G-:JX1E^Y@;?;CY^6)^4/IB*6$^B>4TMY&\JT9HSFV13Z"35AV-[PY1L@6(O:F&?.U*,)$L?RD9I MNJ_!]U,TH^S,W;U<561%@VJQS`0Y4&/M?VI3E^Y*"L+W9Z#(>2VRG"\#.;+,(D`CO;*>!.X]2;*82D)\0IV_ M.VKI9JW5"<&>`4G34K<#HQ2(7S<$3AQVZ\`9ACT-N1IHPN,FB9,U>83*L1ZS M\QBX#IAH0!`0'91!;;JR`SME5UJ7RLX'+F7BUV62]\@X<(9G%\DG\6S@] M`VT;#/Y'C`P"S72##@P]`/*!]KJV'C1!&B#3I1VXDQZ*VT?&=9@/=1BY7+Q' MRH''4GUDUAV_R^VQ'/-V)RZ$Q-[>H6[56,!'DM6HL(O7O;AI/?DP./!8JH]< M>P'Q2][.2PQ#Z&TO;M58P$=>>%F^\.*'F#_DDNN2?^9U;1!31S>@8CBV0W28 MG=O8U?]E?)9NNYE*A@\PTUI:\N]4EZ(QJ.8%4(;!$OJB_53T+U:UD#E,-F5A MFG6/%?R\.)S<,`!PH90]OX`P&7Z'FW\```#__P,`4$L#!!0`!@`(````(0`) MRK)S=P0```82```9````>&PO=V]R:W-H965T:;7:CV="G`05<(1)T_[[G6&`8B5X\CTQ(M$3L29ES!R$%61U'!9 M'1UYKGBR;R85N>.Y[LPIDJRTB6%5/<(A#H)[4H%^>LK/L MV(KT$;HBJ5XNYV^I*,Y`L0T%O/2V?I`--VO<_``8;=JOAA8S^Q5> M'4\UI#L`1VALM7^/N4PAHD`S\0)D2D4.`N#3*C(L#8A(\M;\OV;[^K2Q_=DD MF+L^`[BUX[)^SI#2MM*+K$7Q'X%82T4D7DOB@_IVW/LRR;0E@?\?)-XB8,%L M7(I#MIHHQ4F=;->5N%I0>B!D2DORZ]:?+M?,*B4E;3'B+82HBZA"8!:2-Z4832P?T]J(AGD/1]W/9:4,P M:NM80[H!W+U83Q-RBYAKD/@6XDU[%D4L)'TH%B,\_;0`.]$X"7`#C7[@]OQ- M=$+"`%7OXT-!@XA&$;$)H;@`*4,7YI`C&.IHH&RFQ2\DR+*I%!Z2VUU1@0PB3UPJ=,,'=6NG&/@]ZA\!=Z:/2%,78[`>; MH+FX$:PKUDHA),Q]Q336UI&_G*EFXV[J/4.*Z.571"-8%QVH3PX)0TN23?WI M0EL!T1#P$4G:JFGL?OTHLAETE\>#W:!5X`R0V,BB6L$^IEG!_F]>`HRZWW"#]P.MD,,6 MU.\Y6L5$[;C1!SWG/D3U@8U,\S'>91FU/]7'7%L6+8A\S`,7_U1(U$+NZZ3U M882H5K"Y#:R,I():H6IAH>H+&8$,^J)Q2&R$J!;@24,+#RX0G#7VTH/O[@`R M6AF%Q$86U0JVO4$VNA?DD:Q0LU2SHK7R.`PL/%A;UU)&=U]1XVR8R M"HF9":):P8ZI67E@YZ4^JV0EN"DL`K6%M5CZOC?3=K4(SMPCZPB/Y9]#R`L= MN^E`6?#JR".>Y])*Q06/U!Z\L?5W^^/^DX=',>U^R%9P_(/[3C\`I_!S1OV0%*GO+C?G.&7X_/ MK=/;,=L\%I7VKRVWW>ZV]IO=H:DT!,=K=.1/3[MM%N7;;_OL<%9*CMGKY@S] M/[WLWDZD;;^]1MU^<_SZ[>W3-M^_@8HON]?=^5>AM-G8;X/1\R$_;KZ\@MT_ MG^.8/=TW'YQ@ M[3G-UN>[PD'_W64_3I6?&Z>7_$=ZW#U.=X<,O`UQP@A\R?.O*#IZ1`256Z)V M4D1@>6P\9D^;;Z_G=?YCF.V>7\X0;A\L0L."QU]1=MJ"1T'-C>NCIFW^"AV` M_QO['0X-\,CFYWW3A89WC^>7^Z;7O?%[;<\!\<:7['1.=JBRV=A^.YWS_?^4 M4&%1J<332N"IE3C]=ROI:"7PU$K<&_?6=_PN]N1"ZU!:F`!/:AVLN5"AJRO` M4U>XO>DY[;[7N]Q03]>#9]G#][H*YEW167AJ'1WCJ0M][NMZ\-3UO*OZ[(`K MB@;Q!UW3OZXF1=4Q8>WM[S`IMUIF(&4<6R(D"9R!J#;B(.8@X2#E8,C!B(,Q!Q,. MIAS,.)ASL.!@R<&*@W4%M"`\98Q@4'Y$C%`-QHB\.R!@@N:R@)`$58DXB#E( M.$@Y&'(PXF#,P82#*0)%35(-CXB:JBFB!IY>Z!)IUP.0T7<:F3=+IN/D1+R MREJQK@6/ MM1VC$MM<32KF*N*"YTW';]E`CI10Q5Q="QZ56CU[^">E4&FN(C7F0@)ST=R_ M\[??F0L9+]F+6FQ[-;'"XK;M?H9*R.\4"0LKC'2A.@]@-A*7.LFL1)-NG8*T M%*^XRC4ICQ5UR)PL-]1$MV(N2MOF:E)-P%R7C=U0"?FJM\Z-QS:22)?WS.`N MU986:P(9=B7^M[9?T[):1>AWEH.F=UB.TK;EFMB!]NP.A4K(ORWBY,!D:E?_ MN?$GYJI(5Z@$OVRG=(4F.O@W3J>JL]TVD2[F9%HJN,(I#AQQ+:_\:5J.>FQ_ M%:H!08Q,!+ML!H^8TU?1:@D"KVU"CQX4SM^4PHTD)^9610/8,20DI5 MMQ@8MN]2$BEJV?9BVOD.>U66"AD)^7*`QU@,NQT$-L9#+>7W"WN]OM/K]9A, M1#+5"-=J)!K%MI02U50I%$7 MMO5R$CD>6UAC(T5^3:2N5**AJ6C4>VVV)XR,%*D?2UT3B::$(.QE[[TV6P)F M1HK4SPFYY=A92+0D=%']RDB1^C6A0KT=;\SA9;SIXOSZZU%]%JCNT0JYQJ80 M;W-QAS(H(E2UR>VS/"PV4F130LCH2B4:$JJJ]]HL>QX9*5(_)F343R2:$K+5 MLY5A9J1(_9R04;^0:$G(4N^PX;HR4J1^3:A0;P<[Z@Q7R`JX0)&CD643/SS& M1HIL2@@9EZ42#0G9ZMFKF9&1(O5C0D;]1*(I(4L]C\C,2)'Z.2&C?B'1DI"M MGJU/*R-%ZM>$9,#A1%(7<+.%7W7!5FBQY[=&U7!+%&G4,?M\+%$B*Z82#0E5 M$R^OS:[P1D:*O#,F9)P_D6A*R%+OL`/QS$B1^CDAHWXAT5*CBB=6$JVMBM92 MC;?K-3/7!/*Z7*Q0PR*IK@MI5\EE!UM+K\9!R3E+H;*([= M_*8N(1FSOJ>$3'M#0A?;&Y&4'4:VY(])RK0X(61:G!*ZV.*,I"ZV."ABBRN2NN#3-^Z'`:UL+XJ!)$9[D2*KH/3*B.`G3-"(V5&0$W%FBU:2ZGMI-?S_3[+ MJA)+MSWP\2#&5S`/LLY_V%74^0WN1ZFS`WR)@@&"A[%2O,0T4E0QDBC6"-*I MXN.LMMOV76&3:J]3[&*V37A(D3:92%XWX-11QS)1(RN0E5>%Q:NS$#,Q=$1U M>X'M\[4Y#]?IW\(5&>WH1 ML@/*+BQ"(U4&5",/,H]R),AA2U+X'0!\@(7"]X`$MD"61=4*>N!P.O_!"< M]0WN:*%.\94W*QFXG0#W^KIV?"@IU@Q1IPLEQ1[&2B+0ACN:U`;?J#_4V3F` M+M=;"1VNT3,`X^ML?P#GUX8%;K\#/%+++L$E>(`G:UD"=^$!WG37E?2@I+A] M8*;#[1J4%*_?14D?2OIUVMQV@*=VV0Z\$@CPGD&6P)N!`*\;9`F\(`CP^K^N MI`LUW$U!25VOX68CP'L+V0YI`1X M.R-+X'U*@&]+ZDIZ4%)G#]S00DF=/7"5!R5U]L!%4(#7/+*=V`_@V[,:#L;4 M]2MVV@%^G"%K#!P_P'=E=27=8%#;.KS!@FE6IPU>9`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`D'Z7V=:=?ON!$J_N1G'.9DWYE3G>FZGLDXX7,2+\RX^6K\M%P[8M* MOV^JXI7,1[\RW^Q53>-01QSZ!0DOX/XQYM*ZW`7$/]X6WFY#XB^ M_];RLIJ.DO-U'=/V\W/$YHCJ9UW+TLQXSH+ MX8X'\M"9#D/[GT8V#6GAY8MP^E\.O^3II!;:7.#-I:% MSQ9BOA!N`QN$-HAL$-L@L4%J@\P&N0T*&Y0VJ&Q0VZ"Q06N#3@/G),]!(^K/ M'Z&1<",TXM:]8:")9DKFLP5G"6P0VB"R06R#Q`:I#3(;Y#8H;%#:H+)!;8/& M!JT-.@T8@M`T\1&""#?7IS2%:(/&-16X&6QZK'Z&:<-.KQJU],Q"7 MAKBFHV<-K8,19PN`A$`B(#&0!$@*)`.2`RF`E$`J(#60!D@+I-.)(1(M8`R1 MQG/%I#OW'U)MR8B@R$=I#ZZ+!O/`'L#:U&,BPF^^7Q3Z0`$@()`(2`TF` MI$`R(#F0`D@)I`)2`VF`M$`ZG1@-3[M/H^'%Z)C2)/;&T2' M<3`ZC`X@(9`(2`PD`9("R8#D0`H@)9`*2`VD`=("Z71BB"2V_(9*QX=';VZJ M(1'=RKFE?40!HA!1A"A&E"!*$66([6'30I?@PMQ0&_?W"KHE*8U5XEPJ1#^ MLA?-H7$VT?]SP]^L-@LXAU(^E,CH#/+JLC.<.5/=[62BJMV/V%BYT)K0559F M]Q#+<+U[O#=6.BSGC7XCD2'2W!K;O@@4B^8V!;\R!0^DU4SO/$-&UW!_98VW M2&8D*^YB,5^Q1V9CB.6NWAB_&"O#ZMBHLT1&3[E2;3\L=46L6]3Y8N@IL]G< M]6:642"-9GKG.'CGRD2FJWG?,\RVB]FD=V36E]KN+?45YM;(D,@4P>KGOHC! MBY%QU=?7NW(N+BXLFX!M=(7'G$^L>262&=W)T)B7,QH>=@L<'%&[F2T@EG!O M4'Q8\1F*#TC?YXN^3-754(`H1!0ABA$EB%)$&:(<48&H1%0AJA$UB%I$G8$, M+4A!4XMW;OQ[/V8WE8@4T:;$*WL"5U8\O`)$(:((48PH090BRA#EB`I$):(* M48VH0=0BZ@QDZB96P:\?0T($:Q:12!LP/J(`48@H0A0C2A"EB#)$.:("48FH M0E0C:A"UB#H#F5J(];2NQ3MOYR*$;(LDE^KTHU9F5]9L[,N,VKXU0!0BBA#% MB!)$*:(,48ZH0%0BJA#5B!I$+:+.0*9N]J;E^,I#;"]M>09$78,G+U]::2A` M%"**$,6($D0IH@Q1CJA`5"*J$-6(&D0MHLY`IA;VCNF]8PBW4F)_+%8&YABR M@VS*BJ4,$(6((D0QH@11BBA#E",J$)6(*D0UH@91BZ@SD*F;V"?9<]\[0J.T M&X;!-2`Q[VISGQ7>\&5&8[P=,K*4(5I%B&)$":(4488H1U0@*A%5B&I$#:(6 M46<@4S>QD=-U^\7<)S>,6H2"`D/]L-+G/D`!6H6((D0QH@11BBA#E",J$)6( M*D0UH@91BZ@SD*F%V&'J6KQW[I,[55VD`5ECR`X'N`%8U-E15?,4.4(RH0E8@J1#6B!E&+J).( MXL=45$,U\82!,8)LU5YW;-"[,8,/$FF"^(@"1K1@.#2UXUF1K%!9<5-'C)3> M,:)$HCG5\N#>FUA!N%19L?N,?:FX7(ZH4!EU]];D7BHK=E^AKQI1HS(><=\J M*W;?L:^^<4R][:C%.^]T'H8S)#($'ZPT%+"5+KA[906^0V7%=8H8Z8*#^X2M M=/?>Q`IYI,E/L<4<'(=&_-#*6R8O<5(^6^1M0P,MP[5G=ME16[[QB- M""[B%_HM\KV"#W$0/0;L#4A3UT<4,#+J9,>J0V7%=8H8J2:+$26,3/=6?"95 M5NP^8Z3&" M!=)JJNZ4(:((?<6($D;ZPLN;6`&'5%EQ(3)&JO%S1`4CP[UCG4"6RHK=5XR4 M^QI1(Y'6$BVBSLAH"DF=8F2J5D*^!A&32S9AG?D_G4XR8! M(THYY'/MH\B0K89SW?ZW.HQ MPH.Q"?:EE;XO1A0BBA#%B!)$*:(,48ZH0%0BJA#5B!I$+:+.0.:H_J#8DH>Q M)8F,V)+G6+="7UGQ?!8@"A%%B&)$":(4488H1U0@*A%5B&I$#:(646<@4[>W MQ98\C"U)I`T8'U&`*$04(8H1)8A21!FB'%&!J$14(:H1-8A:1)V!3"W&8TMO M?OS;P^B21+3(4;Y-G<;W[VH7\*KGUZ>X>Y=(*[Z/*&`T M/';K3AQK;QHJ`U49/2Y@5N97>]/7;6FFN#EE9+:\%9CQE147-E!(3?BXIV&K M8?U]<3&;75GWA(A-+BL`'SX-G[_GJ4 M43WM&R`*):(GVL0W'2@*/IFY4*?A>C3BJ+U,)>TMQ5"GMW;+85NA1Q&G$M&5 MM2I:FW)?62DAAXQS=4X72BN*AHHJ.JXSMW>YD>'(K.'H0IT^0D,%$^^-<%=] M_4LD%`D`024R!;4BO#YGU`4=,HJXWZ&91KJMM!(OLI#&XI%CV(I+YV,:VTO> M(72H-.8F^$4_QJ6P>+_.VDXB"A"%B")$,:($48HH0Y0C*A"5B"I$-:(&48M( M?.])M=?02X?O-PT??'E:;;^M_-7CX^[D=O-#?)MI+EZ_..#APU$WWM5"+,YH MQ-@ITPE]4ZK_+!2D7/+7INP4UUN(Q\=&O+E32NG/%B'/C%+Z"1)2YI32AT4@ MY8)2^F@BI%#9Z`!ZI`14T=%Z.E1/>D=N)(=#6>BA[)$4E_+0)#F60E_B&G9S M4#*74OKUB95"'^_Z,L9OR%4_<5GV-\+1V+6I\O2V2.5=/3*4V=Q0ZL'+*M/*6(M@BFT:%R()>%8BDLI M8TU%2QA*&?-&*\E%-)IRXU'U*8:#U[GQJ`$H2C"60DU`>U9,H>/=A8@98PJ= M\BY$Z!A3Z+!W(8YRQU(<2AEK`SH^HI2Q-J!S!DH9:P.*4E/*6`GHS'LA`NE8 M`CKZ7HAX.J;0"?A"G&^/I3B4,E9J.E.CE+%2T^$+I8R5FD+WE#)6`CIN6HC# M)"P!G4Q0RE@>>GA@(4XD,`\]0[`0!Q.80H\2+,2#`F,I#J6,U90.)REEK*9T MBD4I8Z6F,Q!*&2L!O2R[$*_"8@E"QZ64L>N$SIQ2QOHU/3"S$$_(H#=Z_&4A M'B+!E!MJ@YO1LM&C'0M_-(6>\"`5QMJ-'@6@E+'ZT)DQI?3U.3_,C_3)P9?E MMU6YW'Y;/^].'E?W=-N;]&N3[?#1PN&/O7S/]>MF3]\:I%4Q?0B-/BZYHG=. M)V(M=[_9[/D/JN+YX7.5G_\/``#__P,`4$L#!!0`!@`(````(0#25UQ4`PD` M`'\G```9````>&PO=V]R:W-H965T3KV?F27,B_.=WUK,.KWLO.^..3GY[O^?_X,O]WT>V6U.Q]V MQ^*-KEYWZCX%T^HE$\/>7[S"_V;Z?L M7#4BE^RXJV#\Y4O^6J+::?\1N=/N\OWM]=N^.+V"Q&-^S*M?M6B_=]I[R?.Y MN.P>CS#OG]9XMT?M^@\F?\KWEZ(LGJH!R`V;@?(YSX:S(2C=WQYRF(%P>^^2 M/=WU'RQO:UO]X?UM[:#_YME[V?I_KWPIWJ-+?ECEYPR\#7$2$7@LBN_"-#D( M!(V'K'581^!?E]XA>]J]':M_%^]QEC^_5!#N"!9F!/1%* M^^((`X!_>Z=S_GW/#]7+7=^9#B;NR+'`O/>8E568"\E^;_]65L7I M?XU1/2,E8DL1^)4B]LW`&H^FG]`82PWXE1K6='`SF8RG-RZ,Y$KO<+6>`OQB MRYN/M9S*EO"+X_[TW&$AU;W#K]1P!JXUFCE_,^J9;`>_..J)[OS*="W(D29D M(EF:<-BZY0=#9JG`PW]0Y=-!LQP%P=-4<@8Z`;?I_@1;8Q*<@H""D(*(@IB"A(*5@2<&*@C4%&PJV+6!X%Q;& M5WA7R,"6;*0S<>>\L;$ASBKGQ\3CRD2YG)&`D9"1B)&8D821E)$E(RM&UHQL M&-FVB>%^V(Z8^\>PJW3?%G'S$*WN^O"OD$V6$TFE;R/"3V^FG@3BI52_Y M_ON\@"G`/MJQ2SAPEFA.&$+$])(D+2\QXC=D/*N/)&/+M6=F7@?*`*<1,I&( MD;@A-LRXY7RR9!)EA-)I6\CPD"@+^2E,>^C/XO5W'H(,0!<)%=-%DAA)8H], M%RR4$8[39R209%K[D0B$RKSE#9N<[2)EA+W$C"37>DF5>7]Z-%TJ2@*^RC]]OQ8U),E71$;"3EUSM`MMA3/W M);+-AN3P%6@K;!ARK8BC6#=LI=R4[,&)MD+YU-`RO2B._FTO7E_;5E,IP.D& MM><2P5D&T8(CGZ.`HY"CB*.8HX2CE*,E1RN.UAQM.-H:R'2I.,^W7?K_/@1H MZ@)RDB2[T%QI34-A@BGZ.`HY"CB*.8HX2CE*,E1RN.UAQM.-H:R(R' M./%_13R:R@$Z0B_.+5E,V`HM./(1&=N:2S;20%NA?(A(RT<8><*A)M MA?(I(BV_1-2N7FR'W*I7:*4;KA&9@R#)NM%6.(@MHEK+C!MH=<1-'^,^=-`5 M%1S=WAMDZ^$OI%4+^8BF*K8!1R$BK15Q%",R;G\.R8!$6Z%W4D1:?HD(4D^? MIAQR$%BAE6ZX1F0.@MSU-]H*![%%5&N9(0*MJR'ZV$G;$C+DN".1F4_DP+#` MACI&OD3VK!4VJ>76QVUWZEHVO9F'J-2\71!/2R-$6CQ&9(QJ1+(\0:OF>&\- M)B30J31HC7&);73_*X[6$DWTO7;#T=9H:,9+E$SMK?!O[O:RPFKO>!(9)QR7 M;!`+2UKI(/B(]#/60")[5,?%LFZF\-J-[%NA-!KK*4L,0C M=?$NR3S2I;RSI5;&];#B:"V1XZJLVW"T-1J:@8&!&X%IS@R?W>N$"EE'$AD9 MZY+=8F$U5JV$]"5RZA=W]3.#`)%5Q^O;%(+%P\64(BX>UUU59,NV5D6 MV%!GOB_1I!VG1LL13WM^W%LW,\?IV/!4AYC7$5>/$8'O]$$6S8C+XXV+6B MN2@1F8N2WMS02M]_?(G@'0"Z(Y#($<^M1+`M9V9/Z":*4KI=A$BKQXB,8;%@ MHQ4N5)>,.Y4&KRMR_>Q/<1NX,<"5>@L@;>!SEX?ZL$OX'#JIIT:Y#9_'=/0PA^%V MCG;LP6LH/J*'B?<`SQ7XA?G$@_J!MX'JS1/E`;\"11PX MI&M@4#O`E:XV4+_!"+JNP&$5VM3;"W47M)EWMH'JV1.U&!\;%-&>J+_X%:B2 M/5&&\2M0+'NB&N-7H&;V1$7<=64"5[K:^%,/7@!UM)AZ\/:&<]_UX'4(Y['K MP;L,SN'A((DEW/*C)6I.<-H,*@O+M>W`*C&M4*L0\K=HL"RC"=FSY%222K8BG!18 M0OTBI[7HU&DUZ[ MN9G(ES3A3+!,FB!GM85./2^MI05*ZU5*P8&*W>`DB]#&">,YLM:K)I\_E)S% MQ7]#Y.S\A=/T&ZT(A`UM4@VX9^Q!4>]2!<%@:S(Z;AKP@QLIR?"ID#_9^2NA MQUQ"MWTPI'R%Z?.>B`0"!1G3]952P@HH`'Z-DJJ9`8'@I^9ZIJG,(^3YIKOP M'3\`OG%/A(RITD1&\0F74B<.U$0.YZ M`5;KI@EGCR5>KS@[&S#AH%Q18S5]G3!`1I]*:T'G]+^8(!\ELE$J$8*5`@$( M:.WCVO.\E?4(_4@ZSG;*<8:,7<]0X2O9_1@XC('X`K#`D;8%@7R`+:6B;/4% M;7O@Q:<[\M`S^B'[,7`8`_$%,/#@?8@'I1(AF"JZ-(NNV_-&E6];TE5SFJ+-39##!(DOD8$Y MV`[&YCS8KU[?:?HEI`8U7OH:MAT"%^W.M4>K:M>1`CU']Z\.&X5RZ$CS9JTZ MMKMPO\5CK0$$#>[!-7-J[;DN1A[8Z9-&\VK4=?_C>7?=\^>)(C[@,8NRH M);EV([OT9_90-M8B8SOS]]A1Y*&=#O%[.Z,8=]WSBP;I$=?L=*2V04'@OBS9 MMA?M.==NY27A1[(C12&,A)W4&19`-1K5Q^O&59F.\"T M",MZBF]FX:8YOL5BP'#@-T@9H@:+HXTQ3E$18%`62CI._[Z[8 M"%:=NKH(XFHXL[-+KE:WS[HE3](Z9;J")E%,B>R$*557%_3']X>+&TJQ\(+&RY1[R=XWJW2N;%G/H M-+>[?7\AC.Z!8JM:Y5\&4DJTR!_KSEB^;<'W<[+@XI5[6)S0:R6L<:;R$="Q MD.BIYR5;,F!:KTH%#K#LQ,JJH)LDOUM2MEX-]?FIY,$=O1/7F,-'J\K/JI-0 M;&@3-F!KS`ZACR6&8#,[V?TP-."K):6L^+[UW\SADU1UXZ';EV`(?>7ER[UT M`@H*-%%ZB4S"M)``/(E6>#*@(/RYH"D(J](W!%E)2( MO?-&_PJ@9$@J<`VIW7//URMK#@3:#6C7UIGZ5_#P=NFM*'R-3(/T[]2V_<%NKSI%65D`91]=@U(;Q%1;> M])`EC"#C8>P,KPW\923& ME*@A*8OLRV(].IP+#WDXEOGX_MOEO/A:-FU57W=!^+`*%N5U7Q^JZ\LN^/NO M3^_6P:+MBNNA.-?7G M\E*T#_6MO,*38]UBN@;"P[9Q\5$?C]6^ M_%CO7R_EM1-.FO)<=)!_>ZIN;>_MLG=Q=RF:+Z^W=_OZ<@,7GZMSU7TGI\'B MLM_^^G*MF^+S&>K^%B;%OO=-'PSWEVK?U&U][![`W5(D:M:\66Z6X.GI\5!! M!3CMBZ8\[H+G:H'^J\JT=_;]H3_7;STUU^*VZEC#;P!,R\+FN MOR#TUP.:8/#2&/V)&/BC61S*8_%Z[OZLWWXIJY=3!W2G4!$6MCU\_UBV>YA1 MAI7Y\A`?B[N%2X-&!&BF^[((+`U:$[[8(X>TCS51P"?/&Y;+M/%;H, M%OO7MJLO_PI02$D)7Y3:QZ(KGAZ;^FT!?`.ZO16X>L(M..YS$AZ&+*>2A.S0 MR3-ZV06P4"%^"S/[]2F.H\?E5YB-O<1\$!CX.V#"`;&$;(:4((UQ2O;IZ2,C M&"/C=&$J'X1A'$8EPL+$/`Q6GDRRT8?#08`;%Y&LAS)$!@(#KH9"DP'!,@`W M[H4B&$@"YX/;,(T'QR*T`#F$!HA[:`13Z&&2I64\R^-D6)693R@$\U#"0ON! MN2 MT+S4WL07H4J(UXJRX!X-T5HT83*9PQTY]HS49H54^=.62*!?V`#.N^OXZQ5-.GT]IXNRIA'BM7AH2FB(B31;V_K>,A*:. M]";.WV:"/R\E"0GE1H*G=IPG.#'^FT(32Q/@;)<3XB[R4 MAM!\9TB3R5^DJ0@)9P+&^P71,"T$>@(3(R^;:E%0#9SE)$(T15.\A)EJ2P1Y M$N6P^2)-HFE"OVTA)"&UM/-42".XERX"Y&E7#>^(3F,M.; MQMR%F4J(37'L)3.$UJ()Y3&W7JQ)")&7;QS:9QJI19%RPOF;Z,1B+SDAM,&? M:HDD?T)T7/A#X7#G#]%:K=+$^5,)9&;8?-)DX4_3$.(OC1]R2.^^ MGL2FGO0FSM]$+Q9["0JA#?YT[90HR'WN6T.LB\)I0$YQV0()JB*6K" M7'5%8O])E`-_B:8[]_DCM%:KK749)<1K]=*:Q&Q=I,G"'\K`:!:1OS1TV'[X MBDF3E-[$Z9OHQA(O22&T09\Z625]SJU+HLG.#'VFU)`#2(AMOUPEQ.GSDIK$ M[%VDR4*?)B,DGTYOCQ)34GH3YV_B2$^])(70?`-(DUE3:I&4,(,WQ',G`@W4 M@E@59>)$3[T4A=!:-"$REI(TM2"53%.';99*F1A]Z>E-G*:)DSOU4@Y":S7U M+8G>-J<6Y:+.1I(N+>-6=F*]*;.'\3K4CF)2B$UF9P2E`RBZ!$J\1!4&BD M%L4J*!.M2.XE*(0VUJ1J"<2:E"B'-9E["0JA>:V]B:])E1!;DSGJ@?,.(+06 M;4I0 MY!8]<>HO::`6Q"8G&]5$,([67G)":(JFEEJX4:>G6(\2Y2`G:R\Y(32OM3>Q M]3A*B-?J)2=KH1WC(TZ:S/4(%Y#8OL(C#M]9W6]/:)16CTU+-OJ1+2XKB1M! ME[)Y*7\JS^=VL:]?\2(2_.KX]#B8Y2VI--L^0^,*I[7^)%MMGZ$KLCU)X(EU M3`YC0`DM8W(8`VO2\F0-8\1%+3V#"'*#7Q,L8V(8`Z^N;4\@#KP!M3U9;Y]! M"BQ/D@B>$'EZ!@G.CO5)"*E9?6V?K1F'D+%8,GJ,$#*&WYHM>860,?RV:7D2 M0<;P$QD\60[NX'+9K7@I?R^:E^K:+L[E$3A?4>?1B.MIXD-7WV`MP!6SNH-K M9?3O":X1EG#=:H7GW+&NN_X#!A@N)C[]!P``__\#`%!+`P04``8`"````"$` MTN.(`SL,``!^.0``&0```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`/WD(;VO\6E>DG]SM4>]J-!J.KR8TE`O=]LA/59OJ ME[_<<8^-KWYA+5<];S@8_X;QO8#[0K\T!F`EEP;!;O/H%S;`X*+I^O7LJ29C MN#UO[VZ.Y;<.K7`:P.EUJ_8+;ZJF'T_#NOEF8OYL7M*$5%H^*C6W77(D3;D3 M+::O=T$PNNE_I06PTS(SE/%4U\OR&A)O2C\9H_$JLF:H18=0R*$B!I4\M2'0S<"9$U0JPZMQ4Y=J*HY3WL MI-2X=M*$'&390'1T7@O9IM.$^OOS:E$CQ..+05$")&UJV:K%T9`U0JPZMQ4Y MIINTFJZGXJ[STW[W>5;2$&A3;(EC`PH,ZG!!*7$-5Y-A%3-7,O.:V%;2,I-F MRD5`8JB5`$DUH2%:U@[$;&J$&I/8BAR3J)0,8RACDC_+UY^9A,)%MHG2XMI$ M$W=6R#.F$>)^AD`B32958.9Y5\'DRAUM#'42(&E#++,-1'O4J(H[-3&;6Z2)FL)?[_S1 M@/X)$X*6!$@*>C--AI5>2O6NKIU_TGZV2L=^*I]!`U)&J)[H7<=C,5@8U24($I9D;/GPKS4 M4L-Z8GH]3WG0_!/'5.ZTXQI:!?9_?[6KS%',58U&9M;-$86((D0QH@11BBA# ME"-:(%HB6B%:(]HXR#6UBO+1U)S@OSTYK;,%-YR)KI]O(,`K'4 M9UKHLO5K121CK`\H,II8*D:4($H198AR1`M$2T0K1&M$&P>YUE=!O[2^NK'Y MW9L:I:?:ULV1&`37.)K;QQ+86&2EV4HRZ$D2I MJ7A!?6:D6'WNZ')-II**]YC"=7)":X4;G7EVOE+G#XA"1J[)Q%X4&2E6'S,R M1W."*&7DJA=+*S-2K#YG5*EW3::2#C29R2W>%!=[=>KB&,S.9K3!`(6ZHJ_# M^8$GPOW("/!@8D:VK4!SRE*-9IE_&0'6G#-J,9/**RZ9BF)/ M+(W,PIM[@$*-?"LU111CQ011BA4S1+E3T9TR*D>P;?&+,=YNX8QHJIC-V1?7+G.6LC(E1N9F/V)T765*GB>TQ%SNMF6& M5JWNA*5,6RDCTU;&2+1=_*#WB6*L1+2\V[%SE'R1EH9`1E30N M\GT1!T=&BG7%C(SZ!%'*R%$/KT%&BM7GC(SZ!2-[SOF!.&&7+&4JKABYG1`3 M<6VDN!,;1I4NUV_MZ=%OQOH4JX/7,#G24H[7M)0YV"*6,BAF9$R1($H9D4HS M`P)QE&9&BJV3,S+J%XQH=[!TB<-[R5*FXHJ1VPEQJJV-%'=BPZC%12J1P:W. MN.AM>0;E">`CC:P\@Z4,"C6R\PQ$,59,$*58,4.48\4%HB6B%>I:(]HX%=W5 M0#&%8^I?'-1*7&Q6&KE+5`0G>IYZF'.O,F-4E"!*#;(ZA6[1 M/:C3(WJN$]M0;M1P%Q>(EHA6&@7F!F&-:.-4=-P2R)15!6'!P.Q,;[HHJK2X MJXB1NXI$7CC74M0_'G>H$?U@%#'R*F]]F`S(7<);J"A!E"+*-**KM.JB@0;N M:LZQS@+1$M%*H\#D*FM$&Z>BZQJ5,=HKIHJ/_\[3;*!S4&M1,7(6U43$(W,C MQ3X)-0K,P1DQJA^[O6$P&,-FAYH21*E!EU852_&J&HGX*V#@2$W5C])`I77^W)NI_R]^8LI._]+%E#6,B M#SZM&:I^GAO=;=M`-?=ZCX`EO?([+QOBPGINP8R@-&( M;AJLO@_%D3,W4NR:$%&$*$:4($H198AR1`M$2T0K1&M$ZHL8RCCUG4MM_?J+ M%?5GV0_%\;&8%\_/I\ZN_**^-#&ZHF.@P?R-CN'T(UUCD)E$R6?/1)&_4+2^B*@NJT:@M(6VL="LNF*@Y#;1094$EUKHI>T\$T52<1 MUJ'OKGRL]G-18T;?::E>SR7WJ<,M>F:JNRW\(PV=/K:!#<]HY*T#]U3+;34H M*9^JK`]U4=8]56D=EE#R32:I%KD8".5\5-)6A_)N&F-;"255TXCR$&R'4J2I MRHFPA+(;:J>M9$;MS%K;H9N2Z;RUA"Y,J`=M?:,;D:E*N;$'=#$R59DWEM#] M"/6ZS3J4EE-):QV/2BAT:M'FD0WHX0U+Z-5RJI[DL(2>PZ81/5!A"3UND;:V M$KI*)ANT34*Z!:9>MY70J^]TUMJ#.97,6TOH#9CZUC92>NRDDK;QT//O5#UK MXGCH%7B:M):DY(16'Y"AVUI/R2T/-HX/?]3;UM;H!+U+H^]I<\XT2IL MMR2M]/J26ZRH.4W:UO:I^;8V0C)OV_A",FZ;GI@F>!M/:'I7O-]TB+[]]KI] M+%;;X^/^Y=1Y+AYHHZ\SG&/]_3F=[NB/VWXJS_2]-\IFZ%M-]#W'@CYU.%"? MAWPHRS/_04;J-]^C(!``!` M`@``$0`(`61O8U!R;W!S+V-O&UL(*($`2B@``$````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M````````````````````````G)%=3\,@%(;O3?P/#?H,2'[B1O*H-E*@%CQ;L\J(0EHK:P:.K+;B@P">19#P5MD3[$"S%V(L] M:.ZSV#`QW-9.\Q"/;H<-;4*K8TS];KG;"E.X=@^>#46FZ;)FFFG$?T) M?ED]/'6CILH<=R4`L>-^*N[#*JYRJT#>MNSPYJK$^WV!?V>%%)T=%0YX`)G$ M]^C);D@VT[O[]1*Q24YF:3Y/R7Q-?_\ M<_8%``#__P,`4$L#!!0`!@`(````(0#RHK$+]P(```P*```0``@!9&]C4')O M<',O87!P+GAM;""B!`$HH``!```````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M`````)Q674_;,!1]G[3_D.4=4BC:)N0&05O&)#80*?!HN65L=)XGA,U@PLX_+$E<*I1?, MXJ=^2%11"`XCQ>L%2)L<]GI?$WBR('/(]ZI5PKC->-S8CR;-%7?\S-WDN4+" M*3FMJE)P9O$OTU^":V548:/Q$X>2))N+!-EEP&LM['/:(\GF)\DX*V&(B=." ME09(LIX@%\"<:-=,:).2QAXWP*W2D1%_4;:C.)HR`X[.(&Z8%DQ:I.7"V@\_ M+BMC=7JO]-S,`*PA"0:TDWZX&;LY%D=I_YN/P%%G9)OL-UM`'MTP^0#OJ7$0 M+N%(MC^+M;=EF`A;@KDJKIFV`57Z:*ZU+)Y;*TI+L9)(#S;Q^]%:R.A<6\G<%4Z0+,@C)++/@S&NH*N@5[@#O*=-6 M>@-DR,R,GI?JSYL@KD@V0S8S5>:X2>D("A&L,@+#M:BNJP. M0GXH]"L=*M1+A_]V!%,;A&96\?F2T_BQQL[LCJ-GZ/P<"RWP1#!>KV#P/=,: MM\66(U>-'8$6#6(;H)>"344IW-$3S)/54P./-3:)CAO7JF#4#7`7<&!+'W/4W".G6N-T=+PWI)*03-L5M$,SIE0PHU&*"D*5.76G#M=^=E*VT`>MU5MXIL&>SNT2H)QX2 M[G-WF;!\W9A^D-NJ^5UBO@RB8"CDWM]5$C?`N6;XDMB>)/_1SO`"7Z^L)#>/7?MXRX].-KO]7OXI-F8(\GZ&9?^`P``__\#`%!+ M`0(M`!0`!@`(````(0"I^C`/Y@$``,P7```3``````````````````````!; M0V]N=&5N=%]4>7!E&UL4$L!`BT`%``&``@````A`+55,"/U````3`(` M``L`````````````````'P0``%]R96QS+RYR96QS4$L!`BT`%``&``@````A M`/"@[F3T`0``R18``!H`````````````````10<``'AL+U]R96QS+W=OH`P``XPL```\````` M````````````>0H``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`#<;Q.9O`P``"PL``!D` M````````````````]!H``'AL+W=O&PO M=V]R:W-H965T&UL4$L!`BT`%``&``@````A`/WWU=VP`P``=`P``!D````````````````` MN"<``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``& M``@````A`,L&UL4$L!`BT`%``&``@````A`"1P#6<9 M!@``EAD``!@`````````````````/#\``'AL+W=OZ>+>1D\``!6QP``%`````````````````#"2```>&PO&PO&UL4$L!`BT` M%``&``@````A`%/I/N63`@``P`8``!D`````````````````F)<``'AL+W=O M&PO=V]R:W-H965T@,``+8+```8`````````````````#B= M``!X;"]W;W)K&B& M%`@%``#8%P``&0````````````````#HH```>&PO=V]R:W-H965TF``!X;"]W;W)K&UL4$L!`BT`%``&``@` M```A`/7/,A$\$```R58``!D`````````````````GJ@``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A M`'^$2[I4`@``@04``!D`````````````````.-8``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A``G*LG-W!```!A(` M`!D`````````````````1><``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`-)77%0#"0``?R<``!D````````````` M````:@&PO=V]R:W-H965T M&UL4$L!`BT` M%``&``@````A`"Y_A\S9!P``W2@``!D`````````````````[Q8!`'AL+W=O M&PO=V]R:W-H965T1Z,@$``$`"```1`````````````````'$K M`0!D;V-0&UL4$L%!@`````N -`"X`=`P``` XML 13 R33.htm IDEA: XBRL DOCUMENT v2.4.0.8
Derivative Liabilities (Details) (USD $)
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Summary of weighted-average assumptions of fair value calculations for warrants granted and subsequent revaluation    
Number of warrants 3,060,000  
Fair value of warrants liabilities $ 3,917,722  
Warrants [Member]
   
Summary of weighted-average assumptions of fair value calculations for warrants granted and subsequent revaluation    
Expected dividend yield 0.00% 0.00%
Expected stock price volatility 134.00%  
Expected stock price volatility, minimum   90.00%
Expected stock price volatility, maximum   93.00%
Risk-free interest rate 1.75% 0.14%
Expected life of warrants   9 months 18 days
Expected life of warrants, minimum 4 years 1 month 6 days  
Expected life of warrants, maximum 5 years  
Number of warrants 15,562,351 600,000
Fair value of warrants liabilities $ 3,917,772 $ 185,400
XML 14 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 15 R25.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stockholders' Equity (Details) (USD $)
3 Months Ended
Mar. 31, 2014
Mar. 31, 2014
Securities Purchase Agreement [Member]
Mar. 31, 2014
Series A Convertible Preferred Stock [Member]
Mar. 31, 2014
Series A Convertible Preferred Stock [Member]
Securities Purchase Agreement [Member]
Mar. 31, 2013
Warrants [Member]
Mar. 31, 2014
Private placement [Member]
Securities Purchase Agreement [Member]
Stockholders' Equity (Textual)            
Number of preferred Stock convertible into common stock     1,500 1,500    
Preferred stock converted, value       $ 1,500,000    
Conversion price       $ 0.20    
Number of common stock shares issued upon conversion of Preferred Stock   7,500,000 7,500,000      
Term of warrants   5 years        
Warrants issued to purchase common stock, shares   11,250,000        
Warrants issued to purchase common stock, share price   $ 0.25        
Stock offering costs for the private placement           100,000
Percentage of Preferred Stock cash interest payments   9.00%        
Fair value of warrants issued under securitiies purchase agreement   2,868,750        
Warrants valuation, amount   2,878,750        
Proceeds from issuance of warrants with private placement   1,400,000        
Deemed dividend   $ 1,468,750        
Additional common stock awarded to shareholders   1,255,000        
Warrants exercise price, reset $ 0.25 $ 0.25     $ 1.20  
Warrants outstanding, reset 3,060,000       423,125  
Additional warrants issued to shareholders   612,000        
XML 16 R37.htm IDEA: XBRL DOCUMENT v2.4.0.8
Subsequent Events (Details) (Subsequent Event [Member], USD $)
1 Months Ended
Apr. 30, 2014
Subsequent Event [Member]
 
Subsequent Events (Textual)  
Issuance of common stock 440,000
Accounts payable to law firm $ 110,000
Accounts Payable $ 200,000
XML 17 R9.htm IDEA: XBRL DOCUMENT v2.4.0.8
Debt
3 Months Ended
Mar. 31, 2014
Debt [Abstract]  
Debt
Note 3 – Debt
 
On September 4, 2012, the Company entered into an unsecured loan agreement with TMK-ENT, Inc. that provided for a $500,000 working capital revolving line of credit.  Advances under the line of credit bear interest at 10% per year, payable annually. On November 13, 2012, the Company amended its loan agreement to increase the revolving line of credit agreement from $500,000 to $750,000, and on December 21, 2012 amended its loan agreement to increase the revolving credit agreement for $750,000 to $1,250,000.  The note matures on December 21, 2014. Borrowings under the line of credit amount to $1,018,500 as of March 31, 2014 and December 31, 2013. In conjunction with the line of credit facility, the Company issued 1,250,000 warrants to purchase the Company’s common stock at varying prices from $1.38 to $1.62 per share. The warrants vest one year from issuance and have a ten year term. The fair market value of the warrants at grant date was determined utilizing the Black Scholes option pricing model and amounted to $1,839,250. The difference between the fair market value of the warrants and draws on the line of credit is $820,750 as of March 31, 2014 and December 31, 2013, which is recorded as deferred debt discount.  The deferred debt discount will be recognized and recorded as debt discount as the Company continues to borrow against the line of credit. Debt discount costs will be recognized as the Company draws down the available line of credit, and will be amortized over the remaining term of the loan. As a result of the amortization of the debt discount, the Company expensed $84,790 and $199,852, respectively, for the three months ended March 31, 2014 and 2013.
 
Annual maturities of debt are as follows:
 
2014 (includes TMK-ENT, Inc. line of credit repayment)
 
$
1,028,136
 
2015
 
$
9,540
 
2016
 
$
6,629
 
EXCEL 18 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%]E83,U-#9D-5]B9F0R7S0T93%?8C,Q9%\U-38R M-69F,C$Q-S4B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I% M>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D1E M8G0\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O M#I7;W)K#I7;W)K#I%>&-E;%=O#I7 M;W)K#I7;W)K#I7;W)K#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D1E#I7;W)K#I7;W)K#I7;W)K#I%>&-E;%=O#I.86UE M/E-T;V-K:&]L9&5R#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O M#I.86UE/E-T;V-K7T)A#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/E-T;V-K7T)A#I7;W)K#I% M>&-E;%=O#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E=A#I7;W)K#I7;W)K'1U86P\+W@Z3F%M93X-"B`@ M("`\>#I7;W)K#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D1E#I7;W)K#I%>&-E;%=O#I!8W1I=F53:&5E=#XP/"]X.D%C=&EV95-H965T/@T*("`\>#I0 M#I%>&-E;%=O7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)T%R:7-T82!0;W=E2!# M96YT3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)S`P,#$T,C0V-#`\'0^)V9A;'-E/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)RTM M,3(M,S$\'0^36%R(#,Q+`T*"0DR,#$T/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)U$Q/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N M/CPO3QS<&%N/CPO2!#;VUM M;VX@4W1O8VLL(%-H87)E'0^)SQS<&%N/CPO'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA'0^)SQS<&%N/CPO'!E;G-E'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPOF5D+"`D,"XP,#(@<&%R('9A;'5E.R`Q.2PT.3@L-CDT(&%N9"`Q-RPY M.3,L-CDT('-H87)E3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%]E83,U-#9D-5]B9F0R7S0T93%?8C,Q9%\U M-38R-69F,C$Q-S4-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO96$S M-30V9#5?8F9D,E\T-&4Q7V(S,61?-34V,C5F9C(Q,3'0O:'1M;#L@8VAA'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA'0^)SQS<&%N/CPO'!E;G-E*3PO'0^)SQS<&%N/CPO&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@W-3`L M-#$S*3QS<&%N/CPO7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6%B;&4@86YD(&%C8W)U960@;&EA8FEL:71I97,\+W1D/@T*("`@ M("`@("`\=&0@8VQA'0^)SQS<&%N/CPO6UE;G1S(&]N M(&1E8G0\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO&5S M(%!A:60O*%1A>"!C'0^)SQS<&%N M/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA'0^)SQS<&%N/CPO'0^)SQD:78@86QI M9VX],T1J=7-T:69Y('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3H@ M8FQO8VL[)SXF(S$V,#L\+V1I=CX\9&EV(&%L:6=N/3-$:G5S=&EF>2!S='EL M93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN M+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS M1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE2!3;VQU=&EO;G,L($EN8RX@86YD(&EN($YO=F5M8F5R(#(P M,#@@8VAA;F=E9"!I=',@;F%M92!T;R!7:6YD5&%M97(@0V]R<&]R871I;VXN M($EN($UA>2`R,#$Q+"!T:&4@0V]M<&%N>2!C:&%N9V5D(&ET6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY4:&4@0V]M<&%N>2!I2!S>7-T M96US+B8C,38P.R8C,38P.U1H92!#;VUP86YY)B,X,C$W.W,@<&%T96YT+7!E M;F1I;F<@4&]W97(@;VX@1&5M86YD('-Y2!T:&%T(')E;&5A2!A="!O<'1I M;6%L('1I;65S('1O(')E9'5C92!E;&5C=')I8VET>2!C;W-T3H@8FQO8VL[)SXF M(S$V,#L\+V1I=CX\9&EV(&%L:6=N/3-$:G5S=&EF>2!S='EL93TS1"=T97AT M+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P M=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y M.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E>'0M:6YD96YT M.B`P<'0[(&1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY4:&4@86-C M;VUP86YY:6YG('5N875D:71E9"!C;VYD96YS960@9FEN86YC:6%L('-T871E M;65N=',@:&%V92!B965N('!R97!A6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[)SY);B!T:&4@;W!I;FEO;B!O9B!M86YA9V5M M96YT+"!A;&P@861J=7-T;65N=',@*&-O;G-I2!O9B!N;W)M M86P@86YD(')E8W5R65A M6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6EN9R!F:6YA;F-I86P@6QE/3-$)W1E>'0M M:6YD96YT.B`P<'0[(&1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[(&9O M;G0M=V5I9VAT.B!B;VQD.R<^57-E(&]F($5S=&EM871E6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[)SY4:&4@<')E<&%R871I;VX@;V8@9FEN86YC M:6%L('-T871E;65N=',@:6X@8V]N9F]R;6ET>2!W:71H($=!05`@6QE/3-$)W1E>'0M:6YD M96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I2!C;VYS:61E2!L:7%U M:60@:6YV97-T;65N=',@=VET:"!O2!S='EL93TS1"=T97AT M+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P M=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y M.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I2!C;W5R2!A;&QO=V%N M8V4@9F]R(&1O=6)T9G5L(&%C8V]U;G1S+B8C,38P.R8C,38P.U=E(&5V86QU M871E(&%C8V]U;G1S(')E8V5I=F%B;&4@<75A6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3PO9F]N=#X\+V1I=CX\9&EV('-T>6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@8FQO8VL[(&UA3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[)SY);G9E;G1O7-T M96US+"!A;F0@:7,@2!A2!T;R!D971E3H@8FQO8VL[)SXF(S$V,#L\+V1I M=CX\9&EV(&%L:6=N/3-$:G5S=&EF>2!S='EL93TS1"=T97AT+6EN9&5N=#H@ M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN M+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[ M(&9O;G0M9F%M:6QY.B!T:6UE6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$ M)V1I'!E;F1I='5R97,@9F]R(')E;F5W86QS(&%N9"!B971T97)M96YT M3H@8FQO8VL[)SXF(S$V,#L\+V1I=CX\9&EV(&%L:6=N/3-$:G5S=&EF>2!S M='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R M9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL M93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SY);G1A;F=I8FQE(&%S2!A<'!R;WAI;6%T97,@:71S(&QE9V%L(&QI M9F4N($9O6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@8FQO8VL[(&UA3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^26UP86ER;65N="!O9B!,;VYG M+4QI=F5D($%S6QE/3-$)W1E>'0M M:6YD96YT.B`P<'0[(&1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY, M;VYG+6QI=F5D(&%S6EN9R!A;6]U;G0@;V8@86X@87-S970@ M;6%Y(&YO="!B92!R96-O=F5R86)L92XF(S$V,#LF(S$V,#M296-O=F5R86)I M;&ET>2!O9B!A2!A(&-O;7!A2!T:&4@87-S970L(&EN8VQU M9&EN9R!I=',@=6QT:6UA=&4@9&ES<&]S:71I;VXN)B,Q-C`[)B,Q-C`[268@ M2!W:&EC:"!T:&4@8V%R2!S='EL93TS1"=T97AT+6EN9&5N M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R M9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI M;F4[(&9O;G0M9F%M:6QY.B!T:6UE2!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@ M;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S M='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY4:&4@8V%R6%B;&4@ M86YD(&%C8W)U960@97AP96YS97,@87)E(')E87-O;F%B;&4@97-T:6UA=&5S M(&]F('1H96ER(&9A:7(@=F%L=64@9'5E('1O('1H96ER('-H;W)T(&UA='5R M:71Y+CPO9F]N=#X\+V1I=CX\9&EV(&%L:6=N/3-$:G5S=&EF>2!S='EL93TS M1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE M9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D M:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^4F5V96YU92!2 M96-O9VYI=&EO;CPO9F]N=#X\+V1I=CX\9&EV('-T>6QE/3-$)W1E>'0M:6YD M96YT.B`P<'0[(&1I3H@8FQO8VL[#0H@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT M.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M M9F%M:6QY.B!T:6UE2!T:&4@8W5S=&]M97(@:7,@9FEX960@;W(@9&5T97)M:6YA8FQE.R!A M;F0@*#0I('1H92!C;VQL96-T:6]N(&]F('1H92!S86QE('!R:6-E(&ES(')E M87-O;F%B;'D@87-S=7)E9"XF(S$V,#LF(S$V,#M!;6]U;G1S)B,Q-C`[8V]L M;&5C=&5D('!R:6]R('1O('-A=&ES9GEI;F<@;W5R(')E=F5N=64@3H@8FQO8VL[)SXF(S$V,#L\+V1I=CX\9&EV(&%L M:6=N/3-$:G5S=&EF>2!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P M;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P M<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M M:6QY.B!T:6UE&-E'!E8W0@=&\@:6YC=7(@;VX@ M82!C;VYT6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I28C.#(Q-SMS(&)A;&%N8V4@3H@8FQO8VL[)SXF(S$V,#L\+V1I=CX\9&EV(&%L:6=N/3-$:G5S=&EF M>2!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@ M;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S M='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$ M)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I M2P@=&AE6QE/3-$ M)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I M3H@8FQO8VL[)SXF(S$V,#L\+V1I=CX\9&EV(&%L:6=N M/3-$:G5S=&EF>2!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y M.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[ M)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY M.B!T:6UE7-T M96T@2!R97-E6-L97,L(&UA;G5F86-T M=7)EFEN9R!F=71U6QE/3-$ M)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I M6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY4:&4@0V]M<&%N>2!A8V-O=6YT6UE;G1S(&ES(')E M8V]R9&5D(&]V97(@=&AE(')E<75I2!U6QE/3-$)W1E>'0M:6YD96YT.B`P M<'0[(&1I3H@ M8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY4:&4@0V]M<&%N M>28C.#(Q-SMS(&%C8V]U;G1I;F<@<&]L:6-Y(&9OF5D(&]V97(@=&AE('1E3H@8FQO8VL[)SXF(S$V,#L\+V1I=CX\9&EV(&%L:6=N/3-$:G5S=&EF M>2!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@ M;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S M='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[ M(&1I6QE/3-$)V1I'!E8W1E9"!F=71U"!B87-I2!D:69F97)E;F-E M2!F;W)W87)D3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^)B,Q-C`[/"]F M;VYT/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3H@8FQO8VL[)SXF(S$V,#L\ M+V1I=CX\9&EV(&%L:6=N/3-$:G5S=&EF>2!S='EL93TS1"=T97AT+6EN9&5N M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R M9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI M;F4[(&9O;G0M9F%M:6QY.B!T:6UE2!I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[)SY!&5R8VES92P@8V]U;&0@9&EL M=71E(&9U='5R92!E87)N:6YG3H@8FQO8VL[ M)SXF(S$V,#L\+V1I=CX\9&EV(&%L:6=N/3-$:G5S=&EF>2!S='EL93TS1"=T M97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z M(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P M;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E>'0M:6YD96YT M.B`P<'0[(&1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY#97)T86EN M('!R:6]R('EE87(@86UO=6YT65A7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA6QE M.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E:6=H=#H@ M;F]R;6%L.R!L971T97(M#L@+7=E8FMI="UT97AT+7-TF4Z(#$S<'@[(&9O;G0M'0M86QI9VXZ('-T87)T.R!T97AT+6EN9&5N=#H@,'!T.R!T97AT+71R M86YS9F]R;3H@;F]N93L@=VAI=&4M#L@+7=E8FMI="UT97AT+7-T6QE/3-$)V-O;&]R.B`C,#`P,#`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`S("8C.#(Q M,3L@1&5B=#PO9F]N=#X\+V1I=CX\9&EV('-T>6QE/3-$)V-O;&]R.B`C,#`P M,#`P.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M#L@9F]N="US='EL93H@;F]R;6%L.R!F;VYT+79A'0M:6YD96YT.B`P<'0[('1E>'0M=')A;G-F M;W)M.B!N;VYE.R!W:&ET92US<&%C93H@;F]R;6%L.R!W:61O=W,Z(&%U=&\[ M('=O'0M6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E M:6=H=#H@;F]R;6%L.R!L971T97(M#L@+7=E8FMI="UT97AT M+7-T6%B;&4@ M86YN=6%L;'DN($]N($YO=F5M8F5R(#$S+"`R,#$R+"!T:&4@0V]M<&%N>2!A M;65N9&5D(&ET6EN9R!P65AF5D(&%N9"!R96-OF5D(&]V97(@=&AE(')E;6%I;FEN9R!T97)M(&]F('1H M92!L;V%N+B!!F%T:6]N(&]F('1H M92!D96)T(&1I2!E>'!E;G-E9"`D.#0L-SDP M(&%N9"`D,3DY+#@U,BP@F4Z(#$S<'@[(&9O;G0M6QE M/3-$)V-O;&]R.B`C,#`P,#`P.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R M;VUA;B<[(&9O;G0M#L@9F]N="US='EL93H@;F]R;6%L.R!F M;VYT+79A#L@9&ES<&QA>3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)V-O;&]R M.B`C,#`P,#`P.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O M;G0M#L@9F]N="US='EL93H@;F]R;6%L.R!F;VYT+79A#L@9&ES<&QA M>3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0MF4Z(#$S<'@[(&9O;G0M'0M:6YD96YT.B`P<'@[('1E>'0M=')A;G-F;W)M.B!N;VYE.R!W M:&ET92US<&%C93H@;F]R;6%L.R!W:61O=W,Z(&%U=&\[('=O'0M3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)V1IF4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@86QI9VX],T1L M969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQD:78@86QI9VX],T1L M969T('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1IF4Z(#$P<'0[)SXD/"]F;VYT/CPO9&EV M/CPO=&0^/'1D(&%L:6=N/3-$6QE/3-$)W1E>'0M:6YD96YT M.B`P<'0[(&1I6QE/3-$)V1IF4Z M(#$P<'0[)SXQ+#`R."PQ,S8\+V9O;G0^/"]D:78^/"]T9#X\=&0@86QI9VX] M,T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE M/3-$)V1IF4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X\ M+W1R/CQT3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R M;VUA;B<[(&9O;G0M3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)W1E>'0M:6YD96YT.B`P M<'0[(&1I6QE/3-$)V1IF4Z(#$P M<'0[)SXR,#$V/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&%L:6=N/3-$3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[ M(&9O;G0M3H@ M8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@8FQO8VL[(&UA3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M M7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M3QBF4Z(#$S<'@[(&9O;G0M'0M86QI9VXZ('-T87)T.R!T97AT+6EN9&5N=#H@,'!T.R!T M97AT+71R86YS9F]R;3H@;F]N93L@=VAI=&4M#L@+7=E8FMI="UT97AT+7-T M6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R M;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!L971T97(M#L@ M+7=E8FMI="UT97AT+7-T65A2X@ M5&AE(%!R969E2!A;F0@;6%N9&%T M;W)I;'D@8V]N=F5R=&EB;&4@:6YT;R!S:&%R97,@;V8@8V]M;6]N('-T;V-K M('!U2P@=6YT:6P@4V5P=&5M8F5R(#,P+"`R,#$U+"!E86-H(&EN=F5S=&]R M(&AA#L@9&ES<&QA>3H@8FQO8VL[)SXF(S$V,#L\+V1I=CX-"CQD M:78@86QI9VX],T1J=7-T:69Y('-T>6QE/3-$)V-O;&]R.B`C,#`P,#`P.R!F M;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M#L@9F]N="US='EL93H@;F]R;6%L.R!F;VYT+79A#L@9&ES<&QA>3H@8FQO8VL[(&UA M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE M=R!R;VUA;B<[(&9O;G0M2!A;F0@075G=7-T M(#(P,3,@<')I=F%T92!P;&%C96UE;G0@;V8@8V]M;6]N('-T;V-K+"!S:&%R M96AO;&1E7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A'0^)SQS<&%N/CPO#L@9&ES<&QA>3H@8FQO8VL[)SXF(S$V M,#L\+V1I=CX-"CQD:78@86QI9VX],T1J=7-T:69Y('-T>6QE/3-$)V-O;&]R M.B`C,#`P,#`P.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O M;G0M#L@9F]N="US='EL93H@;F]R;6%L.R!F;VYT+79A#L@9&ES<&QA M>3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M&5R8VES M92!P6QE/3-$)V-O;&]R.B`C M,#`P,#`P.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M M#L@9F]N="US='EL93H@;F]R;6%L.R!F;VYT+79A#L@9&ES<&QA>3H@ M8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M2!R96-O2!S='EL93TS1"=C;VQOF4Z M(#$S<'@[(&9O;G0M'0M M:6YD96YT.B`P<'0[('1E>'0M=')A;G-F;W)M.B!N;VYE.R!W:&ET92US<&%C M93H@;F]R;6%L.R!W:61O=W,Z(&%U=&\[('=O'0M6QE/3-$)V1IF4Z(#$P<'0[)SXF(S$V,#L\ M+V9O;G0^/"]D:78^#0H\9&EV(&%L:6=N/3-$:G5S=&EF>2!S='EL93TS1"=C M;VQOF4Z(#$S<'@[(&9O;G0M'0M:6YD96YT.B`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`C,#`P,#`P.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[ M(&9O;G0M#L@9F]N="US='EL93H@;F]R;6%L.R!F;VYT+79A M#L@9&ES M<&QA>3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$ M)V-O;&]R.B`C,#`P,#`P.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA M;B<[(&9O;G0M#L@9F]N="US='EL93H@;F]R;6%L.R!F;VYT M+79A#L@=&5X="UT#LG M/@T*/'1A8FQE('-T>6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT+69A;6EL>3H@ M)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0MF4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS M1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V1IF4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX] M,T1B;W1T;VT@8V]L6QE/3-$)W1E>'0M:6YD96YT.B`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`P<'0[(&1I6QE/3-$)V1IF4Z(#$P<'0[(&9O;G0M=V5I9VAT M.B!B;VQD.R<^36%R8V@@)B,Q-C`[,S$L/"]F;VYT/CPO9&EV/@T*/&1I=B!A M;&EG;CTS1&-E;G1E#LG/CQF;VYT('-T>6QE/3-$)V1IF4Z M(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F6QE/3-$)V)O M6QE/3-$)W1E>'0M:6YD96YT M.B`P<'0[(&1I6QE/3-$)V1IF4Z M(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^36%R8V@@,S$L/"]F;VYT/CPO M9&EV/@T*/&1I=B!A;&EG;CTS1&-E;G1E#LG/CQF;VYT('-T>6QE/3-$)V1I MF4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CPO='(^ M#0H\='(^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N M="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B`G=&EM M97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R<^)B,Q-C`[/"]F;VYT M/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N M="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B`G=&EM M97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R<^)B,Q-C`[/"]F;VYT M/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!C;VQS M<&%N/3-$,CX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R<^ M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS M1&)O='1O;3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R<^ M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS M1&)O='1O;3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R<^ M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS M1&)O='1O;2!C;VQS<&%N/3-$,CX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US M:7IE.B`Q,'!T.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L M969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US M:7IE.B`Q,'!T.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\+W1R/@T*/'1R(&)G M8V]L;W(],T0C8V-E969F/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M M3H@8FQO8VL[(&UA M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE M=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@8FQO8VL[(&UA3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M M6QE M/3-$)W1E>'0M:6YD96YT.B`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`P<'0[ M(&1I6QE/3-$)V1IF4Z(#$P<'0[ M)SXQ,#@\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W M:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T M('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1IF4Z(#$P<'0[)SXE/"]F;VYT/CPO9&EV/@T* M/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1IF4Z(#$P<'0[)SY2:7-K M+69R964@:6YT97)E6QE/3-$)V1IF4Z(#$P<'0[)SXF M(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$ M.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$ M)V1IF4Z(#$P<'0[)SXS+C8S/"]F;VYT/CPO9&EV/@T*/"]T M9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T M;VT^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=T97AT+6EN9&5N=#H@ M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN M+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[ M(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q M,'!T.R<^)3PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1R:6=H M="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=D M:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N M)SL@9F]N="US:7IE.B`Q,'!T.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@ M86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT M('-T>6QE/3-$)V1IF4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^ M/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$ M8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)W1E>'0M:6YD M96YT.B`P<'0[(&1I6QE/3-$)V1IF4Z(#$P<'0[)SXR+C8P+3(N-C@\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D M(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X-"CQD M:78@86QI9VX],T1L969T('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I M6QE/3-$)V1IF4Z(#$P<'0[)SXE M/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)V1I MF4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!A M;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=D M:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N M)SL@9F]N="US:7IE.B`Q,'!T.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@ M86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@8V]L3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)V1IF4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CPO='(^#0H\ M+W1A8FQE/@T*/"]D:78^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=C M;VQOF4Z(#$S<'@[(&9O;G0M'0M:6YD96YT.B`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`P<'0[(&1I6QE/3-$)V1IF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^3G5M8F5R(&]F(%-H87)E M6QE M/3-$)W!A9&1I;F6QE/3-$ M)W!A9&1I;F#L@8F]R M9&5R+6)O='1O;2US='EL93H@3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M#LG M/CQF;VYT('-T>6QE/3-$)V1IF4Z(#$P<'0[)SXF(S$V,#L\ M+V9O;G0^/"]T9#X-"CQT9"!W:61T:#TS1#$P)2!V86QI9VX],T1B;W1T;VT@ M#L@8F]R9&5R+6)O='1O;2US='EL93H@3H@8FQO8VL[(&UA3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R M;VUA;B<[(&9O;G0M6QE/3-$)V1IF4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!W:61T:#TS M1#$P)2!V86QI9VX],T1B;W1T;VT@#L@8F]R9&5R M+6)O='1O;2US='EL93H@3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1IF4Z(#$P<'0[(&9O;G0M M=V5I9VAT.B!B;VQD.R<^26YT#LG/CQF;VYT('-T M>6QE/3-$)V1IF4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T M9#X-"CPO='(^#0H\='(^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$-30E M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI M;F4[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE M.B`Q,'!T.R<^)B,Q-C`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`G M=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R<^,3$U+#`P,#PO M9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$ M,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V1IF4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE M9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA M;B<[(&9O;G0M6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I M6QE/3-$)V1IF4Z(#$P<'0[)SXD M/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H M/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T M>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE M/3-$)V1IF4Z(#$P<'0[)SXN,C,\+V9O;G0^/"]D:78^#0H\ M+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O M='1O;3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R<^)B,Q M-C`[/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,3`E M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI M;F4[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE M.B`Q,'!T.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T M('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V1I MF4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!A M;&EG;CTS1&QE9G0@=VED=&@],T0Q,"4@=F%L:6=N/3-$8F]T=&]M(&-O;'-P M86X],T0R/CQF;VYT('-T>6QE/3-$)V1IF4Z(#$P<'0[)SXF M(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q M)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M:6YD96YT.B`P M<'0[(&1I6QE/3-$)V1IF4Z(#$P M<'0[)SY/<'1I;VYS(&-A;F-E;&QE9"!O'!I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S M(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$ M)V)O3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S M(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)W!A9&1I;F#LG/CQF M;VYT('-T>6QE/3-$)V1IF4Z(#$P<'0[)SXF(S$V,#L\+V9O M;G0^/"]T9#X-"CQT9"!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N M="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B`G=&EM M97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R<^)B,Q-C`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`P<'0[(&1I6QE/3-$)V1I MF4Z(#$P<'0[)SY/=71S=&%N9&EN9R!A="!-87)C:"`S,2P@ M,C`Q-#PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I M9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F6QE/3-$)V)O6QE/3-$)V1IF4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!A;&EG M;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)V)O6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I M6QE/3-$)V1IF4Z(#$P<'0[)SXQ M+#0S,"PV,#@\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F M="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG M+6)O='1O;3H@-'!X.R<^/&9O;G0@3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE M/3-$)V1IF4Z(#$P<'0[)SXD/"]F;VYT/CPO9&EV/@T*/"]T M9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W!A9&1I;F#LG/CQF;VYT('-T>6QE/3-$)V1IF4Z(#$P<'0[)SXF(S$V M,#L\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,3`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`P<'0[(&1I6QE/3-$)V1IF4Z(#$P<'0[)SXD/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS M1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A M9&1I;F3H@8FQO8VL[)SX\9F]N="!S='EL93TS1"=D:7-P M;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@ M9F]N="US:7IE.B`Q,'!T.R<^+C8T/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT M9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@#LG/CQF;VYT('-T>6QE/3-$)V1I MF4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!A M;&EG;CTS1')I9VAT('=I9'1H/3-$,3`E('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=P861D:6YG+6)O='1O;3H@-'!X.R<^#0H\9&EV(&%L:6=N/3-$3H@8FQO8VL[ M(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S M(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)W!A9&1I;F#LG/@T*/&1I=B!A;&EG;CTS1')I9VAT M('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1IF4Z(#$P<'0[)SXR-BPT-3`\+V9O;G0^/"]D M:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@-'!X.R<^/&9O M;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I M;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)V-O;&]R.B`C,#`P,#`P.R!F;VYT+69A;6EL>3H@ M)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M#L@9F]N="US='EL M93H@;F]R;6%L.R!F;VYT+79A#L@9&ES<&QA>3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O M;G0M6QE/3-$)V-O;&]R.B`C,#`P M,#`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`C,#`P,#`P.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O M;G0M#L@9F]N="US='EL93H@;F]R;6%L.R!F;VYT+79A#L@+7=E8FMI="UT97AT+7-T6QE/3-$)W1E>'0M86QI M9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1IF4Z(#$P<'0[)SX\9F]N="!S='EL93TS M1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O M;6%N)SL@9F]N="US:7IE.B`Q,'!T.R<^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O M;G0M2!R96-O'!E;G-E6QE/3-$)V1IF4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]D:78^#0H\9&EV('-T>6QE/3-$ M)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1IF4Z(#$P<'0[)SY/;B!$ M96-E;6)E6QE/3-$)V-O;&]R.B`C M,#`P,#`P.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M M#L@9F]N="US='EL93H@;F]R;6%L.R!F;VYT+79A'0M:6YD96YT.B`P<'0[('1E>'0M=')A M;G-F;W)M.B!N;VYE.R!W:&ET92US<&%C93H@;F]R;6%L.R!W:61O=W,Z(&%U M=&\[('=O'0M2!S='EL93TS1"=C;VQOF4Z(#$S<'@[ M(&9O;G0M'0M:6YD96YT M.B`P<'0[('1E>'0M=')A;G-F;W)M.B!N;VYE.R!W:&ET92US<&%C93H@;F]R M;6%L.R!W:61O=W,Z(&%U=&\[('=O'0M6QE M/3-$)V1IF4Z(#$P<'0[)SY/;B!-87)C:"`S,2P@,C`Q-"P@ M061E96(@4V%B82!W87,@;F%M960@0VAI968@3W!E6QE/3-$)V-O;&]R.B`C,#`P,#`P.R!F;VYT+69A;6EL>3H@)W1I;65S M(&YE=R!R;VUA;B<[(&9O;G0M#L@9F]N="US='EL93H@;F]R M;6%L.R!F;VYT+79A#L@9&ES<&QA>3H@8FQO8VL[(&UA3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E:6=H M=#H@;F]R;6%L.R!L971T97(M#L@+7=E8FMI="UT97AT+7-T MF4Z(#$S<'@[(&9O;G0MF4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]D:78^#0H\9&EV(&%L:6=N M/3-$;&5F="!S='EL93TS1"=C;VQOF4Z(#$S<'@[(&9O;G0MF4Z M(#$P<'0[)R!C96QL6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1IF4Z(#$P<'0[)SXF(S$V M,#L\+V9O;G0^/"]D:78^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=T M97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z M(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P M;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@ M9F]N="US:7IE.B`Q,'!T.R!F;VYT+7=E:6=H=#H@8F]L9#LG/E)E6QE/3-$)W!A9&1I;F6QE/3-$ M)V)O6QE/3-$)W1E>'0M:6YD M96YT.B`P<'0[(&1I6QE/3-$)V1IF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^3G5M8F5R(&]F/"]F;VYT M/CPO9&EV/@T*/&1I=B!A;&EG;CTS1&-E;G1E6QE/3-$)W!A9&1I;F3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA M;B<[(&9O;G0M6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1IF4Z(#$P<'0[(&9O;G0M=V5I M9VAT.B!B;VQD.R<^5V5I9VAT960@079E3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M#LG/CQF;VYT('-T>6QE/3-$ M)V1IF4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CPO M='(^#0H\='(@8F=C;VQO6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1IF4Z(#$P<'0[)SY.;VXM=F5S=&5D(&%T M)B,Q-C`[)B,Q-C`[36%R8V@@,S$L(#(P,30\+V9O;G0^/"]D:78^#0H\+W1D M/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O M;3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY M.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R<^)B,Q-C`[ M/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L M:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V1IF4Z(#$P M<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I M9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT M('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1IF4Z(#$P<'0[)SXQ,3@L,S3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@ M8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[ M(&9O;G0M6QE M/3-$)W!A9&1I;F6QE/3-$)W1E>'0M:6YD96YT.B`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`P<'0[ M(&1I6QE/3-$)V1IF4Z(#$P<'0[ M)SY.;VXM=F5S=&5D(&%T($UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O M;G0M6QE/3-$)V)O6QE/3-$)V1IF4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!A;&EG M;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)V)O6QE/3-$)W1E>'0M:6YD96YT.B`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`@("`\=&%B;&4@8VQA'0^)SQD:78@86QI9VX],T1L969T('-T>6QE/3-$ M)V9O;G0Z(#$S<'@O;F]R;6%L("=T:6UE'0M:6YD96YT.B`P M<'0[(&QE='1E#L@9&ES<&QA M>3H@8FQO8VL[('=H:71E+7-P86-E.B!N;W)M86P[("UW96)K:70M=&5X="US M=')O:V4M=VED=&@Z(#!P>#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY M.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!F;VYT+7=E M:6=H=#H@8F]L9#L@9&ES<&QA>3H@:6YL:6YE.R<^3F]T92`V("8C.#(Q,3L@ M5V%R"]N;W)M86P@)W1I;65S(&YE=R!R;VUA;B<[(&-O;&]R M.B`C,#`P,#`P.R!T97AT+71R86YS9F]R;3H@;F]N93L@=&5X="UI;F1E;G0Z M(#!P=#L@;&5T=&5R+7-P86-I;FF4Z(#$P<'0[(&1I2!S='EL93TS1"=F;VYT.B`Q,W!X+VYO'0M=')A;G-F;W)M.B!N;VYE M.R!T97AT+6EN9&5N=#H@,'!T.R!L971T97(M'0M3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^5&AE($-O;7!A;GD@:&%S('9A M;'5E9"!W87)R86YTFEN M9R!T:&4@0FQA8VLM4V-H;VQE'!E8W1E9"!L:69E M+B8C,38P.R8C,38P.U1H92!E>'!E8W1E9"!L:69E(&]F('=A"]N;W)M86P@ M)W1I;65S(&YE=R!R;VUA;B<[(&-O;&]R.B`C,#`P,#`P.R!T97AT+71R86YS M9F]R;3H@;F]N93L@=&5X="UI;F1E;G0Z(#!P=#L@;&5T=&5R+7-P86-I;FF4Z(#$P<'0[(&1I'0M=')A;G-F;W)M.B!N;VYE.R!T97AT+6EN9&5N=#H@,'!X.R!L971T M97(M#L@=VAI=&4M M6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT+69A;6EL>3H@ M)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.B`G M=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I M;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@86QI9VX],T1L969T('9A M;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I M;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL M:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!C M;VQS<&%N/3-$,CX\9&EV(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)W1E>'0M M:6YD96YT.B`P<'0[(&UA6QE/3-$)V9O;G0M9F%M M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!F;VYT M+7=E:6=H=#H@8F]L9#L@9&ES<&QA>3H@:6YL:6YE.R<^5&AR964@36]N=&AS M($5N9&5D/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!V86QI M9VX],T1B;W1T;VT^/&9O;G0@F4Z(#$P<'0[(&1I6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@ M;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[ M)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M(&-O;'-P M86X],T0R/CQD:78@86QI9VX],T1C96YT97(@F4Z(#$P<'0[(&9O;G0M=V5I M9VAT.B!B;VQD.R!D:7-P;&%Y.B!I;FQI;F4[)SY4:')E92!-;VYT:',@16YD M960\+V9O;G0^/"]D:78^/"]T9#X\=&0@86QI9VX],T1L969T('9A;&EG;CTS M1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE M=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^ M)B,Q-C`[/"]F;VYT/CPO=&0^/"]T#LG M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N M)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\ M+V9O;G0^/"]T9#X\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@F4Z(#$P M<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N M="US:7IE.B`Q,'!T.R!F;VYT+7=E:6=H=#H@8F]L9#L@9&ES<&QA>3H@:6YL M:6YE.R<^36%R8V@@,S$L(#(P,30\+V9O;G0^/"]D:78^/"]T9#X\=&0@86QI M9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O M='1O;3H@,G!X.R<^/&9O;G0@F4Z(#$P<'0[(&1I6QE/3-$)W!A9&1I;F3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O M;G0M3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT M/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T M=&]M+6-O;&]R.B!B;&%C:SL@8F]R9&5R+6)O='1O;2UW:61T:#H@,G!X.R!B M;W)D97(M8F]T=&]M+7-T>6QE.B!S;VQI9#LG(&-O;'-P86X],T0R/CQD:78@ M86QI9VX],T1C96YT97(@F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R!D M:7-P;&%Y.B!I;FQI;F4[)SY-87)C:"`S,2PR,#$S/"]F;VYT/CPO9&EV/CPO M=&0^/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P M;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X\+W1R/CQT3H@8FQO8VL[)SX\9F]N="!S='EL93TS1"=F;VYT+69A M;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^17AP96-T960@9&EV:61E;F0@>6EE;&0\+V9O;G0^ M/"]D:78^/"]T9#X\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@ M;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[ M)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@86QI9VX],T1L969T('=I9'1H/3-$ M,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY M.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y M.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@86QI9VX],T1R:6=H M="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;3X\9&EV(&%L:6=N/3-$F4Z(#$P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P M<'0[(&UA6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM M97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI M;F4[)SXE/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!W:61T M:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+69A M;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$ M;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS M1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D M(&%L:6=N/3-$6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA M6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W M(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXP M/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E M('9A;&EG;CTS1&)O='1O;3X\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=T M97AT+6EN9&5N=#H@,'!T.R!M87)G:6XM6QE/3-$)V9O M;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T M.R!D:7-P;&%Y.B!I;FQI;F4[)SXE/"]F;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$ M)W1E>'0M:6YD96YT.B`P<'0[(&UA6QE/3-$)V9O M;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T M.R!D:7-P;&%Y.B!I;FQI;F4[)SY%>'!E8W1E9"!S=&]C:R!P3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$ M;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS M1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D M(&%L:6=N/3-$6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA M6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W M(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXQ M,S0\+V9O;G0^/"]D:78^/"]T9#X\=&0@86QI9VX],T1L969T('=I9'1H/3-$ M,24@=F%L:6=N/3-$8F]T=&]M/CQD:78@86QI9VX],T1L969T('-T>6QE/3-$ M)W1E>'0M:6YD96YT.B`P<'0[(&UA6QE/3-$)V9O M;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T M.R!D:7-P;&%Y.B!I;FQI;F4[)SXE/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&%L M:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S M='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M M3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO M=&0^/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O M;3X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA M;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q-C`[ M/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$6QE/3-$)W1E>'0M M:6YD96YT.B`P<'0[(&UA6QE/3-$)V9O;G0M9F%M M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P M;&%Y.B!I;FQI;F4[)SXY,RTQ,#@\+V9O;G0^/"]D:78^/"]T9#X\=&0@86QI M9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQD:78@86QI M9VX],T1L969T('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N M)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXE/"]F;VYT M/CPO9&EV/CPO=&0^/"]TF4Z(#$P<'0[(&1I3H@)W1I;65S(&YE=R!R;VUA;B<[ M(&9O;G0M3H@:6YL:6YE.R<^)B,Q-C`[/"]F M;VYT/CPO=&0^/'1D(&%L:6=N/3-$6QE/3-$)W1E>'0M:6YD M96YT.B`P<'0[(&UA6QE/3-$)V9O;G0M9F%M:6QY M.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y M.B!I;FQI;F4[)SXQ+C6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N M)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXE/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG M;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S M(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE M.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS M1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL M>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N M="US:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXN,30F(S@R,3$[,BXV M,#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q M)2!V86QI9VX],T1B;W1T;VT^/&1I=B!A;&EG;CTS1&QE9G0@F4Z(#$P<'0[ M(&1IF4Z(#$P<'0[(&1I3H@8FQO8VL[)SX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I M;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL M:6YE.R<^-"XQ+3@N."!Y96%R6QE/3-$)V9O;G0M M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!D M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@86QI9VX] M,T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+69A M;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$ M3H@8FQO8VL[)SX\ M9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[ M(&9O;G0M3H@:6YL:6YE.R<^+CDM.2XX('EE M87)S/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@F4Z(#$P<'0[(&1I6QE/3-$)V9O;G0Z(#$S<'@O;F]R;6%L("=T:6UE'0M:6YD M96YT.B`P<'0[(&QE='1E"]N;W)M86P@ M)W1I;65S(&YE=R!R;VUA;B<[(&-O;&]R.B`C,#`P,#`P.R!T97AT+71R86YS M9F]R;3H@;F]N93L@=&5X="UI;F1E;G0Z(#!P=#L@;&5T=&5R+7-P86-I;FF4Z(#$P<'0[(&1I"]N;W)M86P@)W1I M;65S(&YE=R!R;VUA;B<[(&-O;&]R.B`C,#`P,#`P.R!T97AT+71R86YS9F]R M;3H@;F]N93L@=&5X="UI;F1E;G0Z(#!P=#L@;&5T=&5R+7-P86-I;FF4Z(#$P<'0[(&1I'0M=')A;G-F;W)M.B!N;VYE.R!T97AT+6EN9&5N=#H@,'!X.R!L971T97(M M#L@=VAI=&4M6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT+69A;6EL>3H@)W1I M;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)W!A9&1I;F3H@)W1I;65S M(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE M.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS M1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@ M,G!X.R<^/&9O;G0@F4Z(#$P<'0[(&1IF4Z(#$P M<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R!D:7-P;&%Y.B!I;FQI;F4[)SY.=6UB M97(@;V8@4VAA#LG/CQF;VYT('-T>6QE M/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE M.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X\ M=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W!A9&1I;F3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D('=I M9'1H/3-$,3`E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T M=&]M+6-O;&]R.B!B;&%C:SL@8F]R9&5R+6)O='1O;2UW:61T:#H@,G!X.R!B M;W)D97(M8F]T=&]M+7-T>6QE.B!S;VQI9#LG(&-O;'-P86X],T0R/CQD:78@ M86QI9VX],T1C96YT97(@F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R!D M:7-P;&%Y.B!I;FQI;F4[)SY796EG:'1E9"!!=F5R86=E/"]F;VYT/CPO9&EV M/CQD:78@86QI9VX],T1C96YT97(@F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B M;VQD.R!D:7-P;&%Y.B!I;FQI;F4[)SY%>&5R8VES92!0#LG/CQF;VYT M('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N M="US:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^ M/"]T9#X\=&0@=VED=&@],T0Q,"4@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)V)O3H@8FQO M8VL[)SX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R M;VUA;B<[(&9O;G0MF4Z(#$P<'0[(&9O;G0M M=V5I9VAT.B!B;VQD.R!D:7-P;&%Y.B!I;FQI;F4[)SY#;VYTF4Z(#$P<'0[(&1I6QE/3-$ M)W1E>'0M:6YD96YT.B`P<'0[(&UA6QE/3-$)V9O M;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T M.R!F;VYT+7=E:6=H=#H@8F]L9#L@9&ES<&QA>3H@:6YL:6YE.R<^06=GF4Z(#$P<'0[ M(&9O;G0M=V5I9VAT.B!B;VQD.R!D:7-P;&%Y.B!I;FQI;F4[)SY);G1R:6YS M:6,@5F%L=64\+V9O;G0^/"]D:78^/"]T9#X\=&0@86QI9VX],T1L969T('=I M9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F3H@)W1I;65S M(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE M.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/"]TF4Z(#$P<'0[(&1I6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W M(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXF M(S$V,#L\+V9O;G0^/"]T9#X\=&0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T M;VT^/&9O;G0@F4Z(#$P<'0[(&1I3H@8FQO8VL[)SX\9F]N="!S='EL93TS1"=F;VYT+69A M;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^-RPV-S$L,C8W/"]F;VYT/CPO9&EV/CPO=&0^/'1D M(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N M="!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O M;G0M3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT M/CPO=&0^/'1D(&%L:6=N/3-$F4Z(#$P<'0[(&1IF4Z(#$P<'0[(&1I MF4Z(#$P<'0[(&1IF4Z(#$P<'0[(&1I6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@ M;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[ M)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@86QI9VX],T1L969T('=I9'1H/3-$ M,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY M.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y M.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@86QI9VX],T1L969T M('=I9'1H/3-$,3`E('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$,CX\9F]N M="!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O M;G0M3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT M/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O M='1O;3X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R M;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q M-C`[/"]F;VYT/CPO=&0^/"]T6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O M;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SY787)R M86YTF4Z(#$P<'0[(&1IF4Z(#$P<'0[(&1I3H@8FQO8VL[)SX\9F]N="!S='EL93TS1"=F;VYT M+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^,3$L.#8R+#`P,#PO9F]N=#X\+V1I=CX\+W1D M/CQT9"!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS M1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D M(&%L:6=N/3-$F4Z(#$P<'0[(&1IF4Z(#$P<'0[(&1IF4Z(#$P<'0[(&1I3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^ M/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$P)2!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@F4Z(#$P<'0[(&1I3H@)W1I;65S M(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE M.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS M1#$P)2!V86QI9VX],T1B;W1T;VT@8V]LF4Z M(#$P<'0[(&1IF4Z(#$P<'0[(&1I6QE/3-$)W!A M9&1I;F3H@8FQO8VL[)SX\9F]N="!S='EL93TS1"=F M;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^5V%RF4Z(#$P<'0[(&1I6QE.B!S;VQI9#LG/CQF;VYT('-T M>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US M:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T M9#X\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=B;W)D97(M8F]T=&]M+6-O;&]R.B!B;&%C:SL@8F]R9&5R M+6)O='1O;2UW:61T:#H@,G!X.R!B;W)D97(M8F]T=&]M+7-T>6QE.B!S;VQI M9#LG/CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=T97AT+6EN9&5N=#H@ M,'!T.R!M87)G:6XM3H@8FQO8VL[)SX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I M;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL M:6YE.R<^*#8P,"PP,#`I/"]F;VYT/CPO9&EV/CPO=&0^/'1D('=I9'1H/3-$ M,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F3H@)W1I;65S(&YE=R!R M;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q M-C`[/"]F;VYT/CPO=&0^/'1D('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W!A9&1I;F3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D M('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O M;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@86QI M9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=P861D:6YG+6)O='1O;3H@,G!X.R<^/&1I=B!A;&EG;CTS1')I9VAT('-T M>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA6QE M/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE M.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXN,C4\+V9O;G0^/"]D:78^/"]T M9#X\=&0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY M.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y M.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@=VED=&@],T0Q,"4@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F3H@)W1I;65S(&YE=R!R;VUA M;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q-C`[ M/"]F;VYT/CPO=&0^/'1D('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W!A9&1I;F3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D('=I M9'1H/3-$,3`E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O M='1O;3H@,G!X.R<@8V]LF4Z(#$P<'0[(&1I MF4Z(#$P<'0[(&1IF4Z(#$P<'0[(&1IF4Z(#$P<'0[(&1I6QE.B!D;W5B;&4[)SX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I M;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL M:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$#L@8F]R M9&5R+6)O='1O;2US='EL93H@9&]U8FQE.R<^/&1I=B!A;&EG;CTS1')I9VAT M('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US M:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXQ."PY,S,L,C8W/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@-'!X.R<^/&9O M;G0@F4Z(#$P<'0[(&1I6QE/3-$)W!A9&1I;F3H@8FQO8VL[)SX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S M(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE M.R<^)#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!A;&EG;CTS1')I9VAT('=I9'1H M/3-$.24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;FF4Z(#$P<'0[(&1IF4Z(#$P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[ M(&UA6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@ M;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[ M)SXU+C,@>65AF4Z(#$P<'0[(&1IF4Z M(#$P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N M="US:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXP/"]F;VYT/CPO9&EV M/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@-'!X.R<^/&9O;G0@F4Z(#$P<'0[(&1I6QE/3-$)W!A9&1I;F3H@8FQO8VL[)SX\9F]N="!S='EL93TS1"=F;VYT+69A M;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^17AE6QE/3-$)W!A9&1I;F3H@)W1I;65S(&YE=R!R;VUA M;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q-C`[ M/"]F;VYT/CPO=&0^/'1D('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)V)O6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N M)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\ M+V9O;G0^/"]T9#X\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG M;CTS1&)O='1O;0T*('-T>6QE/3-$)V)O3H@8FQO8VL[)SX\9F]N="!S='EL93TS1"=F;VYT M+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^,3@L,3,Y+#(U,#PO9F]N=#X\+V1I=CX\+W1D M/CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@ M#LG/CQF;VYT('-T>6QE/3-$ M)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q M,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@ M86QI9VX],T1R:6=H="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=P861D:6YG+6)O='1O;3H@-'!X.R<^/&9O;G0@F4Z(#$P<'0[ M(&1IF4Z(#$P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA M6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W M(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXN M-S8\+V9O;G0^/"]D:78^/"]T9#X\=&0@=VED=&@],T0Q)2!V86QI9VX],T1B M;W1T;VT@#LG/CQF;VYT('-T M>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US M:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T M9#X\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#$P)2!V86QI9VX],T1B;W1T M;VT@#LG/CQD:78@86QI9VX] M,T1R:6=H="!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!M87)G:6XM3H@8FQO8VL[)SX\ M9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[ M(&9O;G0M3H@:6YL:6YE.R<^-2XV('EE87)S M/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&%L:6=N/3-$#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O M;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V M,#L\+V9O;G0^/"]T9#X\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L M:6=N/3-$8F]T=&]M/CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)W1E>'0M M:6YD96YT.B`P<'0[(&UA6QE/3-$)V9O;G0M9F%M M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P M;&%Y.B!I;FQI;F4[)SXD/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&%L:6=N/3-$ M#LG/CQD:78@86QI9VX],T1R:6=H="!S='EL93TS M1"=T97AT+6EN9&5N=#H@,'!T.R!M87)G:6XM3H@8FQO8VL[)SX\9F]N="!S='EL93TS1"=F M;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^,#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!A M;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!D M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X\+W1R/CPO=&%B M;&4^/"]D:78^/&1I=B!S='EL93TS1"=F;VYT.B`Q,W!X+VYO'0M=')A;G-F;W)M M.B!N;VYE.R!T97AT+6EN9&5N=#H@,'!T.R!L971T97(M#L@9&ES<&QA>3H@8FQO8VL[('=H:71E M+7-P86-E.B!N;W)M86P[("UW96)K:70M=&5X="US=')O:V4M=VED=&@Z(#!P M>#LG/B8C,38P.SPO9&EV/CQD:78@86QI9VX],T1J=7-T:69Y('-T>6QE/3-$ M)V9O;G0Z(#$S<'@O;F]R;6%L("=T:6UE'0M:6YD96YT.B`P M<'0[(&QE='1E#L@9&ES<&QA M>3H@8FQO8VL[('=H:71E+7-P86-E.B!N;W)M86P[("UW96)K:70M=&5X="US M=')O:V4M=VED=&@Z(#!P>#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY M.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y M.B!I;FQI;F4[)SY4:&4@=V5I9VAT960@879E2XF(S$V,#LF(S$V,#M$=7)I;F<@=&AE('1H'!I"]N;W)M86P@ M)W1I;65S(&YE=R!R;VUA;B<[(&-O;&]R.B`C,#`P,#`P.R!T97AT+71R86YS M9F]R;3H@;F]N93L@=&5X="UI;F1E;G0Z(#!P=#L@;&5T=&5R+7-P86-I;F'0M2!S='EL M93TS1"=F;VYT.B`Q,W!X+VYO'0M=')A;G-F;W)M.B!N;VYE.R!T97AT+6EN9&5N M=#H@,'!T.R!L971T97(M'0M3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^1F]R('1H92!T:')E92!M;VYT:',@96YD960@36%R M8V@@,S$L(#(P,30@86YD(#(P,3,L(')E2P@=&AE($-O;7!A M;GD@65A"!M;VYT:',@=&\@=&AR M964@>65A6QE/3-$)V9O;G0Z(#$S<'@O;F]R;6%L("=T:6UE'0M:6YD M96YT.B`P<'0[(&QE='1E"]N;W)M M86P@)W1I;65S(&YE=R!R;VUA;B<[(&-O;&]R.B`C,#`P,#`P.R!T97AT+71R M86YS9F]R;3H@;F]N93L@=&5X="UI;F1E;G0Z(#!P=#L@;&5T=&5R+7-P86-I M;FF4Z(#$P<'0[(&1I2!R96-O'!E;G-E6QE M/3-$)V9O;G0Z(#$S<'@O;F]R;6%L("=T:6UE'0M:6YD96YT M.B`P<'0[(&QE='1E#L@9&ES M<&QA>3H@8FQO8VL[('=H:71E+7-P86-E.B!N;W)M86P[("UW96)K:70M=&5X M="US=')O:V4M=VED=&@Z(#!P>#LG/B8C,38P.SPO9&EV/CQD:78@"]N;W)M86P@)W1I;65S(&YE=R!R;VUA;B<[(&-O;&]R M.B`C,#`P,#`P.R!T97AT+71R86YS9F]R;3H@;F]N93L@=&5X="UI;F1E;G0Z M(#!P=#L@;&5T=&5R+7-P86-I;F'0M'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO'0^)SQD:78@86QI9VX],T1L969T('-T>6QE/3-$ M)V-O;&]R.B`C,#`P,#`P.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA M;B<[(&9O;G0M#L@9F]N="US='EL93H@;F]R;6%L.R!F;VYT M+79A#L@ M9&ES<&QA>3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0MF4Z(#$S<'@[(&9O;G0M'0M86QI9VXZ('-T87)T.R!T97AT+6EN9&5N=#H@,'!T.R!T97AT M+71R86YS9F]R;3H@;F]N93L@=VAI=&4M#L@+7=E8FMI="UT97AT+7-T6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L M.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!L971T97(M#L@+7=E M8FMI="UT97AT+7-T6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1IF4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI M;F4[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE M.B`Q,'!T.R<^/&9O;G0@3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M2!I2`T+"`R,#$S+"!W:&EC:"!E M>'!I2`R,2P@,C`Q,R!A;F0@*#,I('=A2!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!T M97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z M(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P M;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@ M9F]N="US:7IE.B`Q,'!T.R<^)B,Q-C`[/"]F;VYT/CPO9&EV/@T*/"]D:78^ M#0H\9&EV(&%L:6=N/3-$:G5S=&EF>2!S='EL93TS1"=C;VQOF4Z M(#$S<'@[(&9O;G0M'0M M:6YD96YT.B`P<'0[('1E>'0M=')A;G-F;W)M.B!N;VYE.R!W:&ET92US<&%C M93H@;F]R;6%L.R!W:61O=W,Z(&%U=&\[('=O'0M3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M28C.#(Q-SMS(&AI M2X@5&AE(')I'!E8W1E9"!L:69E(&]F('1H92!W87)R M86YT'!E8W1E9"!L:69E+B!4:&4@97AP96-T960@;&EF92!O9B!W87)R M86YTF5D(&EN('1H92!F86ER('9A;'5E(&-A;&-U;&%T:6]NF4Z(#$S<'@[(&9O;G0M6QE/3-$)V-O;&]R.B`C,#`P,#`P.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE M=R!R;VUA;B<[(&9O;G0M#L@9F]N="US='EL93H@;F]R;6%L M.R!F;VYT+79A#L@=&5X="UT#LG/@T*/'1A8FQE('-T>6QE/3-$)W=I9'1H.B`Q,#`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`P<'0[(&1I6QE/3-$)V1IF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^36%R8V@@,S$L M)B,Q-C`[/"]F;VYT/CQF;VYT('-T>6QE/3-$)V1IF4Z(#$P M<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^,C`Q,SPO9F]N=#X\+V1I=CX-"CPO M=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W!A9&1I;F6EE;&0\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N M/3-$6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1IF4Z(#$P<'0[)SXP)3PO M9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@=VED=&@],T0Q)2!V86QI9VX],T1T M;W`^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@8FQO8VL[(&UA3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$ M)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I MF4Z(#$P<'0[)SY%>'!E8W1E9"!S=&]C:R!P3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I M;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)W1E>'0M:6YD96YT M.B`P<'0[(&1I6QE/3-$)V1IF4Z M(#$P<'0[)SXE/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CPO='(^#0H\='(@8F=C M;VQO6QE/3-$ M)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I MF4Z(#$P<'0[)SY2:7-K+69R964@:6YT97)E3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R M;VUA;B<[(&9O;G0M6QE/3-$)V1IF4Z(#$P<'0[)SXF(S$V,#L\ M+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L M:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1IF4Z(#$P<'0[)SXN,30\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D M(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X-"CQD M:78@86QI9VX],T1L969T('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I M6QE/3-$)V1IF4Z(#$P<'0[)SXE M/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO6QE M/3-$)V1IF4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X- M"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,3`E('9A;&EG;CTS1&)O='1O M;2!C;VQS<&%N/3-$,CX-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=T M97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z M(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P M;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@ M9F]N="US:7IE.B`Q,'!T.R<^+C@@>65A3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)V1I MF4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CPO='(^ M#0H\='(@8F=C;VQO6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1IF4Z(#$P<'0[)SY&86ER('9A;'5E(&]F('=A M3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1IF4Z(#$P<'0[)SXD/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A M;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I M=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I M6QE/3-$)V1IF4Z(#$P<'0[)SXQ M.#4L-#`P/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@ M=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[ M(&9O;G0M6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R M;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!L971T97(M#L@9&ES<&QA>3H@8FQO8VL[)SXF(S$V,#L\+V1I=CX-"CQD:78@86QI M9VX],T1J=7-T:69Y('-T>6QE/3-$)V-O;&]R.B`C,#`P,#`P.R!F;VYT+69A M;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M#L@9F]N M="US='EL93H@;F]R;6%L.R!F;VYT+79AF5D(&QO2!R M97!O&5R8VES92!O9B!T:&4@ M=V%R6QE/3-$)V-O;&]R.B`C M,#`P,#`P.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M M#L@9F]N="US='EL93H@;F]R;6%L.R!F;VYT+79A'0M:6YD96YT.B`P<'0[('1E>'0M=')A M;G-F;W)M.B!N;VYE.R!W:&ET92US<&%C93H@;F]R;6%L.R!W:61O=W,Z(&%U M=&\[('=O'0MF4Z(#$S<'@[(&9O M;G0M'0M:6YD96YT.B`P M<'0[('1E>'0M=')A;G-F;W)M.B!N;VYE.R!W:&ET92US<&%C93H@;F]R;6%L M.R!W:61O=W,Z(&%U=&\[('=O'0M6QE/3-$ M)V1IF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^1F%I M6QE/3-$)V-O;&]R.B`C,#`P M,#`P.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M#L@9F]N="US='EL93H@;F]R;6%L.R!F;VYT+79A#L@9&ES<&QA>3H@8FQO M8VL[(&UA3PO9F]N=#X\+V1I=CX-"CQD M:78@86QI9VX],T1J=7-T:69Y('-T>6QE/3-$)V-O;&]R.B`C,#`P,#`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`C,#`P,#`P.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA M;B<[(&9O;G0M#L@9F]N="US='EL93H@;F]R;6%L.R!F;VYT M+79A#L@+7=E8FMI="UT97AT+7-T6QE/3-$)W!A9&1I;F3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I M;65S(&YE=R!R;VUA;B<[(&9O;G0M#LG(&-O;'-P86X],T0R/CQF;VYT M('-T>6QE/3-$)V1IF4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^ M/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W!A9&1I;F3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[ M(&9O;G0M6QE/3-$)W!A9&1I;F#LG/CQF;VYT('-T>6QE/3-$)V1I MF4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!A M;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F6QE/3-$)V)O6QE/3-$ M)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I MF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^5&]T86P\ M+V9O;G0^/"]D:78^#0H\9&EV(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1IF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^0V%R6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1IF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^5F%L=64@870\ M+V9O;G0^/"]D:78^#0H\9&EV(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1IF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^36%R8V@@,S$L M(#(P,30L/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R M;VUA;B<[(&9O;G0M3H@ M8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1IF4Z(#$P<'0[(&9O;G0M=V5I M9VAT.B!B;VQD.R<^86-T:79E/"]F;VYT/CPO9&EV/@T*/&1I=B!A;&EG;CTS M1&-E;G1E6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1IF4Z(#$P<'0[(&9O;G0M=V5I9VAT M.B!B;VQD.R<^*$QE=F5L(#$I/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A M;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE.B!S;VQI9#LG(&-O;'-P86X],T0R M/@T*/&1I=B!A;&EG;CTS1&-E;G1E6QE/3-$)W1E>'0M:6YD96YT M.B`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`P<'0[(&1I6QE/3-$)V1IF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD M.R<^*$QE=F5L(#,I/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS M1&QE9G0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I M6QE/3-$)V1IF4Z(#$P<'0[)SY$ M97)I=F%T:79E(&QI86)I;&ET:65S/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT M9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF M;VYT('-T>6QE/3-$)V1IF4Z(#$P<'0[)SXF(S$V,#L\+V9O M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX] M,T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=T97AT+6EN M9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@ M;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US M:7IE.B`Q,'!T.R<^)#PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX] M,T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI M9VX],T1R:6=H="!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y M.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[ M)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY M.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R<^,RPY,33H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O M;G0M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE M=R!R;VUA;B<[(&9O;G0M6QE/3-$)W1E>'0M:6YD96YT.B`P M<'0[(&1I6QE/3-$)V1IF4Z(#$P M<'0[)SXD/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT M('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I M9VAT('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1IF4Z(#$P<'0[)SXM/"]F;VYT/CPO9&EV M/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M M6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1IF4Z(#$P<'0[)SXD/"]F;VYT/CPO M9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L M:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1IF4Z(#$P<'0[)SXM/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A M;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S M(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$ M)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I MF4Z(#$P<'0[)SXD/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT M9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T* M/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[ M(&1I6QE/3-$)V1IF4Z(#$P<'0[ M)SXS+#DQ-RPW,C(\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$ M;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS M1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O M;6%N)SL@9F]N="US:7IE.B`Q,'!T.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\ M+W1R/@T*/"]T86)L93X-"CPO9&EV/@T*/&1I=B!S='EL93TS1"=C;VQOF4Z(#$S<'@[(&9O;G0M'0M86QI9VXZ('-T87)T.R!T97AT+6EN9&5N=#H@,'!T.R!T97AT+71R M86YS9F]R;3H@;F]N93L@=VAI=&4M#L@+7=E8FMI="UT97AT+7-TF4Z(#$S<'@[(&9O;G0MF4Z(#$P<'0[)SY4:&4@9&5R:79A=&EV M92!L:6%B:6QI=&EE#L@9&ES<&QA>3H@8FQO8VL[ M)SXF(S$V,#L\+V1I=CX-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)V-O M;&]R.B`C,#`P,#`P.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[ M(&9O;G0M#L@9F]N="US='EL93H@;F]R;6%L.R!F;VYT+79A M#L@9&ES M<&QA>3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT M+7=E:6=H=#H@;F]R;6%L.R!L971T97(M#L@+7=E8FMI="UT M97AT+7-T6QE M/3-$)V1IF4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]D:78^ M#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=C;VQOF4Z(#$S M<'@[(&9O;G0M'0M:6YD M96YT.B`P<'@[('1E>'0M=')A;G-F;W)M.B!N;VYE.R!W:&ET92US<&%C93H@ M;F]R;6%L.R!W:61O=W,Z(&%U=&\[('=O'0MF4Z(#$P<'0[)R!C96QL#LG/CQF;VYT('-T>6QE M/3-$)V1IF4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X- M"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A M9&1I;F6QE/3-$)V)O6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE M/3-$)V1IF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^ M665A3H@8FQO8VL[(&UA M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE M=R!R;VUA;B<[(&9O;G0M6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1IF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B M;VQD.R<^,C`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`P<'0[)SX\9F]N="!S M='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B`G=&EM97,@ M;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R<^)#PO9F]N=#X\+V1I=CX- M"CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS M1&)O='1O;3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=T97AT+6EN M9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@ M;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US M:7IE.B`Q,'!T.R<^-S6QE/3-$)V1IF4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^ M/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO6QE/3-$)V1IF4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS M1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R M;VUA;B<[(&9O;G0M3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M M6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M:6YD96YT M.B`P<'0[(&1I6QE/3-$)V1IF4Z M(#$P<'0[)SY.970@=6YR96%L:7IE9"`H9V%I;BD@;&]S6QE/3-$)W!A9&1I;F6QE/3-$)V)O3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1IF4Z(#$P<'0[)SY%;F1I;F<@8F%L86YC92!A#LG/CQF;VYT('-T>6QE/3-$)V1IF4Z(#$P M<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED M=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@#L@8F]R M9&5R+6)O='1O;2US='EL93H@9&]U8FQE.R<^#0H\9&EV(&%L:6=N/3-$;&5F M="!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@ M;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S M='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B`G=&EM97,@ M;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R<^)#PO9F]N=#X\+V1I=CX- M"CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M+6-O;&]R.B!B;&%C:SL@ M8F]R9&5R+6)O='1O;2UW:61T:#H@-'!X.R!B;W)D97(M8F]T=&]M+7-T>6QE M.B!D;W5B;&4[)SX-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=T97AT M+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P M=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y M.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N M="US:7IE.B`Q,'!T.R<^,RPY,33H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3X-"CPO:'1M M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]E83,U-#9D-5]B9F0R7S0T93%?8C,Q M9%\U-38R-69F,C$Q-S4-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO M96$S-30V9#5?8F9D,E\T-&4Q7V(S,61?-34V,C5F9C(Q,3'0O:'1M;#L@8VAA M'0^)SQS<&%N/CPOF4Z(#$S<'@[(&9O;G0M'0M:6YD96YT.B`P<'@[('1E>'0M=')A;G-F;W)M.B!N;VYE.R!W M:&ET92US<&%C93H@;F]R;6%L.R!W:61O=W,Z(&%U=&\[('=O'0M6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[ M(&1I6QE/3-$)V1IF4Z(#$P<'0[ M(&9O;G0M=V5I9VAT.B!B;VQD.R<^3F]T92`X+2!3=6)S97%U96YT($5V96YT M6QE/3-$ M)W1E>'0M:6YD96YT.B`P<'0[(&1IF4Z M(#$S<'@[(&9O;G0M'0M M:6YD96YT.B`P<'@[('1E>'0M=')A;G-F;W)M.B!N;VYE.R!W:&ET92US<&%C M93H@;F]R;6%L.R!W:61O=W,Z(&%U=&\[('=O'0M3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES M<&QA>3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M7,@ M*%-C:'=E;&P@5VEM<&9H96EM97(@)F%M<#L@07-S;V-I871E3H@8FQO8VL[(&UA6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P M<'0[(&1I6QE/3-$)V1IF4Z(#$P M<'0[)SY);B!!<')I;"`R,#$T+"!E>'!E;G-E2!T:&4@0V]M M<&%N>2!A2!T:&4@0V]M<&%N>28C.#(Q M-SMS(&1I3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%]E83,U-#9D-5]B9F0R7S0T93%?8C,Q9%\U-38R-69F,C$Q M-S4-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO96$S-30V9#5?8F9D M,E\T-&4Q7V(S,61?-34V,C5F9C(Q,3'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^)SQS<&%N/CPOF4Z M(#$S<'@[(&9O;G0M'0M M:6YD96YT.B`P<'0[('1E>'0M=')A;G-F;W)M.B!N;VYE.R!W:&ET92US<&%C M93H@;F]R;6%L.R!W:61O=W,Z(&%U=&\[('=O'0M6QE/3-$)V1IF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B M;VQD.R<^/&)R(&-L87-S/3-$87!P;&4M:6YT97)C:&%N9V4M;F5W;&EN92`O M/DYO=&4@.2T@4F5C96YT($%C8V]U;G1I;F<@4')O;F]U;F-E;65N=',\+V9O M;G0^/"]D:78^#0H\9&EV('-T>6QE/3-$)V-O;&]R.B`C,#`P,#`P.R!F;VYT M+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M#L@ M9F]N="US='EL93H@;F]R;6%L.R!F;VYT+79A'0M:6YD96YT.B`P<'0[('1E>'0M=')A;G-F;W)M.B!N;VYE M.R!W:&ET92US<&%C93H@;F]R;6%L.R!W:61O=W,Z(&%U=&\[('=O'0M2!S='EL93TS1"=C;VQOF4Z(#$S<'@[(&9O;G0MF4Z(#$P<'0[)SY4:&4@0V]M<&%N>2!H87,@8V]N28C.#(Q-SMS(&9I;F%N M8VEA;"!S=&%T96UE;G1S+CPO9F]N=#X\+V1I=CX-"CQD:78@86QI9VX],T1J M=7-T:69Y('-T>6QE/3-$)V-O;&]R.B`C,#`P,#`P.R!F;VYT+69A;6EL>3H@ M)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M#L@9F]N="US='EL M93H@;F]R;6%L.R!F;VYT+79A#L@9&ES<&QA>3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O M;G0M'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA2!O9B!3:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S("A0 M;VQI8VEE2!O9B!3:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S(%M!8G-T3H@8FQO8VL[(&UA3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^0F%S:7,@;V8@4')E<&%R M871I;VX\+V9O;G0^/"]D:78^/&1I=B!S='EL93TS1"=T97AT+6EN9&5N=#H@ M,'!T.R!D:7-P;&%Y.B!B;&]C:SLG/B8C,38P.SPO9&EV/CQD:78@86QI9VX] M,T1J=7-T:69Y('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6EN9R!U;F%U9&ET960@8V]N9&5N2!A8V-E<'1E9"!I;B!T:&4@ M56YI=&5D(%-T871E2P@=&AE>2!D;R!N;W0@:6YC;'5D92!A;&P@;V8@=&AE(&EN9F]R M;6%T:6]N(')E<75I6QE/3-$ M)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I M2!F;W(@82!F M86ER('!R97-E;G1A=&EO;B!O9B!T:&4@65A M'0^)SQD:78@86QI9VX],T1J=7-T:69Y('-T>6QE/3-$)W1E>'0M:6YD96YT M.B`P<'0[(&1I6QE/3-$)V1I3H@8FQO8VL[)SXF(S$V,#L\+V1I=CX\9&EV(&%L:6=N/3-$:G5S M=&EF>2!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C M:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N M="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE M3H@8FQO8VL[(&UA M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^ M57-E(&]F($5S=&EM871E6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SY4:&4@<')E<&%R871I;VX@;V8@9FEN86YC:6%L('-T871E;65N=',@:6X@ M8V]N9F]R;6ET>2!W:71H($=!05`@3H@ M8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT M.B!B;VQD.R<^0V%S:"!A;F0@0V%S:"!%<75I=F%L96YT6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[)SY&;W(@9FEN86YC:6%L('-T871E;65N="!P M2!M86EN=&%I;G,@:71S(&-A'0^)SQD:78@86QI9VX],T1J=7-T:69Y('-T M>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE M/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P M<'0[(&1I6QE/3-$)V1I2!C;W5R2!A;&QO=V%N8V4@9F]R(&1O=6)T9G5L(&%C8V]U;G1S+B8C,38P.R8C,38P M.U=E(&5V86QU871E(&%C8V]U;G1S(')E8V5I=F%B;&4@<75A2!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C M:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N M="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE M6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[ M(&1I6QE/3-$)V1I2!O9B!P87)T2!I&-E2!R97-E&5D($%S'0^)SQD:78@86QI9VX],T1J=7-T:69Y M('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I&5D($%S6QE/3-$)W1E>'0M M:6YD96YT.B`P<'0[(&1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY& M:7AE9"!A'!E;G-E M9"!W:&5N(&EN8W5R'!E;F1I='5R97,@9F]R(&UI;F]R(&ET96US+"!R97!A:7)S M(&%N9"!M86EN=&5N86YC92!A'0^)SQD:78@86QI M9VX],T1J=7-T:69Y('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3H@8FQO8VL[ M)SXF(S$V,#L\+V1I=CX\9&EV(&%L:6=N/3-$:G5S=&EF>2!S='EL93TS1"=T M97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z M(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P M;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE&EM871E M'0^)SQD:78@86QI9VX],T1J=7-T:69Y M('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$ M)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I M2!N;W0@8F4@6EN9R!A;6]U;G0@;V8@86X@87-S970@=&\@9G5T=7)E(&YE="!U;F1I M'!E8W1E9"!T;R!B92!G96YE'0^)SQD:78@86QI9VX],T1J=7-T:69Y('-T>6QE/3-$)W1E>'0M:6YD96YT M.B`P<'0[(&1I6QE/3-$)V1I6EN9R!A;6]U;G0@;V8@8V%S:"P@86-C;W5N=',@'0^)SQD:78@86QI9VX],T1J=7-T:69Y('-T>6QE/3-$)W1E>'0M:6YD96YT M.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1IF5D('=H96X@86QL(&]F('1H92!F;VQL;W=I;F<@8V]N9&ET:6]N2!A6EN9R!O=7(@6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$ M)V1I&-E'!E8W0@=&\@:6YC=7(@:6X@ M=&AE(&%G6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I7-T96T@F5D(&)A2!T:&4@2!A;F0@ M8FEL;&5D('1O('1H92!C=7-T;VUE2!I="!I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[)SY!="!-87)C:"`S,2P@,C`Q-"P@=&AE($-O;7!A M;GD@:&%D(&-O&-E M6QE/3-$)W1E>'0M:6YD M96YT.B`P<'0[(&1I6QE/3-$)V1I'!E;G-E9"!W:&5N(&EN8W5R2P@=&AE2!#;W-T'0^)SQD:78@ M86QI9VX],T1J=7-T:69Y('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I M6QE/3-$)V1I3H@8FQO8VL[ M)SXF(S$V,#L\+V1I=CX\9&EV(&%L:6=N/3-$:G5S=&EF>2!S='EL93TS1"=T M97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z M(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P M;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE7-T96T@2!R97-E6-L97,L(&UA;G5F86-T=7)EFEN9R!F=71U3H@8FQO8VL[(&UA3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^4W1O8VLM0F%S960@0V]M M<&5N3H@8FQO8VL[)SXF(S$V,#L\+V1I=CX\9&EV(&%L M:6=N/3-$:G5S=&EF>2!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P M;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P M<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M M:6QY.B!T:6UE'!E;G-E(')E;&%T960@=&\@3H@8FQO8VL[)SXF(S$V,#L\ M+V1I=CX\9&EV(&%L:6=N/3-$:G5S=&EF>2!S='EL93TS1"=T97AT+6EN9&5N M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R M9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI M;F4[(&9O;G0M9F%M:6QY.B!T:6UE2!I;G-T2!I;G-T&5S/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/&1I=B!A;&EG;CTS1&IU3H@8FQO8VL[ M(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD M.R<^26YC;VUE(%1A>&5S/"]F;VYT/CPO9&EV/CQD:78@"!L:6%B:6QI=&EE"!C;VYS97%U M96YC97,@;V8@=&5M<&]R87)Y(&1I9F9EF5S(&5N86-T960@"!R871E2!V86QU871I;VX@86QL;W=A;F-E+"!F;W(@ M=&5M<&]R87)Y(&1I9F9E"!C"!E>'!E;G-E(')E<')E2!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P M;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P M<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M M:6QY.B!T:6UE6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[ M(&1I3H@8FQO M8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY"87-I8R!E87)N:6YG M6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I M6QE/3-$)V1I3H@8FQO M8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B M;VQD.R<^4F5C;&%S6QE/3-$)W1E>'0M:6YD M96YT.B`P<'0[(&1I6QE/3-$)V1I'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA'0^)SQS<&%N/CPO2!O M9B!A;FYU86P@;6%T=7)I=&EE6QE/3-$)W=I9'1H.B`Q,#`E.R!F M;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)W1E>'0M M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1IF4Z(#$P<'0[)SXR,#$T("AI;F-L=61E6QE/3-$)W1E>'0M:6YD96YT.B`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`P<'@[('1E>'0M=')A;G-F;W)M.B!N;VYE.R!W:&ET92US M<&%C93H@;F]R;6%L.R!W:61O=W,Z(&%U=&\[('=O'0M6QE/3-$)V-O;&]R.B`C,#`P,#`P.R!F;VYT+69A;6EL M>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M#L@9F]N="US M='EL93H@;F]R;6%L.R!F;VYT+79A#L@ M=&5X="UT3X-"CPO:'1M;#X-"@T*+2TM+2TM/5]. M97AT4&%R=%]E83,U-#9D-5]B9F0R7S0T93%?8C,Q9%\U-38R-69F,C$Q-S4- M"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO96$S-30V9#5?8F9D,E\T M-&4Q7V(S,61?-34V,C5F9C(Q,3'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R2=S(')E"]N M;W)M86P@)W1I;65S(&YE=R!R;VUA;B<[(&-O;&]R.B`C,#`P,#`P.R!T97AT M+71R86YS9F]R;3H@;F]N93L@=&5X="UI;F1E;G0Z(#!P>#L@;&5T=&5R+7-P M86-I;F#LG/CQT M86)L92!S='EL93TS1"=W:61T:#H@,3`P)3L@9F]N="UF86UI;'DZ("=T:6UE MF4Z(#$P<'0[)R!C96QL6QE/3-$)W1E>'0M M:6YD96YT.B`P<'0[(&UA6QE/3-$)V9O;G0M9F%M M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P M;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]D:78^/&1I=B!A;&EG;CTS M1&QE9G0@F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R!D:7-P;&%Y.B!I M;FQI;F4[)SY297-T6QE/3-$)W!A9&1I M;F3H@ M)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@ M:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=B;W)D97(M8F]T=&]M+6-O;&]R.B!B;&%C:SL@8F]R9&5R M+6)O='1O;2UW:61T:#H@,G!X.R!B;W)D97(M8F]T=&]M+7-T>6QE.B!S;VQI M9#LG(&-O;'-P86X],T0R/CQD:78@86QI9VX],T1C96YT97(@F4Z(#$P<'0[ M(&9O;G0M=V5I9VAT.B!B;VQD.R!D:7-P;&%Y.B!I;FQI;F4[)SY.=6UB97(@ M;V8\+V9O;G0^/"]D:78^/&1I=B!A;&EG;CTS1&-E;G1E3H@8FQO8VL[)SX\9F]N="!S='EL93TS1"=F;VYT M+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M#LG M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N M)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\ M+V9O;G0^/"]T9#X\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@F4Z(#$P M<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N M="US:7IE.B`Q,'!T.R!F;VYT+7=E:6=H=#H@8F]L9#L@9&ES<&QA>3H@:6YL M:6YE.R<^5V5I9VAT960@079E6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N M)SL@9F]N="US:7IE.B`Q,'!T.R!F;VYT+7=E:6=H=#H@8F]L9#L@9&ES<&QA M>3H@:6YL:6YE.R<^1F%I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O M;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!F;VYT+7=E:6=H=#H@8F]L9#L@9&ES M<&QA>3H@:6YL:6YE.R<^1W)A;G0@1&%T93PO9F]N=#X\+V1I=CX\+W1D/CQT M9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I M;F3H@ M)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@ M:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/"]TF4Z(#$P<'0[(&1IF4Z(#$P<'0[(&1IF4Z(#$P M<'0[(&1I3H@8FQO M8VL[)SX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R M;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^,3$X M+#,W.#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!A;&EG;CTS1&QE9G0@=VED=&@] M,T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4Z(#$P<'0[(&1IF4Z(#$P M<'0[(&1IF4Z(#$P<'0[(&1IF4Z(#$P<'0[(&1I M6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US M:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T M9#X\+W1R/CQT#LG/CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)W1E>'0M M:6YD96YT.B`P<'0[(&UA6QE/3-$)V9O;G0M9F%M M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P M;&%Y.B!I;FQI;F4[)SY!=V%R9&5D(&1U6QE/3-$ M)W!A9&1I;F3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D('=I9'1H/3-$ M,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)OF4Z(#$P<'0[(&1I6QE/3-$)V)O6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@ M9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXR-3`L,#`P/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W!A9&1I;F3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D M('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F3H@)W1I M;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL M:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D('=I9'1H/3-$,24@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)V)OF4Z(#$P<'0[(&1I6QE/3-$)V)O6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA6QE M/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE M.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXN,CD\+V9O;G0^/"]D:78^/"]T M9#X\=&0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY M.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y M.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X\+W1R/CQTF4Z(#$P<'0[(&1IF4Z(#$P<'0[(&1I6QE.B!D;W5B;&4[)SX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@ M)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@ M:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N M="US:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXT,3DL,S8X/"]F;VYT M/CPO9&EV/CPO=&0^/'1D('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W!A9&1I;F3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D('=I M9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F3H@)W1I;65S M(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE M.R<^)B,Q-C`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`[/"]F;VYT/CPO9&EV/CQS<&%N M/CPO'0^)SQS<&%N/CPO'0M=')A;G-F;W)M.B!N;VYE.R!T97AT+6EN M9&5N=#H@,'!X.R!L971T97(M#L@=VAI=&4M6QE/3-$)W=I9'1H.B`Q,#`E M.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$ M)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q M,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@ M86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F M;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D('9A M;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$,CX\9&EV(&%L:6=N/3-$8V5N=&5R M('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US M:7IE.B`Q,'!T.R!F;VYT+7=E:6=H=#H@8F]L9#L@9&ES<&QA>3H@:6YL:6YE M.R<^5&AR964F(S$V,#M-;VYT:',@16YD960\+V9O;G0^/"]D:78^/"]T9#X\ M=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS M1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D M(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4Z(#$P M<'0[(&1I3H@8FQO8VL[)SX\9F]N="!S M='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M MF4Z M(#$P<'0[(&1I6QE M/3-$)W!A9&1I;F3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D(&%L:6=N M/3-$;&5F="!V86QI9VX],T1B;W1T;VT@#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@ M;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[ M)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)V)O3H@8FQO8VL[)SX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL M>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&UA6QE/3-$)V9O;G0M M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!F M;VYT+7=E:6=H=#H@8F]L9#L@9&ES<&QA>3H@:6YL:6YE.R<^,C`Q-#PO9F]N M=#X\+V1I=CX\+W1D/CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W!A9&1I;F3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D M(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G M=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I M;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)V)O3H@8FQO8VL[)SX\9F]N="!S='EL93TS1"=F;VYT M+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^,C`Q,SPO9F]N M=#X\+V1I=CX\+W1D/CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W!A9&1I;F3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T MF4Z(#$P<'0[(&1I6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US M:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T M9#X\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$ M,CX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA M;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q-C`[ M/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@F4Z(#$P<'0[(&1I6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@ M9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O M;G0^/"]T9#X\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!C;VQS M<&%N/3-$,CX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE M=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^ M)B,Q-C`[/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B M;W1T;VT^/&9O;G0@F4Z(#$P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA M6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W M(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SY% M>'!E8W1E9"!D:79I9&5N9"!Y:65L9#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!A M;&EG;CTS1')I9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT M('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N M="US:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^ M/"]T9#X\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T M=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O M;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V M,#L\+V9O;G0^/"]T9#X\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A M;&EG;CTS1&)O='1O;3X\9&EV(&%L:6=N/3-$F4Z(#$P<'0[(&1I M6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@ M9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXE/"]F;VYT/CPO M9&EV/CPO=&0^/'1D(&%L:6=N/3-$F4Z(#$P<'0[(&1IF4Z(#$P<'0[(&1I3H@8FQO8VL[)SX\9F]N="!S M='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M M3H@:6YL:6YE.R<^,#PO9F]N=#X\+V1I=CX\ M+W1D/CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T M;VT^/&1I=B!A;&EG;CTS1&QE9G0@F4Z(#$P<'0[(&1IF4Z(#$P<'0[(&1I3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D(&%L M:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S M='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M M3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO M=&0^/'1D(&%L:6=N/3-$6QE/3-$)W1E>'0M:6YD96YT.B`P M<'0[(&UAF4Z(#$P<'0[(&1IF4Z(#$P<'0[(&1I3H@)W1I;65S(&YE=R!R;VUA M;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q-C`[ M/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG M;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S M(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE M.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA6QE/3-$ M)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q M,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXQ,#@\+V9O;G0^/"]D:78^/"]T9#X\ M=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQD M:78@86QI9VX],T1L969T('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA M6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W M(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXE M/"]F;VYT/CPO9&EV/CPO=&0^/"]TF4Z(#$P<'0[(&1IF4Z(#$P<'0[(&1IF4Z(#$P<'0[(&1I3H@8FQO8VL[)SX\9F]N="!S='EL93TS1"=F;VYT M+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^,RXV,SPO9F]N=#X\+V1I=CX\+W1D/CQT9"!A M;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&1I=B!A M;&EG;CTS1&QE9G0@F4Z(#$P<'0[(&1I3H@)W1I M;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL M:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!W:61T M:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+69A M;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$ M6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@ M9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXR+C8P+3(N-C@\ M+V9O;G0^/"]D:78^/"]T9#X\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@ M=F%L:6=N/3-$8F]T=&]M/CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&UA6QE/3-$)V9O;G0M M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!D M:7-P;&%Y.B!I;FQI;F4[)SXE/"]F;VYT/CPO9&EV/CPO=&0^/"]T6QE/3-$)W1E>'0M:6YD96YT.B`P M<'0[(&UA6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM M97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI M;F4[)SY%>'!E8W1E9"!L:69E(&]F(&]P=&EO;G,\+V9O;G0^/"]D:78^/"]T M9#X\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4Z(#$P<'0[(&1IF4Z(#$P<'0[(&1IF4Z(#$P<'0[(&1I M3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$ M3H@8FQO8VL[)SX\ M9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[ M(&9O;G0M3H@:6YL:6YE.R<^+C0W+3DN-S@@ M>65A3H@)W1I;65S M(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE M.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T6QE/3-$)V9O;G0Z(#$S<'@O;F]R;6%L("=T:6UE M'0M:6YD96YT.B`P<'0[(&QE='1E#L@9&ES<&QA>3H@8FQO8VL[('=H:71E+7-P86-E.B!N M;W)M86P[("UW96)K:70M=&5X="US=')O:V4M=VED=&@Z(#!P>#LG/CQF;VYT M('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N M="US:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^ M/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$"]N;W)M M86P@)W1I;65S(&YE=R!R;VUA;B<[(&-O;&]R.B`C,#`P,#`P.R!T97AT+71R M86YS9F]R;3H@;F]N93L@=&5X="UI;F1E;G0Z(#!P>#L@;&5T=&5R+7-P86-I M;F#LG/CQT86)L M92!S='EL93TS1"=W:61T:#H@,3`P)3L@9F]N="UF86UI;'DZ("=T:6UEF4Z(#$P<'0[)R!C96QLF4Z(#$P<'0[(&1I#LG M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N M)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\ M+V9O;G0^/"]T9#X\=&0@=VED=&@],T0Q,"4@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)V)O3H@8FQO8VL[)SX\9F]N="!S='EL93TS1"=F;VYT+69A M;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE M/3-$)W!A9&1I;F3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D(&%L:6=N M/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P M861D:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@F4Z(#$P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@ M9F]N="US:7IE.B`Q,'!T.R!F;VYT+7=E:6=H=#H@8F]L9#L@9&ES<&QA>3H@ M:6YL:6YE.R<^5V5I9VAT960@079E6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O M;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!F;VYT+7=E:6=H=#H@8F]L9#L@9&ES M<&QA>3H@:6YL:6YE.R<^17AE6QE/3-$)W!A9&1I;F3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D M('=I9'1H/3-$,3`E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M M8F]T=&]M+6-O;&]R.B!B;&%C:SL@8F]R9&5R+6)O='1O;2UW:61T:#H@,G!X M.R!B;W)D97(M8F]T=&]M+7-T>6QE.B!S;VQI9#LG/CQD:78@86QI9VX],T1C M96YT97(@F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R!D:7-P;&%Y.B!I M;FQI;F4[)SY796EG:'1E9"U!=F5R86=E(%)E;6%I;FEN9SPO9F]N=#X\+V1I M=CX\9&EV(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P M<'0[(&UA6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM M97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!F;VYT+7=E:6=H=#H@ M8F]L9#L@9&ES<&QA>3H@:6YL:6YE.R<^0V]N=')A8W1U86P@5&5R;3PO9F]N M=#X\+V1I=CX\+W1D/CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI M9VX],T1B;W1T;VT@#LG/CQF M;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@ M9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O M;G0^/"]T9#X\=&0@=VED=&@],T0Q,"4@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)V)O3H@8FQO8VL[)SX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL M>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)W1E>'0M:6YD M96YT.B`P<'0[(&UA6QE/3-$)V9O;G0M9F%M:6QY M.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!F;VYT+7=E M:6=H=#H@8F]L9#L@9&ES<&QA>3H@:6YL:6YE.R<^26YTF4Z(#$P<'0[(&1I6QE/3-$)V9O;G0M9F%M M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P M;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@86QI9VX],T1L M969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$ M)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q M,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@ M86QI9VX],T1L969T('=I9'1H/3-$,3`E('9A;&EG;CTS1&)O='1O;2!C;VQS M<&%N/3-$,CX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE M=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^ M)B,Q-C`[/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@ M)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@ M:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!W M:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT M+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D(&%L:6=N M/3-$;&5F="!W:61T:#TS1#$P)2!V86QI9VX],T1B;W1T;VT@8V]LF4Z(#$P<'0[(&1IF4Z(#$P<'0[(&1I6QE/3-$)V9O;G0M9F%M M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P M;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@86QI9VX],T1L M969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$ M)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q M,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@ M86QI9VX],T1L969T('=I9'1H/3-$,3`E('9A;&EG;CTS1&)O='1O;2!C;VQS M<&%N/3-$,CX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE M=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^ M)B,Q-C`[/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@ M)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@ M:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/"]TF4Z(#$P<'0[(&1IF4Z(#$P<'0[(&1IF4Z(#$P<'0[(&1I3H@8FQO8VL[)SX\9F]N M="!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O M;G0M3H@:6YL:6YE.R<^,2PS.#8L,3`X/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A M;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I M;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL M:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!W:61T M:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+69A M;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q-C`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`[/"]F;VYT M/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O M='1O;3X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R M;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q M-C`[/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$P)2!V M86QI9VX],T1B;W1T;VT@8V]LF4Z(#$P<'0[ M(&1IF4Z(#$P<'0[(&1I3H@8FQO8VL[)SX\9F]N="!S='EL M93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^3W!T:6]N3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D(&%L:6=N M/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL M93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^ M/'1D(&%L:6=N/3-$6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[ M(&UA6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@ M;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[ M)SXQ,34L,#`P/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!W M:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT M+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D(&%L:6=N M/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL M93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q-C`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`[/"]F;VYT M/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$P)2!V86QI9VX],T1B M;W1T;VT^/&9O;G0@F4Z(#$P<'0[(&1IF4Z(#$P<'0[(&1I6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US M:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T M9#X\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N M)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\ M+V9O;G0^/"]T9#X\+W1R/CQTF4Z M(#$P<'0[(&1I#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@ M;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[ M)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@=VED=&@],T0Q)2!V86QI9VX],T1B M;W1T;VT@#L@8F]R9&5R+6)O='1O;2US='EL93H@ M3H@)W1I;65S(&YE M=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^ M)B,Q-C`[/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$F4Z(#$P M<'0[(&1I6QE/3-$)W!A M9&1I;F3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D('=I9'1H/3-$,24@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F3H@)W1I;65S(&YE=R!R;VUA M;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q-C`[ M/"]F;VYT/CPO=&0^/'1D('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF M;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@ M9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O M;G0^/"]T9#X\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^/&1I=B!A M;&EG;CTS1')I9VAT('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O M;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXN-S4\ M+V9O;G0^/"]D:78^/"]T9#X\=&0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T M;VT@#LG/CQF;VYT('-T>6QE M/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE M.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X\ M=&0@=VED=&@],T0Q,"4@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I M;F3H@ M)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@ M:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D('=I9'1H/3-$,24@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F3H@)W1I;65S(&YE=R!R;VUA;B<[ M(&9O;G0M3H@:6YL:6YE.R<^)B,Q-C`[/"]F M;VYT/CPO=&0^/'1D('=I9'1H/3-$,3`E('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<@8V]LF4Z(#$P<'0[(&1IF4Z(#$P<'0[(&1IF4Z(#$P<'0[(&1I6QE/3-$)W!A9&1I;F3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D(&%L M:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=B;W)D97(M8F]T=&]M+6-O;&]R.B!B;&%C:SL@8F]R9&5R+6)O='1O;2UW M:61T:#H@-'!X.R!B;W)D97(M8F]T=&]M+7-T>6QE.B!D;W5B;&4[)SX\9F]N M="!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O M;G0M3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT M/CPO=&0^/'1D(&%L:6=N/3-$6QE/3-$)W1E>'0M:6YD M96YT.B`P<'0[(&UA6QE/3-$)V9O;G0M9F%M:6QY M.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y M.B!I;FQI;F4[)SXQ+#0S,"PV,#@\+V9O;G0^/"]D:78^/"]T9#X\=&0@86QI M9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W!A9&1I;F3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$ M;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D M:6YG+6)O='1O;3H@-'!X.R<^/&9O;G0@F4Z(#$P<'0[(&1I3H@8FQO8VL[)SX\9F]N="!S M='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M M3H@:6YL:6YE.R<^)#PO9F]N=#X\+V1I=CX\ M+W1D/CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W!A9&1I;FF4Z(#$P<'0[(&1I#LG/CQF M;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@ M9F]N="US:7IE.B`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`P<'0[(&UA6QE M/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE M.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXR-BPT-3`\+V9O;G0^/"]D:78^ M/"]T9#X\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W!A9&1I;F3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^ M/"]T#LG/CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)W1E>'0M M:6YD96YT.B`P<'0[(&UA6QE/3-$)V9O;G0M9F%M M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P M;&%Y.B!I;FQI;F4[)SY%>&5R8VES86)L92!A="!-87)C:"`S,2PR,#$T/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A M;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@-'!X.R<^ M/&9O;G0@F4Z(#$P<'0[(&1IF4Z(#$P<'0[(&1I6QE/3-$)V)O3H@8FQO8VL[)SX\9F]N="!S='EL M93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^-S#LG/CQF;VYT('-T M>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US M:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T M9#X\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W!A9&1I;F3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D M(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9&EV M(&%L:6=N/3-$;&5F="!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!M87)G M:6XM3H@8FQO M8VL[)SX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R M;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^)#PO M9F]N=#X\+V1I=CX\+W1D/CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1IF4Z(#$P<'0[(&1I#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O M;6%N)SL@9F]N="US:7IE.B`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`P<'0[(&UA6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N M="US:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXR-BPT-3`\+V9O;G0^ M/"]D:78^/"]T9#X\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O M;G0M3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT M/CPO=&0^/"]T6QE/3-$)V9O;G0Z(#$S<'@O;F]R;6%L("=T:6UE'0M:6YD M96YT.B`P<'0[(&QE='1E#L@ M9&ES<&QA>3H@8FQO8VL[('=H:71E+7-P86-E.B!N;W)M86P[("UW96)K:70M M=&5X="US=')O:V4M=VED=&@Z(#!P>#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!D M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#LF(S$V,#LF(S$V,#L\+V9O;G0^/"]D M:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B M;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]E M83,U-#9D-5]B9F0R7S0T93%?8C,Q9%\U-38R-69F,C$Q-S4-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO96$S-30V9#5?8F9D,E\T-&4Q7V(S,61? M-34V,C5F9C(Q,3'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0M=')A M;G-F;W)M.B!N;VYE.R!T97AT+6EN9&5N=#H@,'!X.R!L971T97(M#L@=VAI=&4M6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE M=R!R;VUA;B<[(&9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W M(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXF M(S$V,#L\+V9O;G0^/"]T9#X\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O M='1O;3X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R M;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q M-C`[/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$ M,CX\9&EV(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P M<'0[(&UA6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM M97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!F;VYT+7=E:6=H=#H@ M8F]L9#L@9&ES<&QA>3H@:6YL:6YE.R<^5&AR964@36]N=&AS($5N9&5D/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T M;VT^/&9O;G0@F4Z(#$P<'0[(&1I6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N M)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\ M+V9O;G0^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R/CQD M:78@86QI9VX],T1C96YT97(@F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD M.R!D:7-P;&%Y.B!I;FQI;F4[)SY4:')E92!-;VYT:',@16YD960\+V9O;G0^ M/"]D:78^/"]T9#X\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\ M9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[ M(&9O;G0M3H@:6YL:6YE.R<^)B,Q-C`[/"]F M;VYT/CPO=&0^/"]T#LG/CQF;VYT('-T M>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US M:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T M9#X\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P M861D:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@F4Z(#$P<'0[(&1I6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA6QE/3-$ M)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q M,'!T.R!F;VYT+7=E:6=H=#H@8F]L9#L@9&ES<&QA>3H@:6YL:6YE.R<^36%R M8V@@,S$L(#(P,30\+V9O;G0^/"]D:78^/"]T9#X\=&0@86QI9VX],T1L969T M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X M.R<^/&9O;G0@F4Z(#$P<'0[(&1I6QE/3-$)W!A9&1I;F3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M+6-O;&]R M.B!B;&%C:SL@8F]R9&5R+6)O='1O;2UW:61T:#H@,G!X.R!B;W)D97(M8F]T M=&]M+7-T>6QE.B!S;VQI9#LG(&-O;'-P86X],T0R/CQD:78@86QI9VX],T1C M96YT97(@F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R!D:7-P;&%Y.B!I M;FQI;F4[)SY-87)C:"`S,2PR,#$S/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&%L M:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM M97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI M;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X\+W1R/CQT3H@8FQO8VL[)SX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I M;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL M:6YE.R<^17AP96-T960@9&EV:61E;F0@>6EE;&0\+V9O;G0^/"]D:78^/"]T M9#X\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N M)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\ M+V9O;G0^/"]T9#X\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@ M;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[ M)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@86QI9VX],T1R:6=H="!W:61T:#TS M1#DE('9A;&EG;CTS1&)O='1O;3X\9&EV(&%L:6=N/3-$F4Z(#$P M<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O M;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXE/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A M;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I M;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL M:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!W:61T M:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+69A M;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$ M6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@ M9F]N="US:7IE.B`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`X/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!W M:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9&EV(&%L:6=N/3-$;&5F="!S M='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!M87)G:6XM3H@8FQO8VL[)SX\9F]N="!S='EL M93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^)3PO9F]N=#X\+V1I=CX\+W1D M/CPO='(^/'1R(&)G8V]L;W(],T0C8V-E969F/CQT9"!A;&EG;CTS1&QE9G0@ M=VED=&@],T0W-B4@=F%L:6=N/3-$8F]T=&]M/CQD:78@86QI9VX],T1L969T M('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US M:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SY2:7-K+69R964@:6YT97)E M3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D(&%L:6=N M/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL M93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^ M/'1D(&%L:6=N/3-$6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[ M(&UA6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@ M;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[ M)SXQ+C6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US M:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXE/"]F;VYT/CPO9&EV/CPO M=&0^/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O M;3X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA M;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q-C`[ M/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG M;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S M(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE M.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA6QE/3-$ M)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q M,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXN,30F(S@R,3$[,BXV,#PO9F]N=#X\ M+V1I=CX\+W1D/CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX] M,T1B;W1T;VT^/&1I=B!A;&EG;CTS1&QE9G0@F4Z(#$P<'0[(&1IF4Z(#$P<'0[(&1I3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D(&%L M:6=N/3-$3H@8FQO M8VL[)SX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R M;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^-"XQ M+3@N."!Y96%R6QE/3-$)V9O;G0M9F%M:6QY.B`G M=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I M;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@86QI9VX],T1L969T('9A M;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I M;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL M:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$3H@8FQO8VL[)SX\9F]N="!S='EL M93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^+CDM.2XX('EE87)S/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@F4Z(#$P<'0[(&1I2!O9B!S=&%T=7,@;V8@0V]M<&%N>2=S('=A'0^)SQD:78@86QI M9VX],T1L969T('-T>6QE/3-$)V9O;G0Z(#$S<'@O;F]R;6%L("=T:6UE'0M:6YD96YT.B`P<'@[(&QE='1E'0M#LG/CQF;VYT M('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N M="US:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^ M/"]T9#X\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W!A9&1I;F3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^ M/'1D('=I9'1H/3-$,3`E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D M97(M8F]T=&]M+6-O;&]R.B!B;&%C:SL@8F]R9&5R+6)O='1O;2UW:61T:#H@ M,G!X.R!B;W)D97(M8F]T=&]M+7-T>6QE.B!S;VQI9#LG(&-O;'-P86X],T0R M/CQD:78@86QI9VX],T1C96YT97(@F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B M;VQD.R!D:7-P;&%Y.B!I;FQI;F4[)SY.=6UB97(@;V8@4VAA#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G M=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I M;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@86QI9VX],T1L969T('=I M9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F3H@)W1I;65S M(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE M.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D('=I9'1H/3-$,3`E('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M+6-O;&]R.B!B;&%C:SL@ M8F]R9&5R+6)O='1O;2UW:61T:#H@,G!X.R!B;W)D97(M8F]T=&]M+7-T>6QE M.B!S;VQI9#LG(&-O;'-P86X],T0R/CQD:78@86QI9VX],T1C96YT97(@F4Z M(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R!D:7-P;&%Y.B!I;FQI;F4[)SY7 M96EG:'1E9"!!=F5R86=E/"]F;VYT/CPO9&EV/CQD:78@86QI9VX],T1C96YT M97(@F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R!D:7-P;&%Y.B!I;FQI M;F4[)SY%>&5R8VES92!0#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P M;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@=VED=&@],T0Q M,"4@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O3H@8FQO8VL[)SX\9F]N="!S='EL93TS M1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0MF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R!D:7-P M;&%Y.B!I;FQI;F4[)SY#;VYTF4Z M(#$P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[ M(&UA6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@ M;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!F;VYT+7=E:6=H=#H@8F]L M9#L@9&ES<&QA>3H@:6YL:6YE.R<^06=GF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD M.R!D:7-P;&%Y.B!I;FQI;F4[)SY);G1R:6YS:6,@5F%L=64\+V9O;G0^/"]D M:78^/"]T9#X\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W!A9&1I;FF4Z(#$P<'0[(&1I6QE M/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE M.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X\ M=&0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4Z(#$P M<'0[(&1I3H@8FQO M8VL[)SX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R M;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^-RPV M-S$L,C8W/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!W:61T M:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+69A M;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$ MF4Z M(#$P<'0[(&1IF4Z(#$P<'0[(&1IF4Z(#$P<'0[ M(&1IF4Z(#$P<'0[ M(&1I6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US M:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T M9#X\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N M)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\ M+V9O;G0^/"]T9#X\=&0@86QI9VX],T1L969T('=I9'1H/3-$,3`E('9A;&EG M;CTS1&)O='1O;2!C;VQS<&%N/3-$,CX\9F]N="!S='EL93TS1"=F;VYT+69A M;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$ M;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS M1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T M6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA6QE/3-$ M)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q M,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SY787)R86YTF4Z(#$P<'0[(&1I MF4Z M(#$P<'0[(&1I3H@ M8FQO8VL[)SX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE M=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^ M,3$L.#8R+#`P,#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!W:61T:#TS1#$E('9A M;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I M;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL M:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q-C`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`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y M.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@86QI9VX],T1L969T M('=I9'1H/3-$,3`E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F M;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D(&%L M:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S M='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M M3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO M=&0^/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$P)2!V86QI9VX],T1B;W1T M;VT@8V]LF4Z(#$P<'0[(&1IF4Z(#$P<'0[(&1I M6QE/3-$)W!A9&1I;F3H@8FQO8VL[)SX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S M(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE M.R<^5V%RF4Z(#$P<'0[(&1I6QE/3-$)V9O;G0M9F%M:6QY M.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y M.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@86QI9VX],T1R:6=H M="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M M8F]T=&]M+6-O;&]R.B!B;&%C:SL@8F]R9&5R+6)O='1O;2UW:61T:#H@,G!X M.R!B;W)D97(M8F]T=&]M+7-T>6QE.B!S;VQI9#LG/CQD:78@86QI9VX],T1R M:6=H="!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!M87)G:6XM3H@8FQO8VL[)SX\9F]N M="!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O M;G0M3H@:6YL:6YE.R<^*#8P,"PP,#`I/"]F M;VYT/CPO9&EV/CPO=&0^/'1D('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W!A9&1I;F3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D M('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F3H@)W1I M;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL M:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D('=I9'1H/3-$,24@=F%L:6=N M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@ M;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[ M)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@86QI9VX],T1R:6=H="!W:61T:#TS M1#DE('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@ M,G!X.R<^/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)W1E>'0M:6YD96YT M.B`P<'0[(&UA6QE/3-$)V9O;G0M9F%M:6QY.B`G M=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I M;FQI;F4[)SXN,C4\+V9O;G0^/"]D:78^/"]T9#X\=&0@=VED=&@],T0Q)2!V M86QI9VX],T1B;W1T;VT@#LG M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N M)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\ M+V9O;G0^/"]T9#X\=&0@=VED=&@],T0Q,"4@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W!A9&1I;F3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D('=I M9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F3H@)W1I;65S M(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE M.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D('=I9'1H/3-$,3`E('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<@8V]LF4Z(#$P<'0[(&1IF4Z M(#$P<'0[(&1IF4Z(#$P<'0[(&1IF4Z(#$P<'0[(&1I6QE.B!D;W5B;&4[)SX\9F]N M="!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O M;G0M3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT M/CPO=&0^/'1D(&%L:6=N/3-$6QE/3-$)W1E>'0M:6YD M96YT.B`P<'0[(&UA6QE/3-$)V9O;G0M9F%M:6QY M.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y M.B!I;FQI;F4[)SXQ."PY,S,L,C8W/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&%L M:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=P861D:6YG+6)O='1O;3H@-'!X.R<^/&9O;G0@F4Z(#$P<'0[(&1I M6QE/3-$)W!A M9&1I;F3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$;&5F M="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9&EV(&%L:6=N/3-$;&5F M="!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!M87)G:6XM3H@8FQO8VL[)SX\9F]N="!S M='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M M3H@:6YL:6YE.R<^)#PO9F]N=#X\+V1I=CX\ M+W1D/CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W!A9&1I;FF4Z(#$P<'0[(&1IF4Z(#$P M<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US M:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXU+C,@>65AF4Z(#$P<'0[(&1IF4Z(#$P<'0[(&1I6QE/3-$)W1E>'0M M:6YD96YT.B`P<'0[(&UA6QE/3-$)V9O;G0M9F%M M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P M;&%Y.B!I;FQI;F4[)SXP/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&%L:6=N/3-$ M;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D M:6YG+6)O='1O;3H@-'!X.R<^/&9O;G0@3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T#LG/CQD M:78@86QI9VX],T1L969T('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA M6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W M(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SY% M>&5R8VES86)L92!A="!-87)C:"`S,2PR,#$T/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D(&%L:6=N/3-$#LG/CQF;VYT('-T>6QE/3-$ M)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q M,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@ M=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@F4Z(#$P M<'0[(&1I6QE M/3-$)V)O3H@ M8FQO8VL[)SX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE M=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^ M,3@L,3,Y+#(U,#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!A;&EG;CTS1&QE9G0@ M=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM M97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI M;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@86QI9VX],T1R:6=H="!W:61T M:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O M;3H@-'!X.R<^/&9O;G0@F4Z(#$P<'0[(&1IF4Z(#$P<'0[ M(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA6QE M/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE M.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXN-S8\+V9O;G0^/"]D:78^/"]T M9#X\=&0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY M.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y M.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@86QI9VX],T1R:6=H M="!W:61T:#TS1#$P)2!V86QI9VX],T1B;W1T;VT@#LG/CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=T M97AT+6EN9&5N=#H@,'!T.R!M87)G:6XM3H@8FQO8VL[)SX\9F]N="!S='EL93TS1"=F;VYT M+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE.R<^-2XV('EE87)S/"]F;VYT/CPO9&EV/CPO=&0^ M/'1D(&%L:6=N/3-$#LG/CQF;VYT('-T>6QE/3-$ M)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q M,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@ M86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQD:78@ M86QI9VX],T1L969T('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O M;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXD/"]F M;VYT/CPO9&EV/CPO=&0^/'1D(&%L:6=N/3-$#LG M/CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T M.R!M87)G:6XM3H@8FQO8VL[)SX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S M(&YE=R!R;VUA;B<[(&9O;G0M3H@:6YL:6YE M.R<^,#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!A;&EG;CTS1&QE9G0@=VED=&@] M,T0Q)2!V86QI9VX],T1B;W1T;VT@#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W M(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!D:7-P;&%Y.B!I;FQI;F4[)SXF M(S$V,#L\+V9O;G0^/"]T9#X\+W1R/CPO=&%B;&4^/"]D:78^/&1I=CXF(S$V M,#L\+V1I=CX\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO2!O9B!W96EG:'1E9"UA=F5R86=E(&%S6QE/3-$)W=I9'1H.B`Q,#`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`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`P<'0[(&1I6QE/3-$)V1IF4Z(#$P<'0[)SXQ+C3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O M;G0M3H@8FQO8VL[(&UA3H@8FQO8VL[(&UA3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M65A6QE/3-$)V1IF4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!A;&EG M;CTS1')I9VAT('=I9'1H/3-$,3`E('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N M/3-$,CX-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=T97AT+6EN9&5N M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R M9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI M;F4[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE M.B`Q,'!T.R<^+C@@>65A3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)V1IF4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@8F=C M;VQO3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA M;B<[(&9O;G0M6QE/3-$)V1IF4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T M9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T M;VT^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=T97AT+6EN9&5N=#H@ M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN M+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[ M(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q M,'!T.R<^)#PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1R:6=H M="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1R M:6=H="!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C M:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N M="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B`G=&EM M97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R<^,3@U+#0P,#PO9F]N M=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@ M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V1IF4Z M(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CPO='(^#0H\+W1A8FQE/@T* M/"]D:78^#0H\9&EV/B8C,38P.SPO9&EV/CQS<&%N/CPO2!O9B!D97)I=F%T M:79E(&QI86)I;&ET:65S(&9A:7(@=F%L=64@;65AF4Z(#$S<'@[ M(&9O;G0M'0M:6YD96YT M.B`P<'@[('1E>'0M=')A;G-F;W)M.B!N;VYE.R!W:&ET92US<&%C93H@;F]R M;6%L.R!W:61O=W,Z(&%U=&\[('=O'0M6QE.B!S;VQI9#LG(&-O;'-P86X],T0Q,#X\9&EV M(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I M6QE/3-$)V1IF4Z(#$P<'0[(&9O M;G0M=V5I9VAT.B!B;VQD.R<^1F%I6QE/3-$)W!A9&1I;F#LG/CQF M;VYT('-T>6QE/3-$)V1IF4Z(#$P<'0[)SXF(S$V,#L\+V9O M;G0^/"]T9#X\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[ M(&9O;G0M6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1IF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD M.R<^5&]T86P\+V9O;G0^/"]D:78^/&1I=B!A;&EG;CTS1&-E;G1E3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA M;B<[(&9O;G0M6QE/3-$ M)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I MF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^36%R8V@@ M,S$L(#(P,30L/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!V M86QI9VX],T1B;W1T;VT@#LG M/CQF;VYT('-T>6QE/3-$)V1IF4Z(#$P<'0[)SXF(S$V,#L\ M+V9O;G0^/"]T9#X\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA M;B<[(&9O;G0M6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1IF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B M;VQD.R<^475O=&5D/"]F;VYT/CPO9&EV/CQD:78@86QI9VX],T1C96YT97(@ M3H@8FQO8VL[(&UA M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE M=R!R;VUA;B<[(&9O;G0MF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^;6%R M:V5T6QE/3-$ M)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I MF4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^*$QE=F5L M(#$I/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!V86QI9VX] M,T1B;W1T;VT@#LG/CQF;VYT M('-T>6QE/3-$)V1IF4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^ M/"]T9#X\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=P861D:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O M;G0M6QE/3-$)W1E>'0M:6YD96YT.B`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`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q M,'!T.R<^)B,Q-C`[/"]F;VYT/CPO=&0^/'1D(&%L:6=N/3-$;&5F="!W:61T M:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9&EV(&%L:6=N/3-$;&5F="!S='EL M93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN M+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS M1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O M;6%N)SL@9F]N="US:7IE.B`Q,'!T.R<^)#PO9F]N=#X\+V1I=CX\+W1D/CQT M9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/CQD M:78@86QI9VX],T1R:6=H="!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT M.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R<^ M+3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q M)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&9O;G0M6QE/3-$)V1I MF4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@86QI M9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQD:78@86QI M9VX],T1L969T('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1IF4Z(#$P<'0[)SXD/"]F;VYT M/CPO9&EV/CPO=&0^/'1D(&%L:6=N/3-$6QE/3-$)W1E>'0M M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1IF4Z(#$P<'0[)SXS+#DQ-RPW,C(\+V9O;G0^/"]D:78^/"]T9#X\=&0@ M86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT M('-T>6QE/3-$)V1IF4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^ M/"]T9#X\+W1R/CPO=&%B;&4^/"]D:78^/&1I=CXF(S$V,#L\+V1I=CX\6QE.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R M;6%L.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!L971T97(M#L@ M+7=E8FMI="UT97AT+7-T6QE M/3-$)W=I9'1H.B`Q,#`E.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA M;B<[(&9O;G0M6QE/3-$)W1E>'0M:6YD96YT.B`P M<'0[(&1I6QE/3-$)V1IF4Z(#$P M<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^665A6QE/3-$)W1E>'0M:6YD96YT.B`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`P M<'0[(&1I6QE/3-$)V1IF4Z(#$P M<'0[)SXD/"]F;VYT/CPO9&EV/CPO=&0^/'1D(&%L:6=N/3-$#L@8F]R M9&5R+6)O='1O;2US='EL93H@9&]U8FQE.R<^/&1I=B!A;&EG;CTS1')I9VAT M('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1IF4Z(#$P<'0[)SXS+#DQ-RPW,C(\+V9O;G0^ M/"]D:78^/"]T9#X\=&0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@#LG/CQF;VYT('-T>6QE/3-$)V1I MF4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X\+W1R/CPO M=&%B;&4^/"]D:78^/&1I=CXF(S$V,#L\+V1I=CX\'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA2!O9B!3:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S("A$971A:6QS M*2`H55-$("0I/&)R/CPO'1U M86PI/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M)SQS<&%N/CPO2P@'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'1U86PI/"]S=')O;F<^/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'1U86PI/"]S=')O;F<^/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2!O9B!A;FYU86P@;6%T=7)I=&EE7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`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`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA2`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`@("`@("`\=&0@ M8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'!E M8W1E9"!L:69E(&]F(&]P=&EO;G,L(&UI;FEM=6T@*%EE87)S*3PO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^)S$@;6]N=&@@,C$@9&%Y'!E8W1E9"!L:69E(&]F(&]P=&EO;G,L(&UA>&EM M=6T@*%EE87)S*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SD@ M>65A7,\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2=S(&%G M9W)E9V%T92!S=&]C:R!O<'1I;VYS(&=R86YT960\+W-T&5R8VES92!0&5R8VES92!0&5R8VES92!07,\7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@ M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M M;#L@8VAA3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]E83,U M-#9D-5]B9F0R7S0T93%?8C,Q9%\U-38R-69F,C$Q-S4-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO96$S-30V9#5?8F9D,E\T-&4Q7V(S,61?-34V M,C5F9C(Q,3'0O:'1M;#L@8VAA'1U86PI("A54T0@)"D\8G(^/"]S=')O;F<^ M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L'1U86PI/"]S=')O M;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'!E;G-E'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO2!);F-E;G1I=F4@ M4&QA;B!P'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)TYO(&QE'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'!E;G-E2!C;VUP86YY/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'!E M8W1E9"!T;R!V97-T(&EN(&9U='5R93PO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO&5R8VES M92!0'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%]E83,U-#9D-5]B9F0R7S0T93%?8C,Q9%\U-38R-69F M,C$Q-S4-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO96$S-30V9#5? M8F9D,E\T-&4Q7V(S,61?-34V,C5F9C(Q,3'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M'!E8W1E9"!D:79I9&5N9"!Y:65L9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S M3PO=&0^#0H@("`@("`@(#QT9"!C;&%S&EM=6T\+W1D/@T*("`@ M("`@("`\=&0@8VQA&EM=6T\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)S$P(&UO;G1H'!E8W1E9"!L:69E(&]F('=A'0^)SD@>65A7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA&5R M8VES92!0&5R8VES86)L93PO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^)S4@>65A7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA'1U86PI M("A54T0@)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S M/3-$=&@@8V]L'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO&5R8VES92!P'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'1U86PI/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO65A'0^)U9E3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]E M83,U-#9D-5]B9F0R7S0T93%?8C,Q9%\U-38R-69F,C$Q-S4-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO96$S-30V9#5?8F9D,E\T-&4Q7V(S,61? M-34V,C5F9C(Q,3'0O:'1M;#L@8VAA2!O9B!W96EG M:'1E9"UA=F5R86=E(&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'!E8W1E9"!D:79I9&5N9"!Y:65L9#PO=&0^#0H@("`@ M("`@(#QT9"!C;&%S3PO=&0^#0H@("`@("`@(#QT9"!C;&%S&EM M=6T\+W1D/@T*("`@("`@("`\=&0@8VQA'!E8W1E9"!L:69E(&]F('=A'0^)SD@;6]N=&AS(#$X M(&1A>7,\'0^)SQS<&%N/CPO'0^)S4@>65A7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`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`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA MF5D(&=A:6XO*&QO3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%]E83,U-#9D-5]B9F0R7S0T93%?8C,Q9%\U-38R-69F M,C$Q-S4-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO96$S-30V9#5? M8F9D,E\T-&4Q7V(S,61?-34V,C5F9C(Q,3'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M'0^)SQS<&%N/CPO'1087)T7V5A,S4T-F0U7V)F9#)?-#1E,5]B,S%D7S4U-C(U9F8R,3$W %-2TM#0H` ` end ZIP 19 0001213900-14-003276-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-14-003276-xbrl.zip M4$L#!!0````(`-`PKT1@S72_D8,``/3?!@`1`!P`87-P=RTR,#$T,#,S,2YX M;6Q55`D``ZB1=%.HD713=7@+``$$)0X```0Y`0``[%U[;^.VEO^_0+^#-@L4 MN\`XUON1>5QD\IBZ=V:2FZ2W+787`T6B$]Z1)9>2DK@+[&??0TJV)5NR*)M* MG,3%="8119[?>?#PD#RDWOWM811(=XC$.`K?[RG[\IZ$0B_R<7CS?N_7J].> MO2?][<.//[S[MUY/^H1"1-P$^5(:PPO2R5^]WS]>?)[6EZQ]>5_;UZ3_DHV^ M8O156=$EV3C0G`-#E0Z__(_4ZTV;^NC&T`S480VH^TI6!J4/UR3`!_1O";"% M\8$;C^_?[]TFR?B@W[^_O]]W"8X3=QS=([+O12-&1]8T9>_''_(J`0Z_EZK0 MYO8C<@/OREJ?%E\#@#U)FE6A;_AX5JE8P>QGA:77ETC<:^Q]Q7&A<:7_^Y?/E]XM&KD]'`)?H0>X2K#P"E;F5>9U2"6M]62E![(N5DT)`:.IJYN7TLKJIZ4%!#ST=C M@CQJA[4L.GV7>"0*4'_H>DD//8P#-W23B$Q.X?=B8^C!NZT&0$MJ$.#P#L5) M=;6LK*9BZ&(OKJ['BF@UI:(:2E:PROB$5THUHC!,1]65_(3TD\D8ZD1A#]Y" M!'NENLT5ERL1-*R%:/:AM/ARC+UJ(4!!C0CB9$QJZD!)3:4T[MVX[GA6;^C& MUPQ47E"CI;RTYR9)?54H)/@Z35"\4)5***ZLQTKJ:"9DA8JA=,$I^$FEKS(R M7Y64?=4*5_#[YZFKHJZ9^JV#F'FC"S24F!\[R+O2:F_7'Y-HC$B"@<.Y?\T: MH'R_WXOQ:!S,GMTR@Z&^O3?UW_L/L;\G]:=#Q%$4)N@AD2Z1E]#1)1\]LO'! MRPLQ^(#\Q6]':9Q$HV^:TOOB$MJJ\@W$?#C.?SY&0P2NR#^*1F,4QBYM])`0 M-[Q!(Q0FO^'D=A#Z^`[[J1M8,QNJ'(I@]\(`E^#GLXR;!(/H;R;&3/K?:@&R'L?9BU7Y+&NWXE,(JX MO\1#OUIL8%0X\@M<)RY)CL'[PZ.LUVO0E0HM%LIGFO!+%73H?D6"T]+IDSG) M?LG:5IO?8?SM;/B-FM\Q\IC)/8XQ<,HMBQ22J1!@+"Y*;5XJ1`@@XDLTID)0 MMU<($(TX8`SBA9`[(G`^4R%LK4`6>E,FDA:]:4F&HGN3O)UR6S8D3>ZL-T&\ M\#6ZVWHA4*^B=28$=>97MUL(:D_MP*_F+D6Q9T+86H$LN13ZQV[C4A9D*,JE MG/YQ4AR>MUQJLM+2$2^,Z)V%-=LEM^7NUV%84Q#"M\L$I$MCUY,_4T!(`^HH MI#$RFQ7`KZ,HO$PB[_OSF!BL9&<>WR_QU46(OZ4Z/?1]3.=+;G#N8G\0'KEC MG+C!B]+O2AY?D:XO4.+B$/DG+@EQ>!._*"57,_=\M:M]R0;V?-E'VZH!:F%@ MU]H.[-KB`H>H@7U1:KL%LA>Y0+;%!G=X[Q+_:C)&S$Y^-@I=ZY<%C&>C6EO>M8*7N)CI^1*)3^3@*E9RQT&1\]'S MC9UL.+YST^$7X=X'NEE^L"C(5V6=\VG\5D[U2K/=)2&(7\O8!=*"5B8>4U>[ ML?29:S)?0=QJU_-8RZC:;AODT0Q[6W2ZVP9Y/;K>;8,\;^WN`L/GJJO=6MIS MU-H%@D`8>S!O?T8Q3XWB*GEY4;I;/?:=DWPK\!FIDG/DJV+M^6IV8?;?]_R*W_[?8X'9+!SLCV*TU//Y:PTLQCMWBQ"LSA]UJ MQJM1[BY?['4I^9DX[VW*%]MB->_VN%^MZG?Y8J\^7^S96.=NM?Y%*WNWO+\S MA6F_OR&("2Z+.Y&7$DROJCI/B7?KQFA6OMUVP#QZB9?N5Q@I7LI8.7-$=?P7 MXZ4J06PR7=L-U-UL"8=W](K1ZP!5A;@OSG)Y-Y172F5GQB\FE>;H%J/AV9C> MP0Y#XMEPB#VTRZO).D&]:%ZW*6[D4;?=JCKWD"_/0)9.)&Y7NF0I8W1)")T= MR]PEHSU6%O#VZ'276_9Z=+U+%7O>VMUE?CU773W#Y?&M.R\%$WN MK^YV*0LO5;,O9&UZNU:$GTR;IRXF_W2#%'V@5>PNM-\)@[U]6A>W6F^*`[M]6A>>X&:W^VA M/,D>RN/J6YY^*31+F4%_IE0F=_#7?"VC_/R9Z+>:F<+"1A57CZ%/O9-OYLT_ MOCC3YTZWG>MV>;]3;[O?638'P?N=L@'N?++]^YT&_%FW3]"/)O\:XJ4O)M/G M/_XP^#_EOT__>?XS>D#'AFG9?UR@/_&'P>UW='?R'9.'>\OT=%WW#,/PKO[W M]L/)R:DS^/364DSCT\^*_;S47/X-^P,H:]_:-Y#C-Y9F M,FN7Y96@#X67OZ8CFD\2D35)+]6G#X]1&(UP6-4LKX!*3?3+Z%=S/DX+#)?) MTJ(F.5)#.@E8L%"RL7<^P@_ZZYH."=1Q MI?/H'I$WTB#T]M_UZYJD..9E1P"%N,$@]-'#W]&$DUZQ[]:V-25T".SZE.73 MP+WA)#!T@QAE;9>J3]L\2B%\@D,U?4#OD\D"NW7VIKD="O$93-=@9/%I4U40*D9-B7H!]E+NWR4?>1B`Q>_W!E]/P6H< M1[--1R_UJ16$*<39[,*-;UB*;JX! M"Z:48Q?[)P\T.10=AOY9B)$X5B MJ9JI+BAC)56A&/EK+JH!Q9>?S8-3^%$7^/0X"(49E M:+)1[.#-9`7#Y#-`W9;5]6&>DPAFF\GD'&2>@/>FZZQC&B@*P6^#(EK#I"#^.8BQT'%<<62X$$C64-@?#YUAEVV@'YF0T#J()0OEE M1Y^Q>XT#EG4B4D:Z69K$-!(5B9!+<(YM*LZ:`*=AXP6"<#H5Z89,35,*3JB: MT,90N`1D*JIBM8&RX*1FDRS/(VEW=B;+EE[K*!LQ=(B?S].+Q=^=H&$F*2OE MX;$[1'QS6T/1%),3499SE[\1Q3&E25Q/Y$AIP+A`HY<&4INCX9SY&YKI<*%9 M3OKNJ*]J:G'<7$5.$"PN2:T!Z7,4WEPA,CI&UR(M"&)0NQ#^5E#9#`2?1U(4 M1^,'T8FE:*KI*,6PID$=G=B%)IN6XMC<(`J"$KQ88BJF4ZV1ZK6'M:!P#E<0 M%;2!4MFCQ(K',E7-,1LZ<1?H^*S(42S+4M>"UYW(+-LH1N>=(.$4CZ9JY7D= M/Q0A<8VL6Y92+8OUR/(%UX[C&"5G7TVVG"?($D5%<%W>OUFDL!D`/KUS`RAL M?PIC7S,:LF:#C')'%LS8:$PN20(,"W;="QG79C, M!F^CP$FH.:NYK6&U` MFF4JEJ%TC;VANRFF::N:W#D*H6:[,*@\#>0-S'9I.'@:#M8RVR7W_#38*\^N M<,9A@A'S#1B:8\FRTST*L1VM'#X]#>0-.MI2G/,T'*S7T2S'+@483X.]=4?C MCB<*\[##T.]F?%O:56\B*A#@>COQ;0`>!D%T[X8>.HW(<91>)\,T6,YA%+A: M6'!?K6AW!;KMJO/:H,N]($L./DR3VXC@OY#?7K0U2ED$,>I M&$M=M:A5I"4$$9=ELBSD)J/D`\5YU$"%R/8_?$*K@8>_3Q'G&=HU>4@+QR-:]A[EFU3+ZX)E0EL2+OI M@)AC%T\:K:!-SV^<#6GF>'P)\Q(!?#N6JA7/II4);$B[@6_'5E63B_8G$L7Q M.8F&-1L(K7CNV;917)8H-+X!S885*-,N';*HH7F!8D1OT(')YS&](2=B:>_Y M:2X!VE9-0RMD>JPD)Q17PY:8:A13,+EA7:(@H"1G7T>:&PW&F;)H%LULBL3'] M!J'HMEPZA<5%?Q!ZT0C17$(!+H2GS26AJKJM%KI2!1$!&)I2_U1--[@Q_!H2Y`9T(O')Q2&5TEDXSVX2 M8!T6S8Z>PVF@)QA:@\THJF(:ZX&;6U7VI;X03"VE7]S)S(Y^B1H-(X*R]Z[< M!_II/W!,$8%PSR6308)&+#D*:I*(^;&II@3T2$615=.RBE;0&=PMDDJ#NBU# MULL'J1]1*%`][X(?8;P2$^N5UEAJR`A"TM23;,MH!05B?Z%C$%B\IA0MOD1@ M(\J-5J6JQ5L*!!+N8/./&^W2]T;=&'LT:*5?'*U98%BMLNIE&15`R?MR\137 M:LJ"07*M'>4@];5`_H;PS2T\.[P#MW*#OJ942V=#5JVP!+"A@*M786$4,&VG MT#77`_,X[#0O*MOL1(PLDIUC-"9`@_E[^#E`[(M\,)<8T1N&_F+/!4Q.;44O MG5%I)MH%R(;049.+6=QM0G:BF(P9)P_EEV3'T-D#H MTBC=%)Y^;3?T\\]MQ*<1N43D#GLH/B-'@8M'(F)M32O&?&V(=XJZ:<8BR^8& ML+/3<06C/!OF-P45*@*R.`V2NA7>5H#!!QG:]%0>-]T95,96MFA^G!(HF5Z1 M-N,.>+ZH2U%HN?(KZW2T;T>W&Z2-J13M0AY.F M>YM*Y^VZ8&0Y.TO`-%0S#;N8PLQ#M@N836=,5,VR99$PIY?2U1VM:R=&75.* MD]25Y(3BXO<*ZT-:O-Y%Q.Q"+P;NS23%`VSHSJ7[;3;%MW"+B1![,Y65]K9` M4CB^IOXJ.ROUVPI>S64DFXMQI8IKJ'8&M4FBFJ5JPO$NW_S2A9Q[IJ.OM@<> M'(_#29,:=-NQ39<'MUW?CVG$3T(GC_X^17F)^#.J?;@8=>@N]$*4*%P;XX MW/,3[PYR@\1U52E%X>M!AM<]A'RV<3*?L)?3/$%5V0,$A>R)4!>S'H3'8:+I M7N.E3/Q6=',# MF#4#SRD.P5`%#]2FI6A6XYA70;H[P$U;,8YE%_<:UH-,J\#`0?^AWN;.#:A2 MLB75Q5!+A.&J,B4E%E33M-Y02E]6 MX(=62"]01/@MRY$7;R7)6]^$*O>TM8Y@>?M_-DE@7TAB:7!9+H```\DF]76) M!_64NT++?V''&D!IKC=$!6?DW"5)_LNA!S%"S-9L\B=Y6VYP1K(EGKE'I-E` M,'W+LLNG]KFF.59F2*J&:1?5T2GBK1)-8_+H4TAES=//FUS%6'<<6=5ETRS. MQE:?05[SV'8'P)>.>3\%\(:[JFJPRQV!%G`C&_>I]:<`OIZTRU>.K,9=G67( M9G9LX[>#39Y&FN(!=K;7H.@._+=X?]]6,;?Q[7(;=\[F@>@\<+WL`^FBITCBH#T5M]UM`78I*9[.\17= MLY(N)GE<=+L!*O9F;$/A'!6>EJM-=J(-7;4[4%WFJ1Y-=[6AM&'PC.P+:`7Q MEZ5*?I.5WN$XYU"3YS]?IMU:9[K,U MP3$[:GWR@(B'8Q')^XO'M-HBZ!Y^9UWO$5C/=-T9[VMT2-5H8:2-;'],8YJR M$!^CV"-XG!]ZI"=(8[82&P-4-N^_`NX^!MRKP!]^"I*W/KZ3W`#?A._WZ-B, MAY,]*4XF`7J_1VOU<.A#\P>2/$[>2CZ.QX$[.9"N*96WTL@E-SCL!6@X?2-_ M0N@AV.S1WD\WR5M*:0@XIDW/&L)A`+R]E6AA;^B.<``/$SP"7Q.B>XE$(S?, M2V/\%SJ0%$:&/;A'&97K*/`S,E^C!$F*]),[&K_]=UM5E+=206A2-)2FLI1@ M"B9=IB/`.Z'/+T$">(@]B#>D/,&33A[/HP![&,44?Y\2G3+3![E-?Z8BY!59 M)@V&3S'ERJ9>C#9J1+^3Y0I9LC8/"8X3%XSO'I$WTB#T]J7_@,G0S*Y5^2WU M46XXF3U1WOZG=._&0-6+R#@B]-Y(">3^A=[L)6GR&TF5906*)=H04`Z#]!6I_C>Z8#Z3-V9)WZX8W0(@> MR0C=$9*22/H-Y'H%/Q/I*$<"K>Q#(X!E(M%U\: M18#5];R4LAI,))B-!LB#-FC;UR1R0;FT!P.3!6HSSV"]C4'V7AI+UV@2`6_T MI1GTW*@L_2TT13FG_X.Q@*_`(>!S::Z-=`_SDER@*!,:!$+TT#][?4S!@]6$ M\(!-Q*!Q,$-Z&F=_UP6:NL!5P4(P>&L88=G5=-0>0`7H!M0>P<]4TG$Z'@<8 MA`VZ]E@PVO-1#%RC"BW$DYA>DI/5=&=UWTAY%9);.MA?$&1MQE'@DIF*L_K[ M!:'/?KJJ,;0QF"CP.$;9BB0S:]HYC]&(X6=-2M#=Z$U/M`^/4S#D(DK#6&[@T88^B_D88I"B0/!0$P>,-NH0,IYN36HCR<+P=T?X M/^CU\9QC1P!&7+OMG8EHW_;QGO'8Q_;,Q'Z:$*AHM!82JY*ZS?[Z-S.K2CQRB(.`O2^$^3 M"JA@OCQ)V#5'1*3/D\-K,$SB8K+Q+*6-_/WJZG-&%4&F13$=.(L4L(X'GR]$ZQ-D/@((7^)0').D$0F# M]_`SP$G[_PK%[!5M"7;@KDB56!FV;WA^*(4BX,]UU;V??F7`P+Q#M$Q6!D), M4"*F71;BG>U%`&,!:A&?L8VE[^ZM)/Q!4(Z_=#RI^B?W;XL.QTK\P,:S*8:N M.5&D[[EDC7EX9D)`!PPSMO#+U$//`0:X!3G>/GB(EC&SG"!S3HH`X".X0HER M_;B+7HI7),W$]+X7[Q62:5RP%L.`H.([PGG`6!LN3"#_)7D"X&Y#&*2V;J*V M;@Y0S22Z5IN%,T`M$K@/T]KR.P2^F<`E^6,)-RC""2_S*=BC&%&\"E`AH)A% M+I([G\)65LP*RE0:SHKE#9_[D6OC.T$;M@N5"GI-T;.D1*0Q#=N4[D5J(*=. M(VT(Q%+A?V-$IJ"7&'P+J"+[1"*QK_EUG[O[(POG0)4H[N/[0B-RY[O[#O]_%[PE5Q8?%T+AQ^(NP&MOHI2U1#_0G+,/Y_S. M23"_XVC?A-IS6(UKEHF)@-@KI%AQP:`ZA\9AS"1*K>-I*Q_NPH7U'6Y#=0SB MQN$\6BREEHF&J36;P64I;]&E'^"]:2U$:B?R@N@=A(^ZJ28#^#=L?.KZ'!UF MZ'7PB6/PS67/B+?8TN^V\6(L`R<0O33$CYCJUVY'PN:.'R+5GJ[Z$NTY1(97 M6L.4+G';P3QXX7(`R<]3F--B8!\Q@+4Z=$[TCU35CL;F-GD`:MY6*\Q81L$2 MR)3G?,DR"Y:3E0$*:A"V0?==M(PY``[:L^O`2>!]>\.4_4&"Q(>-P2M=V&<( M_$0L2VP*BKI!BCJIS2Y&CH2>/54'3/]@R0%O\PSF[NS2=5#>32SONV&+%D3J M9H8MW\X=,!-0I!!"%]8*Q`'6&Q@S9DL['M:/4+5P'1"7::",-"P3YCKLAO0$ M=+.BL0&"Q4<[!]W<\`N>"HQ-1:$V*"`4,+"D$"%1"3_U?*\-@H<,;M1C)JN< MG$,SWPE%6&&[6+D'ZCT5[GG\:+,T4BUKC*1YFI9#6Z-P"FE!TN@N8%(*\?AB MMB,F[LVI;!G&E?&JNO+C'1L(M7`B8Z`M5+B!R:*ECRZ(&]^9)G=]"T"+F_E<9` MB)YTE)X`,>W'8THL;($*Y0(+;EBQ_D&2->_I\`I,=R';MR`@61C#GT^[6EW9 M1UU1K0)7&GO;O9L2589T7')TI"^$=PXH&^P8JEG,_]&]\%[2#:<:__OF/C'<]$\,$3B4=R58VABM>,J/X&6HM`-MW$"@H M$8I9,JT13$5F%P4B+8R-3DEDV&!A@:4D8FGR#Q&?@SA]#HV]%4>#(M"M[1JVEWI7`[\7%818)%GA$C7U9@W:*"![:1 MY2H!3K:3;SSM#T8M)8EN_>`[4&![B563R&[4)P44G=Z[`/RE5!:PL!"B`T$1KDO;YB("Y#E M)X0@9>=(7X:-N0.H/+@TKDL&$0+FTG>4HR#2#?!?A'`(UHD,X<750#!AZ%9<+]31.A`KD]7*/%+$:.4YYF20/IB2 MYQ8O@MZX@HOE&A8@&QIG#9'>R\'0-6@'(5PH9..C,HTKDOCC4^PL*"0I)7^PM276C6@)MY]JJ#K,:S%7646,46;%[>=1#5%: M&3(*]U&DL506A%2WXO0(*RD`WY3&*+++BL739_HNL[)\?U8XB/>)!@0HK90@ M+9"#N$D,7+G6"J+?:/T%ELU0 M>94PASY""SS_M-_J7XZ$X)9:61ERBE(ZDW5!468HN"U,"Z&-N!AQQXAY[@`S MO\P&\C=L8E!X*)J!]A%#\=`+)+]??>^Z_2M-UM!"J9I0(I2)8209!4S:*)2Q ME>`8%1&&4H!N4=*51.*UB,,YP31:8!V[R$6EE!0F8FK(%U/9F$Q:3L*7)5Y+ MWFKT,T^$]H=CTH#/"AGEB_H>HVBK5$1.N.#GS!6"*T+5"=2$!>A:D4SPLBBS M"ZQRGDC/36#!DC.1`(_.M\BS9;L5)CWS,S"K>9)=(R"0*;;BC23"<:U6*CL7 MQ1^F\*(P)'KPA4`OMAYG!H_0LY^\;82_')G*1V*]%R.((DF&'FZEQ&RRU MVY$\_U"T'#?6,5*]XO254B5SHT!\(#>WB@(/J0^78GB"2@3$\0E)2H.XF"R0 MW/2;)(E#\#N<7$H429-1?$Z&OPKB5G!I-1/O&QCV'ECG',6%&ISS15RO32EE M>/SH80E5H8U<.+%B0DZN5([^S,<0G^S5).K,A0S`\:5\YC#[9='5_LQ\CH\' MM/R2!3RR.*9%,^Q'CHXCJ=YA$Q&1%O;*>-9[+AR$8G0C:ALRZF#,+:ZR,D5' MH9N3OQ+"EU']0GKTBH?=L(-:: MPN;9-&WCIU8GO$DYN*+TM3*WX-4B%PV5ZV()7."@#N1+=)*P]J-`I9.IDQ%I M-5COO)("6/G<`#'QIF0RBLX*JY;'A)$6TC(I9U"4,,9=>0)K2MD\*:U=.J3% MP6"N@$CLPVH[],U@`P:#S69TR8D4[50>0>S,1@::.\O$VQ3'Z##^1)::(&WR MJ*298&B!= M3AC7BD(T9^(UJ0"';TB:DC$Q9&69;P'&H!L[U!T7@/?C`,`-2@&>,G5X*L+` M8\32LT4X%:O`_TU=8#8'10\^9\M.5VJ!CO$G4V)"!N]6PJ]-%O"MJL)`5!+J MX^*2:S!"9-H9"D$1KN7T2EAO(BQAS5D[%`='7-:-(#FEJ]NHN(L%F&E75G&+ MDI9WC+>Q!BFRY>"@/1K;+B4R5[6O\GS3Q4.B3#AFK%9,8]DK+S9Z!4,)[K(3 MN"4SW^)U-EG%BX@*5>6OC)-H5BTKG*RQA!%`R](:0;:>,POI>J-5 MX;0C;_UPR..5R"&%-?5"`C'60RQ:4F5^KV1>9?)"BR>0`F)W>)^0DSM+'I)U M"7\(Y"";:>&S9UI@F',<95.0Y_%]MQ\YI:(7O;4KYHY;>&J5; M.0U,1,%*J9NJ5*.NE$?QI5P?Y]DP;>*,*HC4II_<$)DM43M4C<]'?X+QQB^4 MP(&.+O'[KZK0O$`E_BI3=3'.VI*ZR1KHZYJXT",\S)30A7U[HS:)( M*IFNIB[&^I)<896T(0DG32_)LY1N+4X45"!L0(0=`4#GMZAG&,_4@*8#WDE2 M+L4@X*MH:5M21T?B3K<.F3`'(>][,-*5#;S_9KDBG( MT*!MZ!9).[M_XH`B9=S2!"Q?=)RT@)-L;EPC-Y'/Q)8Y;467DFC\BIT&L3<8 M<-UGL'Z*VC)(&D6;<93$*7?$ M[]P)DR"%S&G-^)!H6\*U49"605LO%.=I2D.WQ(WC1YS:)THX$(\1EF7C*$HIWARX:4P$).!Q+5$!4GK['O$PG'S`%PQ$D5ZZ38!(D\F6[.1 M1?CZV]+Y/R)9F?@Z36])'A&L&QL$(NASXZ,+7V4\$5Q(:RXI(_0VK<#OK7VF MVY^)6!?I3H+]G23Y`R@;NS6+8`@93I9JSP":D^T'RHTC[GQ8Y/$CX]K']DJD MH`K6Y3*VR97"J%ROV%@'1,>P.VP/NY6:G*E<+I$F3WROFB"M\7_Y=K*I6%(K M!(M8M<]\YCQ/0(@;5J!G492<4[]$ARKGZ?T%Y=X)NC#P*9`E`YG3N8B&/G,V MOR:[3.;\XB6S*=`I,%*><.HZ*W+=65<3FW/RQ$">V5EF'L>&=Q']: MN)&D7$48!)CPQGBF?X?F\WT*%E!7-VA*K$;@WLJ4(]`8(AI3H6@11$FWMY$) M_\#=JA0@OE33J07`#7$`"Q9=ZZ@C,RZ55$OZV`F["!]!3J*1$5.9"\86V&`Z M6,G^->*+"0MO&5.,G\E.2_KKX')QSZM,TFVV<4^)%D.YM12RB[OV,L^:"IW) M"B.JV,1W!*((PL,(,YK.:GO4L@X^3@1>\6:45W,:NS])VR(PKZF*S5DLF(W^ M2?4*%&5)JG9RC!(64M,(6!1$)05W\IQRE7I"RF7:$X@V`Z1OJSK]EMAD\78\ M$7-+ZK$JY7IL#&)J?XG:'3=I(!J(S7)\LYW?6X:29=3C M%`WM/=+YM)E_F"[(4Q$!IJ)O"/W(VNUVMAH,U%)T2AZ*DL)#4>,M4^;4/3-'5V!5"(*HW% M,A+EJ6G#+\DB27EZ)3@B7D_-UY)\DC1@#MR7^%;T1BQ]K+1SDJE)3)]V^1X=OEZ((E(5%^B1YW$MBG"&QN!B M'RJ!]BD-T5'@WZK.L>B>;JMM:G5W>TBTH-%#2V:?4*V*V1IVNPK-HO>ZO._( MWXB.*@]8(Z3:1G)'C_&)5C?SE#HM\8C9&O2[K5'W(N5$4_&H;:"M7O9%I@B)3 MFE1S92\DLCE@J:10X2Y`GT.2L09?A""A.!X;/HC4 M`O(I9/2*%(RWCNW?QDO=^H&=`-'%C0&HD^\.]I;\@1L,_.^L#0^%<_G]/5'W MEC/8)"5H4EK/:!M$/X8DH*JBHO&4013_$FWU(*P9L>PO91M_*G4Y@@?DU]@G M5[5U/`6KA,$AW?G*FT>I!Z(S-::28V[RM2^KK)#9BW-6'/*A"T><2'[(YK=* M?Q?ZY3P[G0Q./3"78DRS$:=Y@#8)^J=(S*:4NXDLM??L=,^W;"8?FFBIGD*8 MVI%J+$2CJBCM&TTC2K?V12[MT]ZX-;X8M2['EX7=X/)=<)/9(K@"DR.W MA?I'>GKI6SCRMW&W=*VB:)&WBXK2SPUSG81:1WEX:M$ZRH,?P4/K*)\\XRL. MBB,/YX#NUUY64\"")Q&A$3VC(X_C?4M%*%B7K6+A(K'JV\?_;;_[[9N<]DK* M3%R(+49\/55^*LSG+OJ&)]28W&Q?% M6@'UGI29N86;23U"6DJ,#6Q).Q[2OT4:+"50R[:O/:'Y]/:#8/W-4%NSL*.OX5M;RD3 MI'`\6>X],V!)5--:.26+G-CQ;A-?)]9.1O!^A;PBS2_M345ZBA/+`Y$B1,=I M=OH78GN=42_E`R5%-7X=YH<86.],;B9Z$F$373D]&4JP0"YYXA>8AR*6H&26 M="=HI4C&:P-DJ:S"6RN3*B34?A78H$PZ8V/&GFPH*/H[B6.[Z%\B`@4\250X M$["O`"::$8%U&X^PRIT@*,1/+WK=%I#I#@2B4A=RM:MQM)@,%]6QJI38BW\> M)X&G,H7D:,/4B](/R(A*:JP)V0NB\1EQ2USGL(Z!#JE)R6*B/J@(ANQ;!%+A MEI*UZBK5/;>\K)Z0RQ7TC`S80AH4Z2PH%#H=XRH[-406ZN,*&>,F@XW#%KCRRY!\]2\O&Q=#'M8@XS)5&@98MY6KV\$M-XL^.82"Q0S#U.K'U9-9,$-Z+)Y-3(9/>,HE.E@Q_W2@?QD89R M1`>A4_[`['9_VN,\C2ES70G%ST^ZXN\E.B7%W_$K`V-R32?W\Y/_FDX9F\V2 M[^SL.1-$/S^YN/CI":J3],W$#T-_\60;;3Q8S+HJ[9/>\DQV8>(Y`SJG%&.T M@(J.GF_DDQ>AO8Y)VDV,2K,[8J4HQ#T7;+\*@2.Z14#]7J3?4,JS))ZAE6!%6+EO#0?>X\NOQ MHQI)L#/7W/:XJK0,J\\):AE6A)51:]2[/&D=[`79N^6)O"7)+NE\&,K#QXEQ M+."B[00F.N@,&>WJVB]#9I#)D$E35RH(*1N%FWT^MB MP78&BJ0<\=FVFK7G(D@],Y((.-5[R`]X1QQ%G3\L@OHIG MKZ=99U,M!'(ZQCMLJRC>MEX+B+D.6*89RK[;-(0KSGN*FU3!@Y<_Q;,I\@>2 MS8F*>^J)'(^"%][X+L`IAJ6+L;*>;6'7/G>UB9XR^$USQ7I?'0)S,Z<(&DNAG$;=$WDSR'78W=*;.4LX^]E2Q9)R?G>L0+;!E MX\RZ\1$+GNH01FTU!6Z]N+5-OE-E89+.,D:I.#;N&ZZ/:>9<--Q('9)(&4DC MO6-\5^SL%#FPF:6J:JA<` MFN$.7!F+R4Q)97I5JPP M]KJO2/S!+Z=S%C=:ZIFO3X%"-IYQ` MI)H!LBC!KBC);&-;."7-,\*OU[H876#V5WF65G'J69)D%_VOU)\*.[,@;RF4E.J+<-&.83ESS2HR%8_%5`;:E/Q/*+4 MI.W4W8,C&D"9:LLDV%8^FPL?][!?#%9WI*OZ*6E0MIWQ`9:I2QD5,3CE&5#: M2-!&@C82'MA(<$KRF-."7"3?YJ^(G([TCTBJ8%?1-=`/93\6UN_END&0SB0] M#$*H4]=+RFE-"RC4F(<;='1Z]\CLE>=39WY-J>=9#;H52V3564(JVTI-[K>Z MHUR^=EJODR-3*)^LRN6%=?@B!3V&0ZY;I<:_LM\O4SP7?_UIEF[=^D5TEJ56 M]-1&B/H(?Y8ZNW8A:G&RBPMQN.Y"-'9H3*WU`JT7:$:^[P8!:44?;%5KXCH< M^^OBQ=?K=B^*>YJGZERL]%7>IAZ>:, M([AYDY;A<$FRQ=+U5XS&M].$2'0VI`;16%[9R/9O&W>0G7I!O@Q5`843MX2[ MKC4<;O(/TG0,PD/V9V0)Q74ON+ZHB`(4)T`(^?AIN7E&1X%*$F-,ZDL.66@N M$]/;/,J;C6?BEM5!9;B#(,<(<[![6-)%U%TE MJPK;7*``X#<1M7UR^4DS#EIBQN1`=:]"`ZH_ZK?[HTJA:H-<7,TTK_;15 M!*68BXQ&G[]V9Q1"G_4I7HQ;YMB,[?;G&7549?TB-2>`45K)4!]),06A7_H!8CM1$C&8%_OQE4 MFBSJ2Q;W8I;(:$^8TC[7(C]"N]RUO4"AGOF9VG=*`3_SHP`DFHQ(XYO`I+C, MRD$1IP?#::I4;250XS0,L@NJ#6A9'Q>2GMLC&Q]GNRK$(YTPBH0![<3ER/,! M)8R',S?I'XW;=`);A(AE:WV?=/F9'-F7?M$*(^W6==SQ@SH!N.PF%4;/A+U$ MA+9\]Z\9D)4G0M[;\`T?^GC%9)VSA;,AI;4FEOST[GN&%'2=;8`>]!#"Y?0<,:.PUNW)0(4C,4OCZ]\[7CO$MH(E`LCL) M5UD--*0&$$4'3=.ET++_@:.RXLE9"BTT>%$2J^)0T4U.YCVD#;S8#4"DMFF- M#49Q[B'U4CI@/.D,!M2<:@S8K[]&C7;;.F@LQ0>9W<^L%U/PF,[T#&V;8F(`04OH/C MHHUSU41%/#7=EB3=5B2=F6B&\B_NXNAX>=F5:A"?5>XENLLK[M]4*>$!JNX%;N^Y[EZ^-$C].U>^<82:C<>/]JW:N#<0[PQ@#B:X\O`H MX(/>DT)&FE)7O4:4!)6%'+^ALR)!T4?AM7B'7HLM`J5QIUM[`#7YG2SYO]Q1 M[ANI$G'?=>Q79\',PLN=8+]OMJHKI2>P?_3M'U!JU9][F@V]YOV#\_X9%3PZK?.-1:N^ M6PNN4/AJOQNKUAV/-IYNS6&MU(MHC1(;UHVHO)M:!35I\SDVG$E_TNQ8*U@U M.VIVK(J94LTC:0E[UGJ';!%"J49)^HX6>+6"]2P$GFGVM,@[L@;R^%&=R5RS M9,W(SNQ>:)8\JA9R[OZ/+\7)O5K_J!6L9R'L^IW1G2)%6MIICM0<>="^_YU1 MMPW_HY60AW6%G![>WI44UMQ)RM5?7.R:OMHP>=$Q!^W+SOA"M-RXB]!HW%'6 M'\*3([;!^%2)+7-1)",\Y-_G5K.DJ]=T]9JFA#!7,RL+ZJ(%P``_Y'&[^VCC M0(-DXD*V*]H.Q;*G0E?$+,WO?76JS*Y+57,6]'"P;D+7/!VZNB^@_AM1L'?+ M@==U$7NU](UH0@9._!'M5+[0=`V\Y#[=Q2O0?)([F8ULX)UDR*OFGGVXYT_5 M#NA*]$ZI;B64:V0UV[\/OHIEI"UE8 MBX1:K>LJFXCD)L&J">)AD%Q?8)L$JZ;>6E6,E]W;#4]=^I2:R&>%QC\L+\() MMW)PP7$TNHA99FF:K?S%J';54I"[G>6JP-EP4/MV/XLZ"*SLC\]SX M42NV6K&M/Y+OVI#@5-7:;"*884$0MTZTGC6J?5.FW]D7P<9^W6.'+#1;U2>:C;NM8;?[7'-,PV&O!7B[\F3U M>ZIA;-49#\^0HS:D7-8?^";#OBOB:Z>W-_80CN&;+MORX%2T^&P^1CQEYXBN MZZTH?7`.V'$C.VNS@U)MUO:CBZV^ME3/ M92,G<"G4P%*MBJJCUDN<^P6HS*.OX5\="9K32!G!J!O/<#ZH(>SG&ZW0)^,N<&`^38.;]+*]TLW0C8 M%$UDVYC"!\SC%N8(PQ\\Y/">(-\PW8A@1?$B@-G#+K9/1\/6Y66O95B<%K$P MG3CTC:=`F*WQT*1EJD#6[QA?4TW:Q2NY82W\B%X-:\HJJI""L2PLWO MP:\OD1.]1'#FQJWJL&S)CK`SRPE0C5IU:KJ>K]$70=%$+1U MG(/DAW!0((&?PF^'XR&HX=R?.A;*YELGG-/C`5L&#E(62O#>,*/76K<6K0B" MV`*Q[/'(#8%OC&>>?VN`BL\62]=?,?8\-V>)U$$>`:@2%I+N,8"5-<("_:_\ MCS+QWE""+;_([M?K=%IH_>09;]F4T9@59""@LJY@H]<^T#K2\5NPHJ:A'P#Y M+Y>!?X/JCH'CX(%-D'/$M##2<02#('M,61!:3L(1',"$BX)%N.(L"B,PB;CE M8GO$J<7GQM):+0!)O%/DLD%5*UD(N&7&''JS6`!`"@"D\):Y-R#U&?NNK$T` M9!D!`UG`<:!%`6<9G`;)D*D'C$6F&>EK-F9=D/H&^/_.0JG%6?'(-!LGH\&_ M::.E8+Y)NP;@CX4#=R;;-':M`,]S4"?3R(8->*!<`@9Q$;2843P10"@ZULYB MSES;F*P*#F$&Q&!<@8!S95=*$W&4_F#8,:Z$H$28AL/6Y>A2(DW9ZK"SS!(M M$'VVE)UJ/(\YNFSU1Q?J20N/>SIG=N0*\8E+Y1<:;C-OM<:J-59M[#[0-9'W ME5W9C$V,K];$(F7&LQ;`V6_F#IL9GT#\6B2C/LUFSA2ELQ00)>)1Z55S9P$J ME_`E2LD!0B@OWV+A[;BN$B0,A*8[,Y@%G_M"3LZ<`+["-W-0M.`_ENEG)&A_WR/^(+R%H)HRTNFL/\&>+BRDMLN6U M)%].FZGBTM/1JA-FK?HJMIKL3ICL#C(R."V945P+`[UU2V9K5W@.@US,$CS$YNCK[ MG,"NSYN!F@W]@=C_\2,M`/!%9SW\^CW&,?X0`8SPK';^=PI#O=T^//:$A,?= M"Z['HY,L)/G-]]HR9@5L4!"QNX\JZX>GCV;">A9M\TWSHM4?Z_%LC8.UX9)1 MC[+84$77N3C9V3)W[2):I"ALU8X:SBM7,CBMV_[?I__VP3=^]*8K9]'V7V9S M:(8Y$=@ULVMFWS`$[/)<&/TX/I?=.U0T2Y7*.&3NUN.NL9TJCB-F=2>[<^ID M-S`INUZS3"-@KT<7RX9?'<=N"J4E3;&#NF,>WWBK":L>OH?4CA.N:Y:Y6*<< M5O-BG?3'G7']DO!T"=2)YC3+KD-8ZN3'9=R%54(EM;'5^_Y@.5'5[AU_>Q'Q M]K5E+5^^=?C4]7D4L$^S=$'3%^8B@&^PK(FRPEY;G-F?9<'M-\#^:T3P+X\? M_$'>ENX(D%R-/ MS-*N#IDQ,N+:#/.5H4ZQE'#T<1W\N`K/I@(/;[E"]&D<[C2^I1J$S$&6R]K_ M6\DMZ)8"&>T$<;F_PWG$C"AT7.<_JGG3:S0+VE^G<]_%"E71@D]U#5GX-G-3 MDAO;U1F!P[^W9RCW'4RQPYK5`%\`M\4$I;&J67462]>!/U<.EO!;-Y;C4A4' M?/U[YVO'^!8P"R3\2H#%Q:6#C4?^'3FP%89EJ2Q8B.8!/YR%J,+%E?'&HBO) M=69Q/X)XVS:#ZX+F)$I`U/8)*$*!+.%U@NQ2Y0T;\B^,7Q9QPGANZP1W%JZ- M71;P!&V&3\'AVMD]`C,Y0..V0'+F-7!C1PMQ8K@C\8@H_*4^ARJ>5.(U=N`F&+3T0V M*"NOV].715TOBWLZBA_E1U&`Y3MA]9[KUD0`)_[7YDS@ASEYX:1H!GAYET_! M`.A=,LXK\7F5411'T[V_D3GW49AS[]"U4:.U%2@)7E<4[ M9PC4B'GJ#ON#U:*>'L]6S'(X+?II,NR:]@]/^^C-/@?2S]QCQ4EA&Y("RLKP M=@O'3,8:D9_Y>D+=SZ_QO+D M3YK[Z@"IYKY:<-_C1[7EOQ)](JG6.UMM0F168-"-&3<^1C5<)UQIN58'2,]` MKIG]O4UYK5`1=VS$$JD;K7&37!AU%;=MS+@W%JV'I7E@N[+V75 M73[LEIG3,`$QZ)CMB\Z%L6)6<'HG6'/PSH'`.I?MRQ.CK]0UD%36YK>3FNB' MR]Q[4OE1\\4+)^AMNM4>!`4GFE=_D&E'NERB;L>JRR5J5BXA+9[AX``-O>II MBM=]&PKR[GTVKZN6R?CX41TU,/J@2HVUFB@C1ZL87^)AQY5JK4^2VDYD&S5F MFB:S3.49+*>W]7<_6#!U.#,^8X;*^0F&!^&HTR0EQ45MR47)Q7-&_(1M9P)K M&D:@I']CP4)SE+ZC#D)85]?7`;O>%N4_K3U_`%YR/.Y,Q8RP,^.ENR6^%)FV MC8]/?8I"'EJB`8P5&O^PO,@*5L;>-8O9*'$]`]JU!NY\HNWCUFALMGJC\>&E M4%W/L=:@GGSF0GDCX7-F0[,S-'=`3/,HN4!MKBNHS8&TR!8IL!CJ!G;]$'R7 M.J^3U$C_S,5:*TU?.Z?[]^$A/8=;T6Q=C'H;!Y@U\VX\089HK*C3"FEA#EQO MERJ(YA'RL?71QX_.Y!K2&FE#O*25G,*-E>*QPLI^+)U@;X6UH3[U<.K8-" M=>^30YM]US\;=6E*\'/-*`V%O`;`[7,AW M17K-5/"&'L"AG<1EFQVRVE(MZ(]A@>Y$C)K3?/W-'.ZYFK!$;'07*7" MO&A=]OO'R=*H.^.PTY_ MW^8"6@PVY(RU&*Q#K^I:<\/]A7A.PZ*4-7U4;Z\M2FU1;I&62;F[MBF+;4JS M?]GJ#<]-[)Z0"-#*E%:F2FW*D;8IS^B\AYV1MBFU&-1B4-N4\3]UG\>2'@+_ MBGCHS%:Z)^"16CW>JL9#EFR9,K.<`/DHRG1?-AS.HR15,Z3IV@N?IFLSG*XM M;/SD2-447\/R;/Q''Y;BQM-.;TB?/.V,^RTC8!R[/3LWS%UU4N00_^NM>ATK M?64\+[AE8`W*^`+3XQ*X;QC'W3T;#4:M_GBH_@8ZJ+1J_WD+X4T@DOEWR0M4 M$FO5%0<=XS??\)>AXWO)T_#P+0N8,;4\["2X"X2=C7)3"Q`M0(XF0-Y7I?E8 M"F1YOI5N(`O?3-&/8P/V%TOF<0M9!/[@(?6:?3IH78YZ0GJ8O5%KT.L2D^1% M5.@;%CSE\<@-X7/CF>??PE,&6RQ=?\78\USCVD+!0Z)1+3P'V0AKALPCO9U: MTX-8`#`Z``-3_C7FO4ZQL6Y_[4L?#&O77".3T>,&04_!7P MX:#7;YF@$_BI%+28[RSXE[T+1T\E1^,-RR,`7$)&ND<,;O6;>BM+:N*LS,=- M1,V!4?&W%Q9?WKY4]4_?8('7B/-?'C_Z6\3;UY:U?/F6!])L?,F-L_'6^Q\>/'(A'G@)V[&"L&84M$%8).=0!SCQ@5D41@&:A>C=<4$A=F8.NMNX82>"V4T$LS`@\=< MC2LS"_12T)S]($05F0Q&`XQ4GC)3'6_J1C8SGIG/BXQB\_+RTO@8&E]>MXQ? M?WV#\($N\:_(FY*=3?JY'X%URRR.:K$-@$Z%#0[_]YY-`NIT.5"F`/"FT+"% M`VOM)P/C66\=D**WEDV1`=:%?5X[4\.RX_!IY`1[9>\>S M/#`T7./O@1\M6\8';]I!F#["(?:D]4*(?=:_&TQ+.C,@$A=D$@+"\37_B-Q5 MRDJZBJZ!_XU1ZKUY'^`WLH2`+M,$"?\,V32DETL@C3G<[4RY"_"+)?S&"W&O MMN-&!''>S!(T![1/6/&N>8$E4_Y'U0NHH?)N^R`(Z_U'AEM>8<]?^.@7Q`^\4X0I#.6[@ M^K`.R*_48P#%DL'=*3PX M#KT2?D^7G8/K<`>08`7PAPW'&ZQ:&#*!.]E:+EU8#!--4^\E]PX+%LHQ)/?> MRO^F2,(7`B@%=O'4\V33+B]<;00^;"_P?SD+@`5=F^?&H8=I1;;,E$SXT"8@Z80**3AGO M(J7OI)82^UM;/5XYXD1!N7T6H%@L%&MB#'\"I&QGH0?.=8`M;8&^S)IPET4+ M06X(JWA$J"'AG#2A``4@AZ-##JU'2"UZCJ#RA`AB_#K0?T.0L&_"+ M[T-_(@ZXBSV!2VM%.@5L14$6ZV\>>OS%A2KVE@S'4[3=5K2=P,Y%.$_PE%`Q M2!E,@JM`7]/(E1!GXABJCR-NGT<3#E`C<$(=I`<*QNGM<8^=JE/HQ[U>8KN8 M\!KC!\.XP.T]3_23+PU2_R[.11I?5&O\8=AGFT"LP1G*92%_K+VYYGO)*+/M@!_=V@Q>+]G_2(C=?:3 M0#NW;*D5.>];(52I*]PI,D?L<<&N7[V(Y+M!5*%&-M6[E$SE'5_ M.B$UO#%JY(Z-\1M/9,K, M_D#+?RW_CTUFE]WVY9%4]1.07X>Y`\Y=]_]2'!36TG^#].^,AUK\:_%_;#KK M[.QWU,)?&P![&`#Y?!DM_,N1-NB8[6&GNZ4%3F,O@0KMC;;YZAMVH)V+OFUGQ+$/A;M)BP0,N]BDKOL#4<]5K]#=/C&ROTZL_$9Z;YRC8U9R>2CZ*/ M)NUI:W_N[PN[-VFQ7(ZQI_W6I3ENC<>]\Q3+#==!RALM[D#;)WH)F!?#UN!, M+H&DA6)9U<.II-WK=@;U/)>Z',)#2YUO\WP3R3!=IYZN=1<](>,+.#,J(E4G M/05<7V-X);UNY2Y.XB5FSVR-AETJJG*X+*47A5E8]`[<%#)5`Y8N)>-8EQ=Y M`;-$(9?KF(]2E&H_G.PM%CP:L[0BI-8C% M.7[H!UGU7KRD5_X27$7U,I%K()K3^O7ZJ_'-$F_8`@-7]2>PRP-0)_X@O;IR5`C2;8EQ?;3;DK MV<_,=3.-/V9Q[RW'`_J/D'84(OII1$1>"FCY>:;U1U$W%O_6R[35R--*"0X! M2VDJNDI!N8ZFS`M5CS;9^@Q;L\CF'0D5.CS=V22S!VP!QT-!?V*3XLS@$0Z2 ME1;&]BY^OA_((N$\;0?50E1K;U8-#N&A[\MLQQ_1;X0Z]MGR!DI+G:D5!([P MB*QS-HD("UTZ44!334!N.'1%@2#-NJP*^OO4A_`>/]*D5Z].A6=@WND.0^IL MFU4Q?K[0Y[,\F[L3#?V=H7^`/B!F6J"<5B.04G]%U4GS%1(?FD5BE;M#-6M; MC8=>]_\Y9+,W#%M75X5/8,=OP)Y<`66?U::%8+>JQ!9/9].Y4:;GY#6>U;9''<59;EI=:3U]JS8$^!W!2T:NO-7VM5=]W.H7M MK#9^OF*^?T9B?K=.-[(V>-BK6#U=.#^TID1!J[XMK'_;CQQRS13J6$^M^P;H MO@&TJBS([>W:$:,QG0,T6]:5]#1;EN.FK=FQ5L!J=M3LJ-FQ-L!J=CQK=CQY MI56WNVID@>"IG,.#(3U-!=*%5#OA\VUSMZ1TJZ1486#$L0Q0UH?+&FR9#H3U MS`SVNK#PNV2F%#P^#?V`M^@7N+:J5V:VJE56I=>R/KN@-E\7&#='?IQX8=]Y MEW@651=SV6PBG!N6P:,%`+12O"R:O5&+B'"M91OVL5.\G[0[R#1^4]TC2@12 M48'R#K7(FD8/2J./']6$2G4ALBY$;GIHL_'0Z[3,`\;V_\FL0'1=K2[13F#; M;]F4T_B%VJ6M+C[P**+TQQ8])K!NSRAVKJ@'S/C'Y87 MH7XM"^].U7>HO>3:2TZKCL?#UO!R=*IT?M>Y0"S][8 M)L*.([IJKO3OOI'#NP[JA(6M$O.X:&BZ+);S7`B$ON=9Z?M MZEQ7V^,IE%OQ6A=Y=#2I/"@51[8?35QV$N1U+)O^OK'>L%M@WZ2ZQO+K;DEV M!2O+3__V(N+M:\M:ODR*R/B59V/K2FIP]@V._C6>\2^/'_U-_?8W=GLUG?J1 MAY/3/@>^!_^Z?_WI99B4!4/P19-`)([]_,1:`OD`N@#=(KND M#6OB"Y\8+\@4\T-F7+:-+PSC0$9">T:60"O$DTZ%MDXDI4SS_.GQ?)Q5)F?I M&'/0Q.%&X`XH*LS&Y"[D8BOAXF6&BRFM=,).Z@,80 M7G,#2K^!Z:H!>F/8;,:FX:;!/HGG)IZ]RJODI6KB/6WBK9!LEBA7AU"8T@K8 M:\QX_#1+_=YWG>E*_.^!5:P'4_YS!U%=<2#LH%W_.6!+2XP)*SVDW*6_=;<; M;J[&(C*6QBAO202BQ(T\*[(=S.L'.@*H<7I8D3040G7"F`=B%Q$NQE7C6H%- M7A9,^,_*^@TKQ8@LZ>6\4S)YU[W MU=^OKC['?YJOGALT_0Z51&>1<;JC?!+5!7AS$$!B+A]ZXZ=B9EOHX]CK!>"D M_7^=U!''_[JB+<$.W%4+'U^!$4W7"FS'C6S`'UPS\0#!Y)4!^W?D(%HF*P,A M)B@1TR"-X2'/BP#&`M0B/CG\EU8IOW0T":OXL:`6IAYX##%/&.>;BX"%:(BT]?4Z*`."C MR`UY;E![PBN29F)ZWXOW"LGTDW@=+*-@R`RA;],T=S7PO'`4/>;>(UVKS<(9 MT#S&J8AFY78(?#/!8>E+4*403G@9]56,&5&\BN9#QJ,99P['^90K9@6%F_A& MZERAO.%S/W)1_0,(+,(?(.E?<*/&DQ!S`Q]3SU(Y4AK3L$U&JF=HT91$>1I7 M`5"&97SV;V$?2BK\;XS(%/02@^F<141BOYQ?$[V@VCV.-[_%E[%E.E(J7:!6;^*T:]Z0U[-\Y^S1[)RL;^;GR%6`!D1SC0?-4%9Y: M)F8'8J^0GL6EA2HB5LO&+*1419[27&B,L/6=Q86V\A9+31L6!7/"ER%NYJ4? MX%UL+9#4!:>43""&O^W,^&ND=6`.\K^43BW&M]@`R_ITY=QE6P9.P&Z8%ZD2 M8M`=0,?AAAV1QI4\1.8"J0\E&GF(XD!I(E-2#&P',!$8,S@G6,GG*/#QN"5+OI" MHT#P-?$R#JP(/P0=)COF"MB24E#\A1^ZOE>&Z036?JH"DU6!:/F MG3`B*5U%]E22,&F1A.$NA_K\:CDD7B/5.VXDJ-$2:)L$BI$6Q$C#"UC('Q[? MVW;$Q+4ZA>WY"Q0[TEXFOQAZ16"=0&B-$^P;`N*CA=HZL%>T]-'K<>,[TT05 M:`%H,3M9V&&`&`GM;$Q0"6>1&XN!0CGS)]SNHG4(BW^8WL6_(PM4CP#=.]@U M@"_9%)E;_59:$L#Z-D.Y"1#3?CRF!,(6J%`BL."&%:LG!4/32?2M>0N$5-^" M@&3A6Q!&3[M5)$JY@$B+D0]P/7BA'^@0@O(D2GQHT;'=Z2I194A_*D?__D(X M#8'ZP122I@"/)FA0+"8N*AM(X<(K`(SYEBWH%RL.J@\(!>Z[5F`LYW[HW_@N MZ`[3C-O_\Q\9IW_\&*X!W$P:E*W,%%>\!`T;'J).(UL842^1K;K+U%HZ(>7W MPR:62^`.$BLV&&E@;-$+/?D'KH\"$?W&B2>Q**@,FXVP0Y*P=E+N8=2TZ#.' MT.C;T50X6$%R,=>5O15@=Z5P._%Q6$7"1YX1(V=98-W&H7`EY,G\\HVG_<&H MI:35K1]\!PIL`T#H#\[]TAQV6[W+RT*($N)P4"K?..P67IW(Y&*Y2YYUCS0\ M+DC'GP!%8+`DV=ZAY*[GJZ4,E*JQ?[^*<"T3F['']KWS@]E79$5KR2IL'<2( M(5"BA>M6RY"PI=PP`>6W8#(O"3>4-X7D_Q8U-[`_R&YTN-1\PL!"B"G50SE0 M;YB(9Y#A**0D_IFT=(LX0PW$Q;Q0%;\)F$O?N:+,(*">6,&U M4"I3`M_B1=`;5W#S8#$9F>!83D;*,P=ST*`=A(X8)D\:.:Y(\I%/&;Z-1.W, M%=$XI9^OQ03E%S(,2*=^0]Y&ZSML#2AWRK:ZU,O%6U:Y#"WOVH&[2_STO8.A M_5^!I&SQU+G*P@0Q6B!6UC9CE$FI*#4:I>`A2W$?A1]+Y7E(S2U.`+&F_XX< M[J3C]45ZVA)6*1-DG^F[S,KR_5DQ(MZW0%\V_A6+W`(9.XO=Z>+%RN^52I)9 M@LS\(:,`J".Z[-H2CW8P3)U$^94/KR"^C\9F8-D,]6`)*E@E>&G#^!2KY9"Q9(G(P'KU+K@L[-4,1;F/A"&W$QIP!S`G('F/EE-E5A MPR8&A8=226?;(HTRHHO`0DG[*7@+Y.N#"/XT^]7WKND!K=FEI5F,*Z1BQ%&; MD*1E6T791BAS"649C4]:393:EN`8-1^&PH2N;5+.4FTWITXPC19@*GIB:C?E M[K`X4QH$5!!0S%_8DGI0'F)R8^!I1>NW179!#"($G]@U_"=%?@I1X)US&07A!H]7D1X5[>9_\&`") MS7!;NFNQ@4$AAM$XAVO(3XD31W.6Z,EFOI#$6",'^-#A:X7^AY(Y9`4 M\#RR8*LHQI'Z<&FMR$'D4O)#&I;B]Y\+1QH(;9TI>'.G>I](WF5_IXPJV,KI4D!6>[LNGT0%$HQ>D M,@%76:PZJ)\C5#/R&V(,45[KR/&O2"P\&XBUIK!Y-DU;P*G5"6]24JPHU:S, MO7:UR(4FY;H,LSH=O-I]B4X29]C\7:9^J9,1V2WBVA0B2OFNL"90;4KFA&S( MHM#$GTHGPI`&*4^4WX?=]OTE*:$H10-K2DDU*654.G;%P8B!'^2'"'S*PO,] M42Q)UX!(MDX%]6.G,#+0W%DFOI@X&(:!'C)`!&F3OR'E`J'0''P7%\4("A6@ M=HPW^#5SX]Q)46TCPVZN-?A+(:I&/98ZE`=(A@P&D*$0M/5Z3"G#XAMPE M&7Q"5I;)#V#CN+%CVG$!>#]VI-^@%.`I#9ZG//4\1BP]6X13L0K\7VI,BH5* M^8P%HAZ6%N@8?S(E)F24;"7\PV38W:HJ#$0EH3XN+KD&W5IF?Z$0%'%13J^$ M]2;"P-.<54$S4X'AB,N\<"2G='4;%7>Q`!/>2@+<)&EYQW@;ZU@B:0T.VHLH M/"DD,F)-H5BTK7)"QA!%`R](:0;:) M9"&YP*T;^(ZOV_(".6M;5UPGX,1-J!6D!BS\LNB"P`B0H_"8OD0[Q@,KZ%:Q&"55XSBRDZXU6A=..O/7#(4=.(H<4 MUM0+"<18#[%H296EO9+IC4C6)?PAD(-LIH7/GCEZ M8=HNR2/K/.^F[TE$)(3)_(LQ&7J05 M2@<>D\.&A@NJ-1N?,Q96RW#;8CEFS4RA%UUY]MM$*WHG3.3S]MU\2:N,*>20 M]J7=-MOY$PQ+P8"I^ZU4#Z^4Q?"E7(OGV=!GXN0IB'ZFG]P0[2Q15E05ST=_ M@C&\+Y0^@0XD\?NOJCR]0)'^*K-M,7;9DAK-&NCK^KO0/CS,4]A2V+<#6Z>E M`,#LV59@?Q8F^)]DJH>K\^9_A07-[SL;`QDVXI*XX#J4"`668A9P<3&#@2'N M((M%P01`$=0O\E^5M8#94J`HA0PO<0OS@H!S4"F7E[K-L&8E8:%6G+4)KR&# M/`(L!JJ[022SMFXLX6*6Y?FMO$FO'%3X_F+VQO@C+"@WBEF]9*(D2?:V\*K! M;]`-Q15G2U_;UN1;J7"*3*N?VRT!HJ"8/1I-*U&LKX]%1V*$IL M`.A?PC>E8!`I7[BQ%^1VH<0IT7`"53#?0Z%+J1W3U=3%4%F2_*M2)R3AI.DE M>9;RI\6)@JH%H*(X1=O"ZABB24*J+C0=+TZR;-4,UFAI6](60.).MRB9`)*0 MZ*T;RZ$T8UJ<`FO3N#Y#Q)=)C8Q?2:VU)HS2QO`.PUQE61DAW*UP^*O_D%TL M@K=K>)4EKULZ:R6R?J/PSI1K`@Y!_M,&OX@KF42;#BS0:[Z&`%;[-?%\&E5: M\N_B!HI#;Y3!BB@U_*7(,P-*M[EQC=1)OA-;9GX571I8[0<\\<'#]G483/@, M5E!1HX6KKV^,L7G1,7ZG]>2?0MBH$U3:8%H1)=#:0L(OK97TI*8<)G%B&O$C M=\(D6"%S1#.^)-J6<'$49!W0U@O%;9K2T#UQX_@1=U<)'(C'B*I5X8\T0E-S M8>$W,T;^,E%6P(+XXI)?@:39>KN0!P_!?8T-E-M?IW/,H57'AX$0%%L+WV:N MJ,>2L13E'$\NI!0&8C*0N):H(&F:?8]8."[XQQ4C43F7+NT7:2#9(HDLPM?? MEDYO$DO29&#=6,47P9_4&&]YGD2[+BD+]#;MK=E;.TRW01/F!NDV M@OTS\XV`"`3K2E/(4BT50+.Q_4"Y<\2=C(M<^]ADB=1'P;A<1CBY4N>4`Q8; MY8#@&':'[6&W4JLSE:@DDLZ)ZU4KI#7N+]],-L](ZFQ@N+F.\'D_7BYM>95)0L[UY2I0>RC2E2%^$-SL6 MLS+/F@H5RPHCJJC$=P2BLL!3G9'5]JC3'7R<2,CBS2BWYC3V?Y)R1F!>4Q&9 MLU@P&QV4ZA4H^Y+$Y>08)2RDU1&P*+E*ZMWD.>4*Y818S+08$*T"2#U7M?8M ML43U$<@TX%#UBT!Z%3PU7*U=X8Q-3^$BT];K1`-!!;V?AF.[^W M#"7+8$DEN[E,[J9E\SLK0/66?V;!USF@48OHN*/P5,1%'#="TOX5R>`SNK\1 M35IL;Q/;`H-,DAA6?0QEY<`^>S0V>,!:X1414IFGE*G)1XQ6X-^ MMS7J7N1\*D@TYD7KLM]O]49CY9WE&2JF2[\E;^(?+)@ZG+7B9GM(<$KK62>[ M*C?3EELG?4%]QIS2S\0*7YA*EA/EEU=QF^:WC$\#9REK,L_RQLHC1UL66]GR MC. M_?CY25?\+4>LX=\*-V4#B.F[W4:BYVBR6>,$J>KMF=FCD$FW_O.-K"['R&4QF9T_6+,!U1L.?0.DC3WS\A&2%8^O9.IZ M#BD-F_!HMKJ]BY;9+Y^Y?F>*>2C:EK,<\W(O&>)[AE)OJ&58DT]0R[`BK%RV MAH/R2>6G)K_NH+>I79S0L+P?]SHLK_D2!.Z`/:[ZK7>`IJQ#45;];U%]UF7R9C-R`/T. MQN(I<(`C-?D5!JFOIJ%SXX2KO9V"92(!\2$(_(6L-BC`:9YUBHEOG4C+2+Z` M!@LIMRIA/HC'L^R"*Q$_$\R6#=KBT[;$Z`033%\9V>_D!GJ(ENPW4OAPWW7L M?:3].L\5,&9A^"#'E;NBU<,+A(1-@;#/A%Q<3>7]'ATB)!, MS93CWWRO+8OJK+`HTS";CW8_88J'O/Z:`.DQ@F(UHTO3O&CUQQ>:WIH$:6.E M8$T"TS7#2J]S<4]QZ1HH`97R:HI4@$H:3V,Y@]S"H!S(4HH==8#M4;A:ZHF5 M(#^>I_7A!7[E:->]N)N;)C:'5'*AV:3AD&L&UPQ>B.Q.]2!O$/U0'I*NDRN4<:Z%^T\+?5DEW]C3[-UW^%LW7WC/?4[S)J#IVGM5&@MXRFK"'.M77\-AUUGA!Z, M9P^3_-4P^FDR[)KV#T_[.-KN'$A?9\>N(>Z=:ED,.\`AWK:Q M@50S^T>LXFHL=VJMHA:0G@'_7?;;9O>(A6VGSX+:4;'>N<+AW]LS#+`XZ'AC M/*0Q27M2V>-'C1`66JS5B`+-SA@$6V>\1XMF+=F:3-O-@?0,N+!C#OY;C2`U M7_4Z(^W#N&\?QJEA*_9;N,Z,!HNH65#[4E;=Y<-NF3D-$Q"#CMF^Z%S0)*+3 M.\&:@W<.!-:Y;%^>&'U53:TO6+%2MO?^*=GU2O9.OT%G?.N,[P:`=YY9N*GN M;O[)I>/6'SQ-="='=#H'O%ZPZSS8`^?!)ICOFZV-3'M:N]=Y[XV`7?/[X?/> MSXO+SR_%OR&J5;/!*Y(7-055@ZP$'2 M=C3[:?;3['?/[*=+C?(,!JM:AFB36].D>)51QAJ,]CE?LE1X:DEZY>$Z(GN;1L-HNJ1$/!PT;)+G[U+"Z;D-! MWKW/<:FGGW#\6X3B!%5[DF7<^,(6EN/AN/$_[]AJH+FT=B+;T"QS%);YDWX" M1O'5#0NLZ\VN]=/:^KL?+)@ZG!F?,6GA_`3#@W#4:9*2XJ*VY*+DXCDC?D+5 M/["F800J^C<6+#1'Z3OJ((1U=7T=L.MM<=_3VO,'X"7'X\[40'/^W&ZGNZ5" M%!FVC8]>?(I"'EH>GI5AA<8_+"^R@I6Q]T"M)L1C:PW<^81@QZW1V&SU1N/# M2Z&ZGF.M03WYN/8Q!MLWGPW-SM#<`3'-H^0"M;FNH#8'TB);I,8%QO5%\%UJ M@TY2(U4N=>,:_X,5QU&`VNGIZJ,-H=3SNA7-UL6HU^IV=RE\;-[9;0'UT+54 M6B75*FF5#*G>+D,ZFL!U6B/5&FE3$'QX+VDEIW!C97BLL+(?2R?86V%MJ$^] M$N3'"_@^/#MOO8_O->K=L)O^V:C;127[N6:4AD)>`^!V9<2JUU##>.E06G-3 M:'%#.D3=06\NY+LBO68J>$,/X-!.XK+-#DY"(<_E-,3]HH_D0:Z$S%K3_,Z: MZ:!4,[7]:.*R6NS[Z/IY=2PT5ZDP+UJ7_?YQLC3JSCBG(@"T,_WP-D/93=DP M]NZ,=VF`T7@6R+'R#LKLB9SWL-/?M^Q=U$YD&YIC=#\ZW8^N\1QUFJ2D^]%=ZWYT^HXZ$F'I?G3G=CME@O![ M6+$/#7]S:EIUT;"&5)-"[1!<5U";`ZFFVMHFQ!5H;,T*^AVZ-VS=2:")D)Y! M-R"SU;\8M8XZ!?SAS_'T(&VLV-,]N0JSND:[=(F]1ZI^_$@KJPV!5"NK->T' MT'B9+A^D96_?3;R*D9W!#FN9PQWZQC3O%TX.TL1)/:ZG%/;#ZY\-_6D?5 M.FI]$:S;R.ZGPDXM#S.=08GU`]U25K>4U2UE=VPI.^ZVAKJC;',AKP%P=RUA M.Y6.LF/=4;8AH#<7XH>P\=91M=YKO[-G0GH"-CH;D*AMD:]+NM MT3%2.TZ,B1J^C5UN@,>/:DFKN@7&[O;#L'>VC'WV;8'&G8M]VP*="`GH&*06 MB7F4]4:MP=GU/=3-9A^RV6RC24>;F]K58JD M^ZPU.-]K[NSMQE%GH.U&+=^TW:CMQJHM9>^YGVI8WD^U$M44-%W-$=+=FK`> M];B*_E5&E<=JZ/O><@+J%_3!6T8AO^*S%A\(VTH=+7UV8P6.A226^51U45(?EI$>GE9[GONQ'RSG0,PO M#2L*_:+&P,4$7TA^0&K^;;Q4`1%7I<])8$Q=B_.?GUC+I7%T[I,6Q=\QT%%06M&W><"8\1&^G'/C'0HQMQXQD##)=9. MW%]CI;LGD:^PU4"%+ MX[ MZG8W=IP^59%<;XWTV*>.V:^XK4@KHQ4Q]K3?NC3'K?&XO!W%20OEAA-\>;G( M#K1]HE>`>3%L#<[D"DAJ0.3?F3VJDI#LRFN5"/O7#J0K$))ZAKFS^S0\M=R,/G]9^WX!5MP*:/J,M M"R%NA6>TY?B&,O"*:IW#'=5PV+5(/QCQ_U_DAQLJ^4YOPY0[RF'9,]JSA;7\ MY7E2I[=A>/]WML$;>WH[?O8KNV&N8>XR<*?)5T"38=?7U\'(_BMLQ)DY4\L[ M)XW5#^LF%LS<[T&`UC"Y#2L-P?F=76.\*0I?K0MF;#^A"<9L,BK+0U^]4" M5,U^FOTT^VGVT^RGE=!#&]4;QP\4K+BA`?YN">.%;>]%TKK,=[4_>5_8-`H" MQ[M^;7&'ZV1SG6RN_>5'\"C^DUF!P3;V'S^]3;]E4T8%X-B4]WRVO;'_[UDZ MCHLN[8L-$S`:J^>]9O`N#T[*F%BNY4V9\0_+BZQ@9$IHK=V1K=YW#96C#0H37# MLLV6#2!NEFQ^Y]EIB]CBJ#\>I,/"`6<3GYC\'92*'MN/)BX[`;(ZYB3P^\%W MPV3]/N&ZAG+H(<-WNX;>TF&[#]X-D(,?K+Y8MQ^M$-18R^6%L;DK_M>G638Z M!PJQ(W[T^]>W3T`)GCH+>!S#/;_T!R/X20)DX8L*(?G3#[Y_\#X'_I3Q@X!B M#KN]R\L"4#)O*H0%T4K=MKXP3,MGV^!YRZ8(3W\C/-T"4-9>=!!P*J%G9W#@ M/3QZ5Q\'#+;K!3;_>MK"&2`UM&[?T=.N,*)Z[Z'QM+5#X?_ M)5=S@#4^!VS&`J!H>ME'BOC\=74=,'J:?OT5*9V"U9\CG-;-6?R]^'T*`YR@ M32/APV_OB4I2F-BZQ[HAY!XV6/!N\1"Z[9C].T";K%J1,@]_CN,AI0/D=[H3 M\/>T]R,?^*$Q<>6%CNVX$;HYDH-Z]V/J1C:SW\.MB#N(0A(F7<&_>ZH>Y&@\B"X.$'D_BDZ M_E;&Z\5EO]\;C8^(V#<^#_D'#U:`2_[3[+7CNOC`)^]W;PHKN0R$':(JL*8A M_Q2`-G`=6(N*-VOEBWY/*.YM(ULTJ$%_<&$>=#>_^M[U-Q8LWK))"/J@/.IL[3<#]YO`/.W6^;>L(^PZOPP>^KV+LS^*-G4G2#:>VN8 MM_/MUC_$CBZ'@^Z>VY%0W&T7%[ M:TJS,=^`801/O_:#P+\%VGUC8>I:N-H$?W?0_LJ6"']O(_SY:W>7]Q\#;K/? M_LV_:1[V@RWT'..`_<'.5+O"VAJ;R.TI>&F<7R[$.XW$0_]Q5]=,Z:3 M$II9@GV>WD0/[HJ.N64+9:!LV\)'ZX>SB!9'(9DJJ"][_S'@KDHR9N^(@+_[ ML70"TD_>PE$5&W^25,R+&-X,[+^@D&R;O7;/W`QC[EW;0!/JT:87?-BN`V9:V\^-*@5+_U]0;7X\O:EU&ZEI50-=[T*6K"BQH*7K+U;&<:@ M!B]\CXR9/RSJQ_J9>OA]=#RDVD+@WO_S71EH@*N_EBSXB[3HG&PR._V+''`5 MH=@=>L%SAX5^U-L5>@'%&O1_@/C=?`6LP?C+9_.?N;=G5HG?@3K.IYGZ345+ M[M8*[&^K)5NWO?[ZPER0"/9G*PA7W["L`-L=@LG[>I7^1GD:>.2&B=T&0'<5 MU%FX[@;NCKZ>7SX/MT!Q96,3"-(#O_E7-C`Q;-%R/UN._<$#>>V$H!7*I++D M\3^=1WSUKX08BI M*F\=/BWU#>PHZ2]ZW?$P)3VWOO20$%82\'>"<,TG*FZ"ICBV"R,?11[`#3N, M.6OME\D')"-KCXK2^Z#;Z2F^W+;)DHO_FU]P@?SNV2Q8@^PX@G&[1K%)I=@! M_+LC@$Y@!XHYVID/[XJ+9"=IF?$Y=D/0HTJ*DX>L(H]$$^[8#N@?7RVLP11\ MB;O_3$F%[+-K35-;/JR$R`F(3=N)B0$T%ZRBLJX9.E_2C/O&XG-EIZJECGWN MA<9T]U(>]VZPQEN,8^K)=2S#(X6T\`A94D(;5ZQU[L?(&4<7OV>ZV\RW2K;M:C'5(/IL-`/=KIU'P3" MHYG&M3^;HVI0U7<46QRNA2%"^;M/P1?,)-S9JU>57TJ8?M#KFPA^5:".L8&D MM49BCWYQ^/<=]X/QL;Q1=^^[&6Q'.>9+/#24!\2Y.1R.>OVAN=]^1-X$\)Z- M%C`#@8/RY@J?O"96?+U*?B)U42+X=&IGM!`Y*^]^+-DT3&[@+V5*YYYW3K$^ MG3K)H^^F]JC;F$*D\;?;=:Q1MPOJSIWT_O!!0R/O]WTQK]E))_[=PZ9JB,,[ M,+#9Z0\T^NY*@F9/XW`O;>ZD*1)W_QZLN71J4#61>!!<#L3U8AX+FT7;JQTN M[\3;`H/]4?^\,7A`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`J[+C+IF'X#C2\4S+/0Z*Y MNI%7&_5V=!0;]B0P>A<[[!#YSW=$ZV3[*R<[:]1?V,)RL&$Z8A&[6B\'@ MWB%B^\-_]D5L_P'WT4`T%F8!C%6>Q(G@LIP+REY?L=G>-I(<4Z;;`VZC@5@L MI,C1/PY^(05\\!<="P,]F3#[8$2<[R3/X@8.Z2=;.7 M],D/2KFO#3X$4O>C]CMB?8N+^O+^45^)X*DZX0M;PM9`E?XT$U?&IUE*OXZA M](.5?-'5!$.L3S#XXR?"!8+&@GWA^/A.@KWWO?Q M4J'_'O@EPZ-J^ M%'+S?LADE)KGL".`Q]S8W0]V8(Z&=]Y8(35L']>TUMCZEW<.WHV&LU@PVX%+ MSUT9OF?`9X:-[8S\F7&-E&/X@6$:H6_TC16S`F[,`G^Q_K/.QC*^XD%04AI^ MFL42$N6=:D/]S5?"T+.E6ZB:G-H\QV]D7JH17[N__\B@KTW\*2B5$%BV7"M8 MO?>#&7/"]=D>'.FG:D.J^[@J?WFW6+K^BC$@'P6TP6D3!MQS@6$9(ZV+08%7Q8K11-SCQ,\&SBJ,RKI?QW M+92\X?!R='F'VML*N#D8[N-J7A_?],%['X514+GC6@V0;8Z$9^N(V,BH/ILN MEYR91BOOH-T<"9]OY@Z;?0+&MT+2E&?.E.UBKJ05IKUVGQ?M7$Y(^.87/7(P M<7YG+4]996)[5U$X]P,<^W:(_O:B'?R!W")E@!X#"S>6XV)D`NX&4G\/A(PC MH2(/;8H44WDS\*W2*G"-BEK>;[[A,N#M<&YYAMGM_H0:&VIO,\L)C(45?&>A M<4,N'_F%NFE)AX@UPM6:IK<)N/29JJO_-?/8S`E1)RI&W-V5N][%V!RG*DLJ MO_IH\#ZPO"S0?WN9VL*=,"0G"28?TK"TY.B)>"M:B9N])Z/N&`NO*K[PP+!M MGKLY&EY>]G8"[1[[+]]#XU1RUEX>JS?EQFW5&9F':MD-N#WV%(-:X/;XO3\? M8J#!L7M5'@"9!R34>Q8"!VATE3:C>6Z_M12 M7ZV]07HA[GS^AQL!F<=3;S3HI525:OLY#@;N:0AF/EWM!LZQN7!YKV[\@6"+2PYT?Q@+>/^?HCP_G`6/I0)"($6$HJ),;.UZVLTV. MMINUV<<'E8`%UEQOU.MGPT%;X,F?()7I'?QF*QF$6?#B-$<==A+@X33%M,=A MG_EJAQTS5Y]]%4&"+IC_Q^QKQG]UK`EJOT[)K7>HT:L%LOUB.$COK3*<1]S< M9J],_]([._!2__2.S.`A0Y?#^W?,GG`4WHG@$`?O" M8-]36$(4O'_!6=X8N@,]RHE77^V2'+_9"S[&\'>!\#XDH`^-B?T$9VU14;*^ MROG@7RV7D2UN>5/XBX6A*_HLW-WGW^_VNL/>`>AE[ST<$X&DH'_PI@$LQX!] MZ+]W1YK9$^EN]PIVK)U?V;:#3UMNUDWSS2?[;.Z[-@NJ>A.NP>@APY[R_A`> M$G7JV.+OJS9E')F]1)VO!FG6F[)/W=ZV-OGF3K-%=M!LBL:P'',#]X&J748A M[(2JX3^/CZ:2(,517G9P4_.7SX?J%[$5]@R&(A!2_X[@V7NU73 M+)_\\M]N^,IV;@S+=:Z]GY^X;!8^,7BXWY-)./G3AGF%!FR\M3&1-?>YXK#W/_=@/EG/+XR\-*PK]5P9NM^UX M8-W";[H(#'T2HL-I!H_@@QY[9=S.G9#1*U(PWCJV?QLO=>L'=@($K06@3KX[ ML!RN"83A?V=M>"B>9'038Q+?0- M0++ZR@>MT;&9886A'WALQ8UG7Z?S6^:ZQI_.8CF#$UVPP""ZQ?\W0.3[4ZQZ MX"WCUU\_/\>T=""*:\LU4!=U0/LV`@:X0]>N`R^%2X7/A`<=7VH93TU3`&E- MIWX$J%E:*U1A$3(>3>>&:]T:,R=8=&K/LJ=&2$PZ\N$H0MB+=VU86$\'6H\H MB;+7JI M6,6297M(`Q,&#SCY!<4Q7/3,\2L.6!0YY(;EV;`DI?!QP`181VC_&4O?=:8K M8`RPD@1-+656(&T1]12DS8_6BF#81FCJKY3J5*;49,)T44F4_K]+,)#=SHP*0&_9$5<+UV!A(E4T;*X44 M=@?[^__:;>.][X<>J@]@J)*X:K=QZ\`'WU_.Y'>_PA_&#_HH!%A_?@+[0FEG M/Y&?!CYRYSP,ER]?O+B]O>W\F`1NQP^N7P#F^R_PZQ?XPR>X](NUM>E3?,1Y MB?\+?_[_4$L#!!0````(`-`PKT2@HGJ&P`@``(V!```5`!P`87-P=RTR,#$T M,#,S,5]C86PN>&UL550)``.HD713J)%T4W5X"P`!!"4.```$.0$``.U=6V_C MMA)^+W#^0^`^.TXV/6UWT9S"<9*%@71M))NV;P4MC6.B%*E#2K[TUY>4I8TM M411E>RW*V:?/ M]]V?.V>__N\_W_U",/U[@@2<208JKCNS*`H_]'J+Q>)\.>'DG/&7WKN+BZM> M1MA94WY8"KQ%O;C*:"][?_[V\.3-($!=3$6$J/?*I9K1\5V^?_^^EWPK207^ M(!+^!^:A*%&A4JZS4@KU7SRSH*9I>20,])9:'B!>31/\'*<26>+",@/JJJ_53U=C. MO25^P+RM#HBR/./;!DC;3\P[16*2V#@6W1>$0FGKRZL>D$AD3Y2IKKH7EZFI MOT\?_]470G8_B#D'&F4=$#0!DG3[5PE=[\AB#I"8&:1;?YT'JL^WY4/5/# M_^"2X1,'N84I2#W\`1.1,"-00N\^%"6"IYC\MQ*37J[2.?WBI[+J.7ZYLT]5 MUJQWEB9:;6QVJ@3:R"&_8>$!D2X*+!:?&/4JD;!A=A@>&_%=K(:&5,YH7["L MV];"RUAWM_1(K.;6'QGS%Y@08YZU87<8-SL%7*R$QIR%P*/56'I:)"NXN__' M.`RDHYGSLIG-8:3,@EN73&\I/3]@-,$$1Q@L4J&.N*E)]!BMU%32?OJ<9VC4 MC\O-7C9[SHOO8G:7(P/$:#J053&V6-C0D[<$%[WP+N;O02PB%J@)2\@$MBEY M2SE:@DVI_"XFZ;L@)&P%\`C2IN#7"L@6O"V!S$(3%Y<\LD6`1Y@#C2VR41E# M2V`J$]]ZZ:.Y2N'+"J;G\;CF.*O?5$OPK*]8BO2/CB&]"Z3MQZX"I)\.`U)Q M&U@]^=(_$V+`:,219ZCY*CD<-WJE_*G)?W9I7-P"QW.I_QQJ#0TSF^-`V2F1 MHO7>);0>&'WY##RXA8G-Y$E'W1)LM+)_F=!^6Y_1K\]8K9&7T#?IRW9RES"X MXM%%)4Q.K5G2=VJA1AL&&@@^!UG3=L"'R]<> M2RL:I\+,(9-7.^#X%CXJ7.(I8M[?,T:D:83:GHM6!G_0$3=P%G"]Y)4(\SLB M,1@DUE(WZK_E!M<<^"O*[F)8&;`@8-0*CR)I2\`H"N[BUE+?ET$DD6*,L#^D M`Q3B")E.@Y1RM`274OE=W%IZA`AA"OX=XA33%]'WO#B(DPV66YAB#YN2L0US M2T"S4>7;Z1!S`=>G?JW<7V:$_OV+PA< M'=6Z1ZVE'(L6J0CT)7VUSE2-:&B//XD0(+UF)I/=K1QDA"4GJE-YC/,'(U^C M7ET*07'F8%3"Q4CS!(2H-Q.`2AV)%+SO!YC*8<&3O8YJX&P;:`>"MMHXMEKK M:LP:4BDBJ!,P-E%KD_K8XV#7HJQQCRZ:.._36T*[&(,.D>):@(-&]&^UC]$Q M7FUZ+PVO#M%A&DL#OHIV`U/&84WW&2U!W"UEJ)9FQ13QU5`JDVRRJ>-W+(GL M0QH!!V%^U?\K]MK8V-HS%#)*SK<&>J5!K'?CWF06_@215?+( MT1T_&J8.DX[M&SF',U?SI1R-#A"MN8MQK$3TZCS50"P[U3JN!2[RE=1W8"M* MW=QW3]AB[YTH34-'V(C2]'K\N*Z$&',VQU*5F]6S`'](OY2_?4^FQZH-\#J- M'#OL[).X&AS:-4')C_N<-BY.7&XAY.#AQ![R,X'$S-3O!XQ'^)_DN0$O._:6 MPVBGI(O'_)YFB,,-$NJRNT!5)U5XEC&T',$RM5P\^S<4(E8GR$;3Y.")]+,_ M$.=(9JI[QI^`S[$'8L0'!.'`%$IKMM-RA&MJ>]@K*L]Z(#Z-I>BWKAEBR M$!0Q4?II8*S=0DL!K*WG86^L*($N<2+E4^#?QESV.P:.F;_A2]+#'@UOS-=H MH,W`U5#3R?LGMOQ.+4'>8I%]K^)`"320T8.K MN=UHFK\"\AY3:36"YV`ZR67=0LL!MM;3Q3LR3G55?G]8;1?9#9=H-+,R*<56 M&T'KOT.:U@'9U57:"^W-BXX[-=AR]'=5V^(:#R>\HOBK%+5\0,=^1^>1`+:J8(>O6BE1! M\-QMDK5P+?">'*P%#3-4G;H!M2AWR0V2M=`M;>/D4"[5-$/;J3M5RVN$UQM$ M]X3>KL&3\P,[M3.GJ%[^.O[!)F?WO^\Q1=3;<_];VT@#/^CA`?C)^8_7K8KM MBUNDYZP?@+H_0#TQ*+MK@RX./P/,FA\*V4EM%[?>=;H,J50?D7$\(=@;3:42 M^MVA'=HX0>1+-'5Q)WY3_(?-7Z"P!#?'>!H>KUTP#AP$;..W8U,#: M!5+-04)K95TL=9JI[T\0<:VR>YT`[ZGN)U(2^<^_4$L#!!0````(`-`PKT0_ M[NW$_!\``+^"`@`5`!P`87-P=RTR,#$T,#,S,5]D968N>&UL550)``.HD713 MJ)%T4W5X"P`!!"4.```$.0$``.U=67/;.+9^OU7W/Z32SXXCN7NFNVMRIQ0O MW:IR(I?B)/>-15.PA`E%NKDX5O_Z`;AH(T``),`#*GR*8V,Y&[;#[YSSKW^_ MK/U7SRB*<1B\>SUZ\_;U*Q1XX0('RW>O/]_?G/WZ^M6__^]__^=?/@Z^/;@Q M>D4Z!/&[UZLD>?K]_/S[]^]O7AXB_TT8+<_';]]>G)<-7^2MT-H]PT&9_UO0\]-,A:$ M=+WBMJ#_.RN;G=%?G8W&9Q>C-R_Q8DL7:;-(MM/L#_#+>?['UZ^HO-S(BT(? MS='CJ^+'S_-IM1\.DO,%7I\7;G13/]%(6W5L392&:Q<'9@C-AVY%9S;$ MV1JM'U"DD\B#<=M0N"+$1%[Z@,ZVC&NDDS5Z&VJ#,)EH73+%@!E-)4&BP=WX MZ3L98?3SVXM\M_CI4^(FB/"7S!X_K=P(K4)_03;9*_2(/9Q\#MQT@1-$=I5C M1BF!;H3)9O@4?D?1&R],RH[8FO#0^_:>['^+RW#]1!24;:OW[H./8B5J M:X9I2>)7-XK<((F5B3KJV)*,*Q1[$7ZB?,T>WZ M!IAHATPY\;PP#1)RJ-Z%/M$7(GI+7.RK4*]GOI9,_Q&2,2]#R--T)&&'E?X0#3E7I+J#B@ MC]@!"A;T(IK_E@ZF[RZ:^0U"[V!&G[[4PXAY.\]NYH]N_)!=S]/X;.FZ3^2: M/KHX1WX2E[^APKLX>SLJGN8_%;]VMF01-M&4_!B7L_CN`_*SN1U^8^?MZU?G M4"1G=U(9]> MDQYI3"@)LWLLW<)>Y0^PW[TP2(@U7OM9/[)RT)+^\'K[=S\DQ\Z[UTF4(D`] MY1OJ%`5UHDQMJR,*KP[\00P= M,=L[%T9TPW-3U2B&)W"VGKC,G)Q^G*O2)6E63X>.3].*VG'%55C7^B(TKL,@ MN_I_.'!;,G15:>O\;$8_+#=J53?Q;.'1D+11%:R.F"U=SYI4?J MX#%0:&1D@4HFBP7.)[]S\6(:7+I/.'%]H6YJ^SG_Z)&2A)P4VAI;H*TY?14% M:''M1@$.EK%03>P.SC][I!\^"X5B+BQ03-7E67NG/F[L_`JI$+6'$8MVBS:T M[#T?S]*$?HZG*(`Z11RW=7Z#U0-+MAP]L$BWYZ3/6)G&<8H65VE$/^.@"(>+ M+ZZ?HEFRJMVSA'V=T=M>+1'LL?P$\A4GJ[O,F8_N?-=#A9?Q6(6: M9W!&AAQ*^A1L@N-"_3];L)[K-J^/Z'OVEWI7KD1_9P3J[]!UMA[R4RCQ%WN5 MF)\B+;1X-(`S`O63R*NFP5E[R*0]YVT=T]G?9AEM\?4+BCP<[[Y9*JY5YEC. M"-3GHFO=\GDK]/P/>Q6=6Z)6!N/1>G`03(BW0HO41P6XIH[^F,>`$$ZB:PX0)(H6M7*V5)V" MZ3GH)6>&S"(`N1RTLP+4HE.)G,]>QSS;G` MT3<5]=9\1C#`^V!,6@5J"U0(U*HL1!;M/U&$W^*KC6&Q1:;6?LU3K\*]1?L$ MX\C=YWF??OK6S85%GJ[K_'?9<4O#$MX3(K\IWER;3P2+A^KZ(MM.3C:A%`07 MO'WF)EZ"GW&R:65A:H/#`K@@GT=RLA%]L._""7(4#&S;M6IP>PQN#XO6]>#V M&-P>@]MC<'L,;H\>&=/@]K#3[5%CX-V/Y*SH\*X11O#X.>P_T4Z^#D& M/\?@Y]"9-JSK)Q@A8H']E.9;^82\-,K2K5R_>'Y*!$"1YU09:>+F;)6Q;73:=4J]U45=X-XY9):I8CJT.'J/JM\;Q8J<=6.B2Z342 M16;E]1-5TLQ3!NKK:*Z,"A,V.2*,Y+\SXSZP\EXE%(1%RM:3H,U0E)6F!'K< MF"HN,_;LBIKT8\LM1:^B++QA(H`>:XDA1'3P& M+#IK+L/@&44))H>GHG8$/8&S'"DO'#$S6M(<<5*IM/M*4*23GSS$2>1ZW&PJ M6BV!V`TBG!Z+/*N46)#;=4;C$T%E9OH`PEQDJCK^1JRK]A;M$HQK%UW4#RK34J;:%_%N4/"]_ M9,:92++'99XHJGA[HH5`S_5]@;(R=:UL"2%8E&J-ZU;("<]3AWU^"H,=9TT\ M+OS1G!&(OPS`*M3%(DH%!HZ&D/9F3-94>.;`6?GXSAC$H]?M"UZ;H`KK^M4" MZ[H,XR2>!H0+(C0B/NS[E.A9\)GFQGOR44+!U4$FFW@6D1?0,G)KP;L-1W3& M(#[#CG>CYJ(I;.8W2+PZJT9T6^_V_IBW-=AP?F,UE+<$&3SD-;MAE\CI>B$P M?-5,:GN.83ZJIRH1#<[I`8D=YFN'O774L&"/GYA!I#B\EM<''*E;(W)I'=D( MK]6L)6N@*AK592%0Y8A:,1"6U1XX4+EN?4CI2"\.EE>Z9!FA[.#CG"K51H90 MK5H/$C;56CY+B>3(W5U8S4S%K0JW?;:`ZH2X([@+:U24(O2VW%R<6C=?CE1W M[_>[-/)6;HRV9'!W5KF.,`4H>8;)D+<4!P8-^F"OD@,GU72!@6"V>X=5.;`( M'7!>DZ]=T$+%GD28?E\_M#1%L+Y0RYP(NQTW/74IS MFI9$X$3:MK$KY+Q6+9P];9\3>_P2&5GBLM^[5N`>H@-!ULAZ1VZOI0W]I&@J M=@N].1_<%[Q.UT+Y'[2#]=X<63);[A5Z[3'X#T1D4B+?;P<;KRPG\F-Z3?IT MLM-%-J*DTA0V)YGB#:B."8O>:Y2#V>-EA!8XN7$][-/0ICR*X'T81>%W^NAQ MG\A?DDV-U:L,`^CBX.B#O3)4>;)GKV)1/B47Z`C%R9R\/?+)\J18'9MNERAL&T-W26JMU/%D4?<$B_?KE">>PXRMBDG7878G>0-&R M>I3(XL6BZ`H6R3E0;Y8F<>(&"V)XBNJK]`<*A]6C0#8W6H(C.'?,LOI+#L[E M72\/6\%&D$J(F$>SEA`$@2#+[SQ[&2"^N-&&'I,1]E!#)I%J.XV@KQQFA3_,_[.CZ MBI/5'#V'_C-97:R[%Q?L8V8ZV#!!636;9+XT$AN\!50BTX"((J6\?@[<=1@E M^&^TN,*Q)XCI$O:%C?U3>)+(<5+JS09_P"2GL(@"RV`9!:EW$5ICYMU-NB]L MG)V"WN0X*?7&=05T@9S)+I*KT">DQ'EJ,*#*&A3LC!>87&D_N5EY$TK8K02" MIKXC"(1F2]$LRF7Z`26K<$'S;L0)0GMTOM]4&Y?-A%@;C=.`E`T5*HZ]NG3S MW7/X#E.,$C%AS#Y6P'LTZU=D10P1V/,Q;(\XFJI[]GA/;G0Q.7VH4UD8N"3L M#(XBJE4#1W-27/U`*K0%FF1(EQ8BF.XB_.PFZ,YWO?JPB?H.P!%I4NN(K3<^ M/_:LNV;EL@&CV;H]`"ML6P06.(4JQU"A?%S],!"Q"_.K-?F4*Z]@Z2=FH M0=JKD5T^8\V*@C[+S6C,PO>@GDQE,,A4N44BI:8]/BQ:5$9JQ1I"L]IXR`GE M8%'9"#VU2$U!:S45BQUQ'7!\=NQ9C[I49,WAIEE7%AYO!JMB@OI$^26-ELD;@P7MRVGB;I[J(@QFVZB1_3F&1::*?&XKS.&"^C6JD0F8R:O ML!4*=K_(HLMY.Z.HGS.&"_5NHA%YIBS*P0-?2W$,%X#>?MVILZKE@Y[.!`!C MN`CUQJN,P4)W>77N0T8ZC<\!F;YR-^6IH/&`SA@NT+RQMMIQVT6>'V7*LD5> M>[II&-H9PX6:=Z_L([XMJC=(II3IL/J)S`9?NKK$^6[)K,E42):M(55&0QM-9M:5ST2^_21T; M>I(DZ0HP#3V$%C$MK+W+YW,<=5EWK$;:Y;9V+'OI'N(SH243$S3)6)KO:NX9F`4GTBIK=/`MFN-^KI$=P+OKE MT&C"GC#[D/)N5P:BX.S+<+[7Y3\?[W+Y;YW\$S)=J>61>/U"KCTXYC[+Y#HZ M%_WRARAP56K-!H3=I>_&\?8(G45SO%Q)9HX6=74N^N4C4>*KU*$9$,1V%SA^ MQ:MMD76]G8L>.C446"L5Q'5<=):8K1*E"Y6<310RS(L8OI5)X-9Z<-@ZB6K*;:<`R2]FQ:ULO=9K8+I>?ZW9FEN;(C,TZE$MIU4>+8'"7$*64F@X_\J MZN7L%H9X'XQ)JT"AT:-66)6%,1_9372631^+XQDKC8&3W!E:^QR;8'+?HWV" M)XSMYXL)>32MU&>!8!?K5R?/WRA+QD MY[:>LS]-=C8W;#78CHRI`TOFR?9$]]R2W2^A3X:AI3L@#/EP=LNSV?7.E*O2 M/=5->8[C;S<10OLE;+NR9=;<,&6`3\^2>;*U"#1OG%]^7 MB&U*\V6<;6XASJY)`,JK^(-8]YZ,309G-&$D%MZC:(2)H+JO\8F!\E*"FF>' MDC496&*0@_HRQL8G!JH7?M)&N2=94=@+.'ID-,!'!OC(`!\9X",#?&2`CPSP MD0$^"P:5H=L:-'N+ZX35HSN,@+T_\IB@X`Y%.%P8-+K#B6#` M$_VPN*JD3FB?NWYYPE'6IPNC8\P&`W;HA^5QQ'4*^(4MAUEH,?5_&#]F*W/! M(!+Z8GH,89T"MJ!ZC?B*:'@T$>HSBMPE$@7_=TP!$+*@'U:J(D.+B@(U?\XS MKR2F#%@?%4#X`TN,6+,`HH47GFS<'W5&GH:4[#QG8&9N\GA;^79_OHJ\*V M0MXV.0/L(A"2U]-$B?U;'U*:^"%.B2^9/$P&&"B2T-,4B[U9`U5IGT+0@B+; M=AX4BC3V-&UC3U>*E#I$81C@G]^*6FC#1[CA(]SP$6[X"#=\A!L^P@T?X8:/ M<"=A3,-'N.$CW/`1KJ,-8P=^5$G95;!B]Z396Q$)$=8\3>@7;-1)<(\U,:.C+DFWW47/"L\@D*S12MN;(SX-6 M5_CI/KP.$IQLA/<,Q9%,?7Z1OH^:4R_;G!K(QYXC"-!,;+EI6F\O%MY&KW"$ M/#*V\-IRV!#VLU2#A>KG"Z/'Z!7EI@I\)^8_80Q&].T4HIK48 M$ZX.5+K#?@9IK1E55K4930["FSWN11)O*0NC3?&5>?+T%(7/:/%^0__H!AN> M/0EKU*8A1;$+QC<<&3;RB2?7MF#>YZ+,-ZTS& MX7-6V=:4,\WE$D$LK!X<,:!Y3]K8%YRT++H)-O=7]C;K)6#FDX;F"B6F$THM M#)]2'3*WB6F[:RB./F7_55I9?T1A;`2WR)_-&0'F[`>V+YXXC)8`ICQ/XSA% MBZLT(M?1?/*,SG@_05".):Y]M\L/XXP`T^.WNFPUX%-+[EF.^@X.NYLP(BRM MPR`CA*>JFB[.&#`??!NUB'C2DD%54@6%`8@>.8)NSA@PJ[E.5;#XTI+O4ZG> M&UV.V]5:^^ZL[^J,`3-SMWXE2O"F)5,E=Z5D[H_9X]8E0AT<09SZ"3GX[L/2 M^Q$LOKI1=A;R%X_J2,ZXIY[#AJSJ2>_(6V.N[T8;LK@?$:;5X<.[-/)6A,%\ MWXWKCA^9OLZXI[X^:>:$:0[U;X'R]]#\[B)3I=#D=,ZXSPXY0_(H[::=S\V0 MW="MRLO,GK(P#6[2)(U8_C*#LSGC_OG%3(NC-!HK'&!U#Z@CV'C&GM`'T6A` M9]QC-U9SCDM+:.>JJK_>Q1E@@1HBBQ;1E4[0VQGWSSVDREZII%X48>+M2N57 M[MPJ)VFR"B/\-_,Y;&PN9]P_+Y-9892FU>LZ2$<M<],\1)\%1 MJ2D;*L5Q00$2?4Q:2L/.DQG(O^^>>:,;E%S1C!O^_-=AG&2;S; M#HH*'US8N["G<]%3KYPD:Z5B0$N/E$[<(MO1:,AS-.0Y4IECR',TY#D:\AP- M>8Z&/$=#GB-KCA'RXW-4&;'TW(>UIIR5;JGOBD? M$Y$3^MK],7$=T(^A0AC M%N-S''^[B1":!@F*4)P`[.$U)`"GWSH=^Q;)^!0"G*7Y[G;_KB$!.!G9B9OW MGHR-QE72B4LGH:M*W#B6"@.U895E4@)[1KP6>"!LS$8HF!<:1R"H"7 M+8=9:@'J6C!^-E;F@H&O6&9A#)F<`MJD>O:;JKF@AP(@K(E5QJ@BJCY!1DZO M-@A@(INN;%6SN+1@0"RQ5\:U!,IH%4D!PI389;E-9*8%+6+'E6#OR@-T)9"D M`+08H257`A51:2G"H-%&'\1L/RC?A.:(*B\KZQ=DLD]=GZ)HQB)[[98:T&J* M.FT70&Q:JE?88@!K1JHR5VW%1L6DI]V'%GV%O*4\(I#F+L M99C&;AP'AW."EF:TY%Y0+QP]Q4FLVT(/.>UHISR:%+0^HWT;(DLZPMHK`"CF M(I/E`&8>P,RJ<,\!S#R`F0P,R69GLLRDC= MN5&RN2=$QN1!19\^[S?[?Q'<'.0',01[MNU:H280B\"$^^0)=_EJ8U,@9.D# M7TWP8N7MV+)SR3;2D2WGJ"EE67A$7N$(>61LX1EYV!`V;2)[(;#U4*7;8,#. M5^S[V%V3C7R-D[^Y,N6VALDRFL+F MB9,6+(=R+7!K;CVELM)ZO5"/VP&G)I,6*9-N+?ABWAY0^+V/2C=QMP%V\[ZF MQJIQ@0K9-;E]M/W<=_3=>9M29O98S M?<7):HZ>,:&6%BC'P?**G=Y:HA0E23#_'#W1?[BGJ61W2)R2XDI3X3/?AX?7H/MP]D?B//^6AG!%<]+3BVFO*GA+-91*\K7C]G#!=`VO!]515OMT7RRB/O[&R[%&]1%`"ESM,D^ MQTTSWW,@\DZ6TX#L2BDEC9;4$*"+ZKK9`%,VK76VK8FD8@]>94=I&3U(X7-" MY$I=-W!@L4CZ(IVQ63IQG=F".S*A/`LQ1SV$Y8H6"%LS%L-K#9T-,O=0TU/# M9C"VX5YV(`J+0+P::IOWHT1Y%WH56]109MP=RHS#FF-'HK5HC^N`XZ'&^`]A MV$.!<5#[MJ'`^&G;]X]97;PKLV;-#0S:/Q%SYDK6(F!6XPQ#HF*I1I(^"2<% M#H<`-EQS(C5>&-P(Z3*%P4U.#%P8O'MK[%"LQJN"F^%`HBJXR8F!JX*?GD4J ME`0_$6`B3%0*_`DK)1B+,B*S/A)2>?V)%DO*\%9JBL@%YAA`02WP5J$F(1'\ M$AJ8-NH>F4:X0XOW*"`_)#0=T16.* M3EY3`DW+B@*]LOFS M<_]0<=L M;80E5S@];/#X\'0DI]&-E155JD2**UGP^H"[7&I$+JTC&_TIFK5DBY]$I[HL M=((<42M\?S';`]<$J5L?4CK2Z][@H6N.[EJ2"9`%W6"=%O)7"%E>+'K[?$I" M[UN>V^PJC;:YA?)LG1_1]^Q/M;<$J0%@W!:R^N"L'VG.[#F?)IX7IH3).W=# M[T2S9(6BRS2**.@I^^KEY?^I4:CL$#"^BG8J5>'-HD5Z1'8[A3+YA<96]+G?W M;71<=,@2T]:V4LJ1E'[,KS^^]$A)I$B]@/3NAYEVV01(0"``@B#PK__^M(G( M`TVS,(G_[9NWW[WYAM#83X(POONW;WZ\^7CTIV_(O__E?_^O?XW"^+=;+Z.$ M`<39OWUSG^?;/[]^_?CX^-W3;1I]EZ1WK[]_\^;=ZV+@-W+DGY^R<&_TX[MB M[-O7__?SQ5?_GFZ\HS#.4O_[9LLW&PC MOFSQN_N4KKO7$*7I:P[_.J9W7DX#CO\]Q__V#QS_/ZE?7WBW-/J&\)$_7I]K MR7F_ATL"O?X+66*%5S0-D^!#/&RI#>A%U_PU]])\Q*IK\`NM^R;)O6C0BFN0 M"ZWU"QW&VQ)N*9XR94>'\;2"G'"M>7N=SHRL.,@U-?_Y@LV_MS+ZE-,XH$&Q M-@YIT)8"L="R0ODG_AZRB*O;)-VGT\NVCXR6M[]_\T[JS'_BO_GU+/%W&QKG MQS';]GF8/Y_'ZR3="'5]?)OEJ>?G!2*Q=('^U[]^^I>/?_S3'W[_PYN__>U7 M!T2O_U*P8&_%*I3)_+E5]A?FG?[Z\7Y'W]X_^9/?_CK]Y\_NRR-63:& MAAM6&A_]^/6;OQ1@Q(L#(@%)#9+\4L#^OW^5BREI.T[W/XB7^L5"V8\]Q*D1 MK_V$&=QM?K1'YSI--N.^@%I7,HI9KZW%3I$I2,RH_]U=\O`ZH"$C]>T[_@,7 MR7=';]XJ0_Y/[%>_RGFOZ5W(IXOS+]Z&=LC@QX^?WOSUA^__],<__'#^_H<_ MOOWTI[_]]5<]_`*B]\,/Y]]?_/7W;][_Z:]_>_O7]^_.WWR^,*RH)7%*R*IQ MA`]L2M?HY3.'\C8IM2P0%4OL$4<)V=\:;FQ88D>M$Y,Q1/?Z//?6K9 M`+BT&C;1H!$?-9"(D80-77H;S$[`XE:B5Y(ZK8(>:EZ9/V96*."6Z&/DW;FH M_P8@I-YOTM`4E?+OA`]`H^C'+1M4LW=*3:]*WX>:5ZY/=VG*9PHSWXO^DWHI M.VZ?L0.,C3K7PT)H=`,E38E10XD<2_A@YE('A`\'5^PST0&BW_ND2ZOBM8#S M[H;BN''#T+HH^7TX2!W?H$![BN1_1Z/AQRP:5+]WR4NO>M\#6D:>RTBJK6K7 M`$+H=1T-6BF1`_$H]*D)`-'D1DG2JO%NJ&5DOK(=']EOLB'JO(4"@V9OTZ45 MI+I?(`:CT_A3$H/"$FBDSMHH-.&7W"MRE^IVBU8E=`!#VHDN6OJ$2FEN^QKWZYRWG^#4_[<0CZ&[$` MW@"8J=-%TP44$6`K(@%)#1+?ME?OWZX^0JNM\U"TJFG-2`P8JTN)88J8@T2:,VKHZU;]E>DN'2" MVP23D%.0X8GQZ,R%4>*L[$,WAJ5WSJF7W=N:`3D62OFKE;;DA/T:A99?6TS+;MZ;C#!HC^(@X!NQ6`FM+ZMC(93#%S<7/I^ MLHOS[)KZ-'SP;B/ZA>9*$SE;32,N<.-IIK1E0]5P4HU?$0916E515 M1+.,>%&4/(ISVCI)29#L;O/U+B)>`9"LR3^_(5Y./K,]<4_>O5T1_C9`I+J? M,62;6YH6OWWW[>0\RFLO9V`__XJ(MSCXO!&+#6WGE)@0+:VFKE*Z]<+@P].6 MQAD]CH/+_)ZF>WZ3K>MBA0K*L[&CLRFL"HHH,+$9!2!IG`10>$?C:*02+!-$ M)H)(WW@^F%?G0'Q%0-4S?$=9.$`V>)96/.?Q`YLV29^9\G/UA_9AH?V?!B5- MZ2O_+,P<*N?&=N6(O`TG9F-U);IDW\IUV`-<>L<*I7%&UY0IC.`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`6YM M>F3.RMSH<"R]?SYLME'R3.DUC43_E)9[;&M\+!!!62(;&EO5(A3,42J!2-
X(%A8]>RAN)/!.?)Q6CL."+40=7$V7@]C5737%%"J"T MK+537W@+4!WUAD1RM1;#0IAB-P*X93$G%*?#5\<@H"5118-`"UH^,MDFJ6BLF*QYH8HV;=^!^PZ6VT??7=$`N_SY/PT?V%=]H..=`3,N:'^@ MA]+V$;H87IJ=9Z"#QY1D??3"E#QXT4Y<`RFG'%=`?OB'BNK^07;/%`EAC-V@ M\PUL-IUE#,2`:/$+XB2^NV'L/J.WSO?#7:!@U\.==+1NA]FH(RY=A(^KLJL^ M>_DNG5(PTD!K-8+:%Z`#LB$[D+"8)DY$[:C&J@@D"C#@<*''W%X1^5P6$JBQG?'Y5I8TB+/OY&- MVX[C*#\5-?#>A(U.&,`50(TPX`R/XL1NWN,H[*5YM4KNH?;N'"O&$"1P#0D` M=&M,_-_NDRA@SB2O[9$_#^_1J,<$;9>-5#8%JS[X=T0.)\=YGH:WNUQDU.8) MN?*`@VUST?LJH.O0#_-6*3IP<]":!K0'L!`5L MSM%!1T<;!_620K7E%0-7Y#S+=C1`82-="O/F#?\?R62G86^7WR=I M^`\:K,@_O_GNS9OOR=93N2+_A[Q=_0L;RM/RWY!0$"][=E1->SOZ""5INXT0 M`AL]Q:?71.M&4S.\$MH4-.$M?C8%=6CKG6DU:E^'E1;.E-@?K#< M@H=VNSHH:F7+[#5JG]E M#]X..MH$AY-2"WCQIW5!$/(<2B^Z\L+@/#[UMB';)+9G)"TXV.M>+3VMERCE M2,*'DO.8J,$HSDF#".$M[(["F/@S$>)^>!G^/<+R>V`[O$Q#$P*U/2-U\$K; M35]9'&!TL$NK[&N:>V%,@P]>RL4G._;]W68G*K2*ZJ:$ M%D"D@"*O:G#D3!.'!3P+S5`[A61>\0AY_?XCJ1#2(*/47_JJR&#R]AN0E MPQC;?EJ:N%(PJ8)"=,J:Z11,1C!`6\P!>4M^<!SLK6A`H\Q&+1W8> MTZLFXU&L`PPPH^XX#JQ4K&VFH08?]`G,@F)#@E[9TFD&K351#JXM5:VT.$$; MO'Z&H%,I<71>G>WV=,WA[4:V>-0^BI)'KL@_)NE9LKO-U[NHJ.)W37T:/I@; MH73'QMR0@D7X'6EO12T+>+).4A(H##S,(%"@<`L/C<;!D?1)Z2PPD+(^:X6C M5H`/JP,'P@SXP_D4NL@F>N^$$39-]:O(XC@N9"^UO:ER$H94 M0*A\RA'TJ92@5AH0.@?+3F*MW*L>5+![\1>%634"KVI]E,AX:B^DFM0Z9NEI4&&RD MS!&;PCX6F##:QI)*6[L(\]YC#KKV[6$X4];RX*C*A%\+:T&5_FTWV,@K-!@4 MR665)CW,LG>@P6'2N^BSE9;:C*&=.2A#R&,LTGPAH^Z=E@P_P/H,!):QT#HB9F'`B\ M#9N#:+<@8HN6#",*?YQDZH^%-T0R/:5(HR,VFL76MX*/BYS'?K*APKW;F+MG M&$V'%@VT4Z6GK_T>0XW)>).F2[8+1$O&S%#5#]QB]WP]*XNMP['XTQ\OHIEJ M.?^%6J>"ML#`'OVTUM]^AB;^N"+LSRBL;O^2Q0@,3W>7Z4Y($V=;NH<$=]]>-K2.*/9T!.6`1&T:371 MV!2G(?0X#LZ8FQPE6WY\5@ALY]0?"MO)U6J3&8VO M&/\8I]2+^2N^3 M%\;<<;F,SV@:/HA`@_4!OQ<-E,?03U]3["H(PD'4\8$D,:G!H7`61M%VQT!> MOXH*VOQ[-H[R]C1K+U2/RWA.3%#BFZQ$3,O"+[X1G.80`1/=6/5O#Z#?J8!>/9M-\^.U5`QC:)VO2TF7+]CVIA;HQ#6_! M:$,2NA:+MHL6M>'_OO-2QA]$#M90GH.[/YU[VF*PC,G7A;Z M/)TPC'9Y9_V73G7BGKREB91O#LD+4B@@HF58JX5#X(.ZTE;N?.."@Y(KYI>GE6JRM5I.A7]\8U>[06:#=I<'<:^.?K6#;IX6AR3&%ZU_'(M)(BITI^]-/68B_PQ2;\J&;I,3R,OW#CG MU3@BAW8P77G1E-J/826ZU-2T'=.!U^SKVSI3KEBAO"AGZKN/,!*82&@BP84B^EH_T%S/<:`9 MXD!-1'7MX,:])$%C<8);7/\L0&@@/Z_LX-1]7@710Y/L0`OWR!'EXG>O>PJ3 M%QHX"S,_V<4Y4YZ;<+>QODCM1P1V*VI!8Y\IY5"D`".O%"".5U53T!=P^@(% M!NX7.$NG^3:P%\OBL9@-\TM2F9%USM1S?!?>1O0XRRCS4L(XS&D4/KCG]5JC M!8^_6-/?>E970G*IK6")!%X1"7XDX!$]BYJ*XCSU`KKQTM^8'X_M[?M$)(;5 M1_4$,!KW8.#VM0N?6.($>$V=4H_7()+_K>5(G'K;,/YX M^BN`R*L"_%NFJ6K)3@H%MDRG443+"CI9(RE)B*]P]&LU@O`D*+D+=]\3:5MT M\-M8!4?.Z)JF*0V*6HEQ<)G?TU0J'F<'9.`LX/[(4.Y8;OTBWEI49>`;0B!2 M;@LN.SX5,UX5F+[E6J$(1M(:#Q+!`W^7RE#(/+P85;AF/K$(^\4"8U;3,M*1 M68L'O#,X2K/:5N<9,@6\C3GVQ3$[NZ8^#1]XS8KA3F(7+CSN82>EEM:A@"45 M,%)_T(K*8OCK5V%]AXN3*_$*6M,9:!U7V&<,K4X$(G)W]1O4T='M0`2O?L[C M!V8XDC3L+%?KJ-7WD.%S6/=IM71`:D"88F5#B6,4A6KD,XF2Q^+M.F_BG!(> M-:,YVY?\`@I74S!7BNMJIZ08M>,\5CP/PQ6>X*LA]&<[U.A`M[6."=X\G.ZR M/-G0](QNDRSLC'98FM$V)CR>:0>5EGYI`4D*4*1>J0N%;.OY!5G!Y&1-ZH!: MD%77*+UD(7([=3O/T>ELH8'7*<6)_%HVVQGO=K80XG,]VS1;VO<"D"A(Y#Y9 M/YW[Y`4%>6DW>0A-O49\!YK[)C;X[2G#8[Z?[IAZKFZD1EQ=ZA#B<0#T-%MN M4Q62EAC(Q1S-/J:]M;0F>)].3U$HJBV(2N:>CR<7REF87:\J-=C@-VT16[KR MGGE@B3\"MMG!CJK/;A9\UM>2.ZZQ:(5.OK2'W_K+,&5?'S0"NML:1TI5,2-' MI@R_3"@DH;V0'$;09B1O7K\*IA,:A"ZAB_8=Z"=:38&W3J&M]^B"$:R/K@O5 M$]0?1.%"CB9:U.3:%D3?/K]^I0IT?=M9H0M!@09HDN%Z#3MO:W/387MT2!18 M^8!]MD*KQAF@'>A!7'%4=%6-`!1E#>?G1T7PX15:M=@/8PJMFM`OK1'8VGQ* M`]'CK2K7<)6J,%U1MT'^@K(_BM_8NC=#L4.Y.H.YT93^`A'A@DC.:P5!2F1$ MOHGEIX`*G_PE"@]H)E[4BZ-L2UYD762#.03C-H71.1B(&H-:.(^9JO*BJ]UM M%/J7:[:^[DHJ1HWK@!C:+7#A@>7^5^!$PI,"`:)$JS%$2X66J`$BR0I74'!J MX@A/N$;GU#CO72M?QAXKI*ZZ"&.:7:Y/17_0(5Y*`P$&1Z1)DUG7B-&B@8D8 MC\Z5Z*/F)$G3Y%%T'DMBPM`+3\'O)`:%@]`I@@7YO#=G:5FZ7$V(<"NV8*>`T?6:Z]BYG_)`2[8?8[=7;2,*,L@GF_SHI4:/K:X=I\2Y8N^TV$OVDO:CH)WT> MKY-T(TJL#LTFLD8+[>O:T]^Z5ZI!5DW'20T8:YK01#370$"J`$XC@`[>GBU. M@%>$\TN_+"KDK#ND=(^V"`S]P:Z^\X;/`^Q&((N>JXNYWWXGW@JH52 M4+%842T_YX-1N)$#6/[Z%?M9W><5%9%HT#JX0[ZIZ]H%?2_G]F"6W[E,[FB6 M:[9MS^N..BRT'6U0TI8F^>=Y-N^X]V:`"Q_S+,Q^V5BOP;JDW_+540UP\4LM M1C%3[+S\329>!<1!&;X^S^G&E('?'6*W1PAVI>5`<^O.0\*2$E@I-E_S6&,;W;GKC*;L+,U;])['#*=HD90Q MN\X+S08_A_F]R/]SS7H=A!JTAYY_91E8\>.0\:"2_EZFEB#I^S2X,CVUA0-;Y:YA>Z&__Y8AW MM'ZS>7?0YVDX(`+IAVI)HSFAK\S5OVR]U0&,%HRCS_C*9G;]LOR'0M+%U&7/ MZ?N76F'!\#[HU'91AB- MT783T,$O7VJH%K]JJQJ'OK6-#>S#0!W_&RLWM0!&<7JW6F^M>6]1S*=H6`)N MA4PB8SQX[P'`]I\M#_RG_,7=<1P4C3J=K8P]7FA[X\"!OB:N58!,0(L04@D_ M5T[+F$#Z&-JWVRCT:_UKE4\(WLAV(K%TL%G62('"WI?IE9?FZA_'_M]W829< M"O4;M6`ONDQYDDO^7!V23Y,X"P-12B>)"R/L:`YG7@1P>'TVWNI"\LST\1E) M\>_:G*ORE^6T?+BKML,RN,8")^X](!L`D%=Y!MK%XOC;^((3ANH\[$A4.7Y%;.G#8VY,0NIF9CHQ+;WY&HLX2S9>V+J:TND:#3"4L='1TK>I MR"]R*!XE;OPJ1EW>#;GX2\ADLTEBX45]IIM;FKJJ\0X$T*J[BZ96`KH8`W$' M/NG2R2]R&"XS,_8#@-L0[:ZP>_K<@E[^*KM^DZ[=V)HZ8%VP<$7C.BG1YX.8 MMP5@=37]%^DIK-8!N/CU57D[SO/*S^-3;QOF7C3,8O0@@[8>?;0:,@;7<1;'Q$5YD01:IJ2`#`[9)8IHR72@((%H2[88L2+B<&1 MIQH&:*O3294AELF'R?=!N%S_">D`MRMZ27,+'U7@B^^5>X\)P.4NSW(O#KH? M^73'IMN`8!<3'32T!$J,69':*!0FPV;M)U[$LR]7Y#.3V7OR[NV*L*_YEKR2 MP-.7?QM:G<>*F+($3TE6)L"0%.)Q^B#=*X>[+])M9O.540L*,+GW;,=?_L@B M<**HC^C&ZVZ_>Q'"F_-^FDVYPD1"J:J0JZ)EK<6$('5?3Z7+)BV]$(A=.AV) MKML3GZ&T%E_;!P,Z-*.?L!X'_[7++PX9 MMD9T\FE!G_9/RK]V"+1$3FX2T@CTDBK0N_=NLTQQ%54!U#2DG`>%]9Z?=W4E M4CRH*VH$2(YL9^/(\.(`BXE3GA!O/\!.J@#[:J^A8`_WD-46F%ZA]=<=F'!. M))Z6\/V^T$?Q%^L.();(D/E;+5H'G(L8N!R`HX3@4$KW/2^1'Y&5#55+/2"> M9<9Y&(313KP+\R-OE[5J<&-SO[IE>H@'UL"$9,]*O]"T:8><*5M8D48VVM0/ M.3G-N(^'YV0-IEBWG5&X@+-19Z6L(,^,DVS#\?&=)DHD:DPH5UFH:J&I@$AE&RN2_2[5D.V&'ZX[X7;^<.5L+?]\]-&MQUL1GM9DGAQS*W@G M4QUNGTE]G&I`2HZ9J62:0LVR*K5#Q@,"5_,T,9G-7YA2811>X6&Y"%8:9&H& M+YX.[(M*&WQM213Z(74N[&S"`.4,&*EJ5P'-_#3<%G593G89;RCLW/#M8V7G!J`??=WZ*1$%HQA/4E/_KG;9TVY`D(K`&AJ:0BF& M$34.DYWI_1#ZLK&=4),*A;,E,&$`O1G74=4C)]@4]7!:$%TKVZZ?E["+DFR7 MBJ#J'C7(KGF->Z;_QK8;?&G_\(S>YA7+78\P.FBHXXN6FK:[,U=09.KLRC"0T2MA2XJP<<1T.F`(WKFH8H-B? MH9R+L9I?O8`?BK)]5@RU4+_@A?>:-0"_)#F=0!$[((96S2X\,$EF(9@<^B`4 M^%2$%UL2G8IWEF[[6P8KK(L[4>4:+M?UR[1K*E[4BW+?XC)$W*.I:S3G"XBQ MLX!Y^6.YTWT5=]*^NT1HFJ81#?-)8MP4:#?+27VYPT\F8Z>#-I/C^66(V5RN M]W>00BJ[5*CK[*.3^NU_AM>N3L\IH6F.VIH&G<6=:%/9';Y&SC4Z^ET\AW`/ MA/6"@UR/&.G1MB-`TF-Y%@I@;GCZY4I_SV.`G4S>A]WT=$"#WO)T4:,7$6RV MQID$1'O\\I()!=Y6@W1/\U3AMT:?_WHQ>F(L>V8K7S4=",`^J@UT.9 MH2OUA6K.C32_S.:3&8]H1@3+7_D4?.<]R,JEC;C[Z<,'?H3JIU@OG#(IB@/) MMQ'X;-(D9-;W(!IM[RJREI='/<@6OPS8W6;T[SO>M>%A2&!0#P_V2$E/4>N( M70XE\8XA"I\Q[Q=#N M-DB+!>YIR>D]?SK%KO@Q_;&*#$_[YB17E35&]ICYM)):G M2"%YZEP$!J*#`:P"$R;OGFQ@+AXMV1Z6/M3=">3+)E MJ@6?Q_4Q8>R'VX@.MZG3S`EM?B?B7*O%,7TTJ`F^BXH=%<;[`POL>$]M,[&L M3[FB$EVNBP=&XH'5LTF7M&\O[!"!7'!9TFAZI'99 M>Z3VBP0E@#MZ%AIK#_$6OS68BZ!;!0AR@S!TD_1=]EEA6?SIL'R&V'C,_-RO M2LPO*BVQ0CL>UM2W2^?SU[],4BO0%5$*!H&BF9GHJY1NO11G3HN;0-L]X+5# M.=JH?Z;Y?1*T)W*SZ!980,RY#75-B9,PW(S7/%($^VM2ZO:T"`(3/HX4KX1" M8KRM=Y7>C6-IL_YC1R_6'+`\W7NY>@K,)#6V&6]0TQ8L-X$J@''(PMM:* MLJ1&&3I[VBUI5G:S`;IXQV\ON^='4X9J:#06;I^N;2R>@8T2^^T\YA?I13BG4Q/IX:'LG(&B M5MGN8BBF'34946BL59^,&0V4%GAT+.5C^$2#XRRC-AZ?/F?&(TLO<2_5NH_^&$`Q;5(*&+655D2"'0FX`[">$]",R)Q:2FF/7>W#LOCN MVVR],.4*]3(]"[-MDGG1Y?HBB>_$JD99ZG%S0!\4!W*F)=(E&G*9D@(1CYIR M5'(OEQLF#5)!SO06-TI]HK5$770!&`O'B_73'UYL1]ZT7F^Q>E_&-GH)2FJPF#;[7+0G&MK16'4G6;9[$VK$M'Q(EYWC M=_2:^LE=++J2CH[L]B*$MMLV-+?CO`*&U(`P[<\EZ$5G;:UEUS+ZVX=M^;V9 M4<8G?A%TQA87)5NN*3X\\0H\U,V*6J&"LJ%V=+8E5$*)*\$:'%&`F+;G$F2+ M.DQH[*:#[!JMI@V>Y8NY,MY[:7"5)L'.SU6)D6?MCNRIG6E$!FTK^VAM5U"3 MXXD"*$K*H+K+F93B8@#U>*#-HX'"]LT%'TK86$S; M;GKJ$&;"]LFA7>A5AV3Q)A1>&H?Q779%4U%V=:#%ZT4#UJ:BE[ZF\!40O!FQ MK&&,:8M-1"1_R^3+4U\8[;@-OTBR&LEH+)NE?)K;=?3@6'K/7:5ADLHNQ]?4 MC[PL$VTR14?(X+]V6X_'O:;"+Z.7ZLY?O4E$F45ZTWM!TP_M1W?!$86>KZXX7K*:?.P=: MAS"%@E]Q5DC*S`:.A\A6?P(5.B,]!0NJYLI>'.^\B&PJ1K!?!D`MVR823@M3 M[HP4;JM770SV3]19GH8^\[A$4.''.,RSXT36`.T$T]/;1G M,#T_37JEWK*D/LN*5/,0V4%(S$3$5*28"X'J@69FI:$X8B]^_EU&THIW&9^7 M>!PG/B=EIKUK%P^?>&YL>N^8Q_?O9(&LD^=6AQ=!BB#!W?<9/2&\4S2>9UJM MEA1:[;;=\JP^`;E]WANH)E$:3BHV;([4H;(-@4\VT2ZU=-;&SK9X55XQ-9OE M^"ET+JO1`(;VH)JTM-[D"DGE`\@O?`@NEZ5O]:X;UKA?5Z3&#!X M1L<:<)>E4U"M'(Y]R,7=A<$*H5IW'/#/P[_.6;+QPJXP:;<2G&5N,"=B'DZ: MM(0PQP3@[1GOQ21YNPSW=S2U-6#Z,(` M[49T4M7=7%F-(K_(<;@<"@Z+O@Z/S`W3[_2*,Z7E.-UW> M^3"=9C$36AMOPZ4A)JWG=,O1$X'_0)P!?'S":^.M=]XXB]X_#8909GUE=;7) MW^!)BK)LMY&_F_X&9\SLX'[#U-QLI^Q:+X\%P.GOO]:D(7<,N2)AGTVT@?O<,ZB&@=?D(V8&H-1J5O$^O*M4P$& MQ?AM9L)Z(V;%I>X[:::\,J']L]S+=R)=AO^KNJ7V[NY2>N?E?$3]]`=B"9;F MCKBQKSA3<47I%@Z+PS6`H5WI)BV: MQZ,XXVZ6BT<<;>L4)2O?91\2K(+2>;S=Y9DLZ_0?.[:@,!>=S,]CYGMNQ`X> MYG*,F0&\UM(0KAB*$$ETJ[+&6ATEJ>%$D"LX/U]J1O71=#1B?WTC)5Y,QU'FC# M/H)#IGR8"AFI82->3FKZ"EX-+<::2AD%%6>B&F=J.FA#O6R7,E7#-+7'%(R_ M2U/>=>R6-X%#YYJ,W6*.$1C'2<`<'JD5/ZM/>1E?%Y]1M/(;[N98XP5W;NPY MH'=I"E^&?*[MB1(1D>T@X=7(7(RHJ0V_ZA->4Q6\F"RO)D7>D759?K*F5O"Y M)([[PLX1L44*YWX<,^+ZREO_9'8^K,A$W30Y,?0I2S4&*20@7>%*;1O30:]5O@$S#7U0X!AGS M2:9>/$%_W*)/GKL1:-+].[7IK$N`6^6,&GBX_\%@X&JA?9\C4B8W8"R7DWE2N&EJ:I>HNK MO5O2E.KK00-7$[*/OG8MR!*"E"#J>?QL=U#NU^;NA"U&S+`REJ[D?*4IMZK' M9,@'`ZQI:;7?>FI9FG'@L'[6EOS"D/0^0#,/F1>G-1W$05MOU/FT>0&;[KV0 M)(RVY0,F'=T/M%8%[')]LLL8YBP[C@,5Y+MQ;*OF`>G3 M.KN",7A5,TP'U@K]VGO\[+&S1.A%SMZ4!@FT:Z2CS=`1/?4>>0E!.135O3\Z M8O(D]Z*E2&$C23ET16[XW.A<2>->LJR"WH4!3"?\G*2_G<=7:>(SE68;S]%! MP_5^UE!C$+='-I1?:F_E8!1ACAGH`.SF;)*PGA;.G:!@>Z1\6L5[::4/=+CQ M[,"$QH)V4:F5.U*.)L5P1,]&G6BZ2!YI*C)=DBPG2>&RK=K^Y&=@V&H#K$Y^M)96K"+/?KFC*?^'=T;<.=R<&'(`7 M)R;*.FY-JN&$CU^1"@*%[76E:)?ER88ICE1V/<5C>&V$KN\"08\`Y@8R$R=O M<8LAHJ.9NN2@0=<^,FH9"X30)MF&YNY[R4Q%=P342L;F,U("(C+10VC\LN,7 M6)R^;>,BSZ]=\H5,^;-?;#:,%>(%*RJC/83N:YI[8J2`)WIMMZE5A:\ M'QN:/`BYLO,LV]'@QVT25TL?G1MA0HTN7\+(!X<U=B4[/*,-ZOF5W^/]Z%_3TIF\K?)ZUV^2RE>=V32 M';E$MH>:<7FW)LNS\Y@MDV;9Y?HDC"*^JLOX1]ZJ=1M1T06V65ZE29W MJ6=??G0P>CCW9B@_VBX.P\3#\A*72%)0V)!$.Z:DE).WJP"YSR(A$?DGHR2] MQT<9AGMT8M>GA,TCHC5I[/103P<-Y0UHJ6D*FQA#U*#9&O3T)>],08,O!X'D MTSC)A(41U(`N_NBU+([R@=\`&%K9=-<3TX&#%0;4TM-^KEV6A1%#(3O;+$@* M7.DYLZ29Z\EI8!'LEF&OT0R(H$^7)AHM!0^H[PL06>`GMUZIM'OHK<4"O,O< MGLUI@)'8(_W3JZ;((7H7AX^&""JP6%*'9V[=D*//5,=W*14]&ERZ('9! M@IZEFE2TPJ/%W^=R$HF?;#IQ->N/6`W#,A[J_;*#4([ MEU?F_FS'8=E(WLYH1$3_^J4),%I(JP#Y%?M`]UY&RRG<:E;;8@/5Q3;4&JYB M"B!2$W],M:X/C<;AEFER(I%9,.MMV6_5^E%-&OR^L&V,9X($L7HZ*GH"WQZ/3^_#>,HX/\)S>\IJ@]]'ROMAC>.L^,V6( MS-T0>@[@5LO\]GL8.Y:.*EXD\=T-33=G]#8_>?[LY=S8/MN6Z+#%`A5G[*6N M_8(KOCOB$(2#K,C),RF@L%3%&$Q;K9J%%\=,Z/AS[S)-BU=UOVUEIX%%\^SD MTAC6ZT$!N=,^EXR_IEO9A2^[7%^E8>R'6R\ZC[\PM7#S2*,'^CF)\WOG9Z(C M)X.^;1O+J\YMG5?;NL*Y(A56F16M\/*,*XZ92-1$XD;A(\S%)>Y$DE<,@F<: M9N3F\]^./GRY69'SV/^.1/R4[C9;8:U,&\`0VN3)BU-<5%_QY76 M,=7BP55BIR19J<5]R,5W0!@;=T#G%F\`0:G'YMI;0B/_CBNI>NRBP?1ZIZ08 M-?L^Q-*2W>6K7@SM\M&##%KW]]':%#+=`>8"<7L-J^]II7'-F"9HA,$.18/: M673``36EZ**@7>J?B8P:AN4"W'7YVHP8J(8#6M$QM0UH`RT>6&;;YW)]*N[_ M/GH^;\_\?+I+4[:_3I(T31YY5HNW97_)GYW#R4ZXH56Q(R=:H6-UE2H1D`+# MBB@R"QRZ( M,6S[\SBG3.KR:R^G9SO>I?R*IF$26%\7.^$$NR9VH]QZFQL]702O#M!T M.Y!?4'E;C%T=HLWND_S!-EN+&,-^__"T#64A]C.FCJR;!EBAPF2AVW1:;^(* ME)QU&"LTQMB>1&6#-T4.>X#=!FNDU-GT-O%@V(&R-.=E51!U"E/;@12CC>VB MW7I?2F!2@T;4?F`HM8JHTI1F9!<'-"7Y/>TQJN@\")>/*TE:$4^2O_6>>6[) M0?@-VOT[V&%H8QP=F?[92U,OSE4]'T1OC)]ML16F"4_%515>!G[STF1_X MT]"GF;HEM;7WPW"#/L9VYX16PLKJ%A*'ZLNCL!")AB@\*$SCU`SH5!+D03%@ M*QFP43D$KWB'`='L`].+;R!N('LM/E`]]+\@=T6\G**3$1`GM\,:)ZA?8D_Y M2,4F\>!Q;R8@W&X+J]@BI$)#PP5D_I7CMN]WP&P13J:X?J)9;KJF[%?B#0PH MO*TF55K94P.!;ADG).1!$;*=AY#Q'L]`2I!Z+IW;QMX_V0M2U?`!AL+L[-D4K.#LA<'I5(1O4J]LC,G;Z8<>;ML^A21 M`67C000O3XA7"=Z6"UX8%RG=*W%+5#"UY.$CESQ=MC=9JXF1.&4S:T9#C?R9 M)EXZ`X8_63F/LSP5\OQC[&V2-`__08.S,/.']*FV0`B=^6)#<^<;I0IH16I@ MI(!#X7N.HU(UF^=51DF@(0L\[<-::*U2/OJQ03018S;,2Y\OTP]_W_&<59K? M)TRS\'`4I5\]7@)&Q&-/GMN#BV%NA8(FG1.R9=F$G.OJKR4A"/,T)`R1,Y`" M=D7X)-QDRINCVV?2"5:,QU>L:`;IZ^WL-=F$<'NUMLPAY9`,B*`-IHE&_19I M;@2D)91Z/Z!U!\IN+(L+9#7_%V_#?KQAKF?F^2++VJI)F`LF,$5O0V5+-NOR MN"(#F]BCQ_0"NP/BS0.E-+75,HU4!2 MCL19%\J9GFTO/>"JWRR!5GI?@V+87LJH_]U=\O`ZH*'<1NR'YNYAO_KU@MYY MT8.=*K=K_+SR("=RZ^;>AH/2 MF!T4M*HD*8'`UL5.LUOSV_?OWY'/^';D^69&+BU,\Q>/T@J(/G848_AK$7 M^Z$7?4J3W?8\ULNMH75E#RK8!K!]=+;/S`*`E!!$@/"6+KB*M7:B&*_C.;[[)`IH MFLGP[)BVIA;88#6]!;4MF:O!%'COZ`5``ARV:SWH06 M]JL7U=(F[#2)F2QG[$L747;Q/%_^.J>!=-OE9*;[D8%: M:0M:#9OILG`):[\38`BJVTQ`WG864H9;Y''4,,U7UQ`5A<@LM.WVZS?0O9@F MKE5SDW2\"OV1UT0J?G]\EU)Q%V(5B1R!'4$%'#=N]!3+X7GBW:_/!<;J;R5. M^(#H+.SHJ<2SD@_/,3QF@R!?52`K_^85.)'D9(_6%[:5@5Q0PVG!KUQ6W7VJ M2>9#\?Q]',)\37S8AV):8WB1V?9CU99EN*XICV57<9$8)VGIX-C78/I&=(J@%(CJ@@$0XEM<%CK.FWL\01+F&Z]$]7&^$;A' M&P<^KY".)CXE`;91T9J5:.E^9++.AADB0TL+&1+;3OI1@(2+A)5 M<$@<7AI/%A&D%0TFLT[8?A&DWH`13$ALFN^IK_V$.$[FM''-$3,[5!.TH&>( M@K/P(0QH',@\+B=_HAL!J$>AH:E=3(@/(\4XE8N(Y\K-C8Q`C4/D3@PC0+E% MR%P*TS[I=RHZH2OHX!.L(S%:W[M2@5K7DB;XCGHG5(^35X8[:$'2/*D[0YRKP425+86J".F>OA%'EMN(JCCI?.71 MZ3J,Q7[_M`L#?C*`^IXKPM9/\13@=%,^1K_-$M7BK\LB+\O*T-1E>AW>W?I:/NRXP_QT;1U&4%)[:]5 M1">E0I%,?VS=)AE3D0_T9HF/5*K'9$9QX^6.HR3;I=2@]N>D"%#;#]1A%H&V M7B03'M.;^:@]1W1]-,(6)6@8SIINPWFN(YL>[I0^+ZG-RW;H0SHHM:(EO\>H[?/(3+Z/!:;+9TC@3LG',5W@G[AM.GJLA*MU-1!G*?(AC1L9F MRZ&RXSB09;*3*+E[-I17Z2XEL\12P.H`+<+GEDFGW+31X,AC#A]/\_0J)`A\ M8WQ,(;L\C$0#C3`FZRHSRO*A8^1G)C5]-R\% M*Q,U5,-)N-)6RZE&SZ?,R^FA=A'7Y*N,_!.]II M[,/\3H!N*2_B4*+E<^M%+$=Y=,MQDOJ\I#:Q:%%5&Z9EG$+,NG"Y4XAF'0=M9Z[# M[+>/*:7%VU#P4TCW@E[4*43#\P4M#E\!X4NHGLDO;W#0,9P/.UISKI3OQ],Y MN(+F@#,M7U[6`<>D&)<_X'2NYL49GL]A'&YV&Y!3CG$]+^*H8^8XO/59$;6: MEW;N<6.\1MNNR&8F[H"??N;ES\LX`UFHR^4.0J;%O#RCY#UIC!*L,U*NZ\6? MC:HO@,)(R=7\=SHKZ3^`7AG/Q"749Z?I^/3RSU(-M8KC2%4L:GSWK@$KS7H# MCSD99:!`X^^#A2U(X*8HMY-5_4B_-EN\'AX,_-_>TY,26IF$2<";EX882 M+U:-Y93S)UY:DY`_#U0\S1-R2^N/1[XCQUU`OZO#\(W*D-S1F*9>%#V3@/+? MA3'[HX119;/B.Y+D]S0E:\]GMH-],EY`.8RS/!6,95B9E1;9;+QMH4#,EB%& MT?6:32>>B]'--DJ>*.DS5V,'AW.N=%%(8TZ'5I-=#`WHFK]M9H2 MLJ;+8E>?^@4<[!VG@:%O[Z9;T8BIP1Q=%F27XNP0/I_7_-O31'RX>J M,)-`E9%KNO'"F#ON"LOKJK+?'M-NZ5T8BX&W7L3K^,S$OP]Q\!*YU\VSP[W: M[;,/\][A:F<_-/OZ2=91B:^$[,^>[*J9]>!26G73)ZNZ<\-"OZX6D;IK*TD<&4SNH(=2[AT$^JW7R=<[_79JPV M/8)KRF4Y6L1J*1_-[W-2XO/C0Q0M;U(1L,/*XZ@5^Q9,>W%'+8.26^2PU37_ MX1D*<6W)Z]UKPYFSV/2.B0_UT-7%PWE-0CG?;*&[Y8]9-ERLC2%>3OZZBREY M]V9%V.;XOF"%42N^B..7#:R2NJ@WDB++^O0SV#V_%_L#K%8!U$+F;L%%)++14?V@[(, MT5VD(]MZ./7?]U9R7CZ^_/M)&^NU]*VE<4WH/(7,*8KLZ"T,<_JF7!+:`_FD M?!_B)63#KVN6-GPSG.1G97^OFE:GLL/JT@#+LB(:<'#M&*97L.,.MQ.NY^", M64>X>]'S[^3K0W\0GOZ+S&KK.J\JD1D\[!^D<='YNKSE),$NY:I^40&' M^;G::R!/"S:_UER6CG_R,KC;\R'Q\?#OG&>R@M.'#H?Q/[R8)'#]%3+ M07N0GHS?B]UW([-\R-ANOB"'B;D#7OY.;=Y>^#7P_.?GB=8"8K=N^^FZ=0YP METD'IU7="5ZAX/M!Q^>EEXCB!+WX=X&[5JY25&K+$@6,\)WXP#]+V<.VGWM[ M?,=Y9H'1/O;'EH77=V@60&_9=#2^=3K%++TTT!/-XM\![G2#1^,C_AP.7$/L MP\-HEWY_?N%U'5I,JF:]SADI89R%OJ@]!I@`VEP("C]])AXOYHV7,\MBHO@\ M[H487-51:W!DCU^M\-/+S4.U_!\=JGA6X47#B^=9)3NF">K M9-B27J"V7KA2N?O"H+W/);^!OA!)W5/BLTD->Z14+#_Z>O&.:Y2W*RY+B#Q> MI/QKLF_6R`%(_'YA^:LQ<'KQ`RO1L"P3/S/S?$_>O15<_/U+N19Y43Q&RGG5;U`5[21!R(>3)]Y.2U;MB$*)UBL]04'&6R^U`SW M8]K00]X=>NA(FA-+)7RMM>:OAU!8`^:CM?A7ZYC+;$2-FXCAP M_P^;#^X9W']/)ENY[/_#Z!<=6+;V+:'#S?T+?3F>_T^"XL6[D#BOZ^6&H%M? M`,YKETN9L9$)SB!L[QFBKXW(T;-DG M"7\FQ;96,3(#==JL9,#&E.R#V,NZEVT?N03__LT[);_\-[^>WH=T_>&)^KL\ M?&"[;!WZ-#V.@ROV(<.`61\W']\-)Y0"=Z2\*5H"DI2@1,$2+PY("8WKA=Y( MBG\.HRCT-N3X._+5O]^$^3_F(R](?'$P%NI]T2]*RR^:U+[HMH#^#HW5';)S MC:;6">$T.N=C&'NQ'WI1-=%/[+_]>F=/D[KC6]K.#J"X6SI+\#U]PS$@4#I3 MD_PYB:)G\@,-[JC>;L^N:N;YD.OR0];5S`/_D+"Z9N3.,G@OSLB6]N'%VBZW ME+=*B._4VH:%-XVHH(^L9CJ[Y;4<7BH>A`46YB4,_'QM(9]69VD3GM%V742/ M6W]'C M[39-'FAP\JQ*)SC%)*:8#C1<,0F_VH5X%%)F`8G*.&,_U8MVUC&774,+W+QF MB,*.)\PQ,Z>2-8G+W+RDQBF_SJE$<$<@=!YG!>$%TW+8C_^:>LF]?YNZFU*9KF= MAEQQPYYCG#G1K0\D"B)Q*,U8%&"MOZ/*U$M0/)<'4W&@B)H\S$/?"'=^(@)# M^8D#^8EE02-9OSS;UWF*!=C<`?DY0IUDT2BYFL`NY& M>)`XNIFBICCNG]-XPP$B`:2F@0]X#R1''&7(FI'C2W*R6IA6%G;&?K@1%!0A4A6Q2\H[: M*8K"":\<=01>Q*ST(?$J'#:A(1_3`LD$7H:XT;YF!?9``_VO9-(.&I.E7:A4C%*1"1FZ3T6/@CH`(9)J]E M0D8D:V78.2/JYI[3_C@7[6-*B"115?& M4;@N*61[<%M06`0HN.7%X"K-3"(6;\EA/QK<)1LL,QVO[.^Q9/"WECWHUH]Q MWC7`I]+-PEGKHV!74US2D2O7N,3:R\>6L^+QXY9C:U6XNMG8%N-MV,+2UG%R M]?:33K+:N*V2-MGR??\^;;67L2WS#9`YC#,K2 M?]SEN[2W#/>L4R.*`4[`Q_EL13$E=ZGYI#R_6DZ+P)=>BITF&T$+!C%WE:LZ MGENWGH=!4T4M9Q.X*J&Q^\D'$KXGF"XOU3GS,W__P' M]SZTGZ.+*,AB7J$0Q,R'_5;2G:T53U2XCX>OO#V^B#,D\;*:-MU[,P;NURVU MO^=Y2=DW^5PO%L3DCEF#)D08WRH4-#H\5!`@*/RE482U4_B]60B;_'W"4,J0 MW;7:;+K!SQ(DEJ7=IP^;;90\4WI"8[H._O,EN1V_BN035LIWS#5_;IDZP[X^1Z<_Y"O@L&%R.9C2'B&_0;^& MGHE?(*D3D!P[W+R)P1IWWH0*]V6-?R"UVVR\]/ER_94=MW?9Y5HUT%"O_]7Y MSZVGI"-*F`=-KG2W5+U$P&N.2!3\)X6D*"]2A(%P=9RN6E^?,-6TO&%L&5RV,F`.:"$E^RS9>*'UI707)%2@K9.* M'@F4XT!DT)J?%@&`#K#13LS/812%WN:K?[\)\W^X=9,W(`"]E=+0U&IX)(<1 M-6Z^CO&#;YX<"3F>GY3A]TM#:4%V>63:+_W719W0H_?PY]"_]VCTP^[NGF;: M+=SV[#KA0(X4W10T94.-(G(8V'[%OGSWIVYNZ[\7PY`\73/(OOX(T@4T0>Y' M40IP@!5M`P/G=;1H:2DI8E5R.)&HHJDC.`C%=J[+GE'5''2 MF5I&VC\J&4EE\:=J]]*](@T(7-_AQ-W(0[`DT-LD._8MZ\[P/JE(/&#'O:EW MA6T1+9W7#:C=)=95JY?L, MP@OB!PWC0&\I!%(K`-VX[>"_JI#!7Z%.PX&22!5N9[O6GX](=V=IAN_,M6^] M-G3SQF&/!4B,PFK[]9MPDF)&^$4FSLQ"(+(1DNR,MTFO[,,W1R8+?'(LO6UTI M6ODZMJBP=++HIM.NDT4)6\_B@'=AQE/I95GBAX)0<1.8EQ$2)G\(W)?Q%.XU ML:B^8RWL@\1%<=N:3DTLNO!,Y8BPZ<+4,:FM"8K!R:CHT%@DHD:@9("*0I(7H7?+*PN$_!V!E^W8JB[C:^KO M4IXUQ@9\2>*T^.>)EX793X4NN:'^?1S^?4>S&U[;O,]G6&8-4*\Z9^9L9SEJ5#6UV'VVY#G_V9-".!D[R*,Z7E.-R/480T% M'BU8I\L@<+_P<40,Q*SW6E_)4=U5\"_$Y3:)[9)^U;*ROZ3#9MI`$[K?AOVW M:#P1D)NUHF+%VZ:CXFV35U7#XW^O/74J'BZ)/_&B[>4UI*H^)CY!MKO-*%M` MG->C?VBLZE+:`>+$@T/G-FLIGH6\6V@<7'>_:3+:(WN\T'Z``P<,NJV["&T! M+TK0H@B&3D!U25U04/<\V,,_TTSP:G65M M^LXV/4^@YET-_./2F;G=J?9ZM%[QWK1#Z6ETWK[*(V]A>MC@XK16$<[7N6;D MH\T7+8K(+NH7T[263SYG70IFNZ3M7M-1L'W^5<#T'5B`NU";'Z(/#0X.F^S/ M3%QQ3Z-\^:*')(ES,0UJZ$\Q^Q(P9+'P,/4/-+CC<>8R6#U%2HL&,71$UX4' M5LDNLG.]!%^1&@)4(=TQ9'_LKHL7Z4D%#^\Z2_K@M)]NK&`W-2?/Y8\_A#1E MO+Q_OJ`/[)-T9ZJ9;]-ZL('?5/=1J[^369$2`#!;;13W76XDS:C`I+5^Z=]> MH#:%S>YFQPXYM#URY87AFK$FT8!9;U-^G"%W;U:8P23^/-[N\DQLO;=V'3JL M4(!KXDZZ3.I7`C"'B8.PXP>*)A[#R/J/7<+/4:+J3T;"F/!67\Q'W'CI;Y07 MC%,=Q!'.[O2`8]A:WWOUGG#"A4:0]%)I_U6^QY7?ZMAY'T-[^)P'?K\ M95N2W_-:O+<931_XXQ"V`SF&8MM]#[+MALO9$)O7@0?#-GPWWL*]PVCAW@W8 M=N_P6S@]6?7MMHNU6^T=;@OW;J2%>P>TM<[H.HQI<$)C]D-^Q;[,F>PHP-S< MB^'/+JR00EL]6]K;H3H!1Q0@X9"D`L7^7L/A@UM&KFPPPL6C:^T8JE]^H;EM M@ZPA&.%?M5E0K0]!U_/Y5H1!8>FK-0F=M;<,015UKX67SNTF[Y#K`7'9@O:'[_(!X\_%AS)X2M97]FS&50LAQ<]3KE.HFB MCTG*;]@&'^SF6Q"TH5R"YR9OMS9M\99+[,?J)9>8>D7JDTL?F>Q/OR*U!9!? M^!*(6@/2(^N"+*_I1?^>7T2+@--^YZKBP,%,OL>F\"+45W6+*0NW(_5LJ\%P MV<*;^+16G^TO/]LGMN#'L\#E?*2?=G+P8,#$O#0IUMI4LK1<6X%F#0VZ]X!6 MJ=UR3HEWX:(JZ8T-][&A$599>YM&1?:9Y'\DIUBNOXF1>( MQA5?\)M,;$%,!F1%RA6MR"NQJ&]7I%P7_UVUM%9$&(?'#OAEBF&-T$;EK(>U MU$+FV_/7!7B=]J75SN!15L9#%%38JGO,P^BYF?XW"?]"`O+KSPOA;$B59QF-9?>KZX+WJ M0>IA%B_;;26C'^S5*YR5<9\;^I3OO,AP!Z5_+VF'$/0YMR7-AD<0]9CO*P6) M)]O&^R-->'!_9_3D6DNV'!"JIT4]*.@9>UR,0X=+6735_$ M7&NC"Q!8G@9GF.CQ0!_0#13VRQKFQ)&^3V=U>M(B&?\L?A^SA8'M>!C:AP/F M27HO97V"E1$%,V<:A^LS\`FHTOH%HXD9\'I[/#U8GD?;[23#X^8>!(OW+O9] MWD4ZN_*>N=&[Y#G=I^P$P-]4BS*9OOR'JQ&RQPMME!PXT.I@K$")@ET1`8V@ MFM&4Q&TE+&]`%7F/[`3>+E8';H!=Q=BNF:\M4N!-:[E?.UUF*U10YQ([.OMV M)8+*BO,0`G;.&UL550) M``.HD713J)%T4W5X"P`!!"4.```$.0$``.U]6W/B9T]5&L[-)*LKWSQ*!(E(1I%EG-BZ3J7[\`+U6L(JXDR"2A>K)=!D!\ MF8D$D,C+?_S7VRKXY07%"8["WS^<_/K;AU]0Z$4^#I]^__#]X>KCWS_\\E__ M^;__UW\$./SCT4W0+Z1#F/S^X3E-U__X].GU]?77M\,UJY'W&8I&[H[7K185C]3CY__OPI_U_2 M-,'_2/+^-Y'GICD$Z;Q^X;:@__I8-?M(?_IX,OLX/_GU+?$_4!K$48#NT/*7 M_//_2#=K]/N'!*_6`9UV_MMSC):_?W"3]2OI?_*WW^9%[W^YB+QLA<+T-/0O MPQ2GF^MP&<6K?,X??J'C?K^[WIN\&V-"D77TBN)?O6CUB;;Y)!SF4[8'&>`7J9UZ\:$#,\HQ9X;=)[C_F@=)WR?NBFB3$H6 MR\4:Q3ES6A%4-I+!B9Z[R?-5$+UVGB=C(%/37"SOGPFCGJ/`)_KJ`BVQA]-. M\Y6,V''B%RCQ8KRF3%LLS[($ARA)R,J]SU8K-]Z0C^.G$)-ONF1!>UZ4D14= M/MU&`9D%2G2T0K8MUTZRT2,7PB( M%W2#W4<BY?D!Y=&ET[3N4.>6A/'<112/[J%8I< M8V*2@4"5Z.#*U)12I2KJP7T,-*>^[=2+.M&>D'`80ZI%>U(''?M0,RTXQQ\% M=`%=H-3%P7#KI_J>P3.)/@16;P/KN0TM=[W,3>`!O:69UJV)T=GX\4F?.OPQ M>M%^+2?(':?/29Z8FN5)K].$,;8`M6-[H:G8J[6=B>"+Z MC.,,T,H=0O_Y[VQBDZ?_O.7(69X M2]@8^9=ANZD>]!YTSO>I&Z<=9EWK/]"\'Z+4#5K-N-9SH+E^0^UHN^TW%$W) M&1NUH^FNI\&YILUY:A-R1T&BI=8Q2HCJRL]I-V0:>Q,D>A:%/GUC*'ZE`W1\ MK,N?5"-O[S,!?<2,8IF^IK\XHL%/'Y,T=KVT&BB@.//A'>6^SF\??OFD/,F2 M%#F9$^3]^A2]?/(1)N0^F=._4`#SC[^=E(^I_T)^O@1^]9QQL.;Z,HU4+"I9S MB>10HIA<8W__0/ID"9EDE!M0Z$EA"":<$RBQ&UP3&7_[/V@CY,)!6VVV<^20)W\!0$GPV-,'/LYC"O,*)YP;_C=R8 M'*\NR(;%H3VON?.W2;)!!*?DR'QHCE1H'LBP'"[4FSC_.DG*'T(HJ?TW*&IO M[Q8"X6>V=?YMTO1O8"D9\:]0C-BMQ2OR2R)AQ4%KY]\GS0P&FI(=_P;+CD)* MU!E2:^_\W0*6'.`IF?+O,,?4*QR@^)PLUZ[M31?M89TF":&J`H#]AE!&#%UR[LL^'PO7BD'P+1&Y-B(>,R5O!2NJ-+N`<_6\H.XJ4`6Q^55.V@CVE M_U="74CQ"W5W^X;2DA2B!2?H!F6/:D/9@EIR71$1WS0Z)>9?A]0G@-Q>B&0+N%QO!F5::LG.PZGS M#:A3XELNDQ?E?,^C)$W$#&2VA[)+M>0D%P/?2CLEEJIJW'U-!&3':KNC'LZ= M;]?58UU:A)N2GO#&4AT[VLJ"&QX\QT3=@0 M/F%R(BP`$T5T^>8%&34K?8DB_Q4'@7`[E7<'L[OI\ET9C!TGIMLX6J,XW=P& M;F&6_#/#:VJE$6_`HF[.";"E29754A!V'*X*YXE:;2B5_8UU68*5UM.#^<$ MV.34BKLB,'8L.Y9P`F[Q,'-/44)JR M?X++2ANAX-!E!FSX:LM]`1R^O^PP;.;$J563CI+D/`ISB'S&27HX,V`CEA;; M5,#P_6DU;26U\,SA]VA&A+K*3LWOYLR`S5XM]VL)(K[K[I0T\4T4/CV@>$63 M`BEK%P;$UC5ABP=Z]CNH9L9O] MG!FP#NVN$EP*K%HW':'U%O`$ MFZEDOTC?,6V)D<-1$$2OE-9747P198_I,@N:(>D*GA8ZXTP\Z8DN5"MN1/O7 MO2+/T6F6/D]0?@[#!T-_(<*NW_@E[065ZZ\5T"S`ZOZQK(%MN^0F_H_##&9$`$$-HU MNZ?U+]WM.3V@$\H87O<[4*:\N4?&9[5-7I@&=]*."C)D/;IU#V5QVQ(H62P7 M:Q3G8\,E";X.RRVAS5G:'&3,WPZ3U9F.<()0\?DT]"_(MA%$>6:O M$J_02T/0#]I\).0;SSM#@L>*;?0>!0%-T(="0J"`8#WU5SC,ZQY23WTYV]4& M@#8CM>"_.C`[=N,&B704.K2)J`5_F1BLVJ&+W8V&M:NPQV"# MF]6W*(SVT54)Z>7'+FE?:)./-J.5$-EAU;\.4T2X4ATX:)BDT+32:`V>.%B) M66P^\^!T/7+M5ST'XNSW,$9N0-^@OK@XI,IJ$>YB(T6Z6M(3/']P!XZK0+/C MG+7;HZX(`6G"&1QFA&`[D^X96D8Q*MH]N&\HN7PCU"/H<>C&FVNB+//02IJJ M)LK/J-5RD=I>>_DJ>/YC[6VD;V*8>DN$/'ALL9=+^(S<@\2&.DX/\+S*+<6# M#:3S\^$HMJ!O*%6Z'.RU`\^:K']<;$S?U#,@Y,JLPH4J[X4S-\$>M5+A($N% M;_V2GN#9D[49K`+(CMQ//Q%^>B:03LDTW"?T+5L]HGBQS%'7GKK59:'=@.`I MF+5%I`-.8SFF1N(T0,M27@71ZR@*"V\GHQ>9T^@&X3U`RS^2>=S&T0LF'#G; M?$^0?QUNS5"G'KFT%`%@"E8:[<&@?1!D[.!NQBUP6O'(TNZX!7RK:L3OW_R9(T5ZT/T1TB=T$/YY5A=T@?(G-JHH_/0?M3F!2QONACA]'I M`I'9>CAG,/E[@').A_[I*HI3_%?^NT#X5+I#^W+T)0!L<5.EB!7[5W6WHN56 M5]0D(I,7=@=H)Y!A)81/`SM4"G6IIR'6Y"Y%O:Z)[/]TX]@EQ+V*XGL4OV`/ M)8OX/'#Q2G3HT1H'VH]D6!'2)@UTU"JOOD!-*2Z6MT5A]1J4\RA,LB!EQRYH MC@#MB3*,A+0@"K1W(D98;<=)7)8XF6S(CHS+FQ9 MAP6LKW"(4Q3@%Z$=77$$<&^<@4\N&E2Q(_+67J^>825'PQ%HXH_PA'P$*O5N M*_ZL$:Q,`*H64ZDX"+B;SL`:2(\P=I1]:H(N;P55F`[E,/F?&BU"&H/(3\/&]PY9^QG%R9:MO@!T?(8]!>!V+0;,"]4/T+-(Q,"MD1UH($5 MWG4L_-&A4$$J,SC#,;3TT!C/IO;.`IYN`RAGH+OL_4ZR`GE!A6AKL-E%*_<>N4&4;"8V@AYF=WI280. M.FL>=:JL6;23&#Z"A:^-C_B=/GW)0NL"^W&,690YL4M3BWS_VV>(%U/(?]*B\K M/*:K]'7FT&;"KJQ61FE*\4-FK&&#K0*&M5\IJX[.'-K^UT$*-"`:L^4`BD`M M,/A$P/!Z,V<.;*HSP=X&(#LL_?N1NENJT(IA29[,L`C;%:UMU2&<.;"!SH08 M:(&UPQ.W)-LBOG7CM/S'J?=GAHO*FN4OVXJ;BYC:K=+-[N1#LTA@OTR,72E$ MN0KI];O.'-@Z:$(8^Z=0C_:DP?.7EBE;GZ.`8$HNT!)[.!U#(M-\:RFG57!( M+Z,IOS](8=1J8@^2\+[]AB-*22JF)^]X<`C&T(4N@#KFE7@*`M`$9%&8OT2\ M8=%A0-@/.B%IDTD29O)`3)NW!Z@NHI6+1;GXF.VA,W]*><1F+1?+M%E:*U[^ M%='\Y*+7T\.VT'DWN3SAO)"RYF_%$\F^U4C*2%9SZ`R9FKSD03!E+`-:CJ>^ MCXL)TW>?Z[`,P9)R5-@/.G.E)FNE6.SPIKU#*2$#\JM"(E(>LSM`)YW49"X? MA!UFL>WI@EQ"47X=5SGS;AM#)XK4/NCNS7SBRK=Y?9/9J?<:0V=J9/-$8)1N MS-[060C>3S"WUR2U&CLB1AZV!<^7R&8.AY',V=O#2'8VV=R7,<]1H/:2Q.X+ MGMY0>\5*T=CA),3!6LIZ.[;7.H.G(U3CI98<',*SY%H[9'@J=.9`'6V@APK6 M?8"7F;^>DY-SYVNZ0U`?J-O<1PK=!JZ7TXOG1V3N"^#)`E5DHP_,MES*^/KV M&WK-_T=\3U/H#YY&T-1I8A^1':X(PEVS@P@<#`">/5"=KRU.%_LPK3AAB.A5 MN-KFL)++-Q1[.!&FX]<>"SRWH"F-P4=G1UB1<%48$A/!8.!)!MOQOH6&X<.W M0MNT*\8*G2%01TLT9PX=GC(.TS!TOKZ.MN%:WKWVE2_&$C7%,?98E-)T.=:.^SU8K-]XLEO?X*<1+[)';;9F* ME&XU48`]FGMFZ%?]Q@Q4JBYS.T$X9U8TKA&>D/O,37"2!RUM&?Q`&'H6B%,/ MZ@\&[>0I9@9[^;5#V=]!9ZBU^27*XQI"#\6A^DKC6`GK@PD6#;>MWEI1F(1( MOOF-H>172!>&^9`[^>F+)2TF.+3BKPH8!E&2Q4A!Z;,[0"C\_9FH:'5.#VC5 MS2=RB@I9CR(-+\MO=(9WI;IAE5V6\Z#0RR+ZG. M^*P^8Z7]J]O(T`NX.RLY^V%WLDQ?#6PS572]2E0#*9T*)3V,W&VJX:7WFD9# MT#N-F"J,FPUS^M,7S%W"H'J5HH%U\I6+X_PQ:,<-E`TH2OA8,@X#/*^;,;/N5* MZ3*.H_@\(J3TN51G.9W+N:\K;"7M\&AA]_R696;]I1!R?Q+&^D-2Z7O>%:>_"%4"Y05#E[E MX^X!D39R_NL-`)T.I]5KN#(RZ!@VSLK^BM+GR&\BD"YK:4?HC#C::UH)D1U9 M&KXG:+&\3%*\1.%3SE_ M44.+&NRHM]"V*H+GVFG#<15,%>,GGF#C-L917*2"("I\J\\VC7#1G$32LH^FO@'M/@DEG%H$FG@MEP(,^8JD[.1>.VA' M3*,,9,M(`^^TRQ>VI]..$*%_&[CA-W>%I`4M^_@H\4M`H2;)5\5NG>V+[#T$[V)J1'?73>#=*O8N;8ITLQJT8\L&A_8>' MEDA]ZO08GC=T-B==^^;HB"1AEH%U"#R5B0*/,Y(V"I9:6VF/VVD&;X?IB)5MP&M#MN%N,W!@#;>WK M?REJE\2VBC52F]8LJ[0!YJ>^:XC;#:]5'5U'X9V M'5=@$&=#9&*QXN;<[O41.@5):TXV8-AQ>;TG+,B-O$6-4ZK=HC`/PQ*?,83] MP%]8!CHE2(DP\0>^`UC2W9W9'OQY0\8D-F^Y6*:]$Q-`J_+91:JY&VVAG8:Y M/&&SD#E_"]XS;ZN9JK&1U1PZF;`F)WD0)JY?SZ.0[/XIS8^LR5-)3_!,P-HK M50['E`48,[@B9AZ]@EF2DBU%9).F3;E-P?Z`I.Y@2S* MP^A'X!,5FY2'?9'KB5I6F!-.@R!Z=4,/747Q190]ILLL*.$GNW(NYUE,>2C2 M?SKC@*5$[DD2.!I.FR162-2V0LR=^_J5W`%C[`:BG9/9'BQW\J`2PH=NAY5K MB^]G%/]Q'=[&D4<(J2(+>QW`,BC#"$,3NQVU#K<`MQ[0-,M\_"*L>\CO!)9D M&48JV/CM**%8*T:S9-PHV5B8N9*^+T6(ASJ-", M+Q%!FQ]"XU`[T(+S]%(?4_:"PFJK%RJA,`E>^`*[(6C^*1X]&,\IS(E/VT?G M/GM,T)\9=5FB-A>%1%*<'E#>^GS&L+6/8/K6<5*>YHG7!]HW7L`E9;9:X]"^ M#TWNT\YJ#^W6+N2/$DM'X]+.V?Y.GV*4^WYR]&>S$92#NJK*9,\8S`].1G>N MMF,U@W(;9]-41/?=?*'4&(?PNZOC;19[SVZ"MG/FZBBUCE!NW#S",]BCA&&< MBJJ^\F\$7G[\QE"^V5J*BSOSL?G-[0%2\X(3=('RMA;37':9:F*PPBWHCM[O M0^17)K13S\M665Z1Z@(ML8=%%DUY9S#7:Q4&L@]UBJ#ZBIP8LJ(J4!:-"9=4 MK5<$/=N4M4(W"A#$':&S6^B62Y6CL4(YUF'NZL+>H759G&^QO(UQZ.&U&UR' MW\@Z?'A%P0OZ&H7IL\A`U6E5PT):S M002HAM4.IUU]].3KHOQ,[0:$MM(-)SP56BMRK6W/>N4Q^'CD:Y$P[?*-/B=G M.'DNG#BW9>%%IFYY[ZD=_A0A3?M)XXZF>Y:\,V[;0!_)%#G"N>_645C`-.GK M4ZT5]%%HC_8"]NQF.VT&?77?\"I;25FTUP[ZR''``3:;&C.>.*-PJ,:H>COH M=%9JC#J<\<2S9K`TONC-1*G?>%)6M=C0I,C&]CZ<8U)-+M!H"IU12DINQLL* M!X8=%AZ"?;$\)Y/%Z97KTL`=;53*\")CDG>;W6T&G7U+@ M#V_6T`'I$BY4#I"U%*@_W'A#SQ4Q]E!2V@1D;%(/@>=94=51OJ$7TG85!^0*!6O0T*^C-+G>^BNHCC%?R&?^H1( M4II(^T)GS=&X0!1E+]F;0K1PQ=F[0G5K(%IP%]1'M,@KQ?GZ*73S["!<_) M7PY937YR;M"3&UR&*;URL?<41BOHNJ7][B@M@-OL11MKX.):P0]P)S/53DC<+L[?`\-I=.%[HTY7!V)AYZ4\ZG@%9'<_EX MH;P751BES-H:EFE?`,RDY(7R9%3CD!)7:T@FSE%"_?P6=%!-/)&I;U$_,!?& M@96XE`:F_,BAHH!9%>:E;ZN'%>FA7"/5V<1F+Q_-M)<\MQJ35)U+>H+Y7?.A_"*'V58Y@$U%`1GG MFU[>?5"7Q2951:2OS?C]I-X']2YDD9YE3E)"8<6.Q73GN%'(0"/N"%9I;@1N M3/M$,!5S9VQI-SQ)%9/72#LZLQ'8D"3<8"UV)5Q6+/9^:S;/(`-GU;@HNI[( MH/55,@"2_T54?CO^'_9U9I#QM$;YSX1FZE[33@`XVKPQ]=T/>50P3YG+^CDS MR#C;-LQ4AV4JW0S\2@8MJ`X9^]M]M>N#-?5<:'3]MPK;GD&&!K=>VPP08&9_ MI;PQ#Q$C9,JD!B4F'KN;+9WYU,QP M(B#&$@!!7M9OX\A#R$^N"*UV>6H.PR5%^[32`,Y\J@8X#7S&\O48WKPOJ'KQ M+_`+]E'H%P9$WJ)EM77FDS2X<:&`9]KA9NZJTD?5;@IY`!J]1>27@Y(.7(<# MY1&<^=1L9&T`&DNOTUU%5V%=.'^]+11T\?=#U5S\ZA3/O%2Y5&>'RS=RM,0) M]]JMUM&93\W$IH&K8GAGLYN/ECC,1>U+AGVJ]`$,Z8&;)-LSQR*^PT_/BFF[ M95V=^=1L<%K(*C'H;&[SM]4+VXB!5,\?6HKT=+RHM_.W29K.-,!5/.YL'FOH M]D$3IS6BTH&2I^WJ="Z6]>G0/4 MJ[=V_`9T6K;N[&7K>:,$FG:P1KOL/M!.CB;YQQ:1!MYIL]F&S#[`7I8-B>#H MEIZ@3US^Z'%DD<\YD4?U-AJ#IX?KB:D<$6+BM\(35TI('AUO5%SS.P\.GK:N M_XW-#)%L3W3'(\+VU>V47!U7Q1(E*[N(L8B"Z$DE1?0`7X=.@V=&R@Q+L![Y MWK>^9='J\FV-O'3W['''?H\?[-NCS_QG1A`'6`4\ZA[7`(]2/Z*`#$/+J4"L M@OVO@Z=&M&X=-.EK21HUD\2ZP\D?5S%"];K70RT$UK>ALE#:MPQXU+6C8'7O MI.(79AUZ"F"Y1=_'FJA3V8Z2WOV3C%O+=N@I@.5V?2=KHT;ED98[;T.#1'IV MI/%ZDM+CHZ/1V=GHY.3T>GIZ/3TTCTT-'IZ>CTU,]M__3I*49/ MY-Q87UYY)@#D2Q.?FAG>1E3?IVZ<3E1POQ3!A.%MCJ1'J=W_$)3;SS1$MDFK=^["L]C:?W&< M]QE"8AE?@W+3F8;8<@CVSCUO1G%"@/*EF8;@LNEERBNF."1^6"5SMN!9%YC6BKQ5@;A9@?C(C606&*6E'FNS.5&/<2J"6@N94P(J! M3V0]M"$G=![QX\%(<`5AQ^&G(O@X5 M366,'X7L/\II]JBM+^X0=7$AOY]'8=M[R-0%`46,I M^T=P+.I`/KY*X9%/5'T38#;.B?WOJ@`4!2]@,(Z34TV[7!,JX3#!7AZB,\P] M8?^;SLGQ+;8UW8Q5>ICZ@:BF$?;)-)!B/_BH,[/_G;8_PAFK:L&4ZE%$`LZ. MD8#'2,!C).`Q$O`8"7B,!#Q&`AXC`?N7OSM$=#*F:1?RDXDT&)#9_GW%`W)) M\+YC96Z.(8%F=C@S1'JO>="+PEO7(5FC6\N^B M(+B*8MJI#Y%M-1$;0Q+A*/F^%;(ZV?IS_-:=PV03I[>64;"U<@R7;$.U@Y>E M;>GZ;4(SV%4DG=YD,[)/;X$I\<+4,?,:&:4YAL/O?)+*(FO=]Y MG*DFQ<:Y36G.<;HYXB>ZSM0X\L[SR4_R6C79C/*364DLBK_[2-UW=*^:;%[[ MZ:TP-6:8#14>H[O0`QDS(X".3D-'IZ&CT]#1:>CH-'1T&CHZ#1V=AHY.0^_/ M:2A%,9PI912RTB`E M(>\#3NGNOVLD.;WT\T%PUYO^CT']$6[B(MS`14F1WTNHX>$9KQ^BRS#%Z49Z M5M(<"=K?I3^)8$M@"_),^ZAT@6/DD;&E&^-^0V@WC19\XJB)BCI0VI:CPV;#'"ZU2[""4F41_@[:NS`)I$M:6D0Q'JG3NS\W/M]W%M MY7\-.+5IWT+;DB"F_,='K7^UUO.7.$IZL:CPOP:5=W4XT12:5 MZR3)D'^1Q>3<7LPZ!YC4O,)FM'5H8'7G-"2W.K7Q>*SFR*QD==@!5_.UL3)_H* M4_FJ%&OA-$N?HQC_Q31Z]/8M9SY%*V:_Y*CDTO8BZXK$>7%Q0%TUR?TF?Q88 M0#P//^G,IVB7'80JE;!.Q+![RLF[+NWCS&TSZ>Y@53P$,^CVJ7"TU84SGZ*A M5P%3Q68P^ZX9-E^NUD&T0>@,A6B)4VK`U.:\\AC.?(KVWW8PMWYWH[KOU*>9 M)VO::;"R1B0W5D[:TYE/UN:K"*[B:1\6WZ&RT57/$V7^N1/US',!Y*_4TM+P]KUV[RN1 M6P/ZM#D^]OAVZ.QPDPAO'T'@(;`T;E-_GR9)MMKZ4WU%Z7/D1T'TM%'(/SW` MU\&3S!D1-L."K$<^&Q)FFJ14Y7YQ0;.YD$O]G9OV4BQ!]=O0*>T&$L,!U@"/ MNL<5P*;3CXCF,`IPNH%8`_M?AT[@9]\J:-+W>.91)-97'.)5MH)=$>4DH%,@ MVKXP:F1^%^D;#%#,?1O!ZB@F`9XJTOKE4:/SN\Y/R"+9'4[^N(H1N@X)))2D M`'N'8`K@B3/M61LR*K_KQ!/*!!MVWQ!,`3X+J-TKHT;E<>:]:$&!1+IQ/J!X MQ=?^PWQXNBE,NTCV@+0UE[HXO=T<7NZ&)W=+$;Z:EQ$BYV$WWG.WK:'3WM%.[,V6KEQAM" M/L*Z+%DLR[($Y6(J0Y&D=66T1K'1FZTE&=ZWBBKCW53R?O7V+2B_LY8"8UA% MB:AB2#;71;Z>U(W3BPH8#KM31W*'VI4\LDFBRGWI6)?OPS]B0IHF56'WOUZ%]#&M\"2Q"WX9JICR+?+3$(:9]OV38=T,J'Z-;`?:<:$#S MRDWM1+-[WNJ<@73JA_;:E09(Q!5G`%S9>B0BKD,L4]6U1B'BCW*:/6JKA3M$ M/33RPO=ASKC,#:BG[4PF[L/.!KC4M4G1!R`<>'VQ<:P"ON;@D>^DQU708C;` MM;-'L@K:$@Z\$MLXCCLU)7)-J(3#!'MYS,4P9_C];P*7W![)D49,'F/%W*9^ MBJDM_'TR#:2F#SX*7`U\?-J811]C=>&8P@L4JE7FBS]&;!TCMHX16T,(VC%B MBRTBQXBM8\36,6+K&+%UC-CJQOBR;!X(O(1LS/=R>;>K_(]E\U`=Y M!Q%8>L0PY2`.I#?JD*2[3K,Q='"5'J_D_-ZAFO9V<(%CY)&QI?O!?D/HM-AL M5K#9UIPYL#[GW91Q$&!W1137"J=_<1G";0N=I%F%)\+)CS06]2OVGET4_#-[ M>D:)F"V,IM`9@I6YPID[=-@(MWQCF&1!*CK),MN!IZ15Y@=SYJ:B),9Z^07. M&@">DW42:0-JT1!C4PN5#?*@VJG,U-PHC@IM5C/#)-;>*T`\SF-1UX?'@_?S M;?J]Q;*BQ7629/QROT-]']:#7R07##$:E"CCE,MJHC]Q^GR'7C`!^@,E*0Z? M+MCU6A1ZP3JT:\J``A0PFX=I75)AI0!14>R<=10Q_Q%8E^^AM`(7.?0QHW[L M39#WZU/T\@F'+V2:Q:&W^/OA<;?XU;G._Z`@*WPR9VNUCK`^TNHRH8$&MG@% M1UM()GZ'UO0/[L%!L3NLVZ_F"M?!9$/9A=,@'[S420W51O,VAXG(M4-M`%BG M5W49:(%JE"4&ZI,]CY*T-,H\1/NGSX=H9X3A&YBTAX)U"-5<\6WQF0JM-7QJ MIZ[2NTL&CZG[K6"=(#7YQ9BZJ5A/V/?K\\!-DBVR17Q';Y`UKV*!$I9U=69C M\)M35[]*>$R%/O9T;2ZOBD6X\@5*O!CG$Y1=G'G]G!EDMH^65V7U2Z0?C[U\OS MH#0Y#?T::;\BET[07X1WR,OBF.ANTN!;%,;5/\E=""<_JN7_@+SG$/^9H406 M`M#G9Z&B`E19S#[D]$V1B?MM;5?^=4@HF5&3#*WV)_'?%'6#CB7HF^%L,9-1 MQ!8QJ<*%J2^TU']3U`W:^U_&,!F;V8BFS>9).O7+6,)FI)W.^?6#G-S3B=$: MVMT>6GG?]%'4!&@U]T1+%S:2`1R@*]#!VS`R?)`Q'W7 M-5G425564(==#%49=^!P&:O71(W&IASK;%\:13%VX*51580'#EVR>VW4B`SK MC3C"Q4'M:U6Y#'D,Z=-O&2HX$/Y(H$0:4R[0D.+#@A/XG\I\HI;;DUO3Z88X!%ED( M+U!Z-.K1-WL,OJ,G1^?1,;W<'YU'C\ZCO8CIV6;[UW]B%!/./&]NT`L*)&ZD M:@.\3X=2==I8(D0E)?,-LXE8ZFNJ-0ZT\ZDZVSJLT_B1BP$5KAOL/".&O%^[+7:%QKM#?4D=0J<.[(FDF[@*_ M,T[44@/N?OR&4@7K@/H@T)Z8RFR5V:Y4@%IQNAC6+`KLE*C'WZ[VS<]]BL@8 MK)NSHW6S&PSQ3I=O;=_#Z#%!\4M1,Y&<=A69I-S`RX+\KW=1$%Q% M,7T;5*%%7]^>N)VS3[)8L6&P#O`TK&Z<0DG$.@VXQ<:-T$)?=N@/(L?V[HD7^A-`V*ZV\/ MTM]Z+J,Q#$]G972BM65F*D.DRW7`=>C%9#AT@8H_!UPFS.^/QF8^_:7!I:\= MACL[SDAC>2:8CKA+Z6DJ(`JTP+W()*!=[=X2PP#'7YM)*L6:2BI]IW79UH(U M[0?[[R'9T@+\%_*_N#B\B9)D$>Z0BT[\DIY0-U M-47D9"\5'HII;Y*'J,CW)/ZRG![0YEP>>]2860-A'3^E7JOJPC^U&I3`TIPNTI:B3^KT91<)37KSW MP4E!T70@Z0;M`RKB`,-BH(#&AO681MX?10VPBRS>%K,I:GA^0Z_Y?PE7I](` M4.Z>JISDK%EE;!9(PJGG11FASJV[H9ILD3ZC^#R+*74+YU>O^(=`%E2'@/+7 M["8-.NAL2%UY@+>;+#`)!5E'T908\(#UEJ&1:3?Z1*=*DW60?_Q_4$L#!!0` M```(`-`PKT0Q7:-+I@T``."1```1`!P`87-P=RTR,#$T,#,S,2YX.)T%#MN-6-7'MM)^M:!2$C"*2\*`,I6?_U9@#>0!"^Z.($._9)0Q"ZP^RVX MV,7-[W][]%QKA2DC@7_6&QZ][EG8MP.'^/.SWN?[R_ZO/>NW#R]?O&?V`GO( MXHC.,?\3>9@MD8W/>@O.EZ>#POC+ZY.3(53I M8@_[_#*@W@6>H=#E9[UO(7+)C&"G9[U\`5+X[!2QY4/+&E^^L"1/COSAY"B@ MDB'_&`KB_AMUH9?K07>@%$284$Q%]A MQO5L45D%HX^(S?1\LDBP#35L@>^'GEY;A],!7R_!J('?!RI,B9WC;68L,U$\ MJ\3V[0!*56)&;+U*4%"A$.-+6L$#)15,(>O/$5JF?#/$IE*HN*`"\[BTCSBO M9H5"2J8AQZS`*A!B6CY94FQ3^$[D^P%''%SLA_=HN23^+!"OQ:=Z*OKD/3!: MXN'S[;C6_\D.?!'8H?"F(]_YY'/"UV.HCWJR_IY%X!NHI4A;=O",^$1*!0[3 MZEL)F_J(?,>*ZK"42MX/BC4DE88,.Q/_@WR&CY)!'9)#>+Z8*R;1<605MJ.W MD6N';G4#@QS$.V#^$;G"#]\M,.;LLX]"ATAW*="N*-/C?`S@W@$D.`8Z9K8B M;NM5RO_S,\82AQL$@P5?8$Y`D#K`\X1Z]$]:HV^]RM77/6ND,+');++$5#99 M[/I-1'HK_%*P0E:+%(+2[=X*$.?@V-'OTWM>B+:BQ9SS/Z M`I3)[&X!CF`1N`XD29"\$)OP*C,T$.OM\;;*'L(<:GT_6:_B*G_NM&TN,+,I M68J&)K./(2,^9@Q"G;O0\Q!=@Q'(W(?,TD80`=DR4X%L]B9P`3H1SZ,'_]OBS"JG#]9$6\W8?V(H.+SP%MBGRD):D69'MZA%EY+LELJ?^<@ M_HHHA4$C'M/27WH8CXLP)O2=@^T"4[*"=E;XBJ`I<4'&+"[0%>D!/2E[SX39 M4K@[!^]=.&7X6PC:?%KAM'>6WNI!_:7TL:=\5L38.3QOL8US42@-?'BTHZ0M M0K>!1H_UFR+642VY­^>@WRU-V&?*49]Z#-\^3>IAO4J>NIAF3OD]FKJ9 M_=+?>AMHTK\IMUY%/-W#3Q_CJ8C64N@Q+F5Y5;%@=W%/PCH5Z<([/;:E;##A MZBZ6VG`P[Q2J";0H'Y>217W4V&7,=QDG+S!'Q-W+D)M4I;=C*2O=UX@;-]L] MPZN3?#DSZ@KT1BGEN+E)P`YC*T*1PJ>1O=!CJ4EO13CS#*'+[O$C#Y/5:,U[ M/:"EU#8'J!4S=P_8\CQKKJ=6%^MA+F6UNMG8#O=C?=1=AKR21`][*0.MCLR? MH=?A.FR!_;`"_%+JV0B^-7R&/P?M<0OXCRO@WR`K3>`_?H8_!VUN2&U%J3=% M*8EM-D5G!]XDO\\[H-);+=`GI3PVFRWHK'\O0*?%LP+.4CI9@K.+'KN`7C-HUD+KS=!9SU_SD"+ M^S;^;UR]^$><$KW%,TL>MSP5![_.>HQX2Q?WXG<+>6).G&CM)Z=6_P:5CAX] M-R$1-=<<_I0F*J(0-YQ4$1]JK#\."I4$2TQ%IQ\DPO<&>]`'`-]4G[R-C-+& M1=--M0$6[!JG"/3K314I?`K[56>0G'F$I^PD)!2`)@'EEE\Z35Y[D#,ZB7X5 MV+*>_*%1+>,`NYPE;_I954>/S(DD;"5(^7CG]I+(NC83I>YT>(4@91;QJY_P M]<6K_O!XV_93*V_8?L*W6_M-)[K;R.12FJOE4U:)$.Z=$&[X=BOA9)WIL?JV MPJA<>Y)@`R@2CAU:UA\^;R.`ROEGQ+@7.;:381L!]'=#M/PV$@;1Y)NVC=5= MQU#GG'1\R8_-O%+SS0ZMY%`9TU_]K)I-)2G>%=%&B(1'/.P`0NF6B#9MITSR M:8?6-9=-M&E?88N?=Y"A?'%%&Q$RKNBQGU6PJ0#%:R;:-)_PB(==FB[>5M&J M[81)/FE;CV_0D>2'UZ M%HJISGJR;6!UK@+&S@-?MGPNG8*J51V1JHL7P)"&Z%JGS0RY3*M.%"/Q MI&@:711PUK,I=@C?CY(>]"?R+XJVI]U0O$3$2>:E+P,*2K'0%;O#5*4W8-H9 MA,RF!10CH/.5\(74=S*;89KO"YLR/AT8>_PJ;FA@8^RP2QIXPL:B`=G1 M00MH1:JD8-"._!"ZPCNHL]5GH0W4?=*ZH9"?7%!HU\JH!B7OJCF^_O%>61!M&M8*<\ M>;^E=?:@1KHXFTX):XQ11V202=+#$QIS:,I,,X5V$[S<;K[6:=2.W#0EKS%? M!,YD5MC%K]6P!:UIZEV21^R,&,.\QG)U1*8IM-O)C'C!3I?I[+=>@[Q0SO&+ MNJH&A:CL.TON\-,%<%([G.)Q=8@SIUC^'CT2ID8I^???7W:'0.OB"MP6LE\$ M'B*^3OJD)/>Q.?+E#^LV=QC2`;G>?1-2>X$83L6]QMX44S6O:J8U236UUU_! MARX$815?A5)NZC==Z=-JJ0S21AZ0KO',FE*#I$\BN6A>01/B)04YF<7U;&R[ MB:4]RIQ\KN>!!XF9S'F_P&@G[X$0TR'7Q"=>Z&F4:LT9?_CPU8,R\E:Z'Y]< M-`J/'K=5.^$T4>TOF/%TTDNC7*%<[:^)/#].B7M,O6RB09&^6&"6V)>(T&M$ M_\'\"W)#K-6@AN8@IJ.WGBJZQ:O`74&7$Z/L9'8N9;I$MMAHM][+9%1#"P1$QQ(:SA7)`5 M<;#OC#PQGYG+N77%!Z%9%AXJOFCT@*@C_)1Z+7HNP&S/9))3S^0N.N1&1>L9 M3%)22E8ZU#T2XL\EW<=U1I(X6FF\U#>-0$E/3NZS3X]+;'/0&-+&\O3&=VC+ MK/ST"14N3:)\A[8.#MS1'$9&L6L[VG(3J2:'2.SH\HI]U6A2]K$@>/;I$=NA MV)$TFT)K#I/11"ITFNIG07^#_!E7;?C6A0B M7YWBVD=E)@W:BC["4?L,LSW!LT-U3Q?`[G%?JS!4V7;Z0T22U]!%BUM->*NMV8^KVL M)KW[9)9Z?.&_Y=$$<"KW0>+SD+8-\T&,"5`E74//G&'QE]N*TZVL\(FV M(S?)ZMMDANJ($[E3)1Z(8J@=<\]6+9CDP7=5,DVI`Z'NV+\,>4CQ'E&L:L`D M$)/X\A:[2(IZB\7G(<3.I@4U7J>1X1`\3<50*%5H'C%C,I,\B]I/SP,FC[KE MYT1RBYO-Q(=@Q6S3,D<\%'_C-)G<59Y#JM49)+@ZDD<_=14)85!W7_7 MD;F0I5>NZNXQ&&C?I$GY5V%W&0R"3IQ.%1;&FPA-BGFV-J6Z=13'\QS[Z"+Z M>DV";"PONQ`O$EF;9M9:/,R=?$U"UXC;)RMJMTU1F7UYZVNQ-IT5OVK1\ M/JS8"/&T;1FX5O\T"NLW0CQM6V:!J_]K=S5'OMJ0FQ1]%ZZ\K5GF;J+\H5H- MHDNG/KQ\\3]02P$"'@,4````"`#0,*]$8,UTOY&#``#TWP8`$0`8```````! M````I($`````87-P=RTR,#$T,#,S,2YX;6Q55`4``ZB1=%-U>`L``00E#@`` M!#D!``!02P$"'@,4````"`#0,*]$H*)ZAL`(``"-@0``%0`8```````!```` MI('<@P``87-P=RTR,#$T,#,S,5]C86PN>&UL550%``.HD713=7@+``$$)0X` M``0Y`0``4$L!`AX#%`````@`T#"O1#_N[<3\'P``OX("`!4`&````````0`` M`*2!ZXP``&%S<'`Q0````(`-`PKT2R#T-(AEL``-3!!0`5`!@```````$` M``"D@3:M``!A`L``00E M#@``!#D!``!02P$"'@,4````"`#0,*]$D=:]+E$U``#A'P0`%0`8```````! M````I($+"0$`87-P=RTR,#$T,#,S,5]P&UL550%``.HD713=7@+``$$ M)0X```0Y`0``4$L!`AX#%`````@`T#"O1#%=HTNF#0``X)$``!$`&``````` M`0```*2!JSX!`&%S<''-D550%``.HD713=7@+``$$)0X` <``0Y`0``4$L%!@`````&``8`&@(``)Q,`0`````` ` end XML 20 R29.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock Based Compensation (Details Textual) (USD $)
0 Months Ended 3 Months Ended
Apr. 01, 2011
Mar. 31, 2014
Mar. 31, 2013
Stock Based Compensation (Textual)      
Share-based compensation vesting period   Either immediately on the date of grant or 1 to 3 years from the date of grant.  
Expense of repricing for options and warrants      $ 76,198
Expenses related to restricted stock awards       
Equity Incentive Plan provided for the issuance common stock, shares   1,550,000  
Number of shares are available for grant as Incentive Stock Options   50,000  
Exercise price for options award   No less than 100% of the fair market value of the common stock on the day of grant.  
Stock-based compensation   70,954 363,369
Compensation costs relating to issuance     287,171
Compensation costs for options granted   65,992 160,751
Board of Directors [Member]
     
Stock Based Compensation (Textual)      
Repricing of number of outstanding compensatory options approved by board of directors     25,000
Repricing of expenses of outstanding compensatory options approved by company     13,575
Salary forfeited to purchase common share   Employees forfeited salary over a twelve-week period to purchase common shares  
Number of restricted shares vested 55,969    
Number of restricted shares expected to vest in future   169,368  
Chief Operating Officer [Member]
     
Stock Based Compensation (Textual)      
Restricted stock grants   250,000  
Compensation costs relating to issuance   $ 72,500  
Stock Option [Member]
     
Stock Based Compensation (Textual)      
Weighted Average Exercise Price, Options granted   $ 0.23 $ 1.13
Options expired or cancelled   70,500   
Stock option granted   115,000 135,000
Stock options vested   141,650 160,000
XML 21 R28.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock Based Compensation (Details 2) (Restricted Stock [Member], USD $)
3 Months Ended
Mar. 31, 2014
Restricted Stock [Member]
 
Summary of Company's restricted share awards  
Number of Restricted Shares, Non-vested at March 31, 2014 118,378
Weighted Average Fair Value at Grant Date, Non-vested at March 31, 2014 $ 2.80
Number of Restricted Shares, Awarded 250,000
Weighted Average Fair Value at Grant Date, Awarded $ 0.29
Number of Restricted Shares, Non-vested at March 31, 2014 419,368
Weighted Average Fair Value at Grant Date, Non-vested at March 31, 2014 $ 1.10
XML 22 R30.htm IDEA: XBRL DOCUMENT v2.4.0.8
Warrants (Details) (Warrant [Member])
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Warrant [Member]
   
Weighted-average assumptions utilized in fair value calculations for warrants granted    
Expected dividend yield 0.00% 0.00%
Expected stock price volatility 134.00%  
Expected stock price volatility, minimum   93.00%
Expected stock price volatility, maximum   108.00%
Risk-free interest rate, minimum 1.73% 0.14%
Risk-free interest rate, maximum 1.75% 2.60%
Expected life of warrants, minimum 4 years 1 month 6 days 10 months 24 days
Expected life of warrants, maximum 8 years 9 months 18 days 9 years 9 months 18 days
XML 23 R31.htm IDEA: XBRL DOCUMENT v2.4.0.8
Warrants (Details 1) (Warrants [Member], USD $)
3 Months Ended
Mar. 31, 2014
Warrants [Member]
 
Summary of status of Company's warrant granted  
Number of Shares Remaining Options/Warrants, Outstanding, beginning balance 7,671,267
Number of Shares Remaining Warrants, Granted 11,862,000
Number of Shares Remaining Warrants, Warrants expired (600,000)
Number of Shares Remaining Options/Warrants, Outstanding, balance 18,933,267
Number of Shares Remaining Options/Warrants, Exercisable 18,139,250
Weighted Average Exercise Price, Outstanding, beginning balance $ 1.51
Weighted Average Exercise Price, Warrant granted $ 0.25
Weighted Average Exercise Price, Warrants expired $ 0.25
Weighted Average Exercise Price, Outstanding, balance $ 0.78
Weighted Average Exercise Price, Exercisable $ 0.76
Weighted-Average Remaining Contractual Term, Outstanding 5 years 3 months 18 days
Weighted Average Remaining Contractual Term, Exercisable 5 years 7 months 6 days
Aggregate Intrinsic Value, Outstanding $ 0
Aggregate Intrinsic Value, Exercisable $ 0
XML 24 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
Going Concern
3 Months Ended
Mar. 31, 2014
Going Concern [Abstract]  
Going Concern
Note 2 - Going Concern
 
The financial statements have been prepared assuming that the Company will continue as a going concern.  Since its formation, the Company utilized funds generated from private placement offerings and debt to fund its product development and operations and has incurred a cumulative net loss of $27,786,979 as of March 31, 2014.  The recurring losses from operations and current liquidity raise substantial doubt about the Company’s ability to continue as a going concern.  Continuation of the Company is dependent on achieving sufficiently profitable operations and obtaining additional financing.
XML 25 R32.htm IDEA: XBRL DOCUMENT v2.4.0.8
Warrants (Details Textual) (USD $)
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Warrants (Textual)    
Warrants exercise price $ 0.25  
Outstanding warrants repriced 3,060,000  
Warrants [Member]
   
Warrants (Textual)    
Weighted average fair value of warrants $ 0.25 $ 0.73
Warrants vested 11,878,000 646,375
Warrants exercise price   $ 1.20
Outstanding warrants repriced   423,125
Expenses associated with the repricing   $ 62,623
Warrant expired 600,000  
Warrants [Member] | Consultant [Member]
   
Warrants (Textual)    
Warrants exercise price $ 1.20  
Compensation costs $ 4,962 $ 126,420
Term of warrants 10 years  
Warrants vesting period description Vest from six months to three years from grant date.  
XML 26 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
Balance Sheets (Unaudited) (USD $)
Mar. 31, 2014
Dec. 31, 2013
Current assets    
Cash $ 1,273,843 $ 297,385
Accounts Receivable (less allowance for doubtful accounts of $0 at March 31, 2014 and December 31, 2013) 41,465 265,245
Prepaid expenses and other current assets 153,988 232,570
Inventory 496,313 496,313
Deferred debt discount 820,750 820,750
Total current assets 2,786,359 2,112,263
Other assets 161,356 172,362
Intangible assets, net 24,802 25,305
Property and equipment, net 56,975 69,555
Total assets 3,029,492 2,379,485
Current liabilities    
Accounts payable 1,018,776 1,175,221
Borrowings under line of credit, net of debt discount 769,784 684,994
Customer deposits 20,850 19,000
Accrued payroll 98,619 146,465
Deferred revenue 61,217 63,311
Accrued warranty costs 140,074 140,074
Accrued liabilities 451,316 496,011
Accrued loss contract 495,369 519,092
Derivative liabilities, short term 0 13,200
Current portion of long term debt 11,193 11,782
Total current liabilities 3,067,198 3,269,150
Long term liabilities    
Long term debt 14,612 16,169
Derivative liabilities 3,917,772 762,396
Total long term liabilities 3,932,384 778,565
Total liabilities 6,999,582 4,047,715
Stockholders' (deficit)    
Preferred stock, 5,000,000 shares authorized, $0.002 par value; 1,500 and 0 issued and outstanding at March 31, 2014 or December 31, 2013 3 0
Common stock, 500,000,000 shares authorized, $0.002 par value; 19,498,694 and 17,993,694 shares issued and outstanding at March 31, 2014 and December 31, 2013, respectively 38,497 35,987
Additional paid-in capital 23,778,389 25,330,474
Deficit accumulated (27,786,979) (27,034,691)
Total stockholders' (deficit)/ (3,970,090) (1,668,230)
Total liabilities and stockholders' deficit $ 3,029,492 $ 2,379,485
XML 27 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
Statement of Shareholders' (Deficit) (Unaudited) (USD $)
Total
Common Stock
Preferred Stock [Member]
Additional paid-in capital
Accumulated Deficit
Beginning Balance at Dec. 31, 2013 $ (1,668,230) $ 35,987 $ 0 $ 25,330,474 $ (27,034,691)
Beginning Balance, shares at Dec. 31, 2013   17,993,694 0    
Issuance of convertible preferred stock for cash 1,500,000   3 1,499,997  
Issuance of convertible preferred stock for cash, shares     1,500    
Stock offering costs (100,000)     (100,000)  
Issuance of warrants with private placement (2,868,750)     (2,868,750)  
Issuance of common stock and warrants for antidilution clause (151,776) 2,510   (154,286)  
Issuance of common stock and warrants for antidilution clause, shares   1,255,000      
Stock options and stock compensation 70,954     70,954  
Stock options and stock compensation, Shares   250,000      
Net loss for quarter (752,288)       (752,288)
Balance at Mar. 31, 2014 $ (3,970,090) $ 38,497 $ 3 $ 23,778,389 $ (27,798,979)
Balance, shares at Mar. 31, 2014   19,498,694 1,500    
XML 28 R35.htm IDEA: XBRL DOCUMENT v2.4.0.8
Derivative Liabilities (Details 2) (USD $)
3 Months Ended
Mar. 31, 2014
Summary of changes in fair value of Level 3 financial liabilities  
Beginning balance $ 775,596
Issuance of derivative financial instruments in 2014 3,020,526
Net unrealized (gain) loss on derivative financial instruments 121,650
Ending balance $ 3,917,722
XML 29 R22.htm IDEA: XBRL DOCUMENT v2.4.0.8
Going Concern (Details) (USD $)
Mar. 31, 2014
Dec. 31, 2013
Going Concern (Textual)    
Cumulative net loss $ (27,786,979) $ (27,034,691)
XML 30 R36.htm IDEA: XBRL DOCUMENT v2.4.0.8
Derivative Liabilities (Details Textual) (USD $)
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Derivative Liabilities (Textual)    
Unrealized gain/(loss) on change in fair value of derivative liabilities $ (121,650) $ 71,400
Fair value of warrants liabilities $ 3,917,722  
XML 31 R24.htm IDEA: XBRL DOCUMENT v2.4.0.8
Debt (Details Textual) (USD $)
0 Months Ended 3 Months Ended 12 Months Ended
Dec. 21, 2012
Sep. 04, 2012
Mar. 31, 2014
Mar. 31, 2013
Dec. 31, 2012
Dec. 31, 2013
Nov. 13, 2012
Debt (Textual)              
Working capital revolving line of credit $ 750,000 $ 500,000         $ 500,000
Line of credit interest rate   10.00%          
Maximum borrowing, line of credit 1,250,000           750,000
Line of credit maturity date Dec. 21, 2014            
Line of credit, amount payable     1,018,500     1,018,500  
Warrants issued to purchase common stock         1,250,000    
Warrants purchase common stock varying prices minimum (Per share)         $ 1.38    
Warrants purchase common stock varying prices maximum (Per share)         $ 1.62    
Warrants vesting period         1 year    
Adjustments To Additional Paid In Capital Issuance Of Warrants With Revolving Line Of Credit Facility         1,839,250    
Deferred debt discount     820,750     820,750  
Amortization of debt discount     $ 84,790 $ 199,852      
XML 32 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 33 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Description of Business and Summary of Significant Accounting Policies
3 Months Ended
Mar. 31, 2014
Description of Business and Summary of Significant Accounting Policies [Abstract]  
Description of Business and Summary of Significant Accounting Policies
Note 1 – Description of Business and Summary of Significant Accounting Policies
 
Description of Business
 
Arista Power, Inc. (the “Company”) was incorporated on March 30, 2001 in the State of New York as Future Energy Solutions, Inc. and in November 2008 changed its name to WindTamer Corporation. In May 2011, the Company changed its name to Arista Power, Inc. The name change more accurately reflects the broadening of the Company’s focus beyond the WindTamer® brand and entry into areas within the energy storage and power management industries.
 
The Company is a developer, integrator, and supplier of custom-designed power management systems, and a supplier, designer and installer of solar energy systems.  The Company’s patent-pending Power on Demand system utilizes inputs from multiple energy sources including solar, wind, fuel cells, generators, and the grid, in conjunction with a custom-designed battery storage system and a proprietary smart monitoring technology that releases energy at optimal times to reduce electricity costs for large energy users. The Company also designs, sells and installs residential and commercial solar PV systems. 
 
Basis of Preparation
 
The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q.  Accordingly, they do not include all of the information required by GAAP for complete annual financial statement presentation.
 
In the opinion of management, all adjustments (consisting only of normal and recurring adjustments) necessary for a fair presentation of the results of operations have been included in the accompanying unaudited condensed financial statements.  Operating results for the three-month period ended March 31, 2014 are not necessarily indicative of the results to be expected for other interim periods or the full fiscal year.  These financial statements should be read in conjunction with the financial statements and accompanying notes contained in the Arista Power Form 10-K for the fiscal year ended December 31, 2013.
 
Method of Accounting
 
The accompanying financial statements have been prepared in accordance with GAAP.  Arista Power maintains its books and prepares its financial statements on the accrual basis of accounting.
 
Use of Estimates
 
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.
 
Cash and Cash Equivalents
 
For financial statement presentation purposes, the Company considers all short-term, highly liquid investments with original maturities of three months or less to be cash and cash equivalents.  The Company maintains its cash and cash equivalents in bank deposit accounts, which at times may exceed federally insured limits.  The Company believes it is not exposed to any significant credit risk as a result of any non-performance by the financial institutions.
 
Accounts Receivable
 
Accounts receivable represents amounts due from customers in the ordinary course of business, based upon invoiced amounts, net of any allowance for doubtful accounts.  We evaluate accounts receivable quarterly on a specific account basis to determine the need to an allowance for doubtful account reserve.  As of March 31, 2014 and December 31, 2013, the allowance for doubtful accounts was $0.
 
Inventory
 
Inventory consists primarily of parts and subassemblies for Power on Demand systems, solar photovoltaic (“PV”) systems, and is stated at the lower of cost or market value.  The Company capitalizes applicable direct and indirect costs incurred in the Company’s manufacturing operations to bring its products to a sellable state.  The inventory as of March 31, 2014 consisted of raw materials amounting to $346,014 and work-in-process amounting to $150,299.  Inventory is reviewed quarterly to determine the need for an excess and obsolete inventory reserve.  As of March 31, 2014 and December 31, 2013, no reserve was necessary.
 
Fixed Assets
 
Fixed assets are recorded at cost.  Depreciation is on a straight line basis over the shorter of the estimated useful lives or the related lease for leasehold improvements.  Leasehold improvements for space leased on a month-to-month basis are expensed when incurred.  Expenditures for renewals and betterments are capitalized.  Expenditures for minor items, repairs and maintenance are charged to operations as incurred.  Any gain or loss upon sale or retirement due to obsolescence is reflected in the operating results in the period the event takes place.
 
Intangible Assets
 
Intangible assets consist of costs associated with the application and acquisition of the Company’s patents.  Patent application costs are capitalized and amortized over the estimated useful life of the patent, which generally approximates its legal life. For the three months ended March 31, 2013, trademark costs totaling $3,396 relating to the Company’s WindTamer® trademark were impaired, while no intangible assets were impaired for the three months ended March 31, 2014.  
 
Impairment of Long-Lived Assets
 
Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.  Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future net undiscounted cash flows expected to be generated by the asset, including its ultimate disposition.  If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets.  Fair value is determined based on discounted cash flows or appraised values, depending on the nature of the assets.   For the three months ended March 31, 2014 and 2013, no assets were impaired.
 
Fair Value of Financial Instruments
 
The carrying amount of cash, accounts receivable, accounts payable and accrued expenses are reasonable estimates of their fair value due to their short maturity.
  
Revenue Recognition
 
Revenue is recognized when all of the following conditions are satisfied:  (1) there is persuasive evidence of an arrangement; (2) the service or product has been provided to the customer; (3) the sale price to be paid by the customer is fixed or determinable; and (4) the collection of the sale price is reasonably assured.  Amounts collected prior to satisfying our revenue recognition policy are reflected as customer deposits.
 
For research and development contracts, we recognize the revenue using the proportional effort method based upon the relationship of costs incurred to date to the total estimated cost to complete the contract. Cost elements include direct labor, materials, overhead costs and outside contractor costs.  The excess of amounts billed on a milestone basis versus the amounts recorded as revenue on a proportional effort basis is classified as deferred revenue. We provide for any loss that we expect to incur in the agreements when the loss is probable.
 
The Company uses contract accounting for certain Power on Demand system sales. Due to the limited number of these systems that have been installed to date, revenue is recognized based on the completed contract method whereby revenue and costs are deferred until the contract is completed. For contracts that contain provisions related to proceeds being paid based upon cost savings generated by the system, revenue is recorded as the costs savings are realized by and billed to the customer. If accumulated costs exceed accumulated billings at the reporting date the asset is presented net as costs of uncompleted contracts in excess of related billings. If there is a net liability it is presented as billings on uncompleted contracts in excess of related costs. We provide for any loss that we expect to incur on a contract at the time the loss is probable.
 
At March 31, 2014, the Company had costs of uncompleted contracts in excess of related billings totaling $143,481( $0 as of March 31, 2013). This amount was netted with the accrued loss contract on the Company’s balance sheet.
 
Research and Development Costs
 
All costs related to research and development are expensed when incurred. Research and development costs consist of expenses associated with the development of the Company’s Power on Demand system and the Mobile Renewable Power Station.  Specifically, these costs consist of labor, materials, and consulting.
 
Warranty Costs
 
The Company’s standard warranty on each Power on Demand system, wind turbine, and solar system sold protects against defects in design, material, and workmanship under normal use for varying periods, based upon the product sold.  Several warranties have specific additional terms and conditions.  The Company provides for estimated cost of warranties at the time the revenue is recognized.  Factors that affect the warranty reserve are projected cost of repair and/or replacement, component life cycles, manufacturer’s warranty on component parts, and historical data. These estimates are reviewed quarterly and are updated as new information becomes available. The impact of any change in estimates will be taken into account when analyzing future warranty reserve requirements.
 
Stock-Based Compensation
 
The Company accounts for stock option awards granted under the Company’s Equity Incentive Plan in accordance with ASC 718. Under ASC 718, compensation expense related to stock-based payments is recorded over the requisite service period based on the grant date fair value of the awards.  Compensation previously recorded for unvested stock options that are forfeited is reversed upon forfeiture.  The Company uses the Black-Scholes option pricing model for determining the estimated fair value for stock-based awards. The Black-Scholes model requires the use of assumptions which determine the fair value of stock-based awards, including the option’s expected term and the price volatility of the underlying stock.
 
The Company’s accounting policy for equity instruments issued to consultants and vendors in exchange for goods and services follows the provisions of ASC 505-50.  Accordingly, the measurement date for the fair value of the equity instruments issued is determined at the earlier of (i) the date at which a commitment for performance by the consultant or vendor is reached or (ii) the date at which the consultant’s or vendor’s performance is complete. In the case of equity instruments issued to consultants, the fair value of the equity instrument is recognized over the term of the consulting agreement, or over the specified vesting period.
 
Income Taxes
 
The Company accounts for income taxes using the asset and liability approach, which requires recognition of deferred tax liabilities and assets for the expected future tax consequences of temporary differences between the carrying amounts and the tax basis of such assets and liabilities.  This method utilizes enacted statutory tax rates in effect for the year in which the temporary differences are expected to reverse and gives immediate effect to changes in income tax rates upon enactment.  Deferred assets are recognized, net of any valuation allowance, for temporary differences and net operating loss and tax credit carry forwards.  Deferred income tax expense represents the change in net deferred assets and liability balances.
  
Basic and Diluted Loss Per Share
 
Basic earnings per share reflect the actual weighted average of shares issued and outstanding during the period.  Diluted earnings per share are computed including the number of additional shares that would have been outstanding if dilutive potential shares had been issued.  In a loss period, the calculation for basic and diluted earnings per share is considered to be the same, as the impact of potentially issued common shares would be anti-dilutive.
 
As of March 31, 2014, there were 1,500 shares of Preferred Stock, convertible into 7,500,000 shares of common stock, 1,430,608 stock options and 18,933,267 warrants outstanding which, upon exercise, could dilute future earnings per share.
 
Reclassifications
 
Certain prior year amounts have been reclassified to conform to the current year presentation.
XML 34 R3.htm IDEA: XBRL DOCUMENT v2.4.0.8
Balance Sheets (Unaudited) (Parenthetical) (USD $)
Mar. 31, 2014
Dec. 31, 2013
Balance Sheets [Abstract]    
Allowance for doubtful accounts $ 0 $ 0
Preferred stock, shares authorized 5,000,000 5,000,000
Preferred stock, par value $ 0.002 $ 0.002
Preferred stock, shares issued 1,500 0
Preferred stock, shares outstanding 1,500 0
Common stock, shares authorized 500,000,000 500,000,000
Common stock, par value $ 0.002 $ 0.002
Common stock, shares issued 19,498,694 17,993,694
Common stock, shares outstanding 19,498,694 17,993,694
XML 35 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8
Debt (Tables)
3 Months Ended
Mar. 31, 2014
Debt [Abstract]  
Summary of annual maturities of debt
2014 (includes TMK-ENT, Inc. line of credit repayment)
 
$
1,028,136
 
2015
 
$
9,540
 
2016
 
$
6,629
XML 36 R1.htm IDEA: XBRL DOCUMENT v2.4.0.8
Document and Entity Information
3 Months Ended
Mar. 31, 2014
May 05, 2014
Document and Entity Information [Abstract]    
Entity Registrant Name Arista Power, Inc.  
Entity Central Index Key 0001424640  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Document Type 10-Q  
Document Period End Date Mar. 31, 2014  
Document Fiscal Year Focus 2014  
Document Fiscal Period Focus Q1  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   19,938,694
XML 37 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock Based Compensation (Tables)
3 Months Ended
Mar. 31, 2014
Stock Based Compensation [Abstract]  
Summary of Company's restricted share awards
 
Restricted Shares
 
Number of
Restricted Shares
  
Weighted Average
Fair Value at
Grant Date
 
Non-vested at  March 31, 2014
  
118,378
  
$
2.80
 
Awarded during 2014
  
250,000
   
.29
 
Non-vested at March 31, 2014
  
419,368
  
$
1.10
 
 
Stock Options [Member]
 
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Weighted-average assumptions used to fair value calculation for options granted
  
Three Months Ended
  
Three Months Ended
 
  
March  31,
2014
  
March 31,
2013
 
       
Expected dividend yield
  
0
%
  
0
%
Expected stock price volatility
  
112
%
  
108
%
Risk-free interest rate
  
3.63
%
  
2.60-2.68
%
Expected life of options
 
.14-9.78 years
  
.47-9.78 years
 
 
Summary of Company's aggregate stock options granted
  
Number of Shares Remaining Options
  
Weighted Average
Exercise Price
 
Weighted-Average Remaining
Contractual Term
 
Aggregate
Intrinsic Value
 
           
Outstanding at January 1, 2014
  
1,386,108
  
$
.61
     
Options granted during 2014
  
115,000
  
$
.23
     
Options cancelled or expired during 2014
  
(70,500)
   
.75
     
Outstanding at March 31,2014
  
1,430,608
  
$
.52
 
7.8 years
 
$
26,450
 
Exercisable at March 31,2014
  
772,308
  
$
.64
 
6.4 years
 
$
26,450
 
   
XML 38 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
Statements of Operations (Unaudited) (USD $)
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Statements of Operations [Abstract]    
Sales $ 129,870 $ 108,644
Cost of Goods Sold 198,226 197,233
Gross Loss (68,356) (88,589)
Operating Expenses:    
Research and development expenses 22,517 126,538
Selling, general and administrative expenses 425,545 734,130
Total expenses 448,062 860,668
Loss from operations (516,418) (949,257)
Non-operating revenue/(expense)    
Interest expense (112,345) (224,820)
Unrealized gain/(loss) on change in fair value of derivative liabilities (121,650) 71,400
Net loss before income taxes (750,413) (1,102,677)
Income taxes 1,875 500
Net loss $ (752,288) $ (1,103,177)
Net loss per common share - basic and diluted $ (0.04) $ (0.09)
Weighted average number of common shares outstanding - basic and diluted 18,495,360 12,676,895
XML 39 R12.htm IDEA: XBRL DOCUMENT v2.4.0.8
Warrants
3 Months Ended
Mar. 31, 2014
Warrants [Abstract]  
Warrants
Note 6 – Warrants
 
The Company has valued warrants at their date of issue utilizing the Black-Scholes option pricing model.  The risk-free interest rate is based on the implied yield available on U.S. Treasury issues with an equivalent term approximating the expected life of the warrants depending on the date of the issue and their expected life.  The expected life of warrants used was based on the term of the warrant.  The Company determined the expected dividend rate based on the assumption and expectation that earnings generated from operations are not expected to be adequate to allow for the payment of dividends in the near future.  The following weighted-average assumptions were utilized in the fair value calculations for warrants granted:
 
  
Three Months Ended
  
Three Months Ended
 
  
March 31, 2014
  
March 31,2013
 
Expected dividend yield
  
0
%
  
0
%
Expected stock price volatility
  
134
%
  
93-108
%
Risk-free interest rate
  
1.73-1.75
%
  
.14–2.60
%
Expected life of warrants
 
4.1-8.8 years
  
.9-9.8 years
 
 
The following table summarizes the status of the Company’s warrants granted:
 
  
Number of Shares Remaining Warrants
  
Weighted Average
Exercise Price
 
Weighted-Average Remaining
Contractual Term
 
Aggregate
Intrinsic Value
 
Outstanding at January 1, 2014
  
7,671,267
  
$
1.51
     
Warrants granted during 2014
  
11,862,000
  
$
.25
     
Warrants expired during 2014
  
(600,000)
   
.25
     
Outstanding at March 31,2014
  
18,933,267
  
$
.78
 
5.3 years
 
$
0
 
Exercisable at March 31,2014
  
18,139,250
  
$
.76
 
5.6 years
 
$
0
 
 
The weighted average fair value of warrants issued during three months ended March 31, 2014 and 2013 was $.25 and $.73, respectively.  During the three months ended March 31, 2014, 11,878,000 warrants vested (646,375 vested for the three months ended March 31, 2013), and 600,000 warrants expired for the three months ended March 31, 2014. No options expired or were cancelled for the three months ended March 31, 2013.
 
For the three months ended March 31, 2014 and 2013, respectively, the Company recorded compensation costs of $4,962 and $126,420 for warrants issued to a consultant (now an employee) of the Company.  The warrants have a ten year life, a $1.20 exercise price, and vest from six months to three years from grant date.
 
For the three months ended March 31, 2013, the Company recorded expenses totaling $62,623 associated with the repricing of 423,125 outstanding warrants awarded to a consultant (now an employee) of the company. No such expense was recorded for the three months ended March 31, 2014.
 
 
XML 40 R11.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock Based Compensation
3 Months Ended
Mar. 31, 2014
Stock Based Compensation [Abstract]  
Stock-Based Compensation
Note 5 – Stock Based Compensation
 
The Company has established the 2008 Equity Incentive Plan, which is a shareholder-approved plan that permits the granting of stock options and restricted stock to employees, directors and consultants.   The 2008 Equity Incentive Plan provides for the issuance of up to 1,550,000 shares of common stock of which 50,000 shares are available for grant as Incentive Stock Options.  The exercise price for options awarded is no less than 100% of the fair market value of the common stock on the day of grant.  The options generally vest either immediately on the date of grant or 1 to 3 years from the date of grant.  
 
For the three months ended March 31, 2014, the Company recorded compensation costs for options and warrants of $70,954, as compared to $363,369 for the three months ended March 31, 2013. For the three months ended March 31, 2013, compensation costs relating to the issuance of options and warrants amounted to $287,171 and the Company recorded an expense of $76,198 associated with the repricing of options and warrants held by a consultant of the Company, while for the three months ended March 31, 2014, there was no expense associated with the repricing of options or warrants.
  
The Company has valued the options at their date of grant utilizing the Black Scholes option pricing model.  Prior to the fourth quarter of 2009, there was not a public market for the Company shares.  Accordingly, the fair value of the underlying shares was determined based on recent transactions by the Company to sell shares to third parties and other factors determined by management to be relevant to the valuation of such shares.  Beginning in the fourth quarter of 2009, the quoted price for the Company’s shares on the OTCBB was used to value the underlying shares.  Expected volatility is based upon a weighted average historical volatility of peer companies operating in a similar industry.  The risk-free interest rate is based on the implied yield available on U.S. Treasury issues with an equivalent term approximating the expected life of the options depending on the date of the grant and expected life of the options.  The expected life of options used was based on the contractual life of the option granted.  The Company determined the expected dividend rate based on the assumption and expectation that earnings generated from operations are not expected to be adequate to allow for the payment of dividends in the near future.  The following weighted-average assumptions were utilized in the fair value calculations for options granted:
 
   
Three Months Ended
   
Three Months Ended
 
   
March  31,
2014
   
March 31,
2013
 
             
Expected dividend yield
   
0
%
   
0
%
Expected stock price volatility
   
112
%
   
108
%
Risk-free interest rate
   
3.63
%
   
2.60-2.68
%
Expected life of options
 
.14-9.78 years
   
.47-9.78 years
 
 
The following table summarizes the status of the Company’s aggregate stock options granted:
 
   
Number of Shares Remaining Options
   
Weighted Average
Exercise Price
 
Weighted-Average Remaining
Contractual Term
 
Aggregate
Intrinsic Value
 
                     
Outstanding at January 1, 2014
   
1,386,108
   
$
.61
         
Options granted during 2014
   
115,000
   
$
.23
         
Options cancelled or expired during 2014
   
(70,500)
     
.75
         
Outstanding at March 31, 2014
   
1,430,608
   
$
.52
 
7.8 years
 
$
26,450
 
Exercisable at March 31, 2014
   
772,308
   
$
.64
 
6.4 years
 
$
26,450
 
   
For the three months ended March 31, 2014, the Company recorded compensation costs for options granted under the plan of $65,992, as compared to $160,751 for the three months ended March 31, 2013. Stock option grants amounted to 115,000 for the three months ended March 31, 2014 (135,000 for the three months ended March 31, 2013) while 160,000 options vested during that period (141,650 options vested for the three months ended March 31, 2013). There were 70,500 options cancelled or expired for the three months ended March 31, 2014, while no options were cancelled for the three months ended March 31, 2013. No options were exercised for the three months ended March 31, 2014 or March 31, 2013.
 
The weighted average fair value of options granted during the three months ended March 31, 2014 was $.23, compared to $1.13 for the three months ended March 31, 2013. 
 
For the three months ended March 31, 2013, the Company recorded expenses totaling $13,575 associated with the repricing of 25,000 options awarded to a consultant (now an employee) of the Company. No such expense was recorded for the three months ended March 31, 2014.
  
On December 13, 2010, the Board of Directors approved a restricted stock grant award to certain employees in lieu of future salary cash payments.  The employees forfeited salary over a twelve-week period to purchase common shares, which were valued at fair market value as of the date of grant.  The Compensation Committee of the Company’s Board of Directors have approved a change in the vesting date for restricted stock held by certain employees from April 1, 2011 to April 1, 2015. A total of 55,969 shares vested on April 1, 2011, and the remaining 169,368 shares are scheduled to vest on April 1, 2015.
 
On March 31, 2014, Adeeb Saba was named Chief Operating Officer and the Compensation Committee awarded him 250,000 shares of restricted stock, which will vest one half each on the first and second anniversary of the award. Compensation costs associated with this award amount to $72,500 and will be recognized over the vesting period of the stock.
  
The following table summarizes the status of the Company’s restricted share awards:
 
 
Restricted Shares
 
Number of
Restricted Shares
   
Weighted Average
Fair Value at
Grant Date
 
Non-vested at  March 31, 2014
   
118,378
   
$
2.80
 
Awarded during 2014
   
250,000
     
.29
 
Non-vested at March 31, 2014
   
419,368
   
$
1.10
 
 
There was no expense associated with this restricted stock grant for the three months ended March 31, 2014 and 2013. 
XML 41 R23.htm IDEA: XBRL DOCUMENT v2.4.0.8
Debt (Details) (USD $)
Mar. 31, 2014
Summary of annual maturities of debt  
2014 (includes TMK-ENT, Inc. line of credit repayment) $ 1,028,136
2015 9,540
2016 $ 6,629
XML 42 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8
Warrants (Tables) (Warrants [Member])
3 Months Ended
Mar. 31, 2014
Warrants [Member]
 
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Weighted-average assumptions utilized in fair value calculations for warrants granted
  
Three Months Ended
  
Three Months Ended
 
  
March 31, 2014
  
March 31,2013
 
Expected dividend yield
  
0
%
  
0
%
Expected stock price volatility
  
134
%
  
93-108
%
Risk-free interest rate
  
1.73-1.75
%
  
.14–2.60
%
Expected life of warrants
 
4.1-8.8 years
  
.9-9.8 years
 
 
Summary of status of Company's warrant granted
  
Number of Shares Remaining Warrants
  
Weighted Average
Exercise Price
 
Weighted-Average Remaining
Contractual Term
 
Aggregate
Intrinsic Value
 
Outstanding at January 1, 2014
  
7,671,267
  
$
1.51
     
Warrants granted during 2014
  
11,862,000
  
$
.25
     
Warrants expired during 2014
  
(600,000)
   
.25
     
Outstanding at March 31,2014
  
18,933,267
  
$
.78
 
5.3 years
 
$
0
 
Exercisable at March 31,2014
  
18,139,250
  
$
.76
 
5.6 years
 
$
0
 
 
XML 43 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8
Recent Accounting Pronouncements
3 Months Ended
Mar. 31, 2014
Recent Accounting Pronouncements [Abstract]  
Recent Accounting Pronouncements

Note 9- Recent Accounting Pronouncements
 
The Company has considered recent accounting pronouncements and believes that these recent pronouncements will not have a material effect on the Company’s financial statements.
 
XML 44 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
Derivative Liabilities
3 Months Ended
Mar. 31, 2014
Derivative Liabilities [Abstract]  
Derivative Liabilities
Note 7 – Derivative Liabilities
 
Certain warrants issued by the Company do not have fixed settlement provisions because their exercise prices may be lowered if the Company issues securities at lower prices in the future, are classified as derivative liabilities, and are revalued at each reporting date. These warrants include (1) warrants issued to 1999 Mt RB, LLC in conjunction with our lease modification on February 4, 2013, which expired on February 4, 2014 (2) warrants issued in conjunction with the Company’s strategic advisory agreement with Sunrise Financial Group, Inc. on May 21, 2013 and (3) warrants issued in conjunction with the Company’s private placements on July 31, 2013, August 6, 2013 and March 31, 2014. The reset provisions protect the warrant holders from the potential dilution associated with future financings.
 
The Company has valued warrants at their date of issue utilizing the Black-Scholes option pricing model. Expected volatility is based upon a weighted average historical volatility of peer companies operating in a similar industry, or if applicable based upon the term of the warrant, based upon the Company’s historical volatility. The risk-free interest rate is based on the implied yield available on U.S. Treasury issues with an equivalent term approximating the expected life of the warrants depending on the date of the issue and their expected life. The expected life of warrants used was based on the term of the warrant. The Company determined the expected dividend rate based on the assumption and expectation that earnings generated from operations are not expected to be adequate to allow for the payment of dividends in the near future. The following weighted-average assumptions were utilized in the fair value calculations for warrants granted and subsequent revaluation:
 
 
Three Months Ended
 
Three Months Ended
 
 
March 31, 2014
 
March 31, 2013
 
Expected dividend yield
0%
   
0
%
Expected stock price volatility
134%
   
90-93
%
Risk-free interest rate
1.75%
   
.14
%
Expected life of warrants
4.1-5.0 years
 
.8 years
 
Number of warrants
15,562,351
   
600,000
 
Fair value of warrants
$3,917,772
 
$
185,400
 
 
The fair value of these warrant liabilities was $3,917,772 at March 31, 2014. The change in fair value for the three months ended March 31, 2014 was $121,650 and is reported in our statement of operations as an unrealized loss on the change in fair value of the derivative liabilities. For the three months ended March 31, 2013, we recorded an unrealized gain on the change in fair value of the derivative liabilities totaling $71,400. The fair value of the derivative liabilities are re-measured at the end of every reporting period and upon the exercise of the warrant.
 
Fair Value Measurement
 
Valuation Hierarchy
ASC 820, “Fair Value Measurements and Disclosures,” establishes a valuation hierarchy for disclosure of the inputs to valuation used to measure fair value. This hierarchy prioritizes the inputs into three broad levels as follows. Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs are quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly or indirectly through market corroboration, for substantially the full term of the financial instrument. Level 3 inputs are unobservable inputs based on the Company’s own assumptions used to measure assets and liabilities at fair value. A financial asset or liability’s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement.
 
The following table provides the liabilities carried at fair value measured on a recurring basis as of March 31, 2014:
 
         
Fair Value Measurements at March 31,2014
 
   
Total
Carrying
Value at
March 31, 2014,
   
Quoted
prices in
active
markets
(Level 1)
   
Significant
other
observable
inputs
(Level 2)
   
Significant
unobservable
inputs
(Level 3)
 
Derivative liabilities
 
$
3,917,722
   
$
-
   
$
-
   
$
3,917,722
 
 
The derivative liabilities are measured at fair value using quoted market prices and estimated volatility factors, and are classified within Level 3 of the valuation hierarchy.
 
The following table sets forth a summary of the changes in the fair value of our Level 3 financial liabilities that are measured at fair value on a recurring basis:
 
   
Year ended
December 31,
2013
 
Beginning balance January 1, 2014
 
$
775,596
 
Issuance of derivative financial instruments in 2014
   
3,020,526
 
Net unrealized (gain) loss on derivative financial instruments
   
121,650
 
Ending balance as of March 31,2014
 
$
3,917,722
 
 
XML 45 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8
Subsequent Events
3 Months Ended
Mar. 31, 2014
Subsequent Events [Abstract]  
Subsequent Events
Note 8- Subsequent Events
 
In April 2014, we issued 440,000 shares of our common stock to one of our outside attorneys (Schwell Wimpfheimer & Associates, LLP) for legal services rendered in satisfaction of a $110,000 account payable to such law firm.
 
In April 2014, expenses totaling approximately $200,000 that were recorded by the Company as accounts payable as of March 31, 2014 were approved to be paid by the Company’s director and officers insurance policy, with such payments expected in May 2014.
XML 46 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8
Description of Business and Summary of Significant Accounting Policies (Policies)
3 Months Ended
Mar. 31, 2014
Description of Business and Summary of Significant Accounting Policies [Abstract]  
Basis of Preparation
Basis of Preparation
 
The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q.  Accordingly, they do not include all of the information required by GAAP for complete annual financial statement presentation.
 
In the opinion of management, all adjustments (consisting only of normal and recurring adjustments) necessary for a fair presentation of the results of operations have been included in the accompanying unaudited condensed financial statements.  Operating results for the three-month period ended March 31, 2014 are not necessarily indicative of the results to be expected for other interim periods or the full fiscal year.  These financial statements should be read in conjunction with the financial statements and accompanying notes contained in the Arista Power Form 10-K for the fiscal year ended December 31, 2013.
Method of Accounting
Method of Accounting
 
The accompanying financial statements have been prepared in accordance with GAAP.  Arista Power maintains its books and prepares its financial statements on the accrual basis of accounting.
Use of Estimates
Use of Estimates
 
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.
Cash and Cash Equivalents
Cash and Cash Equivalents
 
For financial statement presentation purposes, the Company considers all short-term, highly liquid investments with original maturities of three months or less to be cash and cash equivalents.  The Company maintains its cash and cash equivalents in bank deposit accounts, which at times may exceed federally insured limits.  The Company believes it is not exposed to any significant credit risk as a result of any non-performance by the financial institutions.
Accounts Receivable
Accounts Receivable
 
Accounts receivable represents amounts due from customers in the ordinary course of business, based upon invoiced amounts, net of any allowance for doubtful accounts.  We evaluate accounts receivable quarterly on a specific account basis to determine the need to an allowance for doubtful account reserve.  As of March 31, 2014 and December 31, 2013, the allowance for doubtful accounts was $0.
Inventory
Inventory
 
Inventory consists primarily of parts and subassemblies for Power on Demand systems, solar photovoltaic (“PV”) systems, and is stated at the lower of cost or market value.  The Company capitalizes applicable direct and indirect costs incurred in the Company’s manufacturing operations to bring its products to a sellable state.  The inventory as of March 31, 2014 consisted of raw materials amounting to $346,014 and work-in-process amounting to $150,299.  Inventory is reviewed quarterly to determine the need for an excess and obsolete inventory reserve.  As of March 31, 2014 and December 31, 2013, no reserve was necessary.
Fixed Assets
Fixed Assets
 
Fixed assets are recorded at cost.  Depreciation is on a straight line basis over the shorter of the estimated useful lives or the related lease for leasehold improvements.  Leasehold improvements for space leased on a month-to-month basis are expensed when incurred.  Expenditures for renewals and betterments are capitalized.  Expenditures for minor items, repairs and maintenance are charged to operations as incurred.  Any gain or loss upon sale or retirement due to obsolescence is reflected in the operating results in the period the event takes place.
Intangible Assets
Intangible Assets
 
Intangible assets consist of costs associated with the application and acquisition of the Company’s patents.  Patent application costs are capitalized and amortized over the estimated useful life of the patent, which generally approximates its legal life. For the three months ended March 31, 2013, trademark costs totaling $3,396 relating to the Company’s WindTamer® trademark were impaired, while no intangible assets were impaired for the three months ended March 31, 2014.  
Impairment of Long-Lived Assets
Impairment of Long-Lived Assets
 
Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.  Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future net undiscounted cash flows expected to be generated by the asset, including its ultimate disposition.  If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets.  Fair value is determined based on discounted cash flows or appraised values, depending on the nature of the assets.   For the three months ended March 31, 2014 and 2013, no assets were impaired.
Fair Value of Financial Instruments
Fair Value of Financial Instruments
 
The carrying amount of cash, accounts receivable, accounts payable and accrued expenses are reasonable estimates of their fair value due to their short maturity.
Revenue Recognition
Revenue Recognition
 
Revenue is recognized when all of the following conditions are satisfied:  (1) there is persuasive evidence of an arrangement; (2) the service or product has been provided to the customer; (3) the sale price to be paid by the customer is fixed or determinable; and (4) the collection of the sale price is reasonably assured.  Amounts collected prior to satisfying our revenue recognition policy are reflected as customer deposits.
 
For research and development contracts, we recognize the revenue using the proportional effort method based upon the relationship of costs incurred to date to the total estimated cost to complete the contract. Cost elements include direct labor, materials, overhead costs and outside contractor costs.  The excess of amounts billed on a milestone basis versus the amounts recorded as revenue on a proportional effort basis is classified as deferred revenue. We provide for any loss that we expect to incur in the agreements when the loss is probable.
 
The Company uses contract accounting for certain Power on Demand system sales. Due to the limited number of these systems that have been installed to date, revenue is recognized based on the completed contract method whereby revenue and costs are deferred until the contract is completed. For contracts that contain provisions related to proceeds being paid based upon cost savings generated by the system, revenue is recorded as the costs savings are realized by and billed to the customer. If accumulated costs exceed accumulated billings at the reporting date the asset is presented net as costs of uncompleted contracts in excess of related billings. If there is a net liability it is presented as billings on uncompleted contracts in excess of related costs. We provide for any loss that we expect to incur on a contract at the time the loss is probable.
 
At March 31, 2014, the Company had costs of uncompleted contracts in excess of related billings totaling $143,481( $0 as of March 31, 2013). This amount was netted with the accrued loss contract on the Company’s balance sheet.
Research and Development Costs
Research and Development Costs
 
All costs related to research and development are expensed when incurred. Research and development costs consist of expenses associated with the development of the Company’s Power on Demand system and the Mobile Renewable Power Station.  Specifically, these costs consist of labor, materials, and consulting.
Warranty Costs
Warranty Costs
 
The Company’s standard warranty on each Power on Demand system, wind turbine, and solar system sold protects against defects in design, material, and workmanship under normal use for varying periods, based upon the product sold.  Several warranties have specific additional terms and conditions.  The Company provides for estimated cost of warranties at the time the revenue is recognized.  Factors that affect the warranty reserve are projected cost of repair and/or replacement, component life cycles, manufacturer’s warranty on component parts, and historical data. These estimates are reviewed quarterly and are updated as new information becomes available. The impact of any change in estimates will be taken into account when analyzing future warranty reserve requirements.
Stock-Based Compensation
Stock-Based Compensation
 
The Company accounts for stock option awards granted under the Company’s Equity Incentive Plan in accordance with ASC 718. Under ASC 718, compensation expense related to stock-based payments is recorded over the requisite service period based on the grant date fair value of the awards.  Compensation previously recorded for unvested stock options that are forfeited is reversed upon forfeiture.  The Company uses the Black-Scholes option pricing model for determining the estimated fair value for stock-based awards. The Black-Scholes model requires the use of assumptions which determine the fair value of stock-based awards, including the option’s expected term and the price volatility of the underlying stock.
 
The Company’s accounting policy for equity instruments issued to consultants and vendors in exchange for goods and services follows the provisions of ASC 505-50.  Accordingly, the measurement date for the fair value of the equity instruments issued is determined at the earlier of (i) the date at which a commitment for performance by the consultant or vendor is reached or (ii) the date at which the consultant’s or vendor’s performance is complete. In the case of equity instruments issued to consultants, the fair value of the equity instrument is recognized over the term of the consulting agreement, or over the specified vesting period.
Income Taxes
Income Taxes
 
The Company accounts for income taxes using the asset and liability approach, which requires recognition of deferred tax liabilities and assets for the expected future tax consequences of temporary differences between the carrying amounts and the tax basis of such assets and liabilities.  This method utilizes enacted statutory tax rates in effect for the year in which the temporary differences are expected to reverse and gives immediate effect to changes in income tax rates upon enactment.  Deferred assets are recognized, net of any valuation allowance, for temporary differences and net operating loss and tax credit carry forwards.  Deferred income tax expense represents the change in net deferred assets and liability balances.
Basic and Diluted Loss Per Share
Basic and Diluted Loss Per Share
 
Basic earnings per share reflect the actual weighted average of shares issued and outstanding during the period.  Diluted earnings per share are computed including the number of additional shares that would have been outstanding if dilutive potential shares had been issued.  In a loss period, the calculation for basic and diluted earnings per share is considered to be the same, as the impact of potentially issued common shares would be anti-dilutive.
 
As of March 31, 2014, there were 1,500 shares of Preferred Stock, convertible into 7,500,000 shares of common stock, 1,430,608 stock options and 18,933,267 warrants outstanding which, upon exercise, could dilute future earnings per share.
Reclassifications
Reclassifications
 
Certain prior year amounts have been reclassified to conform to the current year presentation.
XML 47 R34.htm IDEA: XBRL DOCUMENT v2.4.0.8
Derivative Liabilities (Details 1) (USD $)
Mar. 31, 2014
Summary of derivative liabilities fair value measured on a recurring basis  
Fair value of warrants liabilities $ 3,917,722
Quoted prices in active markets (Level 1)
 
Summary of derivative liabilities fair value measured on a recurring basis  
Fair value of warrants liabilities   
Significant other observable inputs (Level 2)
 
Summary of derivative liabilities fair value measured on a recurring basis  
Fair value of warrants liabilities   
Significant unobservable inputs (Level 3)
 
Summary of derivative liabilities fair value measured on a recurring basis  
Fair value of warrants liabilities $ 3,917,722
XML 48 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8
Description of Business and Summary of Significant Accounting Policies (Details) (USD $)
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Dec. 31, 2013
Description of Business and Summary of Significant Accounting Policies (Textual)      
Allowance for doubtful accounts $ 0   $ 0
Inventory, raw materials 346,014    
Inventory, work in process 150,299    
Inventory reserves 0   0
Impairment of trademark cost 0 3,396  
Cost of uncompleted contracts $ 143,481 $ 0  
Preferred Stock [Member]
     
Description of Business and Summary of Significant Accounting Policies (Textual)      
Number of preferred Stock convertible into common stock 1,500    
Number of common stock shares issued upon conversion of Preferred Stock 7,500,000    
Stock options [Member]
     
Description of Business and Summary of Significant Accounting Policies (Textual)      
Securities outstanding which dilutive for future earnings 1,430,608    
Warrants [Member]
     
Description of Business and Summary of Significant Accounting Policies (Textual)      
Securities outstanding which dilutive for future earnings 18,933,267    
XML 49 R26.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock Based Compensation (Details) (Stock options [Member])
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Stock options [Member]
   
Weighted-average assumptions used to fair value calculation for options granted    
Expected dividend yield 0.00% 0.00%
Expected stock price volatility 112.00% 108.00%
Risk-free interest rate 3.63%  
Risk-free interest rate, minimum   2.60%
Risk-free interest rate, maximum   2.68%
Expected life of options, minimum (Years) 1 month 21 days 5 months 19 days
Expected life of options, maximum (Years) 9 years 9 months 11 days 9 years 9 months 11 days
XML 50 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
Statements of Cash Flows (Unaudited) (USD $)
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Operating activities    
Net loss $ (752,288) $ (1,103,177)
Adjustments to reconcile net loss to net cash used in operating activities:    
Amortization and depreciation expense 13,084 18,140
Stock-based compensation 70,954 363,369
Amortization of prepaid warrants for rent, non-cash 11,006 7,337
Amortization of prepaid warrants for consulting, non-cash 95,353  
Stock issued for rent and services 0 100,488
Amortization of debt discount 84,790 199,852
Impairment of intangible assets 0 3,396
Change in derivative liability 121,650 (71,400)
Changes in operating assets and liabilities:    
(Increase) in prepaid expenses and other current assets (16,772) (121,647)
Decrease in trade accounts receivable 223,780 365,891
Decrease in inventory 0 43,188
Increase in customer deposits 1,850 18,484
(Decrease) in deferred revenue (2,094) (43,618)
(Decrease) in accrued loss contract (23,723) 0
(Decrease) in trade accounts payable and accrued liabilities (248,986) (69,494)
Net cash provided by/(used in) operating activities (421,396) (289,191)
Financing activities    
Proceeds from issuance of preferred stock 1,500,000 0
Stock offering costs paid (100,000) 0
Borrowings on line of credit 0 2,700,000
Payments on debt (2,146) (2,863)
Net cash provided by financing activities 1,397,854 67,137
Increase/(decrease) in cash 976,458 (22,054)
Cash - beginning of period 297,385 78,253
Cash - end of period 1,273,843 56,199
Supplemental Information:    
Income Taxes Paid/(Tax credits received) 1,875 500
Interest Paid 236 1,511
Non-cash investing and financing activities:    
Warrant derivative liability incurred with preferred stock offering 3,020,526 0
Preferred stock (2,868,750) 0
Additional warrants (151,776) 0
Stock issued for accrued expenses 0 157,903
Application of deferred debt discount $ 0 $ 270,000
Warrants issued for prepaid rent 0 256,800
XML 51 R10.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stockholders' Equity
3 Months Ended
Mar. 31, 2014
Stockholders' Equity [Abstract]  
Stockholders' Equity
Note 4 – Stockholders’ Equity
 
On March 31, 2014, the Company sold, pursuant to a securities purchase agreement, an aggregate of 1,500 shares of Series A Convertible Preferred Stock, with a stated value of $1,500,000 that are convertible into shares of the Company’s common stock at a conversion price of $0.20 in stated value per share (7,500,000 shares of common stock), and five-year warrants, which vested in full upon issuance, to purchase up to 11,250,000 additional shares of common stock at a purchase price of $0.25 per share to 8 institutional investors. Stock offering costs for the private placement amounted to $100,000. Each share of Preferred Stock is entitled to cash interest payments of 9% of the stated value per year, payable quarterly. The Preferred Stock is voluntarily and mandatorily convertible into shares of common stock pursuant to the provisions of the securities purchase agreement, with any shares of Preferred Stock outstanding on March 31, 2017 automatically converting into common stock. The investors received rights of first refusal and rights of participation in future financings of the Company until March 31, 2015. In addition, the investors received most favored nation protections on the terms and conditions of the warrants and preferred stock so long as such securities remain outstanding. Additionally, until September 30, 2015, each investor has the right to invest an amount equal to the amount invested by such investor in the above-referenced transaction in preferred stock of Arista Power on substantially similar terms. The Preferred Stock and warrants have customary anti-dilution protections and registration rights including a “full ratchet” anti-dilution adjustment provision. The warrants associated with this transaction were valued at their date of issue utilizing the Black-Scholes option pricing model, which amounted to $2,868,750.  The difference between the warrants valuation of $2,878,750 and the net proceeds received by the Company of $1,400,000 results in a deemed dividend of $1,468,750 , which has been charged to additional paid-in-capital, as the Company has no retained earnings from which to declare a dividend.
 
On March 31, 2014, in conjunction with the full ratchet and anti-dilution provisions of the July and August 2013 private placement of common stock, shareholders were awarded an additional 1,255,000 shares of common stock and 612,000 warrants to purchase common stock for $0.25 per share, and the exercise price for the 3,060,000 warrants outstanding that were associated with this transaction were reset to $0.25 per warrant.
XML 52 R27.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock Based Compensation (Details 1) (Stock options [Member], USD $)
3 Months Ended
Mar. 31, 2014
Stock options [Member]
 
Summary of Company's aggregate stock options granted  
Number of Shares Remaining Options/Warrants, Outstanding, beginning balance 1,386,108
Number of Shares Remaining Options, granted 115,000
Number of Shares Remaining Warrants, Warrants expired (70,500)
Number of Shares Remaining Options/Warrants, Outstanding, balance 1,430,608
Number of Shares Remaining Options/Warrants, Exercisable 772,308
Weighted Average Exercise Price, Outstanding, beginning balance $ 0.61
Weighted Average Exercise Price, Options granted $ 0.23
Weighted Average Exercise Price, Cancelled/expired $ 0.75
Weighted Average Exercise Price, Outstanding, balance $ 0.52
Weighted Average Exercise Price, Exercisable $ 0.64
Weighted-Average Remaining Contractual Term, Outstanding 7 years 9 months 18 days
Weighted Average Remaining Contractual Term, Exercisable 6 years 4 months 24 days
Aggregate Intrinsic Value, Outstanding $ 26,450
Aggregate Intrinsic Value, Exercisable $ 26,450
XML 53 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.8 Html 67 228 1 false 21 0 false 4 false false R1.htm 001 - Document - Document and Entity Information Sheet http://www.aristapower.com/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 002 - Statement - Balance Sheets (Unaudited) Sheet http://www.aristapower.com/role/BalanceSheetsUnaudited Balance Sheets (Unaudited) false false R3.htm 003 - Statement - Balance Sheets (Unaudited) (Parenthetical) Sheet http://www.aristapower.com/role/BalanceSheetsUnauditedParenthetical Balance Sheets (Unaudited) (Parenthetical) false false R4.htm 004 - Statement - Statements of Operations (Unaudited) Sheet http://www.aristapower.com/role/StatementsOfOperationsUnaudited Statements of Operations (Unaudited) false false R5.htm 005 - Statement - Statements of Cash Flows (Unaudited) Sheet http://www.aristapower.com/role/StatementsOfCashFlowsUnaudited Statements of Cash Flows (Unaudited) false false R6.htm 006 - Statement - Statement of Shareholders' (Deficit) (Unaudited) Sheet http://www.aristapower.com/role/StatementOfShareholdersDeficitUnaudited Statement of Shareholders' (Deficit) (Unaudited) false false R7.htm 007 - Disclosure - Description of Business and Summary of Significant Accounting Policies Sheet http://www.aristapower.com/role/DescriptionOfBusinessAndSummaryOfSignificantAccountingPolicies Description of Business and Summary of Significant Accounting Policies false false R8.htm 008 - Disclosure - Going Concern Sheet http://www.aristapower.com/role/GoingConcern Going Concern false false R9.htm 009 - Disclosure - Debt Sheet http://www.aristapower.com/role/Debt Debt false false R10.htm 010 - Disclosure - Stockholders' Equity Sheet http://www.aristapower.com/role/StockholdersEquity Stockholders' Equity false false R11.htm 011 - Disclosure - Stock Based Compensation Sheet http://www.aristapower.com/role/StockBasedCompensation Stock Based Compensation false false R12.htm 012 - Disclosure - Warrants Sheet http://www.aristapower.com/role/Warrants Warrants false false R13.htm 013 - Disclosure - Derivative Liabilities Sheet http://www.aristapower.com/role/DerivativeLiabilities Derivative Liabilities false false R14.htm 014 - Disclosure - Subsequent Events Sheet http://www.aristapower.com/role/SubsequentEvents Subsequent Events false false R15.htm 015 - Disclosure - Recent Accounting Pronouncements Sheet http://www.aristapower.com/role/RecentAccountingPronouncements Recent Accounting Pronouncements false false R16.htm 016 - Disclosure - Description of Business and Summary of Significant Accounting Policies (Policies) Sheet http://www.aristapower.com/role/DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies Description of Business and Summary of Significant Accounting Policies (Policies) false false R17.htm 017 - Disclosure - Debt (Tables) Sheet http://www.aristapower.com/role/DebtTables Debt (Tables) false false R18.htm 018 - Disclosure - Stock Based Compensation (Tables) Sheet http://www.aristapower.com/role/StockBasedCompensationTables Stock Based Compensation (Tables) false false R19.htm 019 - Disclosure - Warrants (Tables) Sheet http://www.aristapower.com/role/WarrantsTables Warrants (Tables) false false R20.htm 020 - Disclosure - Derivative Liabilities (Tables) Sheet http://www.aristapower.com/role/DerivativeLiabilitiesTables Derivative Liabilities (Tables) false false R21.htm 021 - Disclosure - Description of Business and Summary of Significant Accounting Policies (Details) Sheet http://www.aristapower.com/role/DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesDetails Description of Business and Summary of Significant Accounting Policies (Details) false false R22.htm 022 - Disclosure - Going Concern (Details) Sheet http://www.aristapower.com/role/GoingConcernDetails Going Concern (Details) false false R23.htm 023 - Disclosure - Debt (Details) Sheet http://www.aristapower.com/role/DebtDetails Debt (Details) false false R24.htm 024 - Disclosure - Debt (Details Textual) Sheet http://www.aristapower.com/role/DebtDetailsTextual Debt (Details Textual) false false R25.htm 025 - Disclosure - Stockholders' Equity (Details) Sheet http://www.aristapower.com/role/StockholdersEquityDetails Stockholders' Equity (Details) false false R26.htm 026 - Disclosure - Stock Based Compensation (Details) Sheet http://www.aristapower.com/role/StockBasedCompensationDetails Stock Based Compensation (Details) false false R27.htm 027 - Disclosure - Stock Based Compensation (Details 1) Sheet http://www.aristapower.com/role/StockBasedCompensationDetails1 Stock Based Compensation (Details 1) false false R28.htm 028 - Disclosure - Stock Based Compensation (Details 2) Sheet http://www.aristapower.com/role/StockBasedCompensationDetails2 Stock Based Compensation (Details 2) false false R29.htm 029 - Disclosure - Stock Based Compensation (Details Textual) Sheet http://www.aristapower.com/role/StockBasedCompensationDetailsTextual Stock Based Compensation (Details Textual) false false R30.htm 030 - Disclosure - Warrants (Details) Sheet http://www.aristapower.com/role/WarrantsDetails1 Warrants (Details) false false R31.htm 031 - Disclosure - Warrants (Details 1) Sheet http://www.aristapower.com/role/WarrantsDetails Warrants (Details 1) false false R32.htm 032 - Disclosure - Warrants (Details Textual) Sheet http://www.aristapower.com/role/WarrantsDetailsTextual Warrants (Details Textual) false false R33.htm 033 - Disclosure - Derivative Liabilities (Details) Sheet http://www.aristapower.com/role/DerivativeLiabilitiesDetails Derivative Liabilities (Details) false false R34.htm 034 - Disclosure - Derivative Liabilities (Details 1) Sheet http://www.aristapower.com/role/DerivativeLiabilitiesDetails1 Derivative Liabilities (Details 1) false false R35.htm 035 - Disclosure - Derivative Liabilities (Details 2) Sheet http://www.aristapower.com/role/DerivativeLiabilitiesDetails2 Derivative Liabilities (Details 2) false false R36.htm 036 - Disclosure - Derivative Liabilities (Details Textual) Sheet http://www.aristapower.com/role/DerivativeLiabilitiesDetailsTextual Derivative Liabilities (Details Textual) false false R37.htm 037 - Disclosure - Subsequent Events (Details) Sheet http://www.aristapower.com/role/SubsequentEventsDetails Subsequent Events (Details) false false All Reports Book All Reports Process Flow-Through: 002 - Statement - Balance Sheets (Unaudited) Process Flow-Through: 003 - Statement - Balance Sheets (Unaudited) (Parenthetical) Process Flow-Through: 004 - Statement - Statements of Operations (Unaudited) Process Flow-Through: 005 - Statement - Statements of Cash Flows (Unaudited) aspw-20140331.xml aspw-20140331.xsd aspw-20140331_cal.xml aspw-20140331_def.xml aspw-20140331_lab.xml aspw-20140331_pre.xml true true XML 54 R20.htm IDEA: XBRL DOCUMENT v2.4.0.8
Derivative Liabilities (Tables)
3 Months Ended
Mar. 31, 2014
Derivative Liabilities [Abstract]  
Summary of weighted-average assumptions of fair value calculations for warrants granted and subsequent revaluation

 
Three Months Ended
 
Three Months Ended
 
 
March 31, 2014
 
March 31, 2013
 
Expected dividend yield
0%
   
0
%
Expected stock price volatility
134%
   
90-93
%
Risk-free interest rate
1.75%
   
.14
%
Expected life of warrants
4.1-5.0 years
 
.8 years
 
Number of warrants
15,562,351
   
600,000
 
Fair value of warrants
$3,917,772
 
$
185,400
 
 
Summary of derivative liabilities fair value measured on a recurring basis
Fair Value Measurements at March 31,2014
 
  
Total
Carrying
Value at
March 31, 2014,
  
Quoted
prices in
active
markets
(Level 1)
  
Significant
other
observable
inputs
(Level 2)
  
Significant
unobservable
inputs
(Level 3)
 
Derivative liabilities
 
$
3,917,722
  
$
-
  
$
-
  
$
3,917,722
 
 
Summary of changes in fair value of Level 3 financial liabilities
Year ended
December 31,
2013
 
Beginning balance January 1, 2014
 
$
775,596
 
Issuance of derivative financial instruments in 2014
  
3,020,526
 
Net unrealized (gain) loss on derivative financial instruments
  
121,650
 
Ending balance as of March 31,2014
 
$
3,917,722